var title_f8_11_8368="Contents: Hypertension";
var content_f8_11_8368=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?5/3/5182\">",
"       Cardiovascular Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Hypertension",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Hypertension",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Definition and types",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/27/41398\">",
"           Malignant hypertension and hypertensive encephalopathy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32330\">",
"           Overview of hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/27/25018\">",
"           Treatment of hypertension in the elderly patient, particularly isolated systolic hypertension",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diagnosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/13/5338\">",
"           Approach to the patient with hypertension and hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43080\">",
"           Blood pressure measurement in the diagnosis and management of hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/26/422\">",
"           Initial evaluation of the hypertensive adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32330\">",
"           Overview of hypertension in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Drug therapy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/32/1543\">",
"           Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/39/44659\">",
"           Antihypertensive drugs and lipids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/57/13206\">",
"           Antihypertensive therapy and progression of chronic kidney disease: Experimental studies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/57/17305\">",
"           Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/2/29737\">",
"           Blood pressure management in patients with atherosclerotic cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/41/18068\">",
"           Can therapy be discontinued in well-controlled hypertension?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/47/20218\">",
"           Choice of therapy in essential hypertension: Clinical trials",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/29/36314\">",
"           Choice of therapy in primary (essential) hypertension: Recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/55/36728\">",
"           Definition, risk factors, and evaluation of resistant hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/14/19685\">",
"           Differences between angiotensin converting enzyme inhibitors and receptor blockers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/4/4169\">",
"           Hypertension: Who should be treated?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/12/32966\">",
"           Major side effects and safety of calcium channel blockers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/2/18473\">",
"           Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/7/13434\">",
"           Management of hypertension in pregnant and postpartum women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32330\">",
"           Overview of hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/17/23828\">",
"           Patient adherence and the treatment of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/17/33046\">",
"           Perioperative management of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/60/19398\">",
"           Renal effects of ACE inhibitors in hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/40/25224\">",
"           Renin-angiotensin system inhibition in the treatment of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/41/4755\">",
"           The prevalence and control of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/46/13027\">",
"           Thiazides versus loop diuretics in treatment of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/62/2021\">",
"           Treatment of hypertension in asthma and COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/14/15592\">",
"           Treatment of hypertension in blacks",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/45/21210\">",
"           Treatment of hypertension in patients with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/22/29031\">",
"           Treatment of hypertension in patients with heart failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/27/25018\">",
"           Treatment of hypertension in the elderly patient, particularly isolated systolic hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/27/35256\">",
"           Treatment of resistant hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/63/15350\">",
"           Use of thiazide diuretics in patients with primary hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/52/14149\">",
"           Vasopeptidase inhibition in the management of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/40/33417\">",
"           What is goal blood pressure in the treatment of hypertension?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/50/1827\">",
"           Withdrawal syndromes with antihypertensive therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         End-organ damage",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/61/36825\">",
"           Actions of angiotensin II on the heart",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/57/13206\">",
"           Antihypertensive therapy and progression of chronic kidney disease: Experimental studies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/57/17305\">",
"           Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/51/37685\">",
"           Cardiovascular risks of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/42/6824\">",
"           Clinical features, diagnosis, and treatment of hypertensive nephrosclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/34/17959\">",
"           Clinical implications and treatment of left ventricular hypertrophy in hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/19/25914\">",
"           Clinical manifestations and diagnosis of aortic dissection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/52/18247\">",
"           Definition and pathogenesis of left ventricular hypertrophy in hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/50/20261\">",
"           Effect of antihypertensive treatment on renal function in essential hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/13/3285\">",
"           Electrocardiographic diagnosis of left ventricular hypertrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/23/1401\">",
"           Left ventricular hypertrophy and arrhythmia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/54/25449\">",
"           Management of aortic dissection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/22/21859\">",
"           Ocular effects of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/28/29130\">",
"           Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/56/32650\">",
"           Spontaneous intracerebral hemorrhage: Prognosis and treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Etiology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/60/9159\">",
"           Genetic factors in the pathogenesis of essential hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/23/16761\">",
"           Hypertension after renal transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/15/8436\">",
"           Hypertension following erythropoietin in chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/55/30582\">",
"           Hypertension in autosomal dominant polycystic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/46/20202\">",
"           Hypertension in dialysis patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/60/36804\">",
"           Low-renin essential (primary) hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/43/42674\">",
"           NSAIDs and acetaminophen: Effects on blood pressure and hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/61/34770\">",
"           Neurovascular abnormalities in the pathogenesis of primary (essential) hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/10/7337\">",
"           Overview of hypertension in acute and chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/61/38874\">",
"           Overview of the risks and benefits of alcohol consumption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/35/39477\">",
"           Possible role of low birth weight in the pathogenesis of essential hypertension",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypertensive emergencies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/26/18853\">",
"           Drug treatment of hypertensive emergencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/27/41398\">",
"           Malignant hypertension and hypertensive encephalopathy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/37/28246\">",
"           Management of severe asymptomatic hypertension (hypertensive urgencies)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/28/29130\">",
"           Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/56/32650\">",
"           Spontaneous intracerebral hemorrhage: Prognosis and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/11/18614\">",
"           Treatment of specific hypertensive emergencies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Monitoring",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/60/7113\">",
"           Ambulatory blood pressure monitoring and white coat hypertension in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nonpharmacologic therapy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/30/38375\">",
"           Cardiovascular effects of caffeine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/43/42679\">",
"           Diet in the treatment and prevention of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/9/8345\">",
"           Dietary therapy for obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33866\">",
"           Drug therapy of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/59/2998\">",
"           Exercise in the treatment and prevention of hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/35/30266\">",
"           Health hazards associated with obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/52/34630\">",
"           Obesity and weight reduction in hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/45/13016\">",
"           Overview of therapy for obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/48/13060\">",
"           Potassium and hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/35/24120\">",
"           Salt intake, salt restriction, and essential hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/20/3395\">",
"           Smoking and hypertension",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/63/3060\">",
"           Essential hypertension in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/60/9159\">",
"           Genetic factors in the pathogenesis of essential hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/58/11174\">",
"           Hypertensive complications in blacks",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/12/26823\">",
"           Increased pulse pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/40/44677\">",
"           Prehypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/11/32954\">",
"           The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/7/13434\">",
"           Management of hypertension in pregnant and postpartum women",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Resistant hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/55/36728\">",
"           Definition, risk factors, and evaluation of resistant hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/27/35256\">",
"           Treatment of resistant hypertension",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Secondary hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/41/33433\">",
"           Chronic kidney disease associated with atherosclerotic renovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/1/37911\">",
"           Clinical features of primary aldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/42/34471\">",
"           Clinical manifestations and diagnosis of fibromuscular dysplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/17/31001\">",
"           Establishing the diagnosis of renovascular hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/23/7544\">",
"           Evaluation of acute decompensated heart failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/49/17174\">",
"           Multiple endocrine neoplasia type 1: Definition and genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/23/36214\">",
"           Paroxysmal hypertension (pseudopheochromocytoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/53/28503\">",
"           Pathophysiology of cardiogenic pulmonary edema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/54/21351\">",
"           Pheochromocytoma in genetic disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/54/8040\">",
"           Treatment of bilateral atherosclerotic renal artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/0/26631\">",
"           Treatment of fibromuscular dysplasia of the renal arteries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/54/32616\">",
"           Treatment of pheochromocytoma in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/16/40199\">",
"           Treatment of primary aldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/43/29369\">",
"           Treatment of unilateral atherosclerotic renal artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/21/27991\">",
"           Who should be evaluated for renovascular or other causes of secondary hypertension?",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-B91FDC8FAA-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f8_11_8368=[""].join("\n");
var outline_f8_11_8368=null;
var title_f8_11_8369="Ketanserin: International drug information";
var content_f8_11_8369=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ketanserin: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4323395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ketensin (NL);",
"     </li>",
"     <li>",
"      Perketan (IT);",
"     </li>",
"     <li>",
"      Serefrex (AR);",
"     </li>",
"     <li>",
"      Serepress (IT);",
"     </li>",
"     <li>",
"      Sufrexal (BE, CZ, IT, LU, MX, NL, PT);",
"     </li>",
"     <li>",
"      Vulketan (AT, CH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1979174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Ketanserin Tartrate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1979176\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Serotonin Antagonist",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1979179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of hypertension",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1979175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 20 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1979178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 20 mg, 40 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10401 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-218.7.204.202-C708E0D7D2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8369=[""].join("\n");
var outline_f8_11_8369=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4323395\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979174\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979176\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979179\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979175\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821246\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979178\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10401\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10401|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_11_8370="Ovarian cancer";
var content_f8_11_8370=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ovarian cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 321px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFBAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAoore8Z+Gbvwnq0Wn381vNLJbQ3QaAsV2yIGA5A5weaAMGivRvDvwsm13Qf7Vt/FXhiGGOFZ7mOa7cPaqxwPNwhCnPHWuG1qxGmatd2S3drerbyNGLi1ffFLg/eRsDIPY0AUqKKKACiiigAooooAKK0/Dmi3niDV4NN05A1xLk/McBVAyWPsACa9R034AeIL9gsesaJGT/faf+kdAHjdFd/8T/hdqvw7jtG1e/026Ny5RFs3diMDOTuQCuAoAKKKKACitbwsmnP4gsBrcdxJpglBuFg+9s/w6ZxzjOOat+PY9Gj8VXy+GY5o9K3AwrLnPQZxn5tuc43c4680Ac9RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRU9l9n+2QfbRKbXzF87ycb9mfm254zjOM0AQUV1/j+Dw9c66H8CW90dNEKbwwYjzO5UN82Omc/xZxxiuR6daAEooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK9P8Aj9DLJ42tGSJ2UaPY8hSR/qFrzCu6Pxa8c/2cbD/hIbj7IYfs5iEcePL27dv3fTigDR+GX/JO/ib/ANg23/8ASha80rR07WtQ02w1GysblobXUY1iuowARKqtuAORkcjPFZ1ABRRRQAUUUUAFFFFAHo37P1xFB8UdNE7KqTxT2+WIAy8TKOT7mvQ/iP8ACXxHHqet6r/wlOnw2zO862v2mdn2gdDhCM8Y68V88Ru0bq8bMjqchlOCD7Vs3zeIdOmhhvJNTt5ZoVmjR3dS8bjIYDPII70AepfH+6Sfw74SjiJKx2kB59TboT+ua8SrrrXw5repC3GqXM0dqQCvnSFyoHGAueDj1xxXXeHPBun21o1xcxmUqdpklAIx/u9B+OaAPOdH0DUdWLGztyUXG52IUAZx1PX8K67R/AtuLpY9Sn81yPuI20E/zI/Ku+tYxaahAxhPl+UUK/3l7YrsPCvhCLxS18I5Yre/tE+0QRInM+Og/ofrQB5hqWh2VjCbZrcqoUcxcHP+e5ridf0vz7Vp4d26AcBs5kXPOPp1/OvUtflMmoZZPLmVT567fun6+vFcjq8DmcyhA8eQyliPyx70AeXUVra9Yi3uGmt49ts54UfwH0NZNABRRRQAUUUUAFFFFABRRRQAUUUUAFTWsD3M6Qx43N0ycCohyeK7fwrpEVrA1zfRkyun3W42DP8AOgC1Y6cLC0CyxuzYG0qOCO5OK9I0X4b6NrOlwrc2cjXMoDmUMVZFI6g98Y4znmsLQdKfXNVt0gR1s0kxKzHoO4r3bSf9F08G28qKKJSjO3QgdhQB83ePPhNcaHdTtpF4l1bKAyxzfLIMt0z0OBjnjODwK8xnhlgkMc8bxuOqsMEV9O+MtRieYyBiAVIZXHJP+R+VeaLZRX9yYrkJJG33g6/dGeSPTPTPXmgDymivQtT8EQXN2F0iYxFxuCynK89sjkcZ9a5FtB1MajFYJZyy3csghjjiG8u56KuOpoAy6KkuIZba4lguI2jmiYo6MMFWBwQR6g1HQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFT29rLOSI16dSaAIKkjikkz5aMwHXAretNIhhEU0585Dnco4ArVSGKMmEIqxModVA49KAM7S/DayNA17NxIw/dx9SM8jPr+dekQWkdosUlshcrH5BkkYySBcYGGbJAHTA49qwtNtQsixuwAVwYyexroIJPMultoiFdn3gHkZHUf1oAu3WmqkUcrFl8t1DKOjD2960n04ZezE4EN0vyE9M9dpFaWnIypLHKqujr0bkAjp+FQafYx3KXCvlnTmMN1Bz0BoAppPLbqizwqxtpNmV5wOnWp/DOt3OheNobm2cqkcm4HPEiHqppLq7dTILSFzucCRSvBHqfpUN9JGLKJ98a+XncFGCc9aAOx+L/h+L+0LfXtLKDS9UTzuFyolxyDjpn1rz97S2/sr7S6LGB8oVTuKmvWvhzIms+Hr/wleXCvHPGZrGRjyj91/Pn6E15pNZXNp52mzQbLqF2VoyOhXqfpxQB57qlqznynSOQHO5SOe9cPrekSafN8uXhIyDjlfY17Df263Iae7fZOvy7VGdw9RXPalp1wrqpQfMmAzHG4dwaAPKqK6S/8P+ZcutjhSDjY7cE+x/PrXPzwyQOUmRkYdiKAI6KKKACiiigAooooAKciszBVBLE4AHerNrYXNzkxxNtHViOBXWaRpEOnpDcSKJJjkjd2FAC+EvDRJS8u9odW+WNuqe5967Ww0uS9uZtso+zg7QM81W0XS9T1HUIobOFivXK5Jwf617R4b8LxaLA6EbrrYAzsuQCfT1NACeErCy03S4rGKNftAP70n88n2q34nW2ttL2zStCzsGQK+RnPHvzUt5fLaQyOs8aBiIW+UAsPb071w+sayl5JIZn6NtXjOB6k+vpQBw/iW5nlmSG43EITsKDhjnrWZbxpGV3B1kkIZ/UDPANd34bs9IEFzc3+6a4YkQx5+7/hWVqVpFDapMuXuppMBRzx2JoAxXvnto4XjCIu4rg/eK/Wuc1S8YfPbu8UqsWWRHIKkdweuc966DUtHubWCSSYcSDIZ+MDIz+Ga5K5VXQlXPlk5JbuBQBj3lks5MjM3nucsc5JJ6knuay5LSRWwvz8Z+Xt9a6FEBgLbjljhj6CqcaL57qy7Wbuew9TQBh0lbYt4J3ndlOD8qepPrUDaRIwfyHDFBlgeKAMuinvG6ffUr9RTKACiiigAooooAKKKKACiiigAooooAKKKKACilpcetACVp3baY2kWENvbXEWqRtJ9rmeQGOQEjYFXHy4Gc+tVJvLIR4RtHQjPIIqUlblcnAlYY+rD/EUAbtpptssMLRplmUNufkgjqKgmR7XzGAOUJDLjqD3FXdLm+1aaFRh56DeB6kcGqwmN1KVkynGM+9AF60CtAJ8nyZeWHpmpowjIEJJZflRh6Vn6RN5ETW0ynbG/NaEkq2l0SoHlN8ysP5fzoA2YbfMbLOdxQFlI6nFbek3NpEisSu4/vI2P3kJ/mM8Vz0F9nIJGGTzEPoe4qxYIUh86P5ljbcVA/hPpQB2sGrz874jE+Mgdsng4NWhe/Z9Kcyo5Z34PdTXM3pM0LssmVABwDwf8DUwuvMgVomdZQnzRscq+O496ANSXUS9w8uY4xOoU7v7w/xp940qJFuhDIynBUZ471mT38dxEWaNIxIm3lcgN61PobzzsInlUiNTsf1HuKANfRL9rSa1uNNke3uoJMo0h4GOx9jXcfFa2j1fRdO8Y6UConAjuVX+GQAjn9R+A9a851C1a5hWYFdq/LtU9T3rsPhH4hhur++8I6zufSdUj2Rk/wDLOTHGPrjj3A9aAOLsWkmlLn5iQMJ0HP8ACT6VDdpHJKTcwKWK42A9CM0eKrS/8LeI7rTr8SeXA5TcBtDr1BH1HNKl6ssu+4Z1O3ahC8j60AYN3bskMiPAkeMkDqcdzn8qxptKF8QzxIUVfl3fxetdhqTRz7HeB3VDhnB+bOO9V7GOFZ5UG4qyZ+ZeM46UAeaXGhQNO6KZImB6AZH/ANbFZd1o89vnJVsHHGa9VisHvLcNtSF4s/N/f44rLk0+Zbgq0MTxBctuOSKAPPk0W7dN6iMr6hqT+x7obdwQBuhLV3+oWvlQqbdgyk8Ig+Y8dMVTmt5ERGlGY2HAI5HFAHKxaExK+ZNhW4UqvWtiPRLSFEEGyWYD5i5PX2rodHs4J4kjuQwi4wD0z60oSP7RJDaKPLVs8qSfwoAigtmu4cRKy3CgDb0XFdFpPhbU7ydMWylXIVQx5P8A9atbQtDk1ERy/Y2s4YPm3Mu7zD7jvmvTNPsLPSLQyO3kTbBIAz5NAEPh3SF0K1CyARuSSZN2M1LrniGFIJDbow2D53z3xwQfzrj/ABj4na6vAbP5VRwX3k/KB7e9cprOozajKyRmQBRufD5+X0x70Aa11rf2m8WUfNgEbSfvH/GsDUXMjLJkCIvvdUXpmnWonCRr8oWNSeF6k9zU32YHiRwisu4ofX1+tAFmyjvpYEEEccVsR94n25JP50yKPdI1w04xFj5epLfTtUsuqmJI4hEenygfdx61RuyrxbYG8kN852jG9jQAzVdTl1UGK52iJeMY5Cgda5HUIlHyqixqTwD1x610qRtFI0kzJvYbUU8L7k+uKzNVtJJ4RKR8zttUkYH4UAc0xjSEgHG5iemeKrTwPLC3l8l2wT3xWxf6c1qBu+ZHPLL0FURJHGjKSx7IBQAxLRF2xL80gUAexpQBGvl7vlY847gU1JG+RlIJPB9TU8wWGddmGcjaD/doAn0tIby4+zzQq8QJLKw4ruLP4b+H9SM93GlykJgaNEjfC+e33XB67Qf4e+OtcQHjt0VIDk/xkfyr2Xw/cj+wrFQdpC79o9ccfzoA8A8R+Dta0C4aO9s2dBnEsP7xCAATyPQEZrna+urS3mnkaJ22RGMeaexBPIP1549MVyfjTwN4c1ya7vre2Nm7HaJbb5QzbuW29CTzQB840V3/AIt+Feu+H4HuU8m9tAVAeE/OcruPyHnjGPy9a4J1ZGKupVlOCCMEGgBtFFFABRRTkRnbailmPYDNADav6bpF/qVtf3FhavPDYw+fcuuMRR5A3H2yRVNkKMVcYIqQsY9whdwjrhhnGfY0AQgUuKWigCVYSZvLPDHpTVAWTDjgdRSF2JU55XoadMd58zj5uvsaAGHGTjpSA470UUAWLSZ4pfNjk2uvI9/arkd5/pX2ocx5xInt61l0oznAOM8UAdCJYmuZiGOyVdyt6YpIrlzGSrb+OhHBP/16zLUlTsYM0atzjqM0lw5t0aKGQNEx3KR1FAGpa6gph2MhVuoz0HsK6TTr1iFW3chDjI9K4+zP2qDbN0BwSOo9DW1pyvGxcE71G3HqKAOks71jLjPlyfdYHo+K25biGWNSqBJIjllH8Q9RXHrclAZgu1kOfrUn2syTpPExX+6D2oA6uC9t49NfyyrsGOMcsh+ncU2O6jktJWeQHoV2jFYu6KOaK4wU39Svc1eNqhtnkCsAvOD0I9KAL1qkzSmM3OxT8ylm6GpHE1lEpk/d3du4cPESGIzkMCPfmodNMX9nSXNmUaVc5Rz2HtWbPqE0/wDpHmKhP3kH8hQB7L8RYF8b/DzTvF1uA9/p6iHUoY+4/vYHoSD9G9q8z0q4iurNniBIxg98Y6cGuq+DXjuCz1oafqMcf9lagv2W6zwOeFY+3OD7H2ql8QtJk8HeIbrTEhYRhxJbS4+WSI9M+/UfUUAV9OmifTJ0mIwnzEZw2f8ACq1k0KTySKyKjAfKD2z2FURJLqEUuHiRwv3TwT7VkkS2SqLtd7buDuyMeh9KAN6ZpDaypalNr8EMCTjPWoYzdvH5AhjWUfL5jdJB171W0y+cXCNZ2zeZgoy5J3Z9BU+p2+pPErkOSW2lUyAPrQBl3gLSBCirIOAQvKH6iobaSSaWRJZIZecDP8JHcir0KX0/+jbI2TOGZscD2NXNO8KSSXO+SZEXOCvQBf60AZMMF3PM8MREgDYIQED3Nd14ZsUttNM13YCO27KxxvPueppbdLHRneK3WJ32ZJA7+hPXNU9W8QX0pwyRxrjPljkfWgDsLXWDDaI4RRsTko+Pl9MGuP1XxH514vzs6/326j29DXN6lqNxICQEcycBFJxj+tZ7CFpRHdvKDjPofwFAGveTyXN35kAUoy5YOcs59xU2lB4fMSCzDSPk+Zu4U+9ZUE8i3G21Uoo4Bbr+PrV2Pz1Eh+05jHIwAC7d+nagDUQyb1MWwHnecZ2n2qreWpAMSDzJ2ORtb5l/+vUK6u+GEKAblO5mGCeetVmvZEcvABEMDcz8HA7e1ABLO1q8aFGKRx4LEdW6VYtpnZZJLmEGREAUBuvoBUSG4vXWa7eNUyNqrz8var93Cro5m2jYPlVT+Wf50AY0FpJNM73DbpBkhU6KP8Kliu4Z7iOGdjIVGMEYH0FWGRiBAhMUbFd2BksPU/jzUNxbiO4YxRl4zxnGTQA/xfHFPpsSWuEAUA8fia4F7OeFDPdK23krnjNep+E4bbUNdMWpSYt4uSgGccdK574jSW89462cRW3iJCj0HbNAHBReYVDOw+Y8fStG12hpXI38YT3NUYIZBGN4Lu3PsKuwkxhgUGD6dqALltCqQ7ThpCdzHtXr3wytRe6YXuwwUPkA9wOgryvSozPIHYhVxkCvdvhppzQ6WiTHMr/Pj09BQBparaJ9mIkl8qNm3yberHoB+VYt68dzLFbWyeXBEAx46Ac1r6qgS5mjimMkqD5nPIQnqfyrKWNrGzeQxlppMsc9h2z9Bn86AHa/dR3rwurYihRtnu3r+H9K4G68PWOuyiC7tFYFgkbAbX7EnI9Tj9a6q7dpY5giDEQC4+gzj86seH4IrGK61G7bc9umxPdz1/U0AfKNSRwySAlFJA5JpMAE45Fa2huG3xkcj5h9O9AFaxsllnkjkJLJg4B4Iq6vlxESwrsMLAkAdVPBquXOn6qp+8gx+Kmr+oRCFncfNG3P1U9aAKWq2oy0kY4HPHcVl1q29yfKCSclRlD/AHh0IqpfW3klZE5ikGVP9KAIEjZ0dl5CjJplWLC4+z3AZhlDww9RT722CSbofmic/Ljt7UAVe1JS5IDDtSUAORS2QB0GT9KdDE0rFU+8BkD1q35sAt42Xh16D19QapnMbh0yBnKmgBpp20OCw4I6inwzFJS5AJPJB6VETliVGPagBwYq25Cc/rQMPJlgcE84q1Y25Yhz8uCGBPQ+tLe25tpyyY2kblI7e1AE9svlIFDAs3TIxz2qxFqDW8+ydNg/hNVUkE0AMhIK9f8AEGmm6SQpHPiQLxuIxxQBvPdI8aZfBfj1/wD11pWYhilRZQDHjOU5U+9YtpCkkShSSo6Edv8AGtOzjlSdVkR37gAYzQB1Flptv9ph8jLwOc4Y8fSty/e2sLc2zRbkfooHK+4/wrkY5ZFjkhkVgh+ZSwIKn6jpTo7+UwiZ5TJtG1w/OB60ATxXkUW9PLwSxzgZGPrTnWN4yY1DRA5XHBz71Vii+1OwgkjKtyoB5zUqRXOAgjMZPVkPB/woAls7USTMbXekmPnUdq9lmmPxD+FbSJifxH4e+SZSPmmh9frgZ+qt615TbWl79mQwiNZAMby3BHvjoa7j4YX9x4a8QQapNKwhk/cXUW3IdD3GO4OD+FAHn0Yc3Mctugfqdh4JPpUk11NfsqPa4ZeBvB6+hPrXsHjfwRpmiajNPZwkWlz/AKRAythVBOSox6fyxXH+RYveB4pMyED5cEDPqcjBoA5vTbW5e43RxuuPvhB19/aultdIljSSS7lcRv8AMxL7sfUU7V9RvLRhDCkEo+6Fjlwc++AK53V0e1hNxJM4ZiN0an7v0PWgDo57/TdPh8hDIZj9w4FU9Q1SeeMMsiIpQA+VESB9COM1w0jypcwxySukTPnfwW/KurgtIZCPJvnaErj96WAz7DvQBzuoTNLcMUnnCAdSApPr9akW4QWxU3CeWRyG5P51cuNHgWVoiw3sCyyNnav0AqimmmSLna205HO0H3JzQAlpErQOtqjPc4yXyflHtgVWXda3yyTItzPjAAy2Pqa17iS6RQY2jRFTa7Qf1NZsU0KZkzuA7h/mb/CgC1FN5atI8apJjoSOnpz0qlPqtugP7xkUd+u0VTM8TMCoG8kkjOQPr71QvIYnRmeQs7HhFXOKALlrf2vnEt5nPO7+XFXkv7a4D+eoG1uAeWb0rlYrK6kd5FXbGn8RPOPoKuQTvE0aTRdDnpjj1oA7C2ji8oLuLPId3B4z2/IVp6XC29xIqN2ADdB3JrIsbjznjjhhVVVTkjt+NaNq6WdyQyhvO+bG7IHpnH8qANPUJlS13xJGwHBx0x6VWzEdsf3EcYY5xuPoBVSSzaSOWa4uD5LvuAQc/l/Km2NzHbTbRDJNN1/vFR2BPrQAkitBI0cKtbxsxO/oXwKyNTthLDJvYCJWz8w5c10qxLeThGcvO/BJPCew+nc1Bfm0iYwqDNCg2+Zjhm74/wAaAPPLeObzdy4y3yqD6Us9kVilMZ+Y8fX1rqb+yhhsi9vGftjn0wI1rGeBYo9rsXlPUA/pQBa8PxGLyWb5nyAigZ3N0Fe+6YP7M05FUMbt1AfH8Ax0+teTeBbUtfI6IHliG5W/hB7AV6Wb0IsaOxIiBZjj77dyT6UAI1wkN1MkgVEjHmzEHqey5qhfap58SjOPNO78OwqhrFw5tF3AKZG3yNn8gPWljjScws+AM/MT6AdP8aALqeTa6NNNKfmmY7c/3B1P4/1rM0y4km05zIhwZCVB/n/n1p2pym7JKK3kqRFCD/EfXFP1ZW0/RlOP3jjaiDrjuf8APtQB8wuuxyvp3qxp7MlwhHGf5VAGBZN/3RgH6Vo2aKpcMBmM9e+PWgCzdW32mJmx8wGAfcVJC6y2X2d2ywXKZ9O4qW2lAnkhbgsMj3rNvU8uUyRnDZ/I/wCc0AVXSSJJIZFztO8H0rbto473SzEByBuX2PcVTjnjuokZsedGNrD1U9ar2c72V2UU7kz+dAFCRSrsvYHFTLMFtgo4cH8x2P1FTajGBM8kZykg3CoXgBtVmjOezj0oAJnR1LqAC33l9D61AAScKMk9qTpUxVoHSReVPKmgCE9aXcdu3PA5xTmbfISxxk/lUjQeXP5cx256N29j9KAIKCMEg9amuIlQgxtuQ/mD71OIDcBUChZgvHowoArpPIibFYhfSlSdgNrksnQiiS3ePG4YOdpz2NSwxGOQxzL94Y/+vQBWLdgx29s1LGFZAWYfL274/rWmmk7whxlehIP5VZi0UpIGljIQ9cjOPf3FAE2iyJDIomQMrnIC9PrXZwQoYo3Klo05Gz7y/wCIrm7DS1WKSRcZjOSo9PUV0dhLb+SAzkgDr6fUelAGZd3oiupIoZS+48Nz+RqnbSBJyAgJyCNxxn2960LmOye5R4YnbJwwByAa24Yba9jFvJCqMRlGYZ59D3oAit7UxRGeDyzA4+ZFIyPwNI10km6OBhtPcAYB96oXGlXFu5jKuiAk5DZ/TvWtp1pIkSSlG+U4cADDD1weRQBMl8rW4in82J1IxJGNwz+FWra9vI7gskpHYfKSuPXFQ3AVVY2sQhLckuB/jUdhHeJJtZ12dcmQ/nigD2fwhqLeNPA97oMrxNrWnL51p0JkQdsH67fxWvIopbzzJ41CpcliACSCvtg/yrd8Jand6Hr8Gqww+bLbnHynAZT94H6j6103xU8N20WqQ+I9JUvY6wBIoX+GU9Rj1PXHruoA4S01GK1kZbkE3Wdu8g8n+VZfiu9nvn2uMMMYbaBx+GP5VseLvDjab4iutNneSOW0YBnVhzlQwIH41zoMjXh+0SK8eMEuu3+VAGVbWcrXiRTMZc8gM39T0roRpl/HbloNqRfxASkgfj3qjcmCHUIZIkbYOdyNlR+Hetp9VuLkhVm2LHjDFev0GOaAKEVtdWsoFzL58nZCeMf1qvcu17OSrJAIzyHzj64rTu5i7gyKsjHhk29PfPQVWuS9tE0VmqpNIe5DUATLGf7NeFpN0ZHDKhOSf5Vx89rLZO5KlUxj5hgmuyj1K+sUQ3IDgnBCcD+WTWP4j1RtQEkYt1UZA3uQMUAZWjWoFybi92JGBlY8ct+tWb2WGQu9vBgdGO7r+VR2UTiQc+dxwMZFaFvHKqOViVJ34y/yhR7DvQBV02KYxgNGY0DZVQMlvwrQ1fTJry3WWziICjJJGC3v7CrunzvaoyJErTNw0v8AdFak2or9lWJUeL5cBnIUH1J70Ac54cXZL5bpukxk4H6D/GuntbCeWVi3MYXOPU+lYuizWlvq8jStGCQFUkHk+gHeunWGVFkneSQIx78Z9gKAMq58oo0d0ZSq9dgxuP8AdHtVe3UTW0jpCVAOEUd/8+tXriWO5lWGZxjGdqnr+XNSZttPslZY90jNwAeSfXFAFiwgjis2kvXhE33Y4F6D3as29do182Eq39wBep7n6VQWVL6/Ilj8mKP77M3zN7Cte7EdxamJCAdu1VA4UUAZETrPBLNPJubrhe57AVyyov8AaDxjOc898V2lpHJDAYLaD98fvzuOn+6Kw7LQmbVwru0KM2MH7xHc4oA9J+H9paWWnC4uBt3KSo6sR7D1PrUmtTvc3Ih8oqmMbF6/j71o6TZxQwLDbqXkyAzN/Djoo96zvECjS45bf5nvbgnJDcqPQenvQBk6p5UdzHG8od15fByqnso9cVq2UQ1Ax2kShI0HzMen41y1jGzXYiJXzeAAOdgrudQjbRfD6QQR7ZpzmSRvvY9AKAIHtIhqQSFt8dqnLnoCep+p7VnalMZD9plw5LbUHYD2pj3DHTjZxExyNlpWHX3NVLMpdILi4Yi0h+6nr/np+NAHzUMHHrWhZS4iVzy0Z2sPVDVBFZvu9RVuxjEolGcOBnHqO9AFi6lMLROBuCHhvb0qvfzCWTMZyGWrVtbFx5bklT0zUVzYNFE2Blozn6rQBnhmVwy5B61YdGlkjcDG8cHtmrDQiS2S4gGSvLJUcS+YrJCxGfnUH19KAEu45BGGwdueR/dNMsGYMwxuQj5l9a2rIrf2Ui7P3yDDL6isGdDBKQpNAFqTTzGwZsmE9/T0pbdkWVoW+aJs/KeqmpbDUgsQhuBuUcZ9RUN7aSW0yzQ5aNjlWH8qAKUqbG45XsfWrds3m25WUZVV+Vu4qVRHMrcYjfkgj/Vt6/Sq8ySWrlcHaw5Hb8KAEUxtLG0a8/xL2NPLiGYywsCFYYU+lLaWxcq6/dIwTjgH3prQTC6xIoLHn60AWUma4MzRqSp529xXQaRFBqUCwzqFnA+RiO/oaoWunqImePv09fpWxp9k6SQTxqxVSMleq/WgDSstJaJdjxERtyGA3D6V0kOlm90mSJfKlkiG5ezY9Qe9alu0R09bm1YBlOJUI4+uO1Wo44fJZ/uSqc8cEZ/mKAOQ8N2VoZJYr3fFcKe/+eRWbrlnCt24sGKqv31X7o+np9K1PEV1A1uyxnMynAkTr9CKy9IlEkbl5CZfunPP4EUARadApOJDJHJnhgP5108JljgVsB5EGSAOCPUGmW9pBJbtKFRJY+oxkfiDTrDa0hIQID03dj/UUAWHEb2aTziZZ16fNxUlle+Wwgn8p4yON3zEf5/Go7hWNlIXljIU42knI/GstJTCPLaWOZW5G9M7fxFAGzcTSCTMPlqi/eUDqPUDFR21yq3RWQeah5xxx9Ky4LqVCEkdHxnjBAI+tamjpa3CbYkEEoHyg/xfQ96AOj02Xw/5+dVtrkRH5ZDbyFWUf3lB449K948H+GrGLw9FbLqH9r6S0yXlm0iANGQQ2MjqMj0HUivnBvs9xMLeWJjIhzwAortPh94+bwnqi2F8P+JNO3zLnLQsf4l9R6j/ACQC1+0Jpf2fxZp2ooqeXeW5Rww4Z0Pf8GH5V5bFvunlENnGqKPnwcj8q+h/jvYJrHw9W/svLn+yyJOjgghkb5SQfTDZ/CvAtNihksHDSMJF4JVcAe2aAKEMqGfbLZrDAnooFaZNnJCPsUbK54DSvlR9Bn+VYrWRkuNjq2Om4HKn8q047eaKIqB5SqO7nn/gJoAq3cKWF0Fe5e5DnLLECPzNMW6juLzaIptq8c84+lWrSQSRzCQW7ygEAkgEVk2N89s0sBt42+blozk/mKAOmht4U2GbykDAgMzb3/AVzmvWKy3CozRog5+XAY+9XYBCbkzz+dCzDCgg/wBelSWsNuzSGXypguT98k59zQBlacrWxWKPzN7H5Rnr+dOvLcw3bz3rO9yeiqdxA/pXSRW8UNusxA8xj1Y4A+lU9ZgthA8iSM07DG1D0+poAzdGumkYmKI9cJEMFmPqa2THa2gY6lG7TnnL9WPp7CuctppbOQmLETDsnUj3NaNjD/aMn77cZWP3pGO1R/WgCO2ggj1SK9ZmEjt8qAAkCumuZp5GjYW7eQTtUPj5voKqWEVha3rrIFkaIcdg3ua6OMxmza7uATIwPlqeMD0Uf1oAx/IWOTzJijKBkheFz9eprDvJJpXaVU8mL+EqAOPYdya2HtZ7mRZRCOR8q7sAfhTYbVoLlhPHlug3Hv8A0oA5qMPBG8nlv5kh+QN2981pRSNaRoY3DP3PUA/X19qZq0Mly7FANoPLZ4IHpWXZRzXFwsc28RjkA8BV9aAPY/A9nZQaW1/fOjORkFu1Zllb2t1rN5e+X5MYbbHkc5/xq14e0r7VbQ5m2RLgsRzwKmuYbVL1Xjl2WsRyFHVzQBNeXcGgWiyhgZ9pMadTk/xGuevLO5W3XU76JwzKSoY/MR6mnJdpNrUt9dpvhhwVTruPYewqh4n8Rz6kmW+WNug7t9PQUAP8OSw2Mq38scbybs4PTPYD1q54hu72+uRJKV3tgqnoK4a11M2NyTcEtKB8i44X6Vp2F5NdpLcSu4VuXcdT2Cr/AI0AWrgzqGSLBH/LVx3PYCqd5M8hWzgOAflGO3r+ArQlR40jRSqk/Njsg9fepzYR2kAnYBpX4jQ9TnufagD5qViDxwRzWlAfJniuYsbJDhh2B9KzVHBOelaNopWIg/NFJ1H9aAOga0VYEliP7mTlG7o3oapiQtOokXj7rCrej3Qhia1u8tazD739xuxqjdF4LpoW5P8ACw6GgClcwSWc7CE8Z3Dj7y//AFqiSQSM6hMbu3QqatTT+bGGH8Jw691qEwoclh8/r/e+vvQAun3LR3Yb7lyvfoH9q1NT05NQhjvLUAFv9YoHesqZBPBhjtuYhlXH8YqfStUmtzwCy5yVoAzbi1a2kUuG8vPX0rbgdI7XY+DC36GuqS0sdZ0pmhCmTbuC9yP8RXJPaFTLZyfeAyhP8S0AMtQgmZFcFx0Vv41qO7cRKSi70U8qR932rLuS6uA4KyLxn196fFO8zqrt8/Td6j0NAGjbugRXtDtBO1h2/GtSxtFmbMoBHQ46iqEemty8QKuBh07GrdoQuDlgAcHB/nQB0troyyJiAbmHPFaFjazW84cI0eQQyMOHqtoV+bKbeCTj+E9R/jXSw+IImm8qaAYYZwRww9qAJdJeNoGiYou7Iw3GR6GsHUtUmsGksrgMYk/1UoPKj0rX1uFDCJ7JwFPLRtyD9DXDareLOxiYsJR0zQBUeWSa6aXcxcchuob6itjTB58wcr5bMMZHUH29apaZAxZY5lBj6rIgyUPv7V1WnwrZho9QVTC3KSAdD60Aa0Gno1sJHY7iNpdeM/XtSx2yrEq7mypw0bcEj1BrL0/UHjvZoo3LDpg8q1aWnXfly5nXD5wAozj6GgCKTS7lw72jfcOcMRkj6Vzt9Lco+DIgJbaVxjH1rvBJ9olYyoBGPldiuD9ayNUt4LCUzBFnTuTkFh6HsaAORm0y9tQLpZiUxk7SMj8OlO0PU7kakil2Ze5VM5H0pda1bTpIvLslMRb+HcQB+FSeHikOLgnzCOAR3+tAHVNHGLgNNIsgk7rlWH4VXura5MotraVLpHPEb9RWlDqETwgiCJHxwA3X3FULC3N/fkwBt6k/OwIP4mgDtfBWv3ulaTf+GfEscg0S+ieJJG5NszAjI/2cnn06+tclpdjJFp5FvKTIoxIp55q3qUMzIN0pmkTsZQQv4daxWe5GXjaQLjaTnpQBUmn23C+fcYbOGXkY+la1lh48nfMpP+tI4/nxWFPHC6BpICXJ+/nr+dbGkwambf8AdxstsvOVbg/lQBBc6ZaTXLl3jjQ9Qrf/AFqhubOK3CxwPIIuy4UZ/GoL26liuJW8jzHJwzhySPwrIZpBcZi80qfvFgSf/rUAaFwisjDz98oH+r38D681HYh4pEUbo4jySOxqxY2lo9m896Y1zwOpIqG2uLVJfLiiklJPGOc/gaAN+Y2s0CtHO8rqMbnbb+QrHUyxDbBGxkJ4Vua0I7qFGzOAGQZ8sHOaYNe3TbrWOKMgckjoKAKM1pJD896/llznYmST9af5vlSJ84VfVB0Huaz728a7vml81pDjPzdM+wohaOXInkkPHATuaAOjs4BdyRCzbfg54QbifU10ke2KLYpluLlh8xxwgrF8N7bCMusbMzjBIP8APua6O0u7d/lkjaLP8OcZ9yfSgCq1y8CiKxt3WX+8R09T9fesueDzZTPdXJZFGdoPH4nvWzql1b+XsgyTJwZGbGR7e1V7xdOjtlR/lCjc7n+QoAqwOL0GCAZ+UHkflWbrK28EwgZg7jBk2Hj6Z71p21wWtZhGvlxyHAYcMV/pWNcW0ckm2E/MCB6/rQB3vhzWIG09LSFGZsYYrzz6VFrdzAIGClI0HDPnkn0HtVLwoxto54ztIC5eYDoOyg1kXcqDUyixmZx9wN9xPc+uKAIbu/hFsckpAOiHrIfU+tZMN211djMeWA+VAOlT30K3M+UkXCklj3Y/4e1bVh9i0PR5bl182+mHGf4V9qAMrR9EOp37SXhWOCM5c55PtmuivIYFACR+XaRfMABgue3H8q5S08QNaRs7hGwche2auWmrvMhkvXzPJyEHRF/xoAv25+0XcclyCEDBzGBn6Crsiy3GrGd/uxIdqZ4X6mqlleR4Mm0B87Y1Pdu5PsKvaehvQ1rCWYzEhnxyR3NAHzGqnzArfKenNX7FxGkkUvTqP61BNtmt1cf6xeD7j/61QxMXBjYj2J7GgDbgcvH5ecg/cPY+xpWLkAkElOCD2qDTvmj2oefQ1r2uxmxcL84GGz3HrQBl3PlyRmaA7ZgMOvqKh0yTzneKU8npWpf6SNxEbYY8xkfxe1VILESgKcpKp4b3oAhaJll8tuq/cJH5qakht/JJbnZnI/2TWotr9qi+YYuovvL/AHh6ipkjQwlXwQeMn+RoAxobuaxk+0WkhVQ2So6D1xV/UbtL+JJVAS4XkEHr9Ky57ceY0IbawJxRZptiMUynbnGR1B9aAJ5ovtEJEq53cqwHQ1Uj08NGJoiflOJF9Ktxzm1mQPkxNxu6j2rRK7JxNBgAj507EUAOsriSOBA679nAfuPY+orYXTY7iP7VZ4DH78Z6H2rMiUxtkIQp4BAyB7H2rf0SFWRvm2kenb/61AEVpaL5B8obwvBRuGStMlfs6LdIC6n5JBx+B9DUklpPG2+VFyfuzJ0Ye9Z92l6+BwD0DDuPQ0AJd3cZiKrcMitxz0B965uWCQXK+djIOQ4Odwro1sZHuVS4Ch26HGA3196p6jZra3ii4B8odAvUUAaemWSmNZIJfnXqO+P61pXDGW0kicBvYHGfce9ZdvFstPtGnzCRB96NvvD6H0q3pLR3cp84Oo7kc4oAoeTPGykbgy8BmHUV0GkCXJ8y4V0P8OcMKspH9mmDKC1uepU5wfcGnukBuPNkjLED5SiY/OgC60Fw1v5sczOAcDkFh7EdxWdqsZFvILlXhmZeGAIX8qv/AG2DTUSWNZIwx5XIZf16UeI743Wlk+XJGSuVxhlP+FAHlqWf2m5eKQqz579D9K7Xw3YWkcGyQKrA8/PyD9K4Nrw294DIo3Z98flXS6bq0MjKZkXI+60Z+ZTQB3YsFlhZi8YTHG6MZz60mnSqBJA9yqADALRj9DWE17BdQhmuWZ1/5Ztxmrmlz2sq743hjfGCsmWNADr8wNA0WIpiOBLGpH5mqtlOYLeVIN8iKP8AV44FWbmazCv86Ek8hkxiktZIPKIiuF3HrsGMUAULOSK9n2ySOAT/AKtVyAa6G0S3s/8AU37NJjmHoB+FUUi3uDajfgZZwBk/SmO0hYPEsxkHGJOSKALwleK5fykhVm5LsBuNZGu28+okPHNCijhtmTn8aJJ42uds+wtjkRAgn863YHszaIu1iRyFchAPrQBzF3ol0lojkuiqM53Y/Q1jWyXJlJMTbCdu8uBmuxk0+XUVkeZlaND8qqSq/wD16xZEVJdpYMwOAE7H8KAJk0oNBm2uIYXA5XG5v1rnLy3SLcGaeVs5I+6Cf612FtMWt3LAxBepC5Y1y2oawiSvmKSRBwA56/WgDOhlMLZk3QwtyQuOfatTTJEvGX906RIcszDj9KpWryX9wGeOPngKMALXRS3UVtbC1aQZPBYdvoKALNq80cpNs+/PTAwFHsK6HTzJbpuYRTynn5vup/jXANfzQzMtrC8wPQtkZNdJoTXE5CSyxpIeXyc7BQBrahHFMfOdgWX5mYDGT6CuWvb8uzRgrljwD/CPf1rsJ7iys0ZTIkr4wq9/qay30+0ERvr1ljiPzYx8zn6dcUAYttczSEKikxpwu7ufU1q2EUdzL5U+XbONi8ZPYVTAnkjlmgUw245Bf5f/ANVXvB5tZbxNzPkHLMON30PYUAeivpUNno9usjqgBDGJOhPue9cB4kguPtbtG3lo3BGMEjv9BXotzc2rhXVg7oMIi8hfpXG6vLBFPJJOQ5HUNzk+gHpQBzWnRW1mvm3eX3nMcQGN3/1qy9b1Q3EzA/LGOiDjJ9/b2q9fXrM0lwyb7lxhd38I9AOwrkJgZHLOTlj949/egCPdvmG5sohycdM1r2V2ilpfuxqPvnqT7VSWKNYiu0kDsKrWaz3moKj4WNGAC9l/+vQB2mjpcXCM6RfO42r/ALK+g/xr0XQ7aDRdLeWRgZyvzOex9BVDRhaWFkiDG4AZ/vO3pU15bS3oVGJ64CLzz6e59aAPkxSQCAaFOWHTr3oU7WBHarUkCNGkkZwh6+1AEsDGOfcOQ3JA6qR/n8q3Y7hZ413fLPHyP9oVy5LpIBna68da19PuEuI/Lf5ZV5BoA07rzEiXYSUzlf8AZPpUtnKpk3OODw4PY+tQxXCvE0THr0zSxtuCyJjzV+VlPce9AD76YxSK8Z+dDwR6e9Rzzl23kYVhzj19aq3SMWZ42IHTkdPY0WRJUrIPkPb0NABLFvdZM5GMc08RGNxjqeoIq6kOxdrA7G6MOxqSVPLhEgwWTqPagCkhSLckse6Juq+nuKeB9nCgs2z+BsZx/wDWq7FFDcRjYfl/hPdT6H2pAXs2EVxGGtyeq8j60AaOjL5m0ZCtj6gj2rRdGSRTDtiuV6D+FxWZHEbd0kgdWtn5z2B/pUuoLI0YkwWIGSFPP1FAGnbarNA7xup8tvvRv/CfaoL29Ziu1GU56Z4NUra4ublQAFl29Q3Wr1jGrSM6qW2/fj6kfhQBcsVmnIVszQA9Dw6UeJtOIgSRwZkHc8MKstepaMji2don4E0fb2P/ANerd1Ib21KxSgNjPlycZ9welAHFwAwtutpcqR9xjz9K2dJgn+We3VldTy0bZGPcVVis2MzLPDz/ALNdBo1rBbOGXIPfOf8A9YoA1YL8wtHK7hc/K5IBU/WpL3U4oGIygVuzDAP0NQ3FvYiORhLgtyyk7gfrXIarqMMcMsAm82A8BGOdv0JoA6aS/tbkeUYY2c9G/wAadfqkOmNCZcAjiNjwPpXlA1OW3lCRyybc8Budv41q3WvahJahZwkkfZu9AEflB70pKwdc8ZOSK6uDSY7dI50MOD1Y8Z+oriLS8hMmWHz59a77SbuyuLERtGkkhHKSttJ+hoAzfEFuqR74wh94zzVTRZ5ovvyuYQeSOTW/d6AjQNKLeXHXCS5xTbHQrMqZLe7uI3HVWQnmgCRLuzdlO/I9SpHNJc3IkdAyusefvCPaD+NZ+pXNyuIpEkbYcA+Vtz+QrQ8P6gMuk0kYXH3ZEyR+dAGrFb2zRL++mODkGKnTT3EUu6Nbh4wPlZR0+oqt5wgkJhKSK3UeWRj6YqU3XlqftPnKh7Bjj8hQA2COV3a4lCy+pkQjFXYIbObLjBYddpNUY5Uuz5aSLg9NwPA/GneZDYyKLnewXoYzgfiKALk06pG0RuSsWOWbAA/xrmNU1K3tJwIpJZWA+8q7VxVzWdZiuUMdojZ/vNxXLTWt1eT4md3z0Jk+UUAJqPibULtPJs0eKAdSDjNVEkuBEZJIwUP940y9s3shiSVCR0UN/Sk09b28dY7eCSQnuBmgC1b3W792BsY9GAziutsbO3t7WObHmSdcEZ/Os210G5t33XnlJIRwhYFh+FaVoJ48o5l2A8Ljr+NACz3nmTKI4RO59OAv0oN0ZE8qFSgB+ZIhyx+tQ6oIowVkmWPHJC8k/U1Pon2qfYkahY+pCL8xHuaAJrG3ZpwTbqhHIXlmJ963ra1EjqbsuR37k+wqK7nFrD5FsIVuG4OPmP4mnfb1tYAnnIbkjqvJH+FAE+qG2uYTZhREo/5ZKcsfdjWFp8UI1AQWwllY8EKMKBUzzS3G2G1h2xMfnbOC59z1rr9Js00+BVQBJ2GcBeT7n0FACNYSRQCWRxEUXAjTt/8AXrkbyZbebyPv3Lc/Mc7Af610mp3xtpVSRiABkAn5if7xFczLbG5unn2GMHknPzEe/p9KAKmr20UVooVmZ25ZumT/AIVxl5lJxtILg8HsPpXXayzXHCvkKMIi9T7mqMGhXBkWSWMhQMgsMD8B3+tAGLbzmOEYB3ucKT1Y+tdd4V0BoY1u5U3tnKA9z7e/vWh4T8JQ3V0b7VWItYuw43ew9BXpJS3DxP5Qgt1XEUYHLe9AHKaNaSNeTXN0f3i/KiDoD6D/ABrfmtzZQIEkBuSvb+Af571VYgztNbqNqk4z0Lf4Cs2eS5uXlMO51Ztpc9GPoPYUAfKw4xkZqxazrGHRwTG36VWUjvSnpjgjsaAJsq3yE5B+63cexqNWMcncEelM7U4lgRnqKANaznWXEczBZuqP/eq40wwS3BPymud3fl1HtWnaSGeMxuMntnv7UAXbe8HKzYDZ259antwQ7YXPfA7iqSopUM6ZHQk9R7H/ABqxbFkwYmLRqf8AgSGgDVRmEIKfOnTHp7VftLeO5T74QngFugPofaqtlNGxzMo2ScMy9KthPJn8i5H7qQfLKP60AUhZyWV02wFHXnYeQfpW9DbxX8AdBsmI+ZOx96kNoDGPtBLbRw46gdjRapPasW2rLGDkMtAFKO1nsbhh5eIX++hGVb3HpS3sbRqvkA7WORg9PpW4mqQzZUL8/wDEhqjJbiR3SMkKfmX/AAoAo2MbtdH92TgfNt6/XFd34L0KLWtUFrPfWdiRGXS7uGCq2P4TyOa5/T0jd4zvAnBwCfX0rXu9OZot5VTEfvqRkCgD05PhmQjeTrmkO7dCsgAYepGaoXPwl8QTAiC40aUdtsxX8ehrg3uVhgFvNG5XHHOcfQjmtqymVrQr5jlcYwzHH/fQ6UAbtj8JfFdqzC4t7CdOzJPz+o5qSH4b+K7C+W7t7NGkiOVCupB/PqK4mRp7C54uri3D/dcTHB9utWrDWNT/ALSitp9fu9Phk4Nw0z7FH4Z5oA9lT4b6L4l0nzdU0SbQtTOVlFs4UFv7ygEgg+9eVeM/2cdaXfL4a1i3vU6iC7HlP/30Mg/lXpsHxL0Hw5o8VvDLqmrtGPnuZSMufUknge2K4nxR+0New5XQtKs1b/p6dmYfTGBQB8+eIPhx4u8PTn+2NFvrQLn9+iGSMj13LkD8cVzj3N3aS7Wk3x9yq5r0nxD8c/iDqErxtrJsYW6JbQIgA/3gM/rXnGoahcalO891IjzyHc0pySx7mgCzZX8EiFngy46lMZrodH1qxtmAu3kiTs4XOPrXKWWmyTuPKI8zsegq7c6dq1smLm1V4/UDrQB37a/A2w2l+sxHTC7Sa6Sxkur+33Q3MC5HIf5TXkWmyW6yAKuxh1VlrstOu7UxBRdmJ+ygYoA0NZa6RzDMvm46FMirOjSxP+6eOBVA581cmsi4SSeM+XKrYPLO9WYBp6xDcxSUdTg/zoA37YWsszAGI46Mr9PwzVyC2usOIoTLGerJjP61zcTSNH+4QNGP4uM/zFXLd47aMNCL6STuAeD/AEoAq6zp5td0kbSb/cgY/KpdJhuZoN1y4ZQM8DGfzqO5WfVZwjxvGq85OAR+Zq3DaTpIscU4cDt98/ocUAVb3Sd/7+ONXUnlHfP6Va0+xto0JEIhlboW6fgK1fsbW6+dd3Ww4+VFTn/CqxLzRs95LIIx90fKufyoA53VdDjVHlP+kTsc5DZA/Cse3nezlEUTkk9RuP8AIV1L6a94GIuZI4f7pBI/Sq0WiJBcAxMOvLbSOPxoAkt5GMCyLDum/vbf8a6CEKtost/IAx6Iq5b/AOtQxhtbL9xENwH32YH+dVlhle0865lEcZ6NwSfyoAp6obVlDvEzEfdQDP4+5rPGo3dvbsHjNpb9Mk8mrsltNCubacxiTjcw+Zvz5qheWyRAiaRpJAOATlqAGRamGIZN6xDgMV5NSwo1zcKLcsXb2/melLpFk0wUEPuJ+9KDj8B3r0DTtNt7VElVUaRQCXfkD6KKALfg/QYLeJrm8lLzAcEDhfxq7fH7PHJLAUSEdWJ3O341rOn2jSgRKu0jOfug/hXG30sOVt2nWTaeMH5F9z6mgCi9nJcySTFcu3zbRyQPUmmaVot/rzSQxuIbRD80gGAB/U1q317bwab5UB2xt99v4n/xqg82oyQCKzzDCBlhnCqPc0AaOl2Gk6VLIgiExjP+sbncaq67dLKMx4jQ8u+Mlvaslbjzpkt1MlzLnhE/iP8AhXSWOgSzSCXWCoUD5LZT1+vtQBD4fWWbypZwZIwf3EB4B/2jW5crLeysVkGAMSTdERfRfU06BIYopnZv3Q4kkA7dkWqM80+oSmG3QQwr3c4SMep9T7UALFEJ3RIwRaIdiKON/qSa1DamSRcKsVpCMcD730HpU2nR20CIIQ0zkY8yTgHHoOyisjxRrJliktLFGeNflklAxuPoPagD46FO6imUoOKAHUpBwCelJTlY4K9Qe1ACEcZH41cshsw4ztP3h3HvVMDJwO9WYpMoInBUg8N3B/woA3gVmj3xspYfeA71JBAWxJEdrYwfQisi1LJLhvlkHf1rVHmxrvjz7gc0AXLaQxl1KE92XufcVdgmZ4jGw82DqpH3l+lZlrcC7bK/LMnatS1/eKQCFmH5P/8AXoAs2l/NCnl486HoMdR/gfatbSZIppCYJCsn8UMnGfoaw41YfMRskz3/AIvY1cWaJmViuJAOfcUAaeo2aiYyQId+OVIwf8+9MtFliQSKpeNjnHv6H0NNDSSxRuk++MHAY9R7GnW73FtebBJsd/uh/uvQBdEa37K3lDP99Thvx/xrftvtX2YozMxXow4NUrZPNb54vIuO6ngH3B/rUkM9xaXPyuWU9VPb8P6igCm8FzIxDAuinKkDDIavWl41vC4aKRGHRhyP/rVbSaQTqzYjLfdLDKMfTI5B+ore0uKzabbfRmLf1z0+oYUAcQ2oQ3haOVoxIpyAflqWwuuonDGMdGRdy/jitzxr4LQR/b9Icsw5IBHP1rG8O6pEH+z3FtJBdrwcEfNQA3VrmE2zfZI43kx91O/4dq81vLZ7y5Ib904P3JDj+det3Vja6jLiVCn+3sGc/UVm+IPBF3bwrcWxkuoCMlWGePY0AeW3OgzxrucZB6bhuBqimmzibdsIIP0H5GvT9O0uMgIhlhlP8DPtP5Hg1qN4XmlVWa3kkYd/lX+RoA5LwnZyPJiWw8yMdSFxXSarodobdnUSIMfdycVoW2lahoimawlATqUbnFWW1CXUISl3Git0LxnAP5A0AeLavDBaXjFULYPGSaom7Cje8br/AHc5z+dd54i8KXt0Xe1IlT/ZYMf6VxV7o1xbIY50eNx1LL1/GgBbC8uW5SRwCe4/+vXYaZBezeXukIiPU4yK4qxhntHw4yn1xXWWI3RKyjCdTslx+lAHbWWn+Wv3UlGOgXOabNN9mJi8mGNWPQOSfw9KybK7RwIxLcL/AMDODV+K0gYsBEpz1PmHP60AWBMxI8hFQerHcx/I1JBqc0JZYTcs464Gf50QRQRQkLcFOwRSAf0pY4GByVCg9wwBP1JNACQ3VzNKZLiO5iU8EleT+Jqe5lRoiFnhTHeY5alubdIlVjIEZv70o/8Ar1mNAPPOLl5HPTahIH4mgBkd9eCT/WSyQj+4mB+dSm5kuDsWeNW7jGSPxrSkt7eKy2NfJG2MkRx5b+tU47fTJkIWK5kc9y3+JwKAFhtHu1Aa4iwON5Ut+QrQmt4oURWZrqUdN7YC/Re1U7diJhFHMiAcBVyxH1xxWiRCoy8Elw/qRgflQBRl/dxeZKyxsfxb8+1V4449hlmYAH7oUDLVrrZNdv8AOygD+AAbV+pqza2KeYYoHWaU9WPAWgBujhBIhEO+TbxuHCiugnliNkY3m3seqw9PxPSs9rSGyUqZkeTqQATj3x1JqnMHvG8qICOJOobgk+poAsTSfaozCgYqgxw2QPq3f6DiqsEbB9rLGo/vdT+AqaKyEamOScqp7A4NTWSWMDARRmTnbuJ4z/WgChKsaTDYFGO78kn/AB+la9tY3l7FHHOrQwddp+UkepHb8a6KCK3WI/Y4kNwB80xAxH+J4FZ99cSRw+VaHzrmU/fPIHv70AQn7J4ekZ4PKa5fgbUyR7CpLMTTNJeXLFV/ikkbCr7e5qrb6ZHZgzXdwZrlup/u+w9P51NPcRXoSKUvHbRfdRRgufYf1oAfd3LXh8mxA8qMcuwwPrjsPrWa95923hkG3PMjDlj3wPT3NWbmRWtiluBFag/Ns5Ln0z3NZ6Qg5a4CwrnLMTlseg96ANhUmjRz5pdnGM54RawL3Wo3nNjZJvKdl5GfU1a1O5E1sEWU29mo+6p+Z65zBhV0tFSIHlz3I9zQB85UUUUAKDinA0ylFAEmSasxH7QUWQgPjhu5quvVWbODxkVNAu9ypIJ6jB/UUAaERZMRTdf4JO30NWYblo22EbG/u54P0/wqGLeQEfnPTPQ1M9uWUMCSo4IPVaAJ0QNJ50fGD8wHUVow7wQ6tnPRj/I1gRTywSFc8/wv6j0NXYbqQndGNrr95R0I+lAG2upfZ2CXCB4X7N2+hq2qRXbhbd9so+ZQ/G4emaw45FnysikI3Uds1b0/MEojk+cD7uTzj2PY0AdFDYZjLxZSX+IDoas2byz/ALgiOTb/AMs3GGH0qXSrmCUiKaTaH4WTup96feaZcW1ypuTsUn5JRyp9OaANP7RLDAokAZB0En9GqpLKJpATvAHTI3Y/Ec0+UTtGF5Mh/iBGG+vY06DSLtRvjjKEjoOn5elAGraw3k0I2JDMOoG7G76ds11ej6haywG1vY/LkAx5cwwfwNcZZtfxIxeDKA4Yocj8QeldPpckMsA+1wqY24w/H5HkfgaALm1pY57eCN5EHTbyV/rXn+pJc6dqQS8iZY8/K7ryPxr0KDTILC5FzZPPGrdAPmAP06Vpz2Fn4mtWhuzukXttwfqpNAGJ4VtJGgMu9J425BUgMP6GtG41aC3kNtjyX6ZyEP4joa5u48MalpM+3SL2VcH7vQ/iOhrF1aDWzdKNQj3AH74XrQB0s2mPcu8wmVMnJ2oMH6jp+IqubeaJ9nlxtGR96PIH6c1J4cW/VQIpo2z0Djn6HFbt3Bqax7ooU8wckYyD+XNAHO2iN5jJBfJA2eBv3fmDmjUPtlmhcz2zN6xoAT9aS5cXUhF3bTQXCn78fzDP9KqNcTxybXvWSMdcxkgj3oAz5rqe6/4+uAOmz5T/ACrBujYtORJCZG6fvZCGrp1kUys1tfWbg9lXnP0p9xZWN9CTKyrN/eKBaAOA1rTIHQSQIw/2WAZfzHNZq2bOoCiFe+FBH8xXVajpEMAJWXzX6fKwx+VYFwUtVKOqqT3A3fzoA0tOsVmhCgwq394sM/yq+mjSoQzvHIB6D/8AXWRoVms0vmedIgP9wf0rq5JIYrbZH58j46uuKAKktti3O554F/3c5/MVasUl8lE+0FYh3CFif0qhtRo8mfY3cO+8j8AKtW0sVvHuSQsx7srGgDQuYrCBFZpeRyWkYg1latcq0IK3P7v0Vev9a0YZbbyy9w6O/YLGT/MGkmiW8iLfZY4gOjyNg0AZGj26FnklzHG38W4Ln8DU80Ia5VIkYIe7MOfqatWmltKTsaOMj/lqXx+XFaEOiGUFDqcbepzxQBXSCaCELb7Nx7Jyf8/jWxa20cdurXztNL2Q9M/T/wDXSWmin7liXn7Fol2r+Z61saRoaxSl5ceYvXJaQj+n6UAUUsmnVROnloeBuO0AfTP86uyx6XpNoVty0k54yD3rRuZUgyWji8v+/IAM/rVdNt2uYIRkceYV2Ig9qAOWme4CMtu7QKxy0jkD8s0QQO8qx2iznH35uWz+dbd3aafbwkq4uZz1ccgfTt+tCahutBFbR4AGOOg/Lr+dAGe/2e13GYu79CWOfwApLF5L6RlLLb26dFTlvxNQizaeYy3MqqF4CIMkfXsPpz9K2IIIngSGEOFc4wo5f8aAJNPufMb7PaDcqnALHIH9P8962LfSTIzSyTHaPvyMcD6D1/QVNaW0NjEsMUCiZhjryBTruyihjUXJeWZ+EjyeP+AigCmdlxcfZrEJ5a8M2Mk/jVTULS2SXykLzSf8tCnOP9kVrW9vFaQtGv7qRz8x6sfYCo7w2umQBpMBj9yJeWP1oA57ULpLYBrkpEqD5Y8/Kg98feb9K5u81A3WGiBWLrvfj8cVJrN9DcXTtOjPIfuxJ39vp71hXBuXf53SPHOxOQgoAs3VzIVCR7iT0yeT7+386QGKK12yScDlznv7mshnO4szMVPHX5n/APrVWkmaadI1QuFPyxJ90e5oA8dooooAKKKKAFBIGM8elWYo/MQFCW28lR1HvVWnxyNG4dCQw6GgDe05iyFWO9eo9fwq28uz5ozlh1B7isyzvY5Gy4EcnfHRv/r1beIzDcjAg9waAGyFXYOi7T+lWYoQzh1BVx3H9RVaASRSfOBtzxnuK0twTaUH4HtQA+2wJMSERlujDlSf6Vea3VmEcy7H6qQflb6GqiBZkZoTh/44m6Gp9MvEJa3lXen9xvvL9DQBp2atFIC6eYAeeeRXc6PrlrDCsVwS0DcFWGQPqK4uPy2GYn+ZehPBHsabLMSdp/dyDsw4P0oA9Gv9OURrc6YEuLN+SqHO0/0pNJ1aS3lEEiAAHBWTgiuP0LW5tOb5HeJ/QdD/AI110fiKx12HyL+1QzAYEsfyuv4dxQB09w8PliR4DFIwxkcK/wCI4/nS6cthPEyfafs8x4KSjhvqO/1Fc/pdvq9gpa3ZrqwPVfvqB9O1XJLqC7ZY5bYRv/BIhwQf6/SgC09rNazmO01BIh2Unj/DFbtqJYoV+0OEk7MACpPt/wDrrNtHeaEwTKDIB0wOR64NQxLd2zNEIg1se2CNv4UAdHbXkPngXKPI3QnaSp/z70zWYC4DWhhkjPWJm5/DPSm6S5tADdB9p+623cPpU+q3NlMm3eqZOMgbh+VAGHZ2jwXm7aCpHKFckVqXUzygJAcOOxLIw/Ais1HW3lGYjcIejDKEfQg1ckl80+Yklwm3nbIvT6NQAySxk1ABpXCTr2K5z+INcfrlhfWdySpSMeucg/rXaC6tb7Aby/tCdNzbCfxps9wI4wtzYwuTwCSH/rQB5zNNER/pc6IfUJmqiWUczfuNTLAn7rAjNdL4n0e4nTz7MQqo5KojA/pXOQ2kIwxlkjlHXc2OffIoAtXGlXHkbRs6cMHxXJapY3FqWEirKO5ZsV3dhHcCTeNQZU/uq27+lVdaDSORJ/pGfXH8sUAcFpk+ybi3j298NgCuti1CNI1Kxg+yFj/SufvrOUPu2eVzwuzirdhFcSuFDRDHcqR/SgDRe4uZH3Q2Alz3cYH6ilivxFL/AKVE6t/cjwo/M8/lW7pVpcRpme5Ij9Qf/rVeP9mM3/HzvkH+0M0AVbS+spIQxEMR94yx/M1RvZVZXe1hQ4/5aGL/ABq7O1sJf9R53u039Kz7maKOQgQRx56AMzUALpdqzus1/K0o67Q+0D8OhrrrKG02LIwWJB91c5z+AHNcjbFkmWSS7jVM8IR/hW/c6rF5AQOjcc4WgDr7K/a4gMNtBKuBjOxUA/Oq07AKVu54Q5+7Hv4H4CuWi1DzUWODzRHn5mZiFH6itWxsLKeRSk6tIO4TgUAUZ43F4oXy5znIUnCg/TvWiY0aEfb5EDDkKeAPotb1pZ2lqhEbje3VgvJ/GsrU5rewJYNFljyXGTQBjS2drNny1mKn+NuM/QdTVaLT7iWfy7aORYhwd+SPx/8Ar1ryatE0QMMbO57Fdo/xptrPPM4EkgfP/LNOFWgCJLGZJI4hgoOpAAz9K6GDTZ1UNGI45CMZHJA+pqvaqqXS/ud7Y+8DjH4mtNbxVk2up2jshLfrQBVltbi3AETuT1ZlHJPtmrtgIYYGlJLTuOdp3P8Aie1Zt/qElyxSBgidDs+Y/Tjis6fWGsV8mNPm9uT+J9aAL9xHOoeUPFaxjkyOM4+g7n9PrXNapepHFI0TNlhgzy/M7f7o/wAik1LVbmSHd8iZ+60nzEn2rmnujNIUbfcSnqz9D9BQBUSJpJHkEjbSfmbqTWVqkzyN5EfyIDkgHJP1Pf6V0l5bzC1OWwcdE7CuZvo3hj2hSO+xfvN9T2oArvcwxIyhi8nQseg9qgi1E2wMdun7xurn/PFRG3k2+bIg3D7q/wAKD1qlIN0ixhSAep7t/gKAPN6KKKACiiigAooooAXvkcGrVrfSwS785B+8PWqlFAHTwTR3MZaM9eqnsadHKYiV67f4WrnLa4e3cMh49PWt+3vIrxAjY3gcY4Yf40Aa1s8cyZUf7yZ5HuKbcWgLKxBcH7rjr+NMscsdrxbsfxLwatEeWDslyp9ex9/SgCaNZ40EiMZQo5zw6/4ip1uY7iPk7W+n9KoR3MsY+Ykeh60FlmOSACeu3oaANODeBhCHHbBz/Or9ncLnbIgLD0O1l+n+FZsGnxzIpim8uXsHOAfx7VI7yRnybxSHX7pcZ/Jh1oA7TQ9VvbGUTWl3MAOoIz+YrqH1Gz1+McxxXg4YxjAb8K8/0i6MCqXQGM/xqeK1pZYPNWTdJbuekqrkfjigDroLi80wiK7ha4g6q+PmWr9j4nkWXAi82IdQw5FYdh4i1Oytwk7JqFp/ej+Zl/rWtZ6jpeoDdJ5SOf41/duPr70Aa8Guwli1uiKp+8jZT9OlSxG2vZMybww/hB6Vk3NkkS+YhW6j6jHyuPxHWptM2tta3EkDekh/yDQBp3Olebse0cKF6gHafyqV2XyBFJIFb1PUVWD6iJv3xiZB02nBNTXlxZzQlJkcSDs6f1FAFW40j7QBJ5Edxj+IIrH9Ka+lnyxtURuOgYH+uKv6PaWDpn51/wB1yKm1FEjXETMfQq4J/I0AYUl1e2imOS2Qp2diCP8AGud1JILti8qrv/6ZrkfrWjqcT3BKzmYp/eCsp/wrOi0kK+6KGaXH8R4P+FAGTBqElnc+XDbxSJ/dWNSf51oSah9oIVtPVJOzF2B/CpLyHIxBaPHL3JUfzpq6ZFLHvIczAc/vP6UAYerR3yHc7sU67WdcCq9uiOB5pjQnrlz/AIVqz2scqtGibmHXcWqtDYvbriKBJ29Dk4/OgC9Bbsyqsl7EYOyk7qsy6dbrF+6MQb18kn9ar26hP+PhbeE/7EXP50+6EDIfJMsjH0JxQBE8+oWoEdtHZAH+Py8t+tIbC6uMvcX4XPJaQAAfQVQhdFlK3KGEL/EFyT9K1I0hmA8pHVT/AMtHQk0ALaWMO8L9uMq92UdadcCS2fFrbyyA8AueDUsKLZxsY7iIHu5GW/SqcNxNNdblaaVQe4+99KANLS7NriQGWA+pG/j8q1iDbSr5NqWzxydij696qrrktrB5UdnKrHsrKCfrWRdahNLIN0Tqx6gsSB9TQB1E887qFZ/LU8fJxn2HU1Ta3tbfLfZVlnPPznJ/rVGMXk0QCXEcCnuB8ze3rVrS9FV5PmdpD6eYefrigDLvbm/nlKCKOOEHhFOAfqa2LCGY2+Z5toH8MYwP/r1tro0cUiNOsWB0Xd0/CpdQuba1j2xbEwOijJNAGEJmtm3MmCeArcs3+FF7qU7xBEjSSU/wr9xPr61zV/fteaixZmWNO9UL7UEtxiHzGzwMsefwFAHUR30kWUkuYo1UfNt5P09qzbvUY5yfs7HaeDIRwfoO9c9a2txeNvfDDPyxKOM+/rWwujShFe6lYSngKO3sAKAHvKWykI3SEfM7fMQP6fSorawCzCZy8jdo0OWb6noK1IdLS3jUXRkCdSOlQXt5HGhW2VYUHCqpyx9ye1AEd87AKtywRj922g5P/AmrHv0XymECAOe46D8e9aVnDGsT3N0+R1x2P19a5rWtQQSu3O0fw56j39BQBUmHlwncQ+D17Z/qa5bVbxLFWkmfazjO3PzP7fSo9a8XBVKWm2WbjBA/dqPT3NcVcTy3MrSzyNI56ljQBFRRRQAUUUUAFFFFABRRRQAU5WKsCpKkdxTaKANiy1mRHUTHGB99Rz+IrdiZLsB2lGDwJEOR+NcVU9rdTWsm+BypPBHYj0NAHY+TPbHP+sjPUA5GPatTTrbzkDwjzMc4HDr+Fcvp+vBgI7jEbf3x0/Gugt7sIFmhIOf4kPH5/wBDQBuCNgnzw717lRhh+FRTKkqgeYWjB4OMlfwrX0fVba9jEd06iT1YYNQ63pwAMsS8H+ND1+tAFW3t5IWWa3mGD1GeDXRWYEkOCrIe+zkVxETT2rbmDvGeuK6vR2triIGK4dW+uCKAL0Mj2z4jIY5/udfrWhHfQXACz2RLf34jyPwPNZl3JdQ4BaK4j/v4wwotpbtmIkdG/ullwR+NAHQW91FDHthmPP8AC4Kmui0m88m3xLKyg9m+Zf1rmNOYs4W/dVHqVyp/GtmC2t4W/d3oaE9Vznb+BoA3I5ISQzlRH69R+BFT3d7awoPLUS4/vJux+IrLj010Tzba6iniPO0fIf0pGS3ZcSIscnrnP8qANFLyeSLKJGp7KelZV9d6gW8to7cZ6Ern8jT7YXavtYRyxHoVJBqSa2ijPmM8kbdfvBqAM6K81GAeVNLMgPTapNG+4kbbHczmQ+iYqZ9XliyPt8yKOgDDmqg1p55wJC8oB4fGCPxoAvLaX4T95K5/66kfyqVwiwmOVmD4+9Eo/oKlD+bCDJqF4i4+7nIrOt9YWxu/3I+0843gHI+tAGRc2Eq3BlEkq88HB5pftF7uCoxIHUmPA/M12A1+WYqZPL2dwy5pb69sbyMIhcP32R8UAcx5c9wuDdkDuEYAVPaxvAfLVIXJPBDHNaiWFnkAW5bPVgmKu+Xb2seImiiY+3NAGbHpUUObi5hcsRn/AFgx+RrE1TUJA5WNQIf+mjf4Vo6lqa22QbuAE+oJ/WuVvNQEkxYEMT0IzigCK6vg0u0bMdzg4/I1DLfXG4fvNsI9BtNWWMksZH2NCP77cVWklaFdpiiB7ZfIoAvWE80qnYwRD3fqadvaSfbFJGWHvuNZZ8qXHnh5Ceqq+0flW3p8cNuitEfLz0VRljQBoaToep3rlnyIu+W2g/WuktJm07NvaxRSyDrtPyj6kVQtpbhoQbwukXZWfbn6gc1Lc3zW9ufIG1exWPA/M0AN1S+uN+ZwGY9EjyB+dc9q+oymIxgxxg/wR8t+Jqpq+o8HzrqWRz/CDj+Vc9Pdtg5hwp6AnGfrQA26vmDbEHA5J/hFVxdMz8ZJ/ikPX8M9Kr3kq/euGQDtGnJqnIQyb9xVfc0AdhpeoAR581YIB1bqzfjVm78TR26/6LuVjwrEZdvoO1eftdtEMu+5v4E/+tVqB2VRLdNsJ6bjg/lQB1B1Ga5yZ5m3HnaTk/jTIJI2lJQGZge54rlbzxBY2MZEhyfT1/Dqa5PWPGV7dRmGxJtYTwSnDMMdPpQB6J4r8R2+mwEXNyrTjG23iI3Dn07fjXk+s65c6nIckxQ/881P6k96y3ZnYs7FmJySTkmm0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABU9tczWzboZGX2HQ1BRQB1Ol+JUjKreQk+rrz29K7HT9cs5o8RSEZHWNsjHupryWnxSPE4eJijg5BBoA9ajvIxPwyMjfgauLcRwyh0IQn+FxgH8a8wtPEFxEw89VlUYz2OPrXT6XrWn6gRDPcNbsSABJ90n6//qoA7oXkMww0CMTxgtj9aHhYDdZyTQt/zzJyv5Vz7WxgCPBKkkTfdZTlW+n/ANalEtzKNsckgI7Kc/oeaAOs0++kj/4/rIyKP+Wkec/iK27W7guyPsUchYcFSBn8DXDWKXpZdk0qkddxrobG0uvNEgdBJ/eHB/KgDtEtLg2xa3nlR8fccYNZk0c0YYz7Ce+WKmlW+1SziH2iVWi/vBM4qe1vpJjueeG4iPbHIoAr2p1JlD2N0uwdm+Y1am1K7WIpd3EOfRkIqxMumSDJa4gf1jOBWfd2lvInyX5b2l+U0AYs2oeVM3yQuCevT+dON48y/KVT/rmc1o/2fYmM7pIZHH98msma1SO5zEI4/wDaRgRQBbiY7CPtUvPX5eP5022t54JDIt+ixnsT/Sp4o2A/cLJJJ/sQk0yaLUSP9JtRGOzPCV/pQBq2e6U5nugE+gGa2rWO2UZWSLH95uK5zTLXEgaeQbfTJA/lWrc6tHarsggh/wB4uD+hoA0rtd0f+jzxf8ByayJJPs5PnTmRj0XH+NVv+EibO0KEJ9FGKzr+8muTmZxs7BQM0AXInWW6zOsMaf3pVBxWzJYaTNBn+0iTjpFtUVyltbzXbbYYkx/t8n8q2rDSbiE5uJbdB6BQT+VAA+l6WFYtFJcN6mQn/CuY1M6dbyMBZBR6j5jXT6hLBbAqkweT/a/w4ri9UVprjdJOoX+6qZJoAt2E8V2wS1SQHpjZzW9aafqULCTy0hT+85+b/GqOgy4QRwSsh7lQAa2JtQ02xQi6uJp5P4vmyB9TQBXuftW4t50rOPSsS/mkdsXE8jn+6rfzNRa1rEM4MdlDKqf7OcmubuZHRDm48pj/AAg7m/E0AaV9ciNDtAjUf3eM/UmsQSm4diPzArPSOa4n+d2cA9+alvpks0/0ieKBQM43c/l1oAsvbDrvVfrzVK+uYolIeYyP0CrwBWBfeJYISy2iGdsffY4XP8zXPXuqXN27EtsU8bU4FAHQTapHbZfeFY9l5Y1kXWvXMjN5R2A9zy351kUlADndpGLOxZj3JptFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAWbW+urQk288keRghWOCM5xXQab4wuYJAbuJZgMnK/K3sPTH4Vy1FAHrekePNMugkV+fJJXLNIh2qfTIyT+QrtPD93ZXwRNPuLC5WRd4iM2H29zt6j8QK+cKcrMhyrFT6g4oA+rDataLuAMKd1ZvMQUsmleevmpGsoxnMLAH8q+bNM8Wa7pjQ/ZNUulSEYSNnLJj02ngiuht/ilryRsLpbW6cnIdkKFR6YQqD+NAHsLA20wRvOjHpKoP9ae09oB86RMe4XKn9RXAWXxcsXdI7/R5/KP33E4cjjsuBnn3rXs/iZ4VeYhbaeDAzvmXC/QYLHNAHTWupR28+62toGHuQTWq+vytHldEhk/2k4Irh7jx14a1BhGkkSuehIZP1IxSW+v6bn93qUEXs1yhB/WgDvrXxHdRRFltfL9tucfjUNz4qvZVJkSAp6Hk/lXOpcr5fmCZ2jcbtyNlWB78VLatZSsdssKE95DQBoPrU930ulRB1BhAxVS6u7WQYeeCV/Qqf6VBf2SBC1vco/sgBrlp4wJyvlyq/qFUA/rQBu3LygfuLUBT3jIH86ghSctlLa5yep81aoC0ndQQsnHoSKjuJfs4Xz5ggY4BuJwik+mSRmgDdkaaFB+5WH1JmGTTG1qfb5TPsXplSWP6VTtp7IQmS41PR0CgsR9sRjge2cn6VNpHjXwtbuPM1e3A9fIkP/slAFmOyluAGSe55/vYQfrSXmkyRx5kkbHqTgfyqOb4w+GER/Lg1WSRQdq+Uiqx7c7uAfXH4Vyus/GFbqHFloUaTZ+9czmVcd+AF5/GgDc3yQ/It6xiHUIMfrTJb60jQndvfHVmya8v1fxnqupSOS0NvGwwI4kAC8dicn9awZ7u4uMefPJJjpuYnFAHpOo+J7YNtN0ioemw5z+Wa5+fxXCq/wCj27OxB/1hxg9s+v6Vx9FAG7eeJ9QnUpE62yEDIiGD+fWsWSR5GLSMWYnJJOaZRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAO3tjG5sfWje394/nTaKAHeY/99vzo3v/AHm/Om0UAP8AMf8Avt+dIWZvvEn6mm0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transvaginal ultrasound image of the left ovary showing ovarian cancer. The left ovarian mass is primarily solid as indicated by the long arrow. A small cystic portion is demonstrated by the short arrow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Thomas D Shipp, MD. Copyright &copy; Thomas D Shipp, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8370=[""].join("\n");
var outline_f8_11_8370=null;
var title_f8_11_8371="Dorsalis pedis arterial puncture site";
var content_f8_11_8371=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dorsalis pedis arterial puncture site",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 306px; height: 590px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The site for arterial puncture of the dorsalis pedis artery is shown.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Torrey SB, Saladino RA. Arterial puncture and catheterization. In: Textbook of Pediatric Emergency Procedures, 2nd edition, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8371=[""].join("\n");
var outline_f8_11_8371=null;
var title_f8_11_8372="Discoid lupus - left ear";
var content_f8_11_8372=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Discoid lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGwAUQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5kidiCsa7iQQAuSaYyHAbHBOPp7U+3leKTzIztcDAYHGKnWS0UQgeZ93Mu7ozeg9qoCu4QRq2G39wxz+VR4+YBPmx6CnTMHcuvG7t6fShFPQEZPGR2oAem1lDPkLjaMdzSmTbIrpvXjAJ549s1NJDEshSKXeqngtwMCobu5efYrYwg2rjsKAG71aQyMuQDkDuT/hURZizsDjJ5A4ojCkNuJHHHuafHbyMCVU7cjJPAGemTQA1lLMAMs2MmgDIAOQCMjA60iM0cgP3WU9SOlTeYqRxeX5nnjO5s8YPYCgCADBJByB+FWkQ2+GuIyC4Iwy4z7ioo5fKUKVwyn1qUrJJbbS7PGo3gM+AD3OKAIdxjX5WJBOCpocMpDSJ94blyMZB70+EgqwZuCPmX29frTZPvBTIMAcZydvtQAtv5bPslk8tezgZApsoEZwG3L2NBcvKjT5I7ADHFWEjEiYUubiQ4EeBtxjqTQBUByed3HegA4OF+uRT0xsOYgSON2e9SRR74ZWfe4QAYDYwSaAISHYkYJIHQDpU+z5B8+SoHBGKg+UAtyM9O9LHkseOlAxrsSeab1OKkPzyAdKsRWkjTYTBwMmjYRVIKnBqWNnRWRH2CQAHOcMOtOvQBIMccVXJO3GTj0oAfFC7qWA6elN27XAfgdc9eKsWe5TuPKvke9RzIfM+VeO9AEJAK5zyDjFTRRsW2vleMkGoiu1yoIbBxleQaszoLdcOS0rAHIpgViAXxnAzQyNG3Ix3BpSeM96fPMZQuewxSAfanCu2Tmq7HLE+tPzhKZ1NACU+MBiQ3amY54qVyoUKByO9AEZ5JoA55o6GnE5PTp1oAcF468VG3J9qnEJwDuxnsac9ptXIcUAVaCSRzj8KXGCQelIRzQAYoobINFAExVFLBsk9setTPaOlsJZSqdNqkjc2fb0ot5EW5hMieZEjDcBxlc81JeKqzOYwxgYkpuzwM8fpQBXWPejCNXd1G4nHQd/wpUdokbaigsuMkdRU9vNAqBWh+boZEOfwweKhuVfzAjknZnAPBHtTAj3sSNhNPjSGSeIM7RR8BnK7sHuSB1pkMnks2BnKkcimtzliTuNAE07QCBUjUF+hfJ7E9B7j1qQPM9slouFV3BZTwXOOCfYc4qmqs5JUZxycdqmkUwsnzZcruO08rntSAavDEYEjc5zk+1DIY3KMoZscY9TVuFGigW5RhGApWMsRktnmqvmNJOCW2sehJ6H1oAYRlQxDHnBY9PpTScnjB9M1YvV8tijqu9sPuV9wwR/OogM/Ki9cYHU5pgINqquVO7vnoRUzIZY3m3scEKMqfm7YyOKS4jjiuGiDq6qQvmDIBPc4pgmkWNow52HsOhpAK9tMJ/J8qUTD+Bgd34CozlVB3YJJBHpShsuGLkMTndnvRvbzt5be2ckmgByviNgAcZzx2qxaBZYnV5kXBz5bZG/3HbIqNfKaEK8vln1KZB9uOagKnp19hQBdmlkso2td+WV8HAGMexpEgneU5Vi55ORzzVN9wOGOe/Bz1rR0qeSCQOXJXIJFADJrFlkIOcitCyiU3Oxn2hUyfer97JE8u/oWHT0qhZbyLt/MIiTovQZoaBO5mSuDdnaMgNgZ71BcJslZSAAD2Oajdt5J4xTlRhGHHQ8YHp70ICbT2RLhRIBhuM+lTagjKSNuQp64qmQ8XtW/ceRPBGYWPmBdrihgYMa8bsYPamsXmc7iCQM8nHAqW5QoxGQVqIbQvqaAGDpTu1BxkYGB6VKVDKWAwKBog/GnBOh6A0+EJvIdWI7YqJyD9wnHvQIurbosJbduJ/IVUfG75TQGZsIM49BUrQtCqvMuAegoAi2kKGYcGmjqeOKUsSMZO0HpSdc0ASiRniEeMkHKnPQelMJbnnmkTB+8SOO1I2aADnFGfWjPFKoBU80AOxnuKKsQRh4wTgUUAN8hnJKqPlYKR7mnXEbRv5MjEOrbSrDG32zUyO0KyBBu81Rnj5gc5FQ3dzc3crPcu0kpOWZsZPbmgZJE8tkQSse50yu9c/LzziqrEqVzkk9d3Q/Snks4+dskYAJPb0qzLJFLa7TGiyR4WNkBwfXv1oAm0qKLVL2Kzmlgsy+Qk8nCBscBvQH1qlPaTW800TqBLC3zgHOOf5VJb2bXFuzI67xIsSxk8sWyePbils7d7i+8u2VnCqxfzOioByTjoBigRTEjDOOM9acqM6nEbs55zjgVY3tZyhkg8qQEMpcbsAjjg1AZ5BNvLbnJzzzz9KAGyRlQN2Mkn5e4+tDNI8Y3HKp0GeRU8EAlZvKLvgZ+77c01HdYmjSNdxIO7HzfSgAsoFmMgYquF3bjnAHTOO9QcgcHn2NThS4eSZtmCMjoT7imyMIyqFEO08kHJbPqRQAxTv4C/N69/pTmcfZlj28hi27GPw/lUsixGzXbEVm3k7/MyCuOmPWqpJxySRQAnpSsDnOMf0pDT1AIOTQA3Jp6SOhDISpAIBHHB61bh+zyQJGtqA6nLy+YSXx2A6A1UuFZJW3RmME5CnsKAHfuo17O+Om3gfj61d0lFnmKkhcDIqgEUoRhy45AwMAVPYFvtAwCT6igDcvnG0Ow5UYIqrdZi0k4wN7c81Hc3HIRx16Uupyq9jCiDpQCVjFqzbxh8hiFyOCTjNQgYODyc9K0LBJg2fsKTD0lBKj8MipcrFxjfZFJY+rLnHqalti8RL/8s/4sVprpV5cn5iinoFVcAfgKtp4eIXaxZvpUSqxRqqM2tEYr+VMf3bDJ7Gq1zA0BUFcHGd2etdONDtUxkMG9zVfULCREG0B1FJVot2Qp4ecVdnNDlhzWwbVls8gA5Gc0q6Ys5CIpSVugI61pwxNFB9nlXmMYOac5EQRy+5o2IBpskhdsnGR6VZvrdo5WGBwenrVZkYcnvWiZDVgErjOG60jMzcuzHPQmkKkdeKcVKqCcH09qYgKZXIIJHYU0eoHFPSQxqQuBnqTSOhRevDDNADwymArtG6moCAwZQPc0DAYZBCkd6QFgdvJye3egATYX/ebgv+z1pAoyQD0554p9wqqRt69CPQ1FQBdhIEY5oqxaWpkt0bA6UUAMmMjXMa2zAyBVAK9iOc/nS3kzSytOwjEsuSwUAgH1+pPNRoWaBsOF29F7nPXn8qYoZUJ5WMHDEHJ59qBj7eGTcsoSNlDbRvOAxxmnX8iSugSE2+z5fK37gD1JHfn8aYZZJigkYSYTYA56DsPpQ8jYIRWBXAYqOmOM0AIyzSRu23jduKg859cfhT47p7SSX7HOwWVAkpXowzkr9OlLa+at0GjuPKnxweVPPGM+4NRXML205BAypxkDgYoEOSQ3E7tO75Ycyfe/PNSpHFLA7xJGPKGWd2++T0AU1BF5kTpcYjbDBsMAVJ9x3FJKpkVpdyK5fBRR096AFN9cCJoklaONzlkQ4DH6UjsgdDFBt+QArv3c46j+dLbxq0Mr+dFG8fI3Mdz+wFPtGijFx58TO7RERsDyj8YOfzoAhjuZUfcsjA4xn2psoRtpjcsWySCuMHPT3pCjndkEH2GcmmsrrjIYD8qAGgZOMYNSOo8mMqvPO459+KQbsbQPlbocdalLE2gVGAG/JGec49PSgCBUYqDjgnA5607oTtIPalSTy/ucsflY+o9KZg88UASRuUIZTtPbH8zTpJ5HcszK3GM7R0p88I80JCpYlAWBAG1u+Pb3qAADJDdDQMeNpXMn5dzU+nyBLxGblMYwarZz7n3HaprS3mmmxEpOOrdhSbtuNK+iH6i265JH3c1btLKS/aNEyEH3iKoz58xg+QQa7L4fxiZJxgFgc+/4VjWm4Q5jfD0vaTUWS6f4at4QGMW7BGCeprUNgkThQhB9xiumisvlUAMvqfQ0S6ZIwydxYkfMR1P1ryXWnN6s92OGjTWiObksBGVkC5z2FTLbofuK23vz0FdI+iTT27+XHJIUjLOFGNo/GqenafMIUXyiUxuLYwBj3qbyauDpq9kYU9m6JvlibyzznGc/jVNrUHdlgvtXbpZIrYlyVbkKzcZ98VVvLGJmcoqgNyAvReeQc/hVqTWwSgnocNdQFJo5VILoCAKiinIZ0lAO7qSOc10tzB58zfLI6xrngdDWc9kgtTOkcjlcCQFc7c9yfrXbSxP2ZHl18Ir80DldUhQvuK4RuC3pWZNYlBzyOo+ldPPEdjME/dn7w/wrNhWIDAmKnJ2qwzj/AOtW6el0cvLZ2kYU1o0ZTfkZAb86qv1rcNs0skwaYYj5xjrVG6gCHGdw9q0U76Ezp22KJQhQzfdbp71OrrKpiYBc42ljjBqOYE8ntx9KiwK0RiOyQcHPH6VO8DvMiRKWkbGNtJCkZRmYFyvOz1HepLYywzsuxi54x3HHWgCtIwZywAGew7GmdaUqwYqRyOuKdsO0MuT64HTmgDWsZx9lj47UVmRvtQAk0UATPgcdcZAB7Uu3dKFdwFAwd3H4VdeJrNpI7q2BbLRnflWjYcc+49DVSSN5FG5sBR3pXLsPjaILt8kMVOd2elEzxg+YnB6tj+L+n4UwmExoFEnmbsHkYI9cdaXeInV9quccqyZz70CGTES4bqoAQLnk/wD1+aCMQ7mGOcAd6tNd3EYuFRIFLgbmWMLge3pnPaoVRjanyx9wb5GB5AzgcUxEUrF4o0J3lRtHGNvfH51GYyBgH3wOMfWrE6q8MTrIo/gYIpU8fxHsevWpLq2a1/c3cXzqQzMDllBHGf8ACgCptJTdsJDdsHNNQgSDYSDnjJxj8asXDzsu9ZNy99p9scj8KiijUnMkWFAySXxmgCSGK4vWkEOXeNd5K9SAeenWqwLDIOSM8ipoZTDOJIw8Y9jkkH+dLdi3Ep+yNMYcD/XAA5xz0oEMKRiY+U7NCM7GIwT9aW3iE7skZVHALKWbAIA6fWkjjL+uz+JgOFpWaTCg5LbdgwO3pQMmt9QkhuI50WMzRAGNygOD0GfXHvUNvIUlMhjEoUlmDdKdEIzIzDICIWO7uew/M1Am4ScYJ7mgCR5i6sGAVeyoMCo1AwT3I4FPYKuerDtx1pbeCS4kAQFmyOaV7asaV9CXTrKW9n8uIHaeGPoK9G0DRo7eFVWMEe46n1NJ4W0j7NbIuxXfGT2rudJslZUBYyKvDKnXHfFeXiMRzOyPZwuEUVdnknjXRmsLrzUXCNwcdjTvh/eC01pUkztk6AHqa9n8SeG49b0i7eJUiiiCusWMEk8ce1eCTwXGj6mVIKTwvkHpW9GXtafJLc569P6vVU1sfQ0OlyNKqSwBAiFm+beZO+4e3+FT6dYxSSoUikRtpJ3gncecH06EVk/DzxfHqmnsZ5o0u4VY5LfMcjH49xitG41meVxFGAiBChaPqV64+lcXL7N2Z6yn7ZJxLE9khkkaFWS2C7ZNrH90cdieueePeqMMEUcTLPdSlE/ebuOM8YwereozUNzemG3Gx3IVAoZvkCtnOcg9vxNc9FcYmMs0jPIW3MzZJz7L7570JqxEm4yOjmt1a02u8iyMdiDbkY6jB/OsJZWtpEO5g4JUnAJ+uO9RXF4WljYP+7Hy+Xnbx9RzVCa8URO21Ewpwp4B/HviiybViZTsW4iTePeDd5EznCZw74P3So7GpLa2he/mEEp8hlL4VhhGHKqSfSufN5GYN7vul68jAU+xFRJc4IO4mMNnB7mtLWML6GlrNhGkHmRFHTjc4GOD0z+PeuE1W2a3PmxEYBz+Nd9NeyXen/Z3KhEBVNq84znDetciSssslpKBw2CxOflziuilOxx1YczuzCspDI0zJGoG35gOgzxVmS3hyCJF3d+36VWvrObRtUCOpEUhwD2IzW88UcyhSoJAyNwycVpUfK7oVKPOmnujm7q33c7R/jWZNCUz0rsZrZGU4UDjB7cViz2KMWMXQE84q4VUZ1KLMPAXB3fN2A7VaScN5e1fLlAIZ1Y/NnufT8KjuITG+09faooTtlQ46HJrdO5yNWFcNuA53DrUkK/umbrjg8Vf1iy8uG1voRm2uV3bkBwGHDLz3Heq8G37NKsYJXPJPYE8UxFRQMHB4zRSFPTGKKAN24uPtztJsma5aTc5b51fI5bnncT1qudifLcHc4z09aQsInUWzu5xw6gg574ojMDlt2/1AHp71JaHRwg+YQH2IRmQDBAPBzVadD0/ecHAOeMelX4ZAdPvIoj8pQY9Qdw4Pr0qjEJpz5QBZpCFAxznpQgG7k8mPKCRsFTkkcVJcMGnSRWLkAEbkwBjgDFPS0SW3lxPFHsbIEpxuOOg9/allupZ/IhcgR28YjRR0AySc+uSSaYiqHZxsOCCxb65q5Da3F7HLJDAfLt1AkfdgD3JPU1XjiIUuyNwdobP50ebGpCnLEH146+lACTQ+UWMLBwuMNj71KSZ5d7fIgwTjp9BmllYSR5iyOhK5745NRrJviCMo3KwxIxPyj0A/HNADbkfvcKyFCcqVOP/ANVRoqvwOAOxNXJcRKYbWVZlkYg/Lz9eemf6VUmiaNykgKkDJBGMUxDZCQSucp29KGbKYJB9z2FLKynGFA4wOcnNJEgcgZHvnv7UAKAFPXAxnNK7xiNCqkNjDEnIznqKaxTa67SWzwc8AemKn043KzhrMHzQC2QoOAOp57UgIUBlYdyeAB1Ndh4Y09vsybUXc/JwOfzqjoGnPezvdTtxgkHHJHevQNEsBFcAKrq8g3KMcg8dB+XWuLE1tOVHo4TD3fNI2vD9gJEEbrl2zyTgAAV3un2KpLAHeM3HlqqxKo2kdske1ZWjQAoDKFEaAHAPzDnkgevFdBYHyYljjXaUZm3v94k9ww9MjH41wLueza2iJhCkpDXCmG3SQqqxsCHI7k+megHWvL/iP4Wt9TeS5tmXzsZLoMAnHpXdalqEkUaoCNgGRkYz75riNa1hLaBnaRcA84NCqtP3BVKUZQ988iiN1o94dgIcdRXX6Z4yzblbg7GC7cdOPrXM69qa3t47xJsHv1NZYjEvJFejKkqqXPueGq0qEnybHdX/AIqilA53sBgYqhDrLiPaiE5OTxisa1s7eSMYlw+Ola1jArsqMoLkgZJxj8KmWGjHoaLGOb97QsPqUzgKFAOODnNRSTSyx7AQSOxHNbMemww+X9ofarc4Tk+wNXzpSIB9nkUAg7jnjH+0alU0uhTquWzOWmkvIkRZIiCwBUEjp9aYFuHk2AY5x64/+tXenw3cS2mV8tiV3hhID8vqO/Wqr6Y0UMVw9o77SCTGMOc559/8fSteRGXtWc8IblW2tglADweorD1NDBdeauR1ypH516Pe6RCJIzaHzo5UBUZxg9SpPY88Zrl/GmmtaWbSXO6KVQAVdgxPvxSjS5XdBKrdWZyPiW7ju9Og+YmSM4GfStDRbmK6sbfLL5yoQQSOoPH4GuQnlLpsPY5BqBZHT7rFfoa0lS5o2Mo13CfMdncTLLciNXHK5C56H3p0kAxgkECuMiZ9+7eVPrmus0Od7uxIlO5kOMjvWc6fIro6KVZVJcrRjXYjJkJOWJI6dMVmSDGWHXGMCuj1C2WE8LhJDg89GrHuYsu5H3QcCtacro56tNpkaX0gsXsxtEDkMRj+L1HofcVXZXjkZWVlPQqRjtUbjacGtBLmO7WOK/YhIYyFkVfn68D3A963OW1itHlUGUkOeQR0IoqRfJUFSxYA4BGRkUUAXbUridpzJs27NicBsep7DpSyQvcuzlsSqBhSNvAHb/CpfkLpMFkIZsPghc+49OnWkguD5wkjbbKp37nUEsahs0SEiliSPybxGClTgxABmbnBPHI+tViUVjIC0coKlAFwG55PtitEWrtcxhvKLS5JZuOevX+lQi0xI8ckoO04z6fQ0uZD5GRTRxAySRb2t87RIV4zjoP8agDhmYqsa+gxmrEqLhhKoPYFBgP7iq0kE0IUkbFb7rkdRnFO4mrCv5ohkWYHBUMgx1JOaYkUf2cMPM84n5V8sY9vmz19sVIJY/KkTYXyQQ2MGpFUujOIiViALEnHfj/IouKxFOGikClSr4BOSO/+elQlFMiqWwoOCRzS3CjzAcnB65P8zU1xbrAzb5opsAYMZyvI9eORTuBAyEyKnlhSDjYR+AqSe2NrdyQSruMTFWweCR6GniRDAFjVTNu3BxwcAY2+nv61FuDMWL7mIB6ck96dxIbcbTJuRdq9QD1qAOVmV+6nPNWoY97kMH3YJ4HOACf5Cq6kjchCnccnPXilcbEZMysEOcnjFaenea9pcW1sAN4DTOCcsg52fTPP4VnxxsSBjHXgV2/h6yhtYovOR0dyC25DyD7is6tTkRrRo+0lqbvhm0V4lVUAjYDnGe3XNdtodl5msxInyuiGQ+pHqPyrmPC+Vt5UhVnEbEAMNq4BIHXr24Fd1pFobYCQFmnlA3lsEKpGOn8hXlu7bbPcpqySLVlIEm3tuWJ94Q4OTkY/z6ValvUjj58s5UDaOAMDGSfwqqxhSJvNLMR2GBjjGOffmsm8vw3mHAYL8pBGF/AVlLyOxK2rK3iDUl+zO7v/AA7j1x7143r+sNezHBxGOFHr710PjrWG2G3jky0gwee1cBJLukZnAyeuBgV24ShZczPIx+IcpckSXzMg5IzWxpluHTL8n+VYUQ3yADua7XQYvnQeWzN0OFBGccD0rqqOyOKktdRLLTVuLvy40YkkBcDGTWi/hvUJl3Wyyc/dVlwa77wnZpBc7ZYYwYlWVd/IZT0OPXPvXUT63pt1qP7u2JNq2yJ4wAGjIyT9Ac8e1VFO1yJ25tjwHUNN14A8SuiDlh2HSswanq1juRnkGeGB5zX0XqEtk1kbfT5tsr5yQu8bs5K9Oc98VwOraXFNeM5ittjsRGCcbWJ5B9D9aTfcPZnmaeKNSjC7ZGBXgYq7bePtdiJzcb227QW6j6V1VxoenQzyNt5UFSFIIzgYOPQ5NZ82j2BRQ0Y8xiT8vB+g7UvaJbj9lLoczN4r1aWKSNZ2VHbfgDoT71m3VzqepuqyPNOAOB1xXYnRYgkiKiEqSrZPJPbBrS0cWtsFY26pImEYFuvPPFVGqnsTKjJbnn9v4f1KZci3YDucdKefDV55M0iLuaEZdR1r16G5sXLSWzqI3QtHKg2qPY1k3e6ziurtMDzZSmB69v0qKk5RV0XSpRk7M8hcdQVwf1ro/DAdLGQkDyy/4n2q9rWji9uI5bVNjSMsCAfxnuTXR6V4YOm2Uq7zcHG4jBAT1FZVKydM2oUZRqXZzOsJ51nuXCkEYGMn6ms+5hBtoyuAAv510mq2gCheRvOAB3FZN3AIeSCYW9B901FOorI3q0tbnI3MfzEjpUe/MRQjnPFa2owbeg4PpWPIu1iK7oO6PLqxcWJwcd6KaKKuxmdlJZbYyZfLD42oi9Bn1PfA7e9LdaRCse+SYMBkgrx2BC+x5qGC+mklxLCHY/xMcZ9PpT7l5EGxIj5MjjKMQSHHpn8a51dbnS7MRbIhdvnMxGQgbsw7A/nVpxDbXkxYLIqLkAch84xj6d6pLcs5lGXSFyQMr8wBPOaY9x5kkizlZWXCK69Ao6D8P60IPPoTXkpNvNA4HnzSKwOwc8EYB7ev4Vn3CK0CbJ/MOWDAjATnj69Sanlmku55iNmCmVLDaMnGePpT5Fe5HmXU7s+ACdoAwOBwBTvbcOW+xQWBXKKjK24dEz2+vXOM8VHLC8YEmTJEuNrtxxWmqlHkK7ZBwBkYGR2xSEq7YlMiyoxJUAFAMcfj1pqQnAzkj8xwm1gM5+YgHmojAxkYAM20++Tir2ou9zO8j43E8kdz047dqY7RR2kkX7xrp2HzFuIx/U/yqkyWis0T+XuMfyZAyD39frTZSSiooTaucdOc9cnvT4ZmidCBGzIQVV1DKfw71HIDgkHPHOOKZIgRwrMQSPu5B6Z4qW7tUjuVWFgwZQ3BzhujDP1BqujEMUA3Bsgj+Va9hZ7Y1LK7H0UUpSS3KhByZNptgGaOP+NmBJPYV3+mRRWtt50hPlx8kY5J9PxrE02DyjGVtZSevK4GfrXU6NaSzfNcANIjF1A+6vv9a8+rLmep6tGmoaI1vD9u0KWokXExVi+VztJOcg+vJH4VvQTSNbsCMFQMFVzkL6+nGKrWKb2ypULtdwzttY+v1PpU09z5SurSPErgKVA2ggDof0rF9zuh2IryRQr+WQMZbDH+n1zXLa3eeVGWzz7CtC7ucsAoUZBzuGelcZ4quitrMxyGCnH9KzjHmlYqrU5Y3OF1m5N3eSzu/BOFHpj1FZvX60vbrmnIuSBXtpWVkfNybk7lmCEOoYnAzgex616R4cCW1naTuW2zpIjZPBwc5xXncdsxGEB9fxrtNIlZzb27oqAABGOcZ7/hWM2jWlCT2PRdKuEurdWaeCGGGMJKhTJkizlf1ZufpXSw+EdO/dt9ou4Y7p/MjlYhFXuSVz+WK4DSrc29wFLbEztIbpg8dfY4P0r01ZbS+8PJFabPPAWRo3bIwqHcAewznj6U1NNGjotSuaOneCLcWzzSSSCdE80scvvyCce+cH6ZNY9/4fsbnWrpJ0t/vgszrjPGV5H159K7+21+L+zJHdw6SIqxRbhu3Ec/1rAGmy3NzqPlgXLJ/r2LkKSOdo45I6Um7mkKT15jnZPDNlqs4gsg8KEhDcqn7tGH8II6+2a4TxV4Wu7B99wckbjuQYBAON3pmvUbmCexhmvpGWO5izMPLlwoI6ADpwM+tc944u/7S8ORyzwESg8/P85yMk4Axg0NJoTTT0PI/tHzFgNzJg9OKb5sYiKqqNvbLjuR3xnpmrF6kTNsiJUkAYPrj2rPv1eKPyNoYISSMc/X3rKERVJW3J4o4prtIgUAcqEAcbVHcACrd1Gl7cyNAHXT7c4IRyfMlI4PNc3HDI0oaZTIuD8y84Pbp+Fdh4cl82CKAbWjiwVAByMc5J+prR3M1ZlfS4pI7iAK7sYSdxZcqp6V1Nsb+WyuLfz1CMMsGiPB7dO3FUtQt3Vbe88wNvPlSheisP8APetaxcyIyxL5jtwMZyPeuGp7krHpUrSicxf6fMkrC42NJHyGjGFFY95bAZJwuc84r1PUNO8zTEnLiaRiULKcsvHII/XmuRu7BZEJb5cDOPQewrJ+6za10eaX9jwdhKk9R2Nc1dxNExDcnvxXoep2pX3GTjIxxXJaxBnLgc9K9GhU6Hl4qikro56insPmPBortPOsdczLbW5EL8yHLKB8pHvVe42mPe0gkbbk4JJB96mmt5FHmrFs2/MuB94kDg1Mk062kkLqrxNIrSbMBs9hn2z0rmudFiFLxwI5DBIoAwQ33cfWpFk85Iv3WxycAEjDls5+nFRyzmRREI1CA4ZmB/DGOcetRw/uU+SJgxwysvTPpg0ikrehaJCqI5XRX2ZMhOBgdvemHznnEZmCsw5O3IAxkfp6VIR5k87iJl2qFVpmGYz74z1qQSbQi4QOxAG0dD9Mc/1qS+mhVidkm+UkzgneeAMd+vQ1XYptVAG2Ek5RDkg+vrV1IHZnFxH5p44242+5FShdisyyOXGMgDHFFxcpn3s0t9sklaLAQKoWNY8heMYHGe/PNVSiDD7GZegGMZNaMTOzs4wq4DYxgL1/T3plxtSQOxjJU4BQZqubUnk6lJ4AqI54YryuBx2qDUreWCcRSL5blQTEW3MvHAb0PtVzzXCM6gquCitt55/kas2tjCwjYxyB8bmZj1bv+HT3PNXeyuyOVt6FG2tA11EQpCMQcnscdPzzXX2NkmzJyp46c4qGz0lzsCuEGVck9Mj0PUVvC3aJCiR5b+Ikc+9clabeiO6hTUdWXrSDASP5FJwOexrStYTCzHDDIBABx1IqCy2kFGyGzw5/Littk4eOTcibTIJFG7I64/z61go23OxNGhJFb2cARpccsRkYAA57/j+dYd9e/aJiDOhXACFzwvXik1eSUxTyTjfISm52bcUHXA/qR61g6hLEqZuAy3cku7aBwiY5/HPanNXKjOxNe3Y2ylwCPXtxXCeJ7hms5C3UnH4elb+oviLKljCQWGRjoBiuQ8RSZgRQOr5q8PD3rmGJqe4zA9hT0BJpByD9at2S5lAxXoN2PJirm5pkB8vdtyvc+ldhpNlJNBFjZJEOcY6fQ1g6bDmaL5Cdy8HHTPFd7p1o9tGqKrFSc8DpXDVep7GFp3Wpv6FYm9HlSxLOo5GRg49CfSupi0SDTpWeKMoWIjWJG3clckAnjGM/jWZ4ZtpLZ1kWR0Z1Iw3Qg11mS8SzrsRhuGex9cD1pwZ2OgZlvoN4ltazSuo8xvkkI4APTJ7VtSTGy0uaS2375i0aQN1ckYMh988+nFXLTUUntW0u7CrBLGQjkcoc5ANWNU3QQW8sWnvJZqpBCsA2MEHr0FaJ9Uctdu/LNWPJ7tr6znaPyvOBzE0bZ/eE9CO/B7dKh1aXydISO4twsikrJKM4B56j9K63xPotlYX8V9BfAzKI5BCDuaPnIY88fSuM8Qa1Hco0E8jTNJwdoGGIJOcDvnr61ZyOSWp50+Lq7UhVIU5wx469Kq3kLTzNIxAIzg9M/j6VryWk8LzRyxAR5BU5znPbI9u1UZokdZCPmjAyykYIA71jzOLsHIpq5XtsNKgMhjyuFUcL1HQduK19EsJIpJLiNyIH3sy9mPpnrxzWbbooDI8iBRyodcE57Zrf0KdI9q7t0JYZ9Bjt+lUpkez6G3BbG8tVgSNYlmG5Q5O9XxnGOmKbo0sltIyDKsvytzitHTo0e9yDK8bZOS3y5xwAO3SqF7anTrtJXYvHcM2GPJB7g+/NZYiN48yOjDe5LlezOntVWZWnHykp5bYPyvnkZA/nWDdQxuzCSMAAkcdRVvT7gR4aMZYEEKw42981LqTI67wka7Mjry+e9ckndHoKJxes2z3A8wR/IvAQDoB05rg9bg2QygLhgCcV6zc4jguFmTKKNpC+/fFeeeKIGWKbbggqQcc++fatqMrNHJWjo0cFJbYbkHOKKu6g/lzKAw5UGivS5meM4pM66+n8syRgYYqXCucl+w49hWK0WYFVSxcnBUjIYgdammE1xfht4ZkIEbDjB9v1qT7DcR7HjeUxngO+Dj+9kdQPaslobSdxsMUsxgij2eY5LE7hwB1+gqYBGtygjLyKSFOPlXPb2waDZSJdrNG6GfcMyhvlHHUf5FaVvbtaJkoxuNxdHZgdw9eOP/10myoopSzGMbliQ84B67z0+b0H+FRmfyTGJV8yZmEkZi+o4Oen1rTS2t3nZXDKVUNJk8n19uKqPBHm4Sf53ZBhowPlwM/px0qShC/H7pWcghTxj2wD+INRzO0UW5lXy8kmRTkHtjH41OrRTwxyPhQUACqPlc+o/n9RUZT7Q+Y4WaLuC4+Zsdh/npU31HbQqbEaVzGzSfIqHsPc56dahe0Pm7pUyCCQV6HH0rVhge3tYopB8u0N8hznjOR9afBC010js3ycjI6+3B96fPZhyXRnQ2xmXZ852AnBHCepx/M1s2lsIwFwAr5yD0Ix+fepYYfMlSIhWZQwJQbsHrjPTB+tathZmQoscaRyZJJ34UDGcfyqZTbLjErwxyZR1PyqmSQvJ/Hv6VsQInko6qd4GS5Xk88gj/PWqtlZyyNHhC6HI3bunQZ/Wugt7YbWIkJ7Bd3OAf14FQbRTK2kJC04OCD1APRfQ4rYiMkCxzqkImjC7SSCrHcTjj8P5UyytFZd+wMzkKi4J7AAjvkZp19Ntin5zISVUqAAxXLbs5x6cce1O5RzfinUCXkmWIQymTD2+/JTHJA9BkjtXO6hfpqd6txyp27WIHt3NaOobr+dZrhljkSMCReQXPXJ9yKw7iIpc4QjYgzwePepve43pYqXcrKZY5ZJGVSAATxx0rmdeckwpnI5b6Vu3wQyiYNuGMkH1rntawJ0X/ZzXTRVjkxEvdZUiXd7ZrW062LMoGOTjOcVkxcYxXRaQC8eMHPUVrUbsY0Yps7Lw3aRvcQs2cpjIJ4Ar1bw/HayloZkBhccknBX0wa8r0l1WYqSQeFHuK76yup2aJFdVGBuwvOK43vqezQ+GyOsggitrwEu0q8CFccnPc1oKq4MTzmSXO5h0UcdqyYXlmtVjDYkgYvGQPbFa+nq7oZQowQRu7jrmknqd8F7t5C2OntciVusm7dHg+hyfw7fjVG81a6Nm8UcmFugRboJNrJt4Lbj0/qK3v7QitLCUJGXfY+4qOFU4H58ZrlXv3ttUuZbWZGjtbbYqsn+tUDHHH3smto6HFiHKpe6M7xbZNYaOyXdwPOmJcFWzvOATz17gfyrgmcIru0W8rgKqA7o8dCMcj612j2f9omK6uY1WAKyqFY7cZzn8PTua8/1yGOG8ma2eR1QfKoJHGByT0/Cra6nlTdtCAys6lcBZznMbLxIPQ+9ZcrEudi4DDBXrU9zIXlLQu7BcYbH3TVJ5GJJBw45JB61zyu2dMFaJFK5253Yx+lX9Dvl2vBKAY26tnnNUbgq0RY539xVexXy8ySg7c9RTi9BSWp6NY3ZhWKVg2YWBCIxGTnv+Fbz2x1bT5cRhJEj3RsX4Qpk4bPrzyOuPauB0m+cwk5JUEA5b8q7nwZqBfUHjYOtvMAF3gbeOuc9acXfRiemqMvTJ2ZlbarKwzhz0rXkUNCxkTaGG5SO2fT8Koa3GkevzvHE0cEx86MEYwp9h754qZV3QDL/ACAnjt+dcclytxO+lLmVzOuwuGYZb1U9/SuU1aMXEzFAPmX5o8ccCuv1aIx7QrB1Kgnb0B+veubu4WjEhRQ42EDnnGKUHZiqq6PNr+NRcFZNwZRt4NFbeo2kctxvXAyozj1or041FY8iVCbb0J7tAJhbx5EUj78Rpl8gAHHp64q9ZwTRW/mSuH3tuCuCcA4J570mlQww6g/mLIgAVUYndyP4ST0HbNbLGDyClxZyuv3tqc4PrkdPb1rNsSRkLJCbOIvDGuwFSSdoKg9vb2qVYYmWR7oq2/DKik/L6ACpraxt5gGlYloCWdemYz0OO7Dv7VdaJY4UaHY0Y6ADIAxnHFSy4ozIdPTEMrpFkNgQPnAXH+NOtrSJ4yDsLD5nBBGw5xgj9MVftU+0CZ/lKKCflPQ/4cfrSAsIgC4JH8Kc57nNS3oWl2Mvyvst8zg4tyNoboqsc5+gNTSrnJii+bJ5B69+tXZYiXUbVMbLlsjPB/pTYYJjDt88b1JjxIOOD/hiluUkUI43wQ6428cHJY1dhtQCDOi7B0XnB7ZI9utTx23zBjJ5rYxnHIHTjtitKztywJMbYxjknBJ/h49Rn8qQ+VEVpaiFwhUGP0xgOO3PpW5Z2RWVVmCbQuF7HHv9ciobO2yFcROyZ2oGO8c9QPfuK2oQjgJEzOyONm/CgY7n6EdfamUlYhLHYpOSdgUsMEZGNv8ATn2NL5ksaSRxAERsUHGTg/44NXUkkRY4yqMqNuKSHBY8jP6k+3H41ngUGb7S5LspTf5ZyHKnAY/lzRYu9i1Zu1srYRHfYWyr52kcDBHpgHHvWLcTy3VuI7WEsjsIgEUFsNwWwOvCntU432xliSNZYFwSzLnDdDyTxzjp7VlXn2dpNtvM1uLdC3mbcBjt+VR35bIz6Yp3sLcg1TRpf7AlvDcRyM960UZDAkoo6nuOfWuZl06ZlGDkAEjZ1NW2uZQ/75m8oN8wYdz3omAGHEhVl5TH8NQ5Xeg0tNWczdQ/MUI4649DWDrS/wClnoNqgV19yvnTMxA3k846Vy+rr/xMJB2GAa6KMtTnxMFyXRRsrcu6t2rpNLi2Mvy59qy7FVzx1PSum0aDcd7jIQg+1OpJiw8Elc0beI8bSNxYDrXeeFVLzLHI2JMjLYzmuPjtwrpJvDANnI+tdhZRbFEyNtPQH0Nc7d2erh42uzrZo3tr3yTnMbHG0cH8fyq9pZinuBCXZfMyMe+K52LUZme3Wd90hBDkd+KuQyKJ7dkchozz2zRomd0ZNx5VudJHJC2hXkMuBIFKq5Pv0+v+Fc3cbYrMwyp5fmRbxL3VgCPwB4p81+VnKGPaHkJ3suARggVVj1FJJZop4maNUPlHrhjz3/HiqU0jGpRcrsyIJLuHSgsWTbNN5kY5IL4JI9ef6VmT2N1NHPfmywJH2uSp5HqvHqBz1rqtDQwrPbLCJbGUq0kqkb0I+42CegPWujXw7NdRJcRXMkE0wBSNJ8jf1ZgM4GfQV0QfMjx69PkkeFajA9o7okMnlXOPnI6jt9P61izRujIzwFoiPv5Jx7/hXsuq+HTHYyyGINCQD5ced7L7d/xrl5PD0RiuQ9u6OGwGB5wcDGBxnp9c1m46jUJPY8+8tjIU4UZxn2rPuLebdtQHZ1JNeiN4YDQyXiq21DsKKcheM/yrB1q3iSFgrL5qn5cf3feslLlZvKleNmYlvNJayFSQVzgN6iut8NahKtwsYlKkYEbdCpJzx/8AXrkYE3MucbfU1p2ZeK6DAEcgenFO+pjyux6L4oaSVoL5SGtzKY0+YE4xyTwO4+lFlEksMhMi4VSSm/aT9PWmRz28vhu4DySmZlwBuAAIPp35qhpsi3CJv+VBglhztHc4rKvbmub4Z291kl9EAnUsSeEJPyj+Vc/qcYa3Yk5I6MDjHtXSXb7lUwOXkyQA6YA+h71iXShhiQDAPCk8Fveudbm81oYCpbHPmw73z1VsAe1FLfxj7ZL5ZAXPHFFb8xytEVrG7+ajqZJmcAp/C7Z4GPT/ABqa3s3tlEkFy9tK7hWycoc/3h37cVet3VLvcdrMT8xfIVjgnJx0JI4FWdVJnubZWUJ5W1SgGA20D5f65NbbHIlczkkuL6aeOXyI5Ik27Ru+U9SR3/p2qeHTp2G+5u8QKSSqR7R/s5HUjn8KsGKOS5a4bCecVOCAcNz37cYFTorOhZY13N8qlH7g46e/rQ31CKexCkWRvjh83eu3PYen1AqxBEEcRmLEjErz0UYz+ff8qkSJYVcLM4YgFTH0K98j8Kd5ShVwcvIo24PP4H6d6lu5qkV3iJiUkHy+QGGBx7CokG+eTI6yE8d+cVZcYEgQgO5xk8gfX3pWSNEiRWQqB2HAyf59KVyrEcSxIdhR1Byf94+38q07NLULxHKMph1Zjln5yRxwOR+IqojswJ34G1hlj931x6etX7H94ksJ2hTl1GRknpjd1HBzxQmOxp2jFEjdTMrheq7cPgcYHbqM81atWhgnk81GaF3VRN5eSCQCSQe/HT3NZ9rHIsnlPtygK5yecHn6c8g/SrdzJG7yyXcyRRbAXRPvtLjggdyTwCPTnrWiRLdi2scbM008JPHAIBIBJ4YZ7qAc54xmqZezmEizzSQxyukqm4OCv3iDnqVKgA1GbkW0Uq388ELIJU+QnfISfm3Htk8Z6YUj3qhrd/GkMYb7PM0yBQ0Z5dMjg5+6SAvT0OavlMnLUk1aWNTGlvLOt40ZkkiYBtpLZAB7kgZz06VzMk4EsqsN2xsqxBG8dP05PNPvtXE9yJY0khcMWEiH5zxjn34JPPcVz7XDs5AZjlsN6cdD/OokjSMuhpXrLcSykMVYfK6/3sVm3DLjaDkjqDxU0SF9jhSxOQc9B6c+tQW9m7zEyKRGp5JNQrGji3ohIDmNnIwAcCuVuW8y4kc/xE12FzhEk2nhFLAA9a47mNhvBI71rSd9UZ4hWSTHaYmJ2+bjPGa7rQVYptUBsvkp61xtntZ9wxjPSux8Nunm24IbAJ5XrntRV1YqGkTWaArcGNVxt54PHXNdboLDaUkTfD3DVkR2gyHfhu49627CPjqRz1A6fWudux7GFStYs3dt+/UKM56Y4NJGWh3edgg43EnkfjU032l5EYNGVHyhupFV7yJvNXaST344NQ5nqU6KT5kW5FmmBVJNqMRtUjOfxpPs0kmwOzfK4GG4yM4/yadYO5DqdxjQ7eR0rVURtGH2MZB3BwM+/rQtSqkVYg06zNxqkqvGiBd2Cx+6MdCe+fWu00PKwNZyBVRyGZQwAz1ByP5iuStrp4nEq7QyE7SRyQeoweoq7ZasiN/pBYoSW3ooUg+gHeuinNLRnn4zDSqdNDvW0i0+zSBVx5xw0m7nnoM/yxXG6norWWoxyQeWFts7cLkE8jp685/Cup0GaW/0544m8vDbg0nIUYzwO/8AjWXf6gDbQ2lqsU0iN88hyS3UdB361vKzR4tDnpVHF6nn11EbSO4CNFMZVIaLBGD6j1781w+uWKqiyrGRuQKcjG5ueh79q7XWJ41u2gSXyLlDuWM5wD3wSPSuK1vVU8q6iSYSAneRnJU8c8en9a5mj0KsonCIAtxgjODznvz3q3HKguASSy7gOO3NV2TzJRswSepzjJpIQoba3PPWmcL0R33ha8zG1odmyYnO716cHpmmWIeC8liVcyROU249DVHw/dw5SFwVD8YXA79a0kVV1WUxMM8Pz1GaiqvdClL3rF2dJLmJFLx7M/f6FfwrHmhYY2bX5Hy/1Fa1xEohWby1LPzuVuw46fnWXMzKrGPC/wAII7D61yXszt3RgXiMLhvLjyDg96KbdLiYgNI2OpB70VvocmpqaZJDqFizqAWdmDRhfuEADH9c1FEnlXqLqBDRjOJN2QM9ASeN39KjmVrm4SWKF7UQEK+3qw7H/wCvV9oFhtnj3jIIbLg45GeT2OO9dF4nJyu5AbhYrVopBG0cnyjjcR0H596iGYJZVKbo1KqSP+WW0Hk+uRg59jVkyBoVSdfncEhcgKOeefw4prtdi4O0JCpRQ24hmGSenbPJ6+lJdirdepbtllLeXDsChc7gwIbOOc9waddKHYlnzuO0KBx/vZ7U7aYSlud64IUnH3QMjI7irThXOMnyx8oJ7Y6/h/8AXqTZRuUspGUEfYhznvn/AD0qaL7wwg8wEgcZGMYGBT2GU3Aq7jkccg/4VIV5UvgEkg44HXjpUlpEQxHKhbABII2nkn19sHrUot2lM8iKZXjQtuB2hfmHPqQSe3rUUHkLES4yx+YDqR14+tSHdKv35ZAY13xgfdwBnB+lNITNGO4Ty913IDAwEWc/dB7keucfX8alCJbz+VfJGsCuJDGV3lU2g4HfpjkH+tULlnhtYmWMOmwbQG5TccAsfTHb3FRT6kkEaxmAiYqreZIM+Yx4Oe4TGQB3BFbxMJEGr6ikksYigMZdAJIiMCPdjAXHYLjn3NcrNP8Aa3nZWcHd8wU8AdPwwa15VmKPJtEbsxOMZ+Ynn6YxwKqJbJavHt6yKcZ6EHtinKTIjBvcyZEd5pFjDrEucHGOQOn4ilsQEbynTAk6NnBGOmfWugWNGLDO8t1JqGC2iK5ZArdgDUSbZtGCi7j4LXbatH5ign5vc/SqskLFSFI25+93NaLo2zaVI9M9KjaLAZQSzYxx0FYyO+lpqYt8nkwT5DY2EZx2rmggJ5FdhqsROm3OedidSfeuRzzmtKOxhiFeSuCxoOgwfQVoaZcPby5DPnORtqkvtVqAHd7U2yYU01od/o2ofbgjbowC2DkjOa7Wxt4xAMMcEckV5Vp0AKho8qT/ABLxXU2VxfRKqiRmHY1k4tnRTk4M7PakanCgkcA1FM4uPlKbCB0HGTWVYahIiYmQk92HatGWVJoVIySehrFqSPbw1eMnZkf2p443RNxznqemfar8VzlFaLPqVPBUjjisyVQ2eOc1PaSNEGC4YHgg1MWejOnFq6J5bkeduckA1NDOGjwgUgDPPb3rNuZf3+zPUcA0QOyS4GD2welUp6kVKScbnR2NyYnjaZ38iNwwCseBnB+lbWo6jHp8ht0Uush3RxqAeAeQVJHIyPwri4ZiGkVJBlxt2k9T178H8a17q6k1i9ZbckGE+YGgj3yNlcZz/dzxjtXZTldHzuMpPn20OL8d6sL+VporZbdUdomxw7f7WB0Fea3SeSrFW4Y4Bz0456dq7/xZI80cc/loZ42dZvLYKc9Bk4GfpXBaszxRsDEm7sVHC/7I9uadrM8qcm9jDjmzIyBznPzVfjRWY45JUFcHocVWhhyAHT5utWAhjKmMGlJroEYvqdb4cyWQ/N50Z+Qg5+uc9jW3fbl1GKTay70G0yABuOMHFcxo95HDIrZbGCMmul1O5W6vLKQ7uIQhX3zUSu4ajikpqxoSpBKm0oYXz+9BH3ff9aydQZQ3yD5fQ+nqa2Nv2iFVmAkLHersfvdufesy8R0LxNsIDEH0Y/WuQ7ltc56do7eQo0cZbqd55zRS3VtHc3Dy3EzJITgqke4D8aK0szB2NUR3cjzTxsxjBjiwWySP4f60u2Q7IXfYituKlCSGxjHP4ce9Ohdbe6ZRLE0ZYb3Vdw3gcEdx160GSFZmCyyyOcMgYbt5/iB7D1BrY5loyybKMgFELK2QsjHAIzxk9fTiqkcCSQnzSd00wUYIIIyMA+nHNOEguWbYphCKd8mDgr025zyferAZFkCyIDaqcxumdpPbGe3pSLsQwqkkDMytuHyh1GcnPJb36CpiocttIZweeo2/nUNudkj7FUoSMhG5Y4PP6Criqj4YIZSxzj1P+TUtmsVYbEsChWbcxU4PekcokkjBkJU7cg5PXr/KnKxCjyyFUck8ZI9/wpJi4I2tna/ClM5GPYc0DYyTYjuokZeOQoz0IxzjjvTACWeJn2pux82c4x39qGuH2OWdWUDJAOCPp6npTGcgBZsbMEZz1OOPfOcCrSIb0GxzCVXjLvBDlnwhO3GMHI7+v4Vg3t3Nc3ZlSdtxyTu/DsOn07VoXjhoz5r/ADjAAOAB1PP+e9ZXmGWePauyPGRgbgPTmtNbHPL4jWiuJzFbo+HQjZzz+tXZrSGW2AZQ23oQcc+gqtp6xm4XfGCvTafX1rTkYZjCARqRzxgfWqsaRa6mRskRclNpaq77mkGW6961bi7gAJIJA7KKpI+6diseVOD83Bpco3JX0FVY4gCziTLbfp9KkDIBweTx7ioZNg8wlBlxjA7U+NCYFZsg+tZSVjppO7sF/BHPYXKISXdTXntegQS5uB1PVa4OVds0ijorEfrTpMrEq1mgTpV21UkjiqaDgVraSyidM44PeiQqKsjrNEt2Z4o1wA3U47120di9rIEkjUAgEADNcvo8WGVs8lx0r04PHd6ekjKFWDAyO9aw2Ka6mQ1hBJIpzt3DsOlQtZ7BuU47Yrp1gXyWuY44x5AH8Wd3vVELBLCZJcArk7AeTU1EjWm2tUYB4ONoP17VM9tlcj5WIB9jTS8YlO0nr3p5m2hVydmfuk8VzcqZ6tPESW5j6gkiMGcncvQeopLe7aMDB6+2a1LyJpQNq79wJUr3rCceXP8AKflPIJrJqzPQVaMol8jcGcBcfewKkVZUvIPnIO0bXiO1iuR17Hn86pQTBT8vVTyc9fSrb3CvFE4KNLG5O0DoD2B9M9q3g7anmYn39EZXiG0nk1NjHZyS2+8ykqCm4cZPoAT3x9a4rWbaGJyUYqSeVzx7fU17Np1z5ksZt4ka4yUcZwNreq9+vFedeKbTZq0gcgMpI2MABWkpaXPDnStI5CWLymUAjcRkGq8qbXzhvXp271pXDhgSi/KvTHbFUym8gyfdz+VZwkKcexmWnnXUZ8tyu/K56Z5//VXYaIbgxRC5bdKiBW46Y7/lWPBbiOTdHwOqgDGRXSQRY8loiCsq8ZPH0BrWU7xZzRp8s02dHbOBbMZCVmHC4ODtxzgd6ypUR0JkXCZwST+uPWtq3giNsfNdEaHBww4IwePzxWbJaPOjsCpG0ybGIG4dMD1NcjWqPQjszAlkAkKojAL8vyrmitBIg6hlMEY9HQ5oq0YhFYwKkVxaLtRwzY8zG7Hqfy/HinzWtv8AZN8z7iV3Rknoe/41T0+5ggMjbsuY8hZFwA2Ow+vpWhLNK4RA22M8h2HUg56egrWXkc8LMgS5hltgk0O0qDlk9u4/nikjHmHy5nkKMdu0twh7H1I/lUs/+mpMWIDSDJb7u5scY9AeKZ9mkW2USB8q4C4IPH+TjFG5SVtCSIRh53D7guERlH3gB1/P+VP3LkO/HPDKep7/AP6qWDylIY4jKghiBwOfTrUwEbqHD8qDyVyKh66msVZWHRbJMlHYOQP4e/071UaSZD8jEEkZByP1/GrNwQyqyuDu4KoOBxjOaqSTYXDrhs8jJAApoJEchFvvBiXk5JBzk/U8iobpXbYIyR5isS7gcfy9KsqwYDDpuYkgJxtOeCT054pGCrGTN++YEcZwMc8g9fxq0YtGNepLDHErMCoUNtznJYA88+36VQumMRzAAh2jd83zcn/CtiZCirJGrboyQcH+LkYB9cVj3YYNOzsBGSqkIfXkYHpx3rVWOeV7mtpreeqCP5iy8g9verd5EyRnynHyfKQpzkVlWLeVaLFvGW++3rn+GtuDTy1rNdSRPJaRuIxIrhXyewX8fzqkUZU+7Z8udgAY4wOtIkEskZ8qQOPQVcubRzOdkytEVDKTwG4yRx3zxUMWTwv7sE8Y6H1qmQrsvWdhss1ubi6QlfmFv3cexoiYeU2YUBY9M8Ae1SwW2NhJzvHAJAyP8K02sJJ0jijWOPqBz1PXn3qJI66T1VznJ2VXQqACDjA7Vyeu23kanKR9yQ7wfrXY6nEbVQJBhj096xNZi+0WCuBloz27CsNYs65JSWhzqKc1oWCEyDAzk4qkEYHvWtpJeKdXUAsPUUSHT91HZ6BKJY/LbggZBrrbO4k8hYxIdnpXFaVERyg+tddpqMFAAyT09qqLZtFI6K1mOwRIxCEYYetX7Sxikk2o2Vk42919arWVmZIY3Eiq4+UgmtWOwS3dytyCzDbuXtkcitLBJpaLc4rW7M2d8drbkJJBFQJMJFORmrmuyMLiRD2O4E9/esIu6LvUEgmuVuzdjvpxulct+fJGCqMyqTnHvVa7KyLvUBCB8w9DSxyCU8/eHY1WuJRHIGdA6Ajev94Z5/Spvdm0ouMW0UhNiV03AN1IHerkMxCMgK4JHbOO+aiu7WCO8m+xyGWDf8rEYOO1NLIkm0/KG+9j+lVaxxqpzK502k3pFncRRRW4mOAhkO1tw6bWHOfaub8SwwOyrdRTxXkg4jYcn33HrWppTLLIYNsZ+TO8gFkx/EKr6sk+pbbK5VnmCE2/mscv1ICk9Dn8K6UrxPIrtqerOAuIxESschwowQfeqDbjHwQE65I61rXts9tdtFKpFwqjKDp9B71RRW3NlV8vP4VzfCVH3ifT4mZAQSXxgenHPFbMHDw8FVY7kB6ZIGfpzWdaQAsoDbR94YONp7H9K1EkMsoLqI/nbfGOgPf9ar7LM3G0kdzoMUUjCOSFJcKxRHP3jtJAB9zmqyWYhs7try0ZI41DJK2VYPkYVc9j6e1XtBtmls4nvSfLcNIiEAE4Axg9ulUtRu0uInh+xyI4yEkMzOFJ78jpS06murdkcrKguJGkKlcngBsACirnkWrE/aG8twcYVuD70UKFwbIt8Ud4iSIpgWI7lcDG7IOB3x/Q1ct7a3hAmCFo2b920Dbdp7Zz2yazfNivrNJh8tyU+bJ5BHFWYRIsSsYXOzhmhbGBjpg/XrVuXY5YRROkCxxMshchB8jt904PPFQW8v73KFVAk4YcgEelTXCu8ETSgxmI5Vt2WbnJU9gakitwIo180H922dpOQB6/XmocrG8VchbMT5wVw4O4HOT357njOKZ54+ZmXaGwX9D6Af8A16nlQeWUIxDxgt1P4fjUEiPtLZBGOTuzj2P4igpka7vMVnIYs2M5wKY2wS7XK7ZBgrk49Rz/AJ60SSJ5RTahyfmYA7gPT2/Kq/Bby4zj1Gf6UXsSx7MHHyjy43GCAM59fwprbRGI154yPoMAH3qQsgQxAI2TtIU/xemfrzULxOuUfYz7cAdd/PY1SZDRXmCiQB2JIzsCDGCP6e9Zphdj5tqMw5+YFhw3XGfStWZGEbiRxuBwqHuuM/gO3NVWjQRbhhWHynC8AdRj+VWjGUSGKIMmAwBk5+Qcg88c9K1LC8TTrWSO78pnlOPJGCrDqDu9s9qpPE42+YoAK42AD9Oxz3qKK3Qlw5791yM/54xWimiPZsluNS82d4oyoEafIvUADsP/AK1QRXm755Qq4645/XvReQOC3lgg43FWGRnPoOn4Vz888kLsyNtlGSI9uQPxPXPNNS5g5eXc7iFzAyiQovQEgZPuD+daC3S9ifYluB+FecR6w4wsgKDH3Qa2YddilhUBCNoBb1Ioejua05rodPfuZElmlZXMg2DPJA9RXMyyApNGmAFHGT971FaD3JuoV3cIcsSvv6VkXVi/lTTmXAjxgZwSanl52VKryameY1J+Xp9elXLJtrKQBx61RilAA3kg/wAQIq9APl4xms5Kx10586Ow0ltvA7jpXUaWXLAKD+FcdobITGZdxBOzCnv2rrNOl8u5VTx2JBoR0QZ2OmxPI8EUqnJmAHPerN3a30d3KsqEIrZz2+lUrW4ZIYmGcxkZx1wD1Ndfea3a/wBjySSY85j8vck4rWyZnUqzhJcqutjzLUoWku2SQkleDj07VnvGYpDG3Kk9K67VkaW0S6EZicgApjk+9c5fxEyYAHHQmuaaserhZc6SKVxaLFCtxFny5PzH1qlLCJEDEd8CtLzmjVY3/eQn+ClaKCVG8gMMD7p6is2k9jq5WlyyMaaJ1QPz5f8Aqyc/lWWLoKqyFgXUkFSOQOnNbM8hWJ4iBtYjBPqK5K5mWObA8xmLsWzjBrSOqPIxadKemzOp0+YCZJoxuJGcFvvD0/H+VdPaW2mapp4t2lvLW4JEi+WjBYiM4I9uo4rze3lbzECl4nbG3byOT0NdQ1zCIHhuLloiI/mkwSrfU+gPoM10U9jyKsuZmf4uhuY782+oO0zjBWfdjdnoSP61y1vEjXJjkwmTk56D0I9q6nXbmZoV3zCcQqUXJyQT0w/cf54rmmRGYKy4Qnvwc9/wrCpubUhwBEpYMSYwB8o68/41sStGZ3ZAwjk/eIrAbkOOQfoQfrWfp6LJIkWcq/yhiMgemfx4x71ZhYm4VdrDBK7CBx7fy5pJ+6xzXvI7/Rpra2s4XvJ7uFoztyozwccA5wOPam6pfI1pcQG+vWMgOEkj4P4g8Co7a6Iskjls1B3bmfbkMo7fQenvVNlimnlCzxQptyDuIJX0zzk89KV9LF8i3ZgSsEbAgzxyS3U0VpN5ahUil2og2gMQe/rRSsQ2ZtrHH5QkeKPHDBcZUjGP6ZrUtnCm4wjlUO7DEEjgZBHcVkQQku+coEGORhfyHStS3Ty4VikQpIOvz9GPXPPIxWjMqa6MmmWeSB0lDMV4LMgynTGaqvDNHHhmAg4bGSGx2/8A1Vf+0sSw27fMOfLxkH0PsKhj38pLhcA4yN+SB0FZM3SKxhEhLLIyEkAKRwPeoJSypJgMdvVu3Xn61LKIo5mWMO2CCFYbuOTTXZZ1iQKvBJIOTnHTH4n9KaB7FSPEnzbiuTyPr+ZNMZSEVViMiYJUjrj+Z/GrJhiWSNn3hNpJ29j2/KnGLJyVIjVdoK8fNjge4pk2Kir1bAK5xuZeh/xxTmTzdgV1O0ZXPHXtntU5i/fYdRGJB8qgdPQn/PFKY90CgbVbafvcDGaNtQ5blF7crnc2P4R6k0xIAVZmUKy8/Lg8D1rVyoRVRUZmXAZucmoI4Ad6uQS3Cnt17072FyXKkcG9OcgovU8E/TsaniRUDDa7rjn5sAt7Y6dqnW3dlVtjPuHXOQBU08i/ZQjLt2/Mu7nJ7+3U1NyuSyOc1EAFirEqOAM5/H6VyupkNI2WHAznBOPaui1iQiM4G1eTlRjNec6pqMsjPgMsbHoeM+9dGHi5M48VNQQ+4nDPjkOOBg063uHibIOQOSKw2mJORgHuR3q9Z3PZuc8GutwsjgU7s6y01SUjaeU6gdqsy6oj28kUmVHXOeprCiuFcJtOMDHWpHwxOBgYrFKzOzmvEswTxmeMSbjHkFip6rVu3uAsrDP7sZwT1xnrWbHgKOgx0q3D++kGxdo6H396mZrQk4vQ6XSbgsxCk7VGa7/w5ZpNcwz3MrQ27nrjOeMnmuA0m3LRMi5Hqexr1OJfs3h6z0uQMksQWQ7RyXc5wfYCs4pXOtVHojotBvLKa2vTOuWHCuB0U8ANVhLS3EVu8MEs8u4KxbOwe6iq+h28kEMYaBS5LAlR1yeCfU11lqJhdp5rMzZIKsO3tW9roJTUXzL8zmrrzBNKLkhSy7doPGOvWuckgIDq/wAxU5Vs8YrrPEUS7ZCmPM7j0Ga5W8LMAiffTnP94d65qiPVwT5kmjLkUO2wjBHFEYMcikZyCMVo2sW6QMwG8etJqLKWQIAMDnA71go9T1lK8uU5/UELTF5CG5znHX3xXC6z8tx2A5FelXcReFmOPSvONfIW4bPXOADVQPIzRLSxWtZW+0qWYgkdBXZPqRk2NNCWSMcquBk9O/Toa5DT40eaJnzycEmug0mdlv23bSAQoD/dYDoCfStYT6HhziT3EhtrRfs0nmaXc/dTP+qk9z2/z0rAnKMrxTO3mNkqw6bvX8+K37uGJfMESGJHJS6hBDYBbhwPQDHI9K5e8Vk8oEAqjMA2ew7CplK5pBcqLMMv2eJH/wCWjMPlzge/49q0NN3S3Z+XpwAOvWsqR3aO3VEzIhbJA5K9R+PNX9H837SoYCQ5yQTg4HPNS9huV2j0LQY4JGe2vLdp55YiYkfiNiBnHselXNQtbaGxnjigjURRBjOdu8zMeF6+nGKo6KFu7tkjhUqVeRQS3zkDIA7gZ9Oauz2cDTXEr2UarFbRz52kKsn9089CT0qlsVLRnOKUeNBOiiRBtICZHFFXIUgSIbLe2mDfMXdwpz7DPSimkQzN2CLePLUF8IyknAB9MUkrTwtGylXI3RZCkYHHJq0srLu85Q6ElZSOM+n09PxolkhjQxMr/MTyT0GOBnpU3Q+WyIg6yOzPxlRkM3T6ev0p97eMsMa+YgQDhFYEjPvVe2k8hTE6COQ4AJH3/wAfWn3c0JZI0jBDEYX+In3/AFqDRbDVnJkYLiJmGGbGQSOQMUwSiKEkgYLBthX5mPPT0qZcKqMMq/zE7/X+WBUQiZ5UaFw5xkMCfl/xPTn8qBpWIkQOASQznoV7+vFPMbSSKIULYPRW+6ByT9Ku7PlBdlVjgnZgfKR1GO5pikLtHl7RjaR1zkelCC2gqxKEQFgWYgle6n098CoZoC2SpD7SM/XvgVOY1cvKARhD1HT8+9NMJRmCH90oz15Of69aoSRC+6RY0ZztiB2qewPap3gCFQChI67cEU6KFRsZWJJ+8T0PU8U6FCcMmASSWwvYntUNmiRCImD7TlR0Ix39MVXeBh94Er2GTxWgB8/CtuPGQP1pbiMkgHdtC5DMefxqHKxpy3OO1q13xuhbamDjHbivINZhktroxSchR8rcnI9jXvd/Esu/zA7R8n5OcccfWvPfFelwm1mmEY8xQPmZcmurCVbSt3PNx9FuPMuh5v604EjkHFEoIYrgjHrSDIr1EeMXreSUYxyKvpcSoP3it+VUbdjjIxV+zdSArhsg8VlLQ3p6k0MxuHwoIx1461u2MbHBAx9KzIo9jZXGK6HSU8wDA6e9ctR32PQoJpam1pm+MQlgV+bIx3r1fw9oks1tcX9y8krD96BI3J9K8/0q2lvmihUgbTxnivYNB0v7No3myzxxO4wjyOOn0pwjpc0bsWI7ye+1OG2tVzHCqszj7oOO1bHnzT3rwxIdtuB+8J6tjkZqloY/cyRwyZaRseZ7e1dAIodG09UAUx4JJzklj/WtEjOcuVpJXZxusS/Z55zLkPIMYHNY+n2yzzDzMK0g2hSe9XrpX1G/uJDndGeRVRwVdWXIII/nXPLVn0FFWhZb2K0IEOpR71O1XAYGq+qQrDeyopDKGOPp2rU1CLZctjH3h0+lZ9/AUlMjMGYndUSVkdlKfNJSvujJuEYRsCcDvXA6tEGMpwMY4J7HPWu81KUJayuxxhf1rz2/kEroqpuO4tjPHes0cmaSvZFa2XLARnjvmu68I28cXlzyMoL5A3pvBx7elcSEcXSJsHK9q6bTZby1VxDE9wka5lXqqqe4PUMMfSrpaanh1GRa7HHHdNMyrGssTcpkoXB42nqM1zF25Eojxxt3N7Z5rrvE9xNKypJPE6lVYOE2lgQByBx0A5HWuMunIGwY2qeBnOR7GlO1zSmaen3r2upRXNvkkRncDxgEYb+eatafKbrUWnkZQzsW54Aye3bpWFG6S5VmYBFGPoTzitvSolw3yl0BwVDbc8frTv7tjO156HZ6XbNqN29xdTzpEq7/ADIDgoAOcY7cVq2lxaahbXQ+2aiyxx7tshVht9R7j+lZFnua7L2V/HbyxoGDcuuwLls9uB275rdELNAWjvLTYgjleGC0wZEPQtk/dzRHXQuo7PUqG2sVZo2eR9nyg5A4xnpj3z+NFQfarW4eSa5Fy8ruxJhwE4OOOfaiq16MheaOelMgXzEZcMeQWzkA1IJozCImMiBfmKbec55+tVlG+VpIIJD8wzkbVXP1q3JpxYbppd4f7+BjHPY1n6l3vsMmuVkR1ym3OC7Hv6ACm2+9GeWAjaQVG8ZOe/vVvyVthtEaeYBt2lcdO+e5pIwDM0hUOXPAHTPvQ3bQvlbd2NjVixSfBIGWO3jPpj/Gp4XUHYdhAXODxvx2P+FMxvLgsz45CnHXPGP/AK9KcOmFXKjGFxls96m5oQ3DY+dmVW6bT27fzoaXdLshOVJCE5684z+dSPgkxsNwThgTjIPYd854p1rKqxvN5OVbKjOccgjPTtxTSIbtoSnc87IjYUAqu7gYUHkk+wNNd18hdqs2VwVIwfp9aaYjsAJfcW/gBbPHB9xntT4R5ZGcO7KVQHOSSf5/41XKCepIWJwerdlDckY6Y7cHFQNnGzaA33i4PT2qeRHVCIsq6scknlfaoXIIIBOD0Pfjms2aImVfMXeZBjG48Z28YqSeExMCRgKBnB3D8+9RKjn+PO459B0Gcj9K1ltD5IdnKxSBgo65A/kc1m43NVKxz08eZ8rKVDDGATWNrdgrQnfJESONuGBOfWunkhwyqASXHXbj6jNVr+xkmtWxudljJbByMf55pU3roFaCaPA/ElmbeZ4VBYRHgZztB6YPp7Vhc5A7V3njmApPFIoy7gockDp6Vw8ikZOcn8iK9ujK8Ez5rEQ5KjRYt2+YACtWAAj3FYsBAZQR1rZtTz+lEx0NXY07Y9Mc10WlRbGVgMZ7HoawbDax6YYYOPWuns42YJkkKOenTNcklc9KHkdt4ctTK6bMIO7elexPoguNOspnSPYUCkseVPr+NeJaLK6SWyrIfLlYY9ucGvWb1pdNspVsPMuXmCrES/Cn6dDWkNgmpXXKbv2ZrazEdohCwtu9efrVXUr6e5tIz5XMQ5yOGkPQfhS6DcXlxZhr+XYFYKVVfvY7E10EkdtLaPI7KAudiDsfX61bV0Q6ns5K6vqcLpEn2dHE3zTOWLH1Jqs8YZ2PQZ/KrN0FWSUrlQSccVTWQ79vb3rnfY+gpxWskWb7BXBA3EDcfXisi/dZOQuNvFal8uwjBzuANYVwxYk5wuetTN6HRho6JnM+K7lY7ZYAfmkOT7Af41yCSrueQKCTkKPfsTWvrsxutRdWAKLwPoO9VrOyW4iQCQKWcDBHT3rOCvoeVjqvNUbK9hdJ58EU8E0mwFRsXbyen616NpDQXFlcKsoRfIx5YOGG04YMcdSOxrJsbSGzvBED5ZMe5Wcj5h/Ac9uex9qw9Tv5Ybi6kYuGcHerIAW6ZJA7579OK6LciPLcuZlHUp41j2RMrLC24NyTz0X8Oa5hZnebLEbADz2FWtU1AS3UzxDhmOTtx3rNjkLTxnblSenb8awUbs3UrI1YY43kZlwuE44+8PX65NdNoVkZQrh1LAjg9MY5NcxaIY7honXy2Tr7fh79a67TFdIhKGGSD94+o+6cdKJb2ClrdmzYxyrdxRWcKzFlYS+flFaIjkkjjpWtFtjsmQSWAlS3MfmJcfPs64A7+1VdGj83VlDQlVkgZWjXPzEL0A96fAYY4rl4NLkiZRuDMS+Oeu1l6dacEt0VUV9Gc7ql5D9rYiG1cNzlScf0opLu7ngmMaJG+PvHygcHPI5HbpRSctQt5m0WLRL027iWbODkk8Ukyo4eMnKgHdg5A47U2YCeUmJoVPJUHoePSoReRiFFC4KAb1cYGO/ze5NTctO24wKzu0TOWUgDB78dyajdCIdpl2gtnYgA6DAOf6VoXJM8Q8qTcSeCRzkf5xUCkRAyLAGZlKYHGwnqMdvrSsMrQKIjy7tuxjfkAVLGruBhVDcbW3ZYHH8qkDLM2zaNx6jG059P0pF2RxEgESq4AyeMd8+1FgvoS2cO52ljkKSIRyTyvY/1/OmEEw+UFIRuMKSTn6dz0qJZXYKiqyuw3Fe3PpTzFtjkeJx5ofCr0xyOfpVkvuPfYIEfdICSFYMecDr9MmrMYAkVmEYkb7hVj8mAOP0B4qP5XyPLOB/E56DI5+vbFOXEw2RqreSQu4qAo49epoeg4jfLEquA2c5ZW9eec+ppmMgkl9qDtj0qaKFPs7NluvzgHg5JAGPrmkMYQsQAGPVt3AGOtZyNUPssTAfMqdyMZ9q3IV2qHV3VXIVUyVYgfeJPbPPHasGPj5lbAOBgdRnkc+1bdqzbvMeTkLvBUAkdB0PUHpj86lFNGXcrsvFGAkYbBIbO30qW7nSPS5Q5AYcImOXznr6EHvVLVEcXO1j/AL2ecex7ZHtwKzL/AFCZrcQiQ7AS3UYI9c1NNpSZpVV4o868fRiSJBHgKZP4j0z1wa87kHzMAScdz1rvvGE4khQBGbcxOM8fhXCzSK7nqGJ5zj+lephb8h89jLOq7EcYAIJ7VpWTmQ4HT1rNTlyMZ4rVsYwhznjtWs9jKj8Rt2fDZ7V0elXE0Fx8zAwkcp3PpXM2zYrZ05GfJ3HOe1cbZ6qtbQ7LTAfOTII54UHj1r1Tw5O87RqyM1tuCM/J2E9AK828N2TyywGQrtByxY8Yr2+11mys7GK0jtoVifggH7oA6k+ta00Oblb3Vc2/Psbaw8ggqIvmBf1FYWoXZmKzwswMo3CL0PSuc8Sa2GKpDOHbPJWsaDVWLKEkkXceNp5NKdRbG+Fy9/F1N/VU8kfvWBmfkKtUowEnXfyTjNU3vW3FAC0h6s3JqeyYgOXA54znpWLkm9D2I05U4WkT35AlJJ6cVy3iK9CQmJOGb9BWze3C7WdjxyxJ9BXm+r6k73DtIBknj5s5GeKl6kVqqowS6saibrkhSGd2GM8cn1q9YL9i1NsTwrJFlldhkfLzx79OtU9Ijupb5PsqCSdm2ruUEcjrzXS3On74Fu7dY5ZYsrOGOwONxHzds544rSC0ueLVd3uc1rN/fz6qxurhRJKjFtzbjk8844HtXJXV/KGZYzyVC+uPUfnW1rlkzTvM0U0ch5YBiyg44571i3cMcLp5ZJQqCOOR6iiUrnPCFmV5lZkAbhh14q3Z2vkWU7sF3MRyTyO4H45HFRQQ+bJwHZXIHy/UcE1pT2/lSyQ3E2QhGU4OX9QfQURVtQqy6IsWitcTyTykSTSMHLevFdRozks0SsVyAcseCc9x3FY2l2zbwF2E5BJI/ix0FdWTL9gjjuGBYD5V2AZH1/Oudu7bOulG0UWbdFi8p3vJ7S5DYCRLuPUjrnnpT57q1+xtGdW1CVjn5HBCls5weemKq2VpFPHAZ9QNtMp4iaNmx6c96s6qltDZNCL2KZ0RiiiJlIzkdeg/H0qoXtcKii3/AF/kcrd/bJZibMlYlAXCDHPv70VQmkKSsBIw6fdcqOnpRUNE3Oz+xCMN5cgaUAOrsBu6dKjiXAaKVMKPmwegB/8Ar1clMcUKNtXzTySOOD2PvVVQzsjsANoxzg/pVF+pG1r5UcbRs7jJxtOCrY4+tIPMeMiKQEk7htGD9Pz4rRQHlFbMeNuVHJ7/AMqhjg82NpACp4G8cbST/nNA+UgTyirmQ4dV8tS4wFPr9cigW6SsA0pLkcALnZz+vbpSSRMkjYBYruyCMkD1p8FrIZcxhyyjcCo/X60ahoQXNrhlZflkyP4yQTjgZ7dKfbJIJI5EYbxhlRjyce3rRC8u+SIBhhi2wjt3JJ+gqVbZTKDGx3RLlGbgtknkD25GapEtChD52XBkeM5YPyCQP8advcwsiFlD5Rs/MOvr26U8/wCkeXuwpYbQfReufryakji2qGfcQMEDjLc8UmOJASFCrhlBI3HrjHHX60KAPLMoDNyT8v8ADj/JqRvLjiYuWYckAH7o9v8AH3oiQTKrwhgMk59T1xUssitQ6PG2NoH3W9Rk/n0q9BOIm2hcyZIVsZB//V1P0qEjcCBuC4YE+vIz/Wo5CqjYHJHI9MDP8sVmzVMoX8i/6tc4A6k9vX8a5vVJSuVY84zg46VsX7eWxckhm5A6Y5/ya47xPdlFchtzdBgg5NKELysRWqKMTk/FMqvKpLAwgZY++Txj1FcrI+58rnHb1qzqbu7kyszN3yarQpkCvZpx5I2PnKknObZJC2W4HPSta3Tbyx9uapwRgEHFaUcZYc9DUzka0Yli3YgAZzXSaOfLIZh8p4zWBBEoTd3B+7itWzuCdqLkY9BXNLQ9Cne1j0XTZkRV2ymQKMhV4H41rLqEzJjfhSelcppk4W3A49Tg5IFaMNyZGGFYIOM+tS5aaHdQS6mo0oLdTge9JBMkcu/GW7EnpUCYYMpYAkcH0qtNqNpZbhdyKrDt1JFZOLPRVaMFds3/ALQexAJ/z1qSS6MUe53CADPX7o+tcTceM4VXFlAWY5+aQ8fT6VzeueILvUNscjEKABtQYDe596pRM6mYwirLU6fxJ4pXy2htm3KeN2eX/wABXEW97LLdH7TllY7hk1X8uXzSJEKs3Hz8VcubS5RIWkIdhuw0bBuT0HHSrUbI8etXlVlzSZ2un3jx6fbT20ipmQKzYBCN296nvbi6C30N1dyeVK22Rl7g8hgOnb8qyrCezis5IkMqwXcAKuV+ZJlwR+uQT6YpuqTeeqklY3kKpIV7OM8gflWstrI5ott3Ysj508H7S+5CAyFvfOcd6zRDEWlZ9pwpwX759B9atWqGXeJWXEgAjIb+MjIX9DV2aIrdrczyRKhLqqKhHIXvWajc0c0tjNtbdQkscSiQmMS5f5QuKLgNc6pL56xeaCG/d/dz3qa8kI8sxsSpAZCwxsHcEe3SotP+6HOMkEDjrTm+VWMormkdBo8DTXEeFOf4SW28j39elbz/AGeCxjZoZxOQQzlsrk9CKx9KtTLcMxXcqruKucH8PetOaJhN5ayBlGW3OeMjoMVyJs9WEUki94aYteed50ZlxhRPgLvwdvNaOq3Ulxo9xIGi8trbEm0qSsqt8w9TkVQ8PWiXE6J5KTOA2I2PEhxlcfQ+/eo9ZtDZaLetf2Uduu0mNsBXMhPAHfGO3Tito3UdDnq2czzTUS32phAWKDjoOKKpahIkd04LlT6cmikk2YuaTseoojmONCRhctscnOPX61OmIkQH513lmVTywx29Kg026kmQLkI5YKGYc4+tWZIYc4534O1/Q+h9ag6VqVi4DK5UqucKEHI+tWZD5rhdjKT0zz35qvGk7qUwVZec461Mm+RWaLewA5/OhFEyo3zq5Cydc/4etRW32iJSwk4G7CkcnkUodWtlilA3ByACSDjrmpI4wkgDcnYTkEnjpT1ApkJLLIEB28DDjqec5/OpQWhn3wOpBBGZB24Py+9TQziIJgIZATz6cfyqI+YSRIp+XcVXPT2psklt2MoRJAQkOAUAAyD1b+VSKux2wnG449xjv6DmoXkFwHZwHJO47cAkEDv25qSQCOMMFIZl5ZWyM+n69qQ1oQzv5yBQ6lJME7uox0AqTICx714HB2gcjp171Fv2uFCF2zwR2HU81PDH8qcYOMjnpxUyLQ9I05LBgVPDA5FZd7J5YYBRuTvjrz2rRBdCRlCQucevsay9UGV3KDtPy+4qC72Rh38xVXyVaQ8k9TzXmPiS+W4upELOQuBgHAHvXd6vMFjco2RH0OTkmvLr8b9zZyepJ7V14aCvdnl4yo7WM6fEj7sdD1PJNLEePqaY5xnmiEnnGfxrvex5i3NK1UqgJHFaUAGODmse3Zw3zDg8YzWxYQuwG4j14rCZ2UJal6FQRitOwtwpOODnmorJVQeo5z61Ztx5aNIX3YIwhPauV6nepJbmtCFQcDnqMdasHVIrJgJXIOQdq8n8qx/NuJ0xEPKPTP8AEaW1sdvzsD5h43Hmpc0ik5PYsXmt3N1xaqIVPU9WzWe9s0jFnLndwdxzWtDZgAYUswGenerH2GQMfkdfl44BH61HtG3oU4t/EYP2AggAbs/pT104yAEgFj8ob1NdNHZg4aSI7c4OM1btrKMiTcgMYU5LHnHsO5oTbIcbHGTaXLJNGEy5cZA3Y49atW8UiusqBFlixgMu0t6fWuxW3swFQRIZHQFmLYxz6duK5jWYrSFN0XmbiDuP+17enFbJNGUmkWrg28likgURx7i4AOAobBA/MGq+mNM1tqkc0IWVHWVfXnoKz1nkmtUtcqVZhgAYbHbn25FVIhcwi4VWLu0Y3bc54I/WrXcybNPDQ2cCTDZKzEDAwFwcjj65GavGaW5l88ztuZV43YBHXg+2P0rMsbmF4i12WM0pdEDDBBwP85oDpDBhUKx5xuDAu3qM/WqvbUh9h9xIJz5YZRuIzjrgc81q6eH2F4wBnB561mWSKZpHbBUjA21rWYxKgAO4HGMZrnqSudWHhbU37GF38qGVfLZ1yJWkx8vt+VTiOMPidTlSc/4mlVJYgpaGPLKxJBIzyCNvpio7aC8u7pjE4Bk+Uqev0z2rFpndF2NzSkjMkFrDZJLcoXkQmUqjcdvfoeKr+KbOe6tCi6fCZMkuRe7hGx4yMnqcVNDeTW16guiHwrRFIPvpkYG3369K5TxV5Ggadeu6ai8d2uySZ4dqxrkEnry3HHSt46qxyVvdd/6/M8R8W3U8OvXMB82J4T5bIxwQw65oqn4p1NdZ1+8v4kZI5mG0OfmwAACfc4zRXqRgkkrHgSquUmz6WmjMc2YgChGeeh+lOtIckGKYp1O0jj6e1Ql5JQ0T4AfhMHsKsW8UcLB4g2ABncc815J9GtiyZipW3VMSDtjO7j1ovLhlDRKGKYB4OMjHP5U2QiVhLuweqjNTSzxIwkfaRgnrncenT2pMtIgZ2a1jDLvIBUjPPrk+tEQkeOFPk80cqqnAYAdfyp5ljYBmA4AyV4DL64qKSV4ykhRjCuBjbkDtnI/CgGNkmDtI6EF85JbtjqD60OxLMkmY5SCAV6N+P0NJ5a4laNhu+UEHqT349qakvIkIXKklcZBXGOQPzFMgcymIAjYj/KwIwcjp/SpYwoeSQJ+7AzIoIwpOBn6dagYLOQckxocMH7g9OlTRzNDEXDpuHyhcgkdBQAijMWEf5NzcsDyOgP4020ZvKAY7QMAcdqVJVCEqx2qSRuGDmpvKUt8xYgY6Hj/PvWcjSOhA5WQeYeTnHvnNZmpTEJIwLMg+f5v71ad3uZ2CgDIxxWDq0hkt2I3BgpBycdKSCWxy+q82shJOMnken+c15xfLGihVEnmhjkEZG3sc+tekakSYHCkjIxyOua4u9tlZyCDg+nrXXRkonmV4c5zh2g4zWhaWocAEc9jVhrFVkURqGJUZIHep4rVlOFX3JNdEpqxzwou+osFtGOcDPQGrqIAY9jctx1ohs5ZuCzZJya1bPTPnHybh371zSqJbnXGm+iIMHykWNSGxhh6+laNlp74V3ILYAU+lalrp5c/6tQE55PQe3rW7ZaasI8xzltwHr+AxXPOblsdVOjbcybWxJySAo4+c9B+FaSWSMqYRgw554yfp2rVtbaJhs2yFiTgxr1x296sfYhGFBWY552lcEc+tZ2udKj0Mn7MBtUkhCc425xVgwExD5UxjO72Pc1cbafL2qyrjIGcnrzUc7fIcjABxkEenc00HKU/ki3MFZsdm5Hpn3FQSt8+z1Xg9h7n0pzTEuAzb16c8gA+1Vbkjy1jLEqnUZwM5/l7VrEwmTSvFbxxM+5nC+wxn0rndakiK7AGboWJPPFXbmUSbsfKG59c/TjtWZfxA7UL7OeXLcAfTuau5zyMy3kjiu280HjBQknOR2A96DcIbtXXG3YVYvxuJ7nPSq0sMkJnJYZwD8pHPNKkdwpT93jfwGI61p0MtLl6NIViDXBU85ViwJz0GPT1qaFjvJVPlYEZPJ5pqwKWxvjuJgMnH3QPQZ61ZhjOWDAAg549aiUtBxjdlyxgLRgM20E7/APPvW9paIblh5XnBlIAPGD/ePqKoWlvny2I4PJ7/AIVvW2xVbepQIQu8H8wKwctbnoUqelhXMnloEkby97AAZ29OvtU0Bu2jYhl8rGenp7+tRT+WhzgtGoG1RxtHY0hklihlhkZ/JGDtzwxx1qb3N3GyEg1AWt9++YwxvG6tMg3bXIwG/D2rgfGt/Bpei6latqsd893B5SW8G5gvzA+YxI4x/WuoubKSaITR3VnCnI/fXARhj1B/nXnGoWz20PiC7utS0uRZrFoIo4LsSOTvU9PwNdeFpuUrvoeRj6qimk9WedGikor0zxbH1HDMYZYreQfvE754q0pjHDO4ct8wzwPQ01bM72kj2Dafm3cjNVFE3ESKpIOSCcHb7Zrx99z6WLaL4jMR8l1ARzmMnv8AQ+lTtbhWCsQxA4PXB9Khhcug4kZVUBCf4TnkVYT7qNbk7mI3rnkUrItOw6NUWSNzt+cleOe3p2pwkXc8aA4VdpYdj9O9CJIzOXTgDDYGSo6k0xsrJ5ROM/xNx2pjsViUYsxxFLv2jC5xSzh2cOoxv5kwOnFSKgDOQSBtJZ1H9fT3qYRBo/8AWrjJKgc9vftQTYpOFS2KRZRsbgmOFI6kVajO+GMHEaqfmA65P/6qjdf3RMe4EkHcw65H+fwp5QxxFlkBPqRwxPAx+tAEl2hSGPfuLY+Y4HPXp/jTIgQMM38OcjkY/wAmh/M8tY852RZy3ynHvSuGwgA2t0XntnFSyo6EMxHks5VdyEdDwa5rUHKRMyMSDnjHFb90SYHX5SwJwcd/Suf1BcxtuGAvXnIoRM2YkgLKSUBbBGQePfisW9scuoyCD0OefxrZnzu3KwCAAYAxnjrRBb78nGU+6T1xk8H25p3Oe1zGj07O4lQCpx16mrS6dt2gjAIzgHqa6OG1DBTnLKPnVuP171KtmDubKlVGQenPf3qHKTNY01a5hpbLAm5VBORyec1NbEiTiMrzjPUmtK6twqqGAduyrRZw5OAuCwGN1Q2bRgXrOCQqSN5IH3h2rXjH+kR4VTnBOVwBx2x1/wAaLSMrmNdu8rwzYwoHt0q3bIzPHEJDukG4HO0k/kaEjVKyJJRBFtjTncuMBeRjnP4mm3Dsu1WwxYZKlSNoHv3FRzwmJsqQyZKjI546/lVWadZgFAPpnHKge/encqyS0KonccOCxUk/McD8KqySfuscliPmU/8A1qSaZlG1vnAGAV5496ou+xyGBAI9eaLESkh01yI5/Lf5SRwwH+eagEyeS20hZRuDu3TBIxj3p0e10/hLryN3FV5oNk5kaLLDsfStErK5zO7I3VCVDFyD3HJ/+tVC7lUnIjG4HHAyavzxtgkudrYOBn9fSqMy/wAOAQO7E0JmTRlTwqzK7+acncQQOKZZIglfyid275d6447dK0lhA+aUMCBu+7nPsaFg/e7h/E3JByf85qucjlbCNMbndcY4yODn3rUsrfzEUksHI45wPrVe1h80/M465yPX0962bWzLZLZypxx29KiTOinTLen27AxmIBmR88LuBPcn2rXdTs2qoZcZYhcFc9eabZbox5azYkVCPo3tVjymCBGO2Q53MOQW9KzudsYWKbqHc7o9qKu3Gfaq1+ZESMTjaWH7tenHqa0JlZQ3n5ZuAV9PfisPVJQCzRAqGH3mbJx6Ckhz0RyPiaDUNRs7hdNt2uGJ2lhhVX8ScDivNNW8O6rpUAuL2yeOAnHmqQ6g+hKkgV1viTVdL1m3j0q9v57I2Uzssiw+bFLuxnIBBBGMZ5rDWfSdF0vU4rHUptRnvYPI2LAYokGQd53HJIxxx3r2cNT5IebPlsZV9rUfZHLc0UHrRXQch9UfaTFO3yfLIdrsDgHPegSDc7xlFkQ4DMeSPTHpTpYk8hlIHIGG7HHao/JUjeM7TwWA6H3rxrH0t7vQuRXRbDxRlWAIdT6HpmrEWJJtvplgTwCe/wCNZ6RTBIpYyNpJQoewHU1bun8q3t96KqcjOMggnv8AyoLRNFGQzbGYBx8wPHtwe9LcJ5THGEXBA34JPv8AXimSSAugjlB4yCDwue34UyQ8ExctwOR1XPPH1pFdSIKvmtEZG38HZzgD29sUBhFGPL3OOnsB7imsoE4Z1xMp6g1NyXV1O0NneCOhzz+n8qVwYu1w4CNkMfmAPOR0Ip8LHAY7MONpGOM9jzUMqbLhovM8zacLtPX3zTk3BsiPBHOOmM9x+IpiHq7TK27dFknMgAOFpkqsWCRpxtynuDyKJy5jEzAFWwf3fGDn/wCtTrqLyY03bWZlVgAc5B/yam40VL05GV28cMM9Kxb+JdrHacZ4I7Z4rZuEQtuVGZVPI6EEj+lZ17GOGIKvjgDnjv8AjwKLkyVznJxtlOSR6mpYQcb0TKr8rDOM/wCHH8qkvICrkhMZxx1I9cUy3YxPtyDvGOnDenP1p3M1E07VwjK+WlQqeqnGBjDe9WXwvlZPCjadq4yP65/SqVo2EIV3bevGOcc9MelXQPnTlirKNjMOcDqPpWbZ0wBQZFOF3BuSc/z9alhh3EbVBJ4+Ujn6Ulsu7IZyu85wP8KtKBCQzYLkEHGfp2qLnQoqxatIl8whHJm3fdXkZHtjP5VZi3eYBExYgk7t+3BxxyfpUOR5YIjkC4yTkAYHoc8j9aS5lbzSq+Yi7R+5lOecfyqkS0MuZZhCA2NzfeRjjaM5/HrWTct+42sN5Y8EHOSe9WPPYSuu0Df02A4Ue3eobgKwBIRlJ4cLj8SB1+tC1ZEmZ8ihiqpE6uBgkHGfr7U1YA773XC9kZe3sfWrxHzo7SEFu6NtqtlYnVAC2PlII+Ujr17mtFY55XJY0jt8K8YIIzuBzgdRUF0/m7c8enrims+WxnAIGAOMimzlinmL5bKCAQO31pthfQpO+BlV2gkglvWq13hduCu1h19DmrUg835GyHBx9PTNRlFwyhz8vzbSMAH+tTczaIY0yQDGz+655pZId8mZIyuSPmwBke1KQ4AJBEndgamhTzArEnB4Jbj8qVylEdbRiOTMSY5OO+BW3ZxlZtwye5U8Zx6e9UrGNvvpleQQDXTWKrkvtUsSM+Zzk/XtUs6KcbEiyyW43wwoI2QjDnP+etV8zyMWCfOoz04A96mngCtIueFP3TyOaZdu0LHL7jIu75TwRj0qXqdKVlqVL2cAgbcZHzbeNp9M1wPjLVxYWMkitiQ5SNR6+tdRrF4sCN8qrhSSe1eIeK9YbV9SeXpCpIRQeB710Yal7SWuyPOx+JVONluyxouqaRFpd4mp6XZ3F+v72GecyYl55Q7Twe4PT1qle61Y3FpLFD4f023dxhZomkLIfUZYj8629Agul8OR3Ph7Tra/1IzOt0zxLNJCoxsCoegPPOKmvYdQuNB1KbxTpdtZiOLNrcfZ1glabcMIAMbgRnPHFeyj5pnB5FFJiimK59VGAbSRIcAdUHH0xT4hJjbuG1htPbj1qKJWEhy3k+qk5H4GlSNigkMnAP3cc1459IWEuHijKhUMY5ZWbHHSlgmEkuxfmBAyrdPzqn5cEEolJJVzkEjOD6Yqe3kIHlxSKfkIAYD5QemKRfmWHiKOCSNvTZj5SO9LJbuWYNI5ByMg4x6Y9ajQTJ8pmUS7sH5cgnHf601JpMAMpOCCQx5GPQ+lA7j1DNMAWY9z3BHbNTShiTK5+YttAAwD7k9DUSXBPBR0OeSOm04qRpQMFAGjIyRnqRn+lIYBROv7oLuUkkkdc9qiU4V228g5Ibt/+uprbKj7rEKTgZ4Bxzn86ZKsiBdygqzfK+OvbmhiQzzG8xR5cmM4BByAT14/LmpVHzMz7WyCowcY56f59allYqAPLXBbcNhx0GCcUrlmXOwBepyOMkYz+Y6VJWpRl3ySuMBHB3Zxw30qpLGzplgcHgHGR9cVcuFyNjEg4B56k8d/pVYAKrgEgAY60hpXMm+tlTcEYDbyMc/hWdJEPmEhIY85PAz/AIVs3QYgscDd0HT8frWdLEdwOef4c4/nSuJxFid/KDfMBn5lB659PY+5rRXaVC8PxkMckj2571miXy92/JDfLwPlz7ircUzRqTuYjAGMDr64qWXHQuRMyIcJuk5JPp9KkV2V/lDMTyowCPxqsrKWzvDvjPTIx1zipUTzE+WUoXyTyeQD93n160kjZSNGJgmDcqk6rwTvyemOB3x7Yqs4QsN0m5sHK9AD6HHGatzRpDaRSSAiRwAdo6A9s5/TFZ8xAYRhv3apzheFHYcdzVMlsYrg8qDkcZzhvw/+vVRlLB/m2r0G8e/SrQCKdzk5I6v/AIimPsliP7xkAPygHJP41KIepUBGcSEYHQKcE/zqCSZipVRLtJBKkAg1oLGiqC8OV7kcMKcqMEIhAAB3Hef1xTuLlMuNSGPfHOAMH8jT5NmAGweSOF6fUVMwwzZclsZyOpqN03uCWIXrvxyOPancjlM+RWimOEZlJzjPbrTniafvnHoMNT3bMA/hP8JJ5FRxKzPlGyxGDlutS5AoiRpwu/1zg9M1aijbexcfKfXsfYUkdsCgIPXsR0+taFhbsAHmBwSAMc459KEXGJZ01GS7yykxgDJK9frW02xodzgBh2yfyqK2jT7OyhtpiPz+rD+tRySO7NksgUZB45NJs3hHQsSrlfNcgJwCw5K/hWHqNyvlMVBJzww649MVZvbpQGcffIwSvf61xXjTXRpllJJGAspO1Ix2JFOEXJ2RFaqqcXKTOZ8eeID89hAQS3Mrj+H/AGa86Y557VJcyvPK8srFpHJYk981Aa9ujSVOKifK16zrS5mdRpsWl6boVnqWo2d3dyXc0kQaCcxeQqY6EDljnODxgVal8PxfZdVvjNLqGn/YGuLG6ZjkMHUFW9GGSCPxrndOl1S4tptL0/7RNBOQ8lvGu4MR0bHb61LLNrWiWtxp032q0trtcSQSLhZB6jPGeOorYwbMfJopcfSimI+q3uDEQJUxz9zHT3pjHzGJhclV4YsMVYU7mJ8sgluSTk0wi0bcWRz2J2kc14p9OOS3hdS6kyRhcs390np+tSeTEhGz58AEccH61B9mWKH9znk4Azw3fmlUyRx8orDpgHp+PahlIfNH+8HLHa2drcYHoKHEIcSq4Xa2cEHn161PMHcotwny8EODkg+n/wBenSxxKI/LXLBcknkMM0hiSS/vflU9NuGPAH/6ulRRxRSkodvlv0Bzx9fSjyXhRvnkJByAMbSAP8Ki3qrx7TIVGGX5ccY70xdCxAJWkK7mdVwQm7G7HFSjcbdQqnd155Bx069qruZiUaLbuYk5IPQ+lWElEas6qRESFIwTs9fp9KQ1YWPeeEAD5z1yB34pk7b5JA/Kj5woP3jnmp4kZ2TaVTA5x0xjsexqIqUyV27WG1mY575BpMogl+YMu1TxgbSMfr0qpcfISp5HICY6H1/OnXBaGUDoAMEqM4qtcDKu7gh8EgnuTUvYaIZUL/vAdqkZQe1UboMoZggAB6lRj6VdhYGPcJNikEK2cAD09qqtK29lcgKDzzwDUsq1ynuKqAp4bpnrinpMpQRnJ7K2fm+lI6uN+UKr1AYk4/CoHUgZPTHI9KRDL9pKGcRyFiycFSv3h6evHpV+OVFt02L8jZKMenXp7mufEuG35LsvKFOGU+vqau2M/m23zsPMjOQp6Mc8kU0JTszc8wK2BkkLkEnG31NRjy5RvQtn+JmP9PSq0bCZVxncpYYz09Kuwp5b4xz/ABKBz9M0mrGydxjxJch0DgqDwQOKiaMW8qghdhPX0q5uDDgbJcfKRzgfSobgbGXzuXJwf/rVJVhjorR7lcAAk5Jz+GarO6mNSjY9dpxmrjku5jdxtP8Ay06DPpVOSDho4duMcsDnNAWuU2YGQHa6Njt2/wAaR1xEWYgr1Yg806VJGjVt29V+XIPQ02JSVPRc8YBzu+tK5KiRYR0+WPYB39aQQgyRmNcNnAUDA/OrYj2bf3ZJJ7cDFXooFyCyhs9Sflx70dSuUrRxuHaOaRTg529hmrVrblJJm5DgYOG4qdobcCL923mbu54YetPUCdULKu7nO3nIqmBaSSQQqioGGdgOOpqtcSMmAwCscjO7O38KfKWiQhhtXg8NyPwrH1W8ihhkYlAirgEnkmla4OSSMzXNRSxheaRiI4xliT1/+vXjPiLWZtXvWmkPy9FX2/xrR8aeIJNVu/Jjc/ZY+Bj+I+tct1r1cLQ5FzPdnz+NxTqPljsITTD1pxpD1rtseazsdItvN8KfZ7WNpZrmKaTykfaZpVdVCnHJ2Id4XvmlW0aHwrLa38D28i28kzwyMcqysgjl2n7hYsyY4yBmuc0vU5rKKWJoormzdg0kE65XcOjAggq3uCKdqGrvd27WsMEFnaFt7RQA/Ow6FmYlmx254oFczM0U6SNlYDqMZGOaKBH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well-defined erythematous plaque with scale, pigmentary alteration, and scarring is present on this patient with discoid lupus erythematosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8372=[""].join("\n");
var outline_f8_11_8372=null;
var title_f8_11_8373="M mode scan II";
var content_f8_11_8373=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F62680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F62680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    M mode echocardiogram scan of the heart",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 194px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transducer is positioned at the left parasternal area and is moved from the base to the apex. The scan that is obtained shows the aorta (Ao), aortic valve, the mitral valve, interventricular septum, the left ventricular (LV) chamber and the apex of the LV.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8373=[""].join("\n");
var outline_f8_11_8373=null;
var title_f8_11_8374="Pegaspargase: Pediatric drug information";
var content_f8_11_8374=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pegaspargase: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?41/9/42133?source=see_link\">",
"    see \"Pegaspargase: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?41/34/42532?source=see_link\">",
"    see \"Pegaspargase: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F206778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Oncaspar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1049174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Miscellaneous",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1049166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?41/9/42133?source=see_link\">",
"      see \"Pegaspargase: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     (Refer to individual protocols): I.M., I.V.: Children (&gt;1 year) and Adults: 2500 international units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose &ge;every 14 days (as part of a combination chemotherapy regimen)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F206757\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oncaspar&reg;: 750 units/mL (5 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F206742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1049178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Limit the volume at a single injection site to 2 mL; for I.M. administration, if the volume to be administered is &gt;2 mL, use multiple injection sites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Administer dose as an I.V. infusion in 100 mL of D",
"     <sub>",
"      5",
"     </sub>",
"     W or NS over a period of 1-2 hours through a running I.V. infusion line",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F206806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1049169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store vials in refrigerator [2&deg;C to 8&deg;C (36&deg;F to 46&deg;F)]; do not freeze; do not administer if there is any indication that the drug has been frozen or that vial has been stored at room temperature [15&deg;C to 25&deg;C (59&deg;F to 77&deg;F)] for &gt;48 hours. Solutions for infusion should be refrigerated immediately after aseptic preparation and administered within 24 hours of preparation. Avoid excessive agitation, do not shake; do not use if cloudy or discolored or if precipitate is present; use of a 0.2 micron filter may result in some loss of potency.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1049177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     First-line treatment of newly diagnosed acute lymphoblastic leukemia (ALL) as part of a multiple chemotherapeutic drug regimen (FDA approved in ages &ge;1 year and adults); induction treatment of acute lymphoblastic leukemia in combination with other chemotherapeutic agents in patients who have developed hypersensitivity to native forms of L-asparaginase derived from",
"     <i>",
"      E. coli",
"     </i>",
"     and/or",
"     <i>",
"      Erwinia chrysanthemia",
"     </i>",
"     (FDA approved in ages &ge;1 year and adults); has been used for the treatment of lymphoma and acute myelogenous leukemia (AML)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F206808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Oncaspar&reg; may be confused with Elspar&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Pegaspargase may be confused with asparaginase, peginesatide",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F3136296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Edema, hypotension, peripheral edema, tachycardia, thrombosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, CNS thrombosis/hemorrhage, fever, headache, malaise, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Lip edema, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyper-/hypoglycemia, hyperuricemia, hypoproteinemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, diarrhea, nausea, pancreatitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anticoagulant effect decreased, coagulopathy, disseminated intravascular coagulation (DIC), fibrinogen decreased, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, thromboplastin increased, myelosuppression",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hyperbilirubinemia, jaundice, liver function tests abnormal, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site hypersensitivity/pain/reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, limb pain, myalgia, paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions (including bronchospasm, chills, dyspnea, edema, erythema, hypotension, rash, swelling, urticaria); anaphylactic reaction, night sweats",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abnormal renal function, alopecia, amylase increased, anemia, antithrombin III decreased, appetite increased, ascites, bone pain, bronchospasm, bruising, BUN increased, chest pain, coagulation disorder, coagulation time increased, colitis, coma, confusion, constipation, cough, creatinine increased, dizziness, DVT, emotional lability, endocarditis, epistaxis, erythema, excessive thirst, face edema, fatigue, fatty liver deposits, flatulence, gastrointestinal pain, glucose intolerance, hematuria, hemorrhagic cystitis, hepatomegaly, hyperammonemia, hypertension, hypoalbuminemia, hyponatremia, joint disorder, lesional edema, lipase increased, liver failure, metabolic acidosis, mucositis, petechial rash, polyuria, proteinuria, prothrombin time increased, pruritus, purpura, renal failure, sagittal sinus thrombosis, sepsis, septic shock, somnolence, subacute bacterial endocarditis, superficial venous thrombosis, thirst, upper respiratory infection, uric acid nephropathy, urinary frequency, weight loss",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1049181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to pegaspargase or any component; history of any of the following with prior L-asparaginase treatment: Pancreatitis, serious hemorrhagic events, serious thrombosis",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1049165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with an underlying coagulopathy or previous hematologic complication from asparaginase; patients receiving anticoagulation therapy, aspirin, or NSAIDs; use with caution in patients with hyperglycemia, diabetes, hepatic dysfunction, or in patients receiving hepatotoxic agents",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1049164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     ; inhalation of vapors and contact with skin, eyes, or mucous membranes must be avoided. Serious allergic reactions may occur; discontinue in patients with serious allergic reaction. Observe patients for at least 1 hour after administration; immediate treatment for hypersensitivity reactions should be available during administration. Pegaspargase is indicated for use in patients who have had hypersensitivity reactions to native L-asparaginase; however, in one study, 32% of patients with a history of allergic reaction to",
"     <i>",
"      E. coli",
"     </i>",
"     asparaginase products also experienced allergic reaction to pegaspargase. Serious thrombotic events can occur in patients receiving pegaspargase. Pancreatitis can occur in patients receiving pegaspargase (promptly evaluate patients with abdominal pain). Discontinue pegaspargase if anaphylaxis or serious allergic reaction, thrombosis, or pancreatitis occur.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Glucose intolerance can occur in patients receiving pegaspargase. Coagulopathy with elevated prothrombin time, partial thromboplastin time, and hypofibrinogenemia can occur in patients receiving pegaspargase (monitor coagulation parameters at baseline and periodically during and after treatment). In patients with severe or symptomatic coagulopathy, treat with fresh-frozen plasma. Reversible hepatotoxicity (hyperbilirubinemia and liver enzyme elevation) may occur.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6222178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegloticase: May diminish the therapeutic effect of Pegaspargase.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F206753\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F206766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted with pegaspargase.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1049173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs during administration, CBC with differential, platelet count, urinalysis, serum amylase, liver enzymes, bilirubin, prothrombin time, renal function tests, urine glucose, blood glucose, uric acid, fibrinogen levels. Observe patients for 1 hour after administration for signs of anaphylaxis and serious allergic reactions.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1049163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hydrolyzes asparagine to aspartic acid and ammonia depleting the exogenous asparagine supply needed by leukemic cells for protein synthesis",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F7825734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Asparagine depletion: I.M.: Within 4 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Asparagine depletion:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: ~21 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 2-4 weeks (in asparaginase-na&iuml;ve adults)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1049180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Not absorbed from the GI tract; therefore, requires parenteral administration; I.M.: Slow",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Apparent V",
"     <sub>",
"      d",
"     </sub>",
"     : Plasma volume:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.M.: Children: 1.5 L/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.: Adults (asparaginase-na&iuml;ve): 2.4 L/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: Children: 5.8 days; Adults: 5.5-6 days; 3.2 &plusmn; 1.8 days in patients who previously had a hypersensitivity reaction to native L-asparaginase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Adults (asparaginase-na&iuml;ve): 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: I.M.: 3-4 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Clearance is unaffected by age, renal function, or hepatic function; not detected in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1049171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?41/34/42532?source=see_link\">",
"      see \"Pegaspargase: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Notify physician if fever, sore throat, severe abdominal pain, excessive thirst, painful/burning urination, increase in frequency of urination, severe headache, bruising, bleeding, chest tightness, rash, swelling, difficulty breathing, or shortness of breath occurs",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Asselin BL, Whitin JC, Cappola DJ, et al, &ldquo;Comparative Pharmacokinetic Studies of Three Asparaginase Preparations,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1993, 11(9):1780-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/11/8374/abstract-text/8355045/pubmed\" id=\"8355045\" target=\"_blank\">",
"        8355045",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Avramis VI and Panosyan EH, \"Pharmacokinetic/Pharmacodynamic Relationships of Asparaginase Formulations: The Past, the Present and Recommendations for the Future,\"",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 2005, 44(4):367-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/11/8374/abstract-text/15828851/pubmed\" id=\"15828851\" target=\"_blank\">",
"        15828851",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Avramis VI and Spence SA, \"Clinical Pharmacology of Asparaginases in the United States: Asparaginase Population Pharmacokinetic and Pharmacodynamic (PK-PD) Models (NONMEM) in Adult and Pediatric ALL Patients,\"",
"      <i>",
"       J Pediatr Hematol Oncol",
"      </i>",
"      , 2007, 29(4):239-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/11/8374/abstract-text/17414566/pubmed\" id=\"17414566\" target=\"_blank\">",
"        17414566",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Avramis VI, Sencer S, Periclou AP, et al, \"A Randomized Comparison of Native",
"      <i>",
"       Escherichia coli",
"      </i>",
"      Asparaginase and Polyethylene Glycol Conjugated Asparaginase for Treatment of Children With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia: A Children's Cancer Group Study,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 2002, 99(6):1986-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/11/8374/abstract-text/11877270/pubmed\" id=\"11877270\" target=\"_blank\">",
"        11877270",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Capizzi RL, &ldquo;Asparaginase Revisited,&rdquo;",
"      <i>",
"       Leuk Lymphoma",
"      </i>",
"      , 1993, 10(Suppl):147-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/11/8374/abstract-text/8481663 /pubmed\" id=\"8481663 \" target=\"_blank\">",
"        8481663",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Douer D, Yampolsky H, Cohen LJ, et al, \"Pharmacodynamics and Safety of Intravenous Pegaspargase During Remission Induction in Adults Aged 55 Years or Younger With Newly Diagnosed Acute Lymphoblastic Leukemia,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 2007, 109(7):2744-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/11/8374/abstract-text/17132721/pubmed\" id=\"17132721\" target=\"_blank\">",
"        17132721",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jarrar M, Gaynon PS, Periclou AP, et al, \"Asparagine Depletion After Pegylated",
"      <i>",
"       E. coli",
"      </i>",
"      Asparaginase Treatment and Induction Outcome in Children With Acute Lymphoblastic Leukemia in First Bone Marrow Relapse: A Children's Oncology Group Study (CCG-1941),\"",
"      <i>",
"       Pediatr Blood Cancer",
"      </i>",
"      , 2006, 47(2):141-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/11/8374/abstract-text/16425271/pubmed\" id=\"16425271\" target=\"_blank\">",
"        16425271",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12682 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-4838B967EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8374=[""].join("\n");
var outline_f8_11_8374=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206778\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049174\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049166\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206757\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206742\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049178\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206806\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049169\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049177\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206808\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3136296\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049181\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049165\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049164\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299829\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6222178\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206753\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206766\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049173\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049163\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7825734\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049180\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049171\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12682\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12682|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?41/9/42133?source=related_link\">",
"      Pegaspargase: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?41/34/42532?source=related_link\">",
"      Pegaspargase: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_11_8375="CML marrow";
var content_f8_11_8375=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F68724&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F68724&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bone marrow aspirate in chronic myelogenous leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 288px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEgAZ4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCTw9oVv8L9Ok1LWLhLnxI0ZW1tIjuAY8DB7+9eSa/carDcz3Or20huNQctK8i8k57GtHxBJfjydUv7ue61AsTtVsmE9vpmm3l3qlz4Zt4Z2X7QkpO08uM9yPSvtqdJxfPN3b/DyR9GqSgnCN099t/66fM6TwV4p1nTdEvPDiyzLpmp2rqsPJeJyOqHtu7jpXLWsXn74LiO4SIKSNqk/N2BPeus8Btc6v8AErwtBKqO8MqLK8RO1lTktjt0r0T4pD7HLZiQlYzI8YQxjGTyCfWo9tGFXkS1lqYVGo1VSiul392v5Hm3hjwhqbXsL2MUxlysjvMdqog5yT0/CverYPbxpfCTDKMsVPJI7r2NfO1/4q1C5uZIr6V4LGJgDErELJjj8a7T4N3s99f/ANkXEjyWbZmtpWYnym7qM8H6Vni6cpx55dDnr02o3vt0PqDTfms4n+b51DAMckZGea4j44XHleCmjfz0gmmRJJoj9wdefrXUSa9pmm6TFc6pf2dpEFwS8y4yPT1rm/Etzo/j3w1cQ+H9TtdQntmE4jt5QxYjsR15z+eK+cwyca0akl7qe55yhK3Nb5nzlq4sjLI0igPCAYyG3Er657U37U8bpHMxZWttrALtIx0B96qeIZLS4uYHhjYyROYponTYQwPRhVSS6uHdzhYkiIMjJzvBP/j1fXW0R7WWuPs7LpuOvbkLqqz2zuYkHzAHBbPr611Xw9ubqHXtJubeOVLqO4WFQ3GQTgDHcHv6VxElyEn8lSzjoQVwyn19jXqHwStH1bxnDLds8semL55uHOc4GFHtzWWIkoUpSe1joxb/AHUk+x9MwsxjXzRtfA3D3rhfiBqUa77UszMQNqqMgnqcntXbQuZWlZHQqcBCFII+vrzXhv7R7Xtnoc72eQJWWO5mj+UpEe34+tfMYGmp1lE8PC0+apY39KheMOsLr9ocB4tz/dXtx2Ge/evE/E/gLxpDrt3qSySXkF4xkN1bXBLAA+mc/hXD+A/FGsaBdvqdrPLC0C+SEPMcq91fNa3h5/E/j/VJhbOJb29LOyGcx7gvPy89uwr6OnQlRk53VrdTup1IW0em/np+h6x8Efi9fHVk8OeJZWurQyC3tr6QYkifoElJ6+ma958TazHo2n+a7qsrHCAjrXybd+AfEcnxD0u1nsb1bK8uY0kuGG1/LUjdk9vqa+jfE2l3l5OzW1qfsMACKR94kdWHf8a8XNKFNTjKj13OOtCKqHG694P8LeKXOo3drcaZqci/vJLI4Rz6kdM/zqDRvAPhfRLs3hsZL0QkFJtUYGJeOQVPFd14e0JpETe25e5x098U74mxPY+C57PTWjtmu2ELTyLlUXlmz2GQpH41yUK+Ik1R53Z6GsK06s40nJ22+Ri6p428O6K1vbWUJ1GCaORvKjI8pcegPQDmuN8WfEZda0q/hv8ASdKfTbeJf9Buz5s07sesfpjrmuKe6RtJju7yeyKtE6JbxuzOGPG5j6+naqWgmxMq/wBvvPHbXEJeL5g5Cr0XH1xXu0sFSprmerXU9uGBoU7Plbf9f1+RUk0fwxea1sD6jpvmARIV/ewgkc7c9h79K+ifhf4C0bw7aQ6paiW/1GaPCXt3gsoI6LjoD6ivCNK8TO/mxpaRNp1vCVSNc5Rc88/3vWvefghrM+q+G5oruJLdreQeXABgpGwyv4elZ5k6ipOzsupxZjRcKXNB6df69TtH0q3di07MSTgAHGz2GKLmwshZLEkIIXG1V69avOUPDOFABJQYOap2IAC5Bw5yke3AjXsPr6188pt9TwdUYFxYA6jD50czBeWQZ2sPf/PFawtZba4aVSqoCGCbiQB0yo7VrPGjRFegxgEdqbDFtjA3rIuMAlf4T2qJPmepXMc/f6IdRjW9tGa2uTlgr/xjHRvrXkfxI8HeJ5NTN7pOkC8CKquWxIcnqUX2r3bUtQg0yylubyUJFGNzM5A2ivnTxt8fLiTSXl8PQvb3i3Rj/fLmNoAeHA9TwMV6uXvEOV6aul3O3CTqRk5xtbzE1XwhdWlpaS+ItUtfDegEgmK/cPK0nRiqjnPt2r2f4cav4Qn0MWng27tXs7U7XCHDbv7zZxkn1r578UXE/wAWvBD6sYZU8Q6M5ge1VjtnV+mz39q5T4L22t6V8TobMwzW0iRyC8Qg/LGFJO4eucV31sM8RSfPKzV9On9WOrE1JYhqFR6eWx9s3Flb3DbpolZv73Qj8RzU2MYC4CgdMVleE7qS98P2k00csTlSCkpG4YJAzj2qzqF7JazWscdrNOJn2MyDIjHqa+d5HzcqPIldOz6F1SSoJBUnse1Z+qaZDe23lSZAGcc9SRitA5yMfjUVzI8UYMcbSEkA47D19/wqUEW09DnIfDAtTcyS3e6JgWUMv3D2Ncfe621jOLSNln8r5nkII3jocegye9dp4w8X6B4ZtC2u3yRkrnyVG52B/wBkf19K8Y0zx14d1vWLiztDM21s+aeN4PX6Y9K1WFrVI88Y6HXRq8z99naQ36zxx5nljRHDeWckPu7H1BrQ0wx6TpYhvJHls97Fpbkg7mJ4Vf6ViJpwsrhJbVzcW7HdGwG4A1089r9o020t72RZkP7yUL/CuM59sVhSg3NRZ0Saegmnao82lb0tTCjZK7FBJPrg9Kp6lcW+k6el1rU621uM/vJOArZ9vzrjfi743h0exOk6HNZXMc0GDPBMC0YyOBjivANRudV1jPm3UkyyHHktKTg9sDvX0dDAOrFSeif3mlGi3Hn7/f8A8A95vvjFo+mkReHLu81e8YrAkOCqsSw+YsfbIFXfjhbap4n+HtsIvmuLST7TPDE+0yJtOSB3K5zivmpreCKzkEXmC8jPzL1IPoPpX0B8Abn+0fAV75ty8+pW1wVbzsuI1IwOD2rWthoYblqwWqf56F1aCglLr/SPl5Hu2gJikIXqwZsb8d/emFh5OJCRh9q/X1r65n+CHhLWQL+X7TZzbv8ASI7ZwFGfQHhexxXQ6L8D/AWjzRXo0pr+SBcr9pkMykjnOzoT+GKVTM6C11v6HFOpyK17s4X9m/w9JqHhS5k1JrxLaWcC08kNErrg7myOoz0z3xXvEelQNapG6HfH3zndgdeawNV8VaFoN1HHdanDYfuwUtWGCB0wqjgVp+GvEtnrluJrC6gu4c7TJEeje47V4ddznJ1UrJl1/bzXtLNLQv3l3Z6PZvPeyhYweWI5OP8APWvmv4j6n4O8TaxdTR+HEu7tnBe6RjHv55yR14zz64rvv2hn2RaeFuZI85DIrEZz79q8Se1d7UyxXSQyA7EBGB/wI17GWYSKgqzbu/kVg8PGcXVkb3hTxXZeDLknQtDtLa6kDIkhG91Hux7GvSvD/wAXXu2a11iwV5o0D+YhAU5/rXiEf7uxO+YIJPlwg3l89h6Z/SoC0sUYWOQKzHcQckj29q7a2Ao1r8yuzslRpy05TutR8F6V4guJL7S79rJZXLPFH+9SM+/cVz83ge+0qWRmuhdQuOdybWAPQ/8A1qksHuNMuZbqyml2xShGVFzGw9GI/ma9ph0j+0NCsr+LaYiFdI5G3EA9VyehFFWrKja7umcdapWozS5tP63Oa8B6BpfhbTv7S068j1TWZ4dpuY1wkKd1Uevqa2fFH9m+JvCzWWqOIZWIcSoPmRx/SptG0i2t/FUS2YXy5jseNurEj72PapvEHhGWPUWcwmSMjdhSSBXzuIlUp1/acz11/wCAc6rNz5m9Tx7/AIVTqWoZhS5tri0b5kcvs2n/AHa9G+H/AMOrTwvbia61NW2cNKzbEiz169M+tXx9stxGkVtJ5Y/hx39Kv/YzrnhvUbN23SSxEIFf5s9QK0qZlXq+7N2Q5VJVHabsmeGeOLq21nxffR3+rwxQQzrb2cu0+UkeeW/+vXMfabvTL+a80K5uIo7dywvIsqz4PHP901Be2Ms1+YOfOgBjPncEen41PFp8lvdLDfjyYYCoUK24ynPzLxxzX09JwUErnbXdXm5IR0Wn9dPL5HR+G9W0fWNREfxESaPzFydQt0KzJ3XcADuHvgmupl+HWkahYrfeGfE26yLfJNcRGMn0ByAc/wA68z1C3RtUurZ1ZWaRZUVZiwiXOcZ719O6V4WVPAugS6gZ5beK3SSSBRghiMhyRzmubE1lR5ZRla/Tp/XzscdSMqTTWj6/8MeWeFPh5YXcx/tPxLEInbJaGMlwfcnoK9ejsdD8F6UbTw86Qy3vzNOW3vKfXmuM1aN9Bji/sTTGkjuWPzBMrCT1LHv9K6yaytzBaQpFG3kptB6E+pHfmvIzSvOUF72j6E1Ks5y5ZO6/rcj0zxPei9OJmmRmwTngfX3rtdQ0mDxBpxWcxyByN6MoZXXupB/nXAWdmW1G3CrJxwWUcL6g1e+K+ieIn8LJN4bvrmza0DPOtvIyvLH34HXHXFeXhk3USTtfqZSbi7xdjm/E3wI8Kpp1/MdSn0xZUOxpbj9zG3UE57V518ONS8GeAfEc1xrniWLUGtyRaQ6dG0qZIwzll46dq828YajqskVjHfXt9d6XHlv3rF1EvoQePwriLd5reT7REilXLIPxH/16+qhSqKDhVm2mR7eVt9z7js/iR4Y1jUdN/sa7jb7YhxK+QUkzwCp/ir1aNNkapknaAMnqa+Wv2ZPh6+q2/wDbmsQ50yGcPZo3/LRl6t9M/nX0j4nvpbDSnktpI45mYKjSdAa8LHUoRqqlTd31IUnJ2Jdd1aw8PaLeapqcq29jaRmWV8dAPYdT0GK+Y/E37SsesW9/pyeFt+mXCmNZJLrbJjs2AvXocZrvviTbal4q+FniCwnlkuJ4FFzGI+rbDkqcdRjJxXxspG3BbHpiu7L8BTd5VNWmbJciUlv39D6WttKv/F2g2mtaTHJqEcqCPzYoACkg4IZB3UH8a5DXLTUFmkdLWdUyLcuYdirjt9c16B+yZJqOn+BdXuEsjNaT6ggi3yhA3y4kK54OAB064r0b4j6D/wAJRoczTLJb3tvNmz+TlxxuGOhBGcGtljvZV3Sla39dD2cPmcptKqkl3/4B8+abpcWpXFlpzvJp/mKJ/OdTlk7hVHXJ7nrX0N8MPCsmk+H9RupZJbi8vpi6tKChMS/cGO2QD+dct8Ovh4LHVnutYsZ4LeFQltFNJ80zgZ5PXaMdOldN4z+I1v4U01LzUnRFY+WiW43lm/uL6ms8bWlXfsaOo8fXdT91R12u/wAd/wAzTuIdRN/JMu4seRg8g/4Vo6ZKU/10siAn5RuyM14hrH7RbxiBtL0NpPMBkcTybCg7jA6/U16V4C8X2PxC8OJf2cH2eYsyvGzZw68lfy6V5FfL61CPPJaHkuD6no0PzxA5BJxlh3NNEkojcbN8q9BnG705rntKuJbaYF23RDgg9F+lbl2WYJJEwHG5T6//AFq54a6M5akeR3PIv2ktTuNO8AxW0z7bi/uFTMakquOTg+vFfK1vczDTp44hIsMiAymRM5KnhQT0Jr728VeFtI8V2S2niC1F3bDkRl2UBuzDBBBFcpoHw1sPCVveW+iRC5t7ufz2F0BI0ZA+VQT2HvXuYHMKVGjyNa/h9510asVHl23/ABPnjSfGeq+AdKs9HttPitr8yG+uHuV3Ekr8qqOqgDPNd18IdWufE0+v6ndWcSahcvH5s8HIfPRR6Dv+FdN4q8DaZ4q1xZdX024OorH5TSQZQ7ewOOtSyaPp3w98NahH4f017aRYTcXUzvuJYfdGT15PSuidanUjaK99nbGpfRLcz/G/xXvPDEk+h+Gbe2vLuzi3TzOeEc/wgdzXK6L8YvE9rqnk6wy3JKeYyxAYAxkrnoDXnS28l15t8ilrqWU7QxxO+O+30zWr4e0PU9ZupLTS9PkkvmJjWcZAjQ/e3npiuuOCw8INNLzbNo0aa3S8/wDM+m/BPimbVraFZ3jCXUfmW0/c57Mp71ueN9eTwx4W1DV5Nh+zR7lVzgM3YV5b4dhGi2Gn2BaWS8hba8mD8rDsB/d9K6D9omzvrz4XXTWMe+S3ljnlQd0GQeO/UV4VTDU/rMEvhk/6+88jERUZXWx8seMfFA8R3dxdz3Ej6geW38glj0VRxxVOV7zTpFuJNOiijiwjyKQHc9mYD09KoSLbQRsUi827IDbI33c9d2R0Gag02U2yTTyyJEjMJWiblpcHIAz719SkopJbF6J2PePg54hvdXa+0xSJNOtEE/mMPmViQML7c17HbSBpJ7a6T7RDKu14u7pjoD9K87/Zh8K7ND1HV76Nz9vbYmOAB1P5cCvVtT0c6e8VzaJ5sMTfMpPzKPXPfFfM4t01ipKP9MdOqmuWR84/Fvw/Y+EfFlrFo6wizuk802/3miXuGBqTWPC2laV4YhmtRJc3Zfzk1ND+7kBHKKPUdKtfGTwTqk+par4ilk+16cGDLcltrIh42t64PevJ73WdVWySzjvJJrCNP3cPOyMeuOx969yhepTi1K/c9OlV/dq7uWPFVtCFiltmXzD94xD73sfcV7R+zjqWiaVa3+nW0Uz6zdL5k/mnEaoAen5815AniGKzkhSe1hu0Chk80Z69c+orvvgfompP8Qlv4rSaDTpLZnebqgVgcDJ684FLGxUqElImpGL5rn0T4Ld3e4d8FJBnjoAKy/FGvQaBcXt9cXhtrGCHcyr/AHsjt7itI3ltoOhahqHkHbbxPNKFySyqCeB2r578QeLf+E8sbyzuYIbOY/OjrMeo5WMDuf518/Swzr1HK3u31IwtB15yn0Oe8feJNN8R619s0KPUY5JY2a68/oV/2M9Ditb4MXWoReKYpdKeS5CIY7pIl2xJH0Ut6n39a890eeC31lZruG5kjWTzZFxhwo+9uPqegr6G+Ddxpt9qGqT6Lp0en2d0FeGJ23SSKDySfrzXr4ySo0XBK6selzWpOT1028v69TR+JEEUscUl1seBrc+b533mOex9a4uw+H91rKCXTpojahAdkjkOR6D3r3/UvDum61p5t7+2jkGSQzfMQfX/AOtXm2p2ms+Gc2srSG2LfJLbxZyv9DXHhMU3Dkg7SXc8GGJ5JvldjyDVWNreM0AcAEqq4AZSOOvvVC7xsSKWPcqks3lnnceuW/pWvqOnXSXjNa+c9u7s0fPz88456Ve8O/DrWtWtprhIG8ppCQjEg59c969h1YwjeTPRjKLV5PQzNGmkhvLyLWG8rycn/Yb0z/hXU+FvFV20U2jReaUZjMkkvH1UjsK5K6v4ljSxijEs0Z3M7EEY7Z9cV0/w/s0vNTmu7qHa0KlWwNpDH+YFTWUXBuSMcU17Jye53fgvUrK3vLm/1COZ2t4jMoiBYn+8230HrVLxZ8Rprq3ltreN9OhPNs0LYkfjuR936VzGqXbTXN7cxTbLSJDbmGH5WK9wR6ZrnobdIF+1W7o8yjKLJ/A+OOO/tXIsJCU/aTV2ZYTBqUrzNGy8f6rCB9slutm/IcvgBcY5Pr9a6zwL8QYrm+iW9t3jhdvLS4cYy2ccnvXmtw/2i+McIVLpuGaQAoxPUY+tXLhn04RRmIRFTvZQeGbpvx2q6uDo1FZxtc7q2BjJaI2vjR4Mv7DWn1nRoXl0y/IYlVyUcdSR2U9jXmF5ESxQRv5qrtAbPHuPU19NfDjX4PFFreaHqLkuqiW3OckR8ZGfY10djoWk6DDLd6na2Mk6HMcnlBnA9s85+lcDxf1ZclRar8exwwx9Sn+6nG7PBPhJ4Bn8QXP2nUIkTTYJkMxZfnlXrgN+hr6rUBVAUAKOAB2rz4a215KzwRmGBDlYkH9B1NdtpUxuLCKVxjjg+o6ZrzMViZYh3tZI4685VHeRNcQpLbvCUUoRjbjisG60sy4YwEsnIwOSa27i8gt4WmmkURgZ/LrWBbeMrC4nZUBEQbaHZgMj1x6VzqjOexNOlUkrxRc0nQ47dEaYZb72OhB9Kg8SeNvDXhqVIte1myspJFLKkr8sB1wO/wBK0Zb/AO06fdfYDm7WJ/LQ93AOPrzXxJ8eodZ87RD4qv8ATbjXLeA29xBY5PkAHK7z0LkHnFdmFwvtpcsnYag5RlJ9P+AVvG/j631HVfElpb2NrJo890zWKhdoVQThh3yeD+lJ8PdN8Ha9cWUPibWr3TQ8gRo1UFCfQN/CD6mvL3bewJ5PenJIyq6jG0joa+gVTlXKm7Ee3UtHFW1P0x8M6RY6FoVnpukx+XYwRhYlznj696Z4pudHs9Enn8RzW0GnJgu87YUHtj39Mc1xnwC1Zr74LeH7q86QWzQsTwNkbMoPP+yB+VfPPxJ8XXni7xhLe3G59Gicx2ED8IuOAcdyeteLhsFPEV5K+z1fU1w2G9rreyR9FeHvEWgizjutEdr2B9wMmQNo9CK8l1X4KeH/ABNrlxf6TNcWltPIZWtbXayx55IU9B9KoRaWdM8F2ywYxeTfaLpl58kYwgx2BOM0vg/Vzo2rafNE5EF3Iq3UcTEqoJwDj1zzXqfVXBSlRk7nc8D7raZ6lDpr6Tp1ppNpYm1srRRHAmTnHdj7nqT612HhNZL2FlnfzLSLiMHqT6/SthNOhuraMzc5UHA/rVuG0jt4CkCrG2MblXFfNaqTbep586ia5TG8eTfZfCt26qMKF6jO3nr+FfE2p6zd+NvGS20TCKOUtFZQvJtSLsCCe59a+wpvEGm+I7u/8LzySRaikRDgAru7HB7Y618+x/Bm40Px5anU3hl8OxHzlmifLPtOVX2JPWvey2UaEZKektzqoc0YKkt76+hzWr+ELfRrN4PEt9BbX1yo+y3duzNuKjmN0HY+tem/s2WEWmyXUpLvNcXmw28bfLb4HBI968G+Ius6jqPjXULm5d0eG5ZYI+0Sg/KAPXFfR/7NvgzVtM0ifV9XheK4vZFn2y5DvjpnPQ1146TWGftHqyqlSkpSjy2t1PZJrNHiLqpaZWKgHoefSk025uGuBBcqkcZBOx/vCrEmQkX70Bk+aRAOX9vpVO8/0hvkJyByF4+hr5CTcWcaV1qbeMMGBGD1NIZMOFYYLHCj1qhp80h3RgqxA4JGOfWppLNXI835zyTISdwPfae34VpFqW5hOLiXa8R/aJ0rUv8AhEbe4hvgtvHdgybxyc5wCf7ucfpXqHiK5lt4VitZZFOMErzj6nrmsoTW2oWj6dqNiL2K5+WZWH+s9M/jyK68LUdCoqh0UPckqj2R8jx28kN4WWRIBFhJ0B2rHIewb0/lXrfwm8e3a6TLpk9tE8sEZ8oxg8R/3mP8R966bWvgPoW2Sey1a5sUBMjCfbIi9yecY471neFo/Angy7NrBrYvRcE/ap3wMY6BQOgz6V7tbF0cTTtFOT9Gek6lOsmo6/I6jwv5us63BNFGylCDO4XC7B/UmvS7+zt9QsZ7S8iWW2nQxyI3RlPBFZnhjVdBv7d4/D93aTxxn5hC2SD6nvW3Xz+IquU9rWPKrScpaqx80+Pf2fryDU/tXgaVPs05Alt5nCtH7hj1Ht1q94L/AGdobd4bzxjqIuWj+dba3G1Y+5BbvX0RXnXxg8RSab4fu4bObyZgm1pD0Ut0/wA+9d9HMMVXtRi/n1JgpTagYPiz4saF4Uit7DQbZ5Usm8oxQ4WMcEBT36nP4Vnab8dmGoPBq2kIbfcP3tvJ0XucHr+FeBbB9rSaOCKUSSBGMh+/nr9PrU+yc28i2wRI4iyDecgHPRTXqrLKHLaSu+9z1oUKUYpSjc+orCTQvE9pePpV1DqWkXA23dqzbjGfpXKax4F8O32m3GmafpsVhJKvlrPGvzj0JHpXingzWr3w5rNpc+ZNCIZB+7Q7VlHdj2NfYmjyWeuaNZ6m8MYM8SyFuhHHPP51w4hVMA0020/617mFZextON9fvueKv8FPDs0NgkMt+JLePbO2AfPPt6V6ZLbaN4Z8O2wl3QWttCI0ZpNijA6A/nW1rd7baXbRLbrC8srqgjLc4PfFfLHxW+Jk974ov/PtXNtp4a0sreQ/u9x4eUju3pU0XVxzSk9Ec9OTqv35WS/r/hj0HVPiFo+r21xZHWXtUvomtkCqQobsd3cV5t4g0HU/CmqWsmoyWcd3cyJcLsjBUAEbWUj17ivK59TnvZCYGYn73Axg+3pX0b8D9Nvdc8K2d3qd0j21pK0EO8b9yjnqewrvrKGChzJ+6z0MLiI0/hV0jH+Ovh2KLxDG8bG0g1GzWaLyovleXGCWqv8AC2/n8G3Ud7qkKxSwQGKG3YlnYMeZAO30r2L4teI4dL8LQNcWK3FxKdsSEDbnoG56etfMl3Je32oNOLlW3sS0zHrjsajBt4rDpVFp+ZrTxDnCzXk/NHtEPxnuINSn3N5eno2C8qj73YD2r1jwR4ztPFVrlVRXxztcMj/T/CvjJrWG4hUys/U+Y3OVwc13Pww1y4j1VZbEJbsjgsh6cdD6Cli8tpSg3BWaOeph6c76W7H1rLpdhKSZLK3YkgnMY5I6Z9atIixoEjUKqjAVRgCmCZPs6zMwRCoYljgAVweufFvwjpU3k/2pFLJnnywWA9ea+dhTq1tIps8uMJS0R5VrPw9sdHijvdZaVY0ACkH5iAeMY61r6pJpdvoltFpM11ZwyDc0kjZknYfwj0+tdq3xG8E6yE0zUr1cvhM3ERVS3ruxgHNReLfCtglg17publYfnER+YAHuG9PavcjiZNpV00/wOnlq05r20X/X4Hml0v2q0vZo7KZHmHmkRjJkRRyPc1ytpD58zz4+yFVKRwMcAnrk+4969J0V0m8iKXfGiqyR4BBxn7xH6VpeL/DNr/ZttqGmxoUCfv4txzKB6+hFdX1iMJcj6ndgq6g3TnuzzC6063Z/PV5Ibh+flycMO+e9PhmmnmMMgTzwvlMpTPHTOexp1sZZkk5CFWCqFA6Z6YPrTbmWG0BhkZkZmLnjcBnjmul66Hppy6nUfDGePTr5Fs5o0ubebEkmcoyHllJ9a9Y+IIYeWMDbIOcDn/GvLvhv4Z2axbKscczzSiWd2bOEBz8vbFev+ObMT2sE20uY2I2j3/8A1V87m0ouomjwK0k63u7HE2W5Y1ihRRI/PPX2Br021m+yaHBLKv8AqoFLqD0wBmuB0qza7uY7aBwJDwzA8rg8j2rtIVefSbqwR908YKZPGa86DulcyqJOSufP3xm+IeoJd/2HpzGG6usfaJU+9Gp+6i+57muY+CGuX2o6n/Y95PLM13vKzsSxt3QcA57HHSj456Je6X4wTUBaFrGdAkDg8rKPvBj1Hciqvg74hDwd4Ve3sdHtrx55yTdTtsIz2I6kivrKVCDw1qcbt/1+B6cptS9x2SR0+s/GO+0vXo7bTdJ321qzRyNK5LOV64xwvFReP/h8/wAVPDkXjfwSjpLcgtcWE+QxZeG8s9ySO/WvLNP0y413W7nyJSGdZJy6Et5KnJYsB944yBX1z8FtBt/Cfg2GwW+kufOfzy0q7NrMBlcdulYY2MMNBTgve/NdbnNWqzUZNL3Xp8j4DvLO4sLuS3vYHimjJV43UqQfcVLp+l3t8R9jt5Lgk4EcK72P4Dmvur4n/Dnw74p1RL7V9BkuLhUAFzbzGNm/3gOuO1N+Hfw60/w3bynSNOtrKQthJ5h5k2D15PI+lYRxdJx52vl/wTjjQh8Ten4kvwp0+60v4F2WnapCkN3DYTLJATym7eQrejYIyPevl5NLge8iE4MwimCtbh9rA5/kD1NfV+r20dlf3n2EiC7uVIu23nD5HXB7mvFtY8AGPUHX7XLCH3MlxEm4NnnPsexpZbi6aqTT0vqd2GcKcWr6eZQvPENlaWi2F1FmVCP3dr8yMff1Iq14N8Pz6lrWQu0pJuNyzZVhnIjC9Mmuot/Bek2sdkiX91fO6hmWNcEnpg98V6x4T8KQaa0V0yGJwMrAD8qn1+tdWIxtOlB8u7Nq+OjGNoHOePfHx+H2jWdqkK6jrN22Y4C2xYl7lj3H868Tv/jF47vHM39oQ2UZcgJBAuEGcdTyfxqn43v5te8V65ql4rvGJpEVcgbVT5VUZ7Vy2oXOjG0t/KW4F42d7Rj5DzwCDwfStcNgaUI3nG8nuaUsLSpwUpWbPX/hX48vL/xb/Zmr3eny3N2p2X/2dRJv/wCebsP73SvV9Ttlvv8ARLyf7P5EmJElUAKpHVG6H1r5Z8BaRfeIdetY7CJo1juYmkeNCzRAMMsa+ufErRC8C3MET28o2uzgEYx1/CvMzPkoVYuPU58SoRqpwVtDibb4feA7TxANXazk1LUnlEjSO2UVsZB29B0r1CLUYzcpbvFJAzj5N4ADY7DmvPre1j0uW4jkKQ7RmEyZKSkdDmt7Q5rjVbq3u4lDQwybXd+nHXbXLWfto8zk2l3OarT5rybOulWNseYoPpkZrm77U4BeRKsCBIX3iRW2/N9O4xWjeapp9xBdQC9iV0UgknAU+ufrWFbWEM8e03kFzcKeqHII9RXBKEkr2MacGleVzYsdTikkCokSnsF45Jq5qeorYxAiJ5JW+6q+vvXLXM1ppc6wSSCa9k/1USjliP5DNTXUVxqkSqJVtr2J1LM/BP8Au/0q6NJy1lsaewTak9ije3F1c30sroUBAXBBxU+kQy+ZJcS52Q8nBxu5qW41KSKU4ulfyhiVJFBUHpxjrUF9rUl5pNwEWLeFDAqpVevUd/zrojRk2uxbptRvY8l+LXj241TVH06G4ddOiGHji+XcwOST6jAxivN7s/2pYW89vMhmiDRmIod8nfdn0rY8QKYdV1a2mZ0vWk+0P8oKqpHQ+lZ2jXysgexsS0I3K3dyO5PfHtX1VGnGnTUYLY9GEYwgktCtour3Wn31rPpEwsr5GJBifAb2YV9W/DHxZL4o0YtdxhLuAASFTw/v7V8nyQQG6RC8LZUyK6gIpBHYj0/Svef2dlUW88gKiWWEPKi5wOeCK4c1owlRc7arY5sY4unZ7ntVeN/HjTLq9sZoIgpSZRcLkfeKdVz617JWZ4h0lNYsGgZtkgyY3xnBxjn2rwMJW9jVU2eVB8skz4k0e2SS6WKQiSNAdw28pnrxXWeE9BsNe1NdOlv/ACbe0O9vL4VVPUE/3vevQvGHw6tmuIpr6Nre5TCyS2y4Drng1BBo0Gj6YbW1tmdXO8SKMlz/ALRr6h4uE43g9z0lVbVorUiutG0+K5MOnqj7RtWeXkZIxt56mr3iLVL7Q/hPcSea0Gn2xIKodrSDPC565JPSnapaW2kwWlzqsqJYZBVFbD7sd6z9Q8R+H/iBp114X+2R/vk/dHaVRGX7pGe4OOK8qtiG+XlXNFPV72H7CpKm13/Q+a77xzrl1qK3EV/cwhCDFHG5ATHQe9bWkaRqfxJupZNO3S6rGN80TuArk9XHp7isrX/h/wCI9H1G4gvLBw6PtVkwVcZ6qfSvb/2dPCJ0i31Se/LR6ncKI0T+FEHJO7+8cV0VsTKjSlUhZ9jz6UXKVpbHGaX8EvEV427V76y05Fba7lg5I/2QOtfQfhqNNA06y0rTIwbe1jA3BAN/qcdiale3s4bwWj6hZxzcExTTqjgH260Szpp149vJbv8AIc7iOtfOYzE4jFWdXbod8IKKskeefHi11OY6XqQldNwZFGfuHrjHrjNeRvePdWUdlJYTsquJTgDBfPVm9K+n1s7PXjPbXse6GQfLu/hP94Dt+FZN58G44APKhW7jDA7PPK57857e1e7luY04UlTqPVBKtGEVFnj2labfeK764k0gQxIm2GXaP3SZGM/Wu+8F+AU0S7hsJLh7y+lYM5X7ir6n29609O0+fT9W/sVYo7FkQTMhfywVJ4JI716l4M0zTtJEqQzQvdSndgPuKj0XPOK2xeOcYtR/r5hUqtLmSPNvjl45lstMOl2RkggkPkvJGcMy45A/DNfP+qaWbieOS4MjQumYxENgA98dTXd/F2T7V48urF4ne209i7Mrhdw65x3rmYb3TrqxWbUZZpJC20RQttKAdMnvXbhKUaVKKityKUVGDv6mtYfDrxTJc2093p0chuGILPcDyox67exFbfh/xpceD9Sk0aK5k1PTo2KXEMrZ8vB+YoT1HtWTonjK+0PTr3SROky3CtG0sx2vAD0YH6Vx72ryxOrlrqV32W94hwDzj5f72aHTnUbjVS5en9eR7DS5XGav/X9fqfQ2uaabSZNV0p2n0fUdskMqoXMYPYDsawjeyWUc17ctdXcEG5khh+d3Cj5lC9z7V7H4B0mWz+H2j6XqkRWWO1WOWM8EexrzL4lTeFfCetpDcar9mvXHmx2yqSUQ8HPsa8uhX9pN0Vq1fXfQ8D226ucefDUk+sySafcwPbOonAOVbDdBzWadOmXU5Yb/AM6SZm27ocsDJ2XJ9fWqusfEfw7Z3ETWU01y0b/diQhSvoc/pXU+C/jD4Ntry2a5trhJJXxuuCAkXue3B716UpVYxbUbnU8fyK17nsfw28OPpNk93eRCO5nACRlcNEn90j1zWz4ms/tFpJIjfOowRWtayi4gimRonV0DBo23Kc+h7ipHRXUq6hlPUEZFfKVpurNyluedz+9zHD+GbeK0uzcQIobaRtzwPX8a32uWtb25uZU2QEBUDEDce5+nvWnHZ28f+riVR7VieN/Mh0Saa3Rt6qRuQZKD1AopxU5qLKlPnZwnjnx74EQfZvEUKXAmBLQtB5gLDuDj9a831KDwL8RdPt9J8M6jaWGo28pe1heAxmY/3Wz1FeC+JNRuLrU7qGeaWSETFgrnJXn3/lUGkb4L2GSMKT/rBJu2tHj+IGvq6WCjSS5JNP8ArodCquD9mtfU+oPA/wANr/woZy6wTXdwMmeOHZHAOu1c+vtXqekSSRXmn2eGkSIFmcnAbjkn6VzHgzxTdax4Ks59UmBuFiQSEnHB7n1NdNpSM8lyyyhZBbEwyEjYhI+8fXFfOV69WdZqr0KnUc4KJ5r8d/i3f+HFg07QIJoby5UkXMgxtGcAop7n1rl/gf4s8T6x4ztXvL7UL+2Nq/m7nPlR8cM2f4s15R4tebVfF13/AGzq6SszGN9UyXjlx/cA/h7DFewfC3xbbaJ4Hu2uZp3jS68mLCcQjb8vPcHrivflhYUcPyQjdv8AU6FB3dOC02/zf9fI7K78baBrXiJoLXUfLu45RDHLNHhJJM/6tT35rSZ1GrQ2lxcTRXR6QKNwl45I7YFeJfCvSX8S+LrT+1Fuhe6ZObrz41HlPEDkhj/eY9DX1TYzQwWy3UsaJeSqyoQDjbnO0H0rysww1Ok4xhuRWcYtJLQwNHh02xnjMzwWyIMuztsBPcc9RXQaZ4s0PUZzBb6laG4BP7vzVJI9evSvkvxjf63qniXU53sbm6KbpJ45lZjax5+ZiD0X07Vy9oZoZ1laK4urEsY1QDlweygdK7I5PGcfenqaTwUHKzbueqfGn4XatYa3d674cSa80q9k8+WK3Xc0LdTx3Un0ryWXS9Su7mKCz02cXbPnyDGVKnuNvavUPBvxH1Twpq1pEb6S70QRtvsrhvnUdSVY9xX0WutabeaVb6pamL7NdosgnI6j3NOtjauCio1I8y6NfqVUlUoLlmuZd7/8OcV8LfDj6DokFnEYE1RR9puCRgFm4xjqQK62+tkuEeCeQyg9WJHA9BVa512K5nSOwT7RPu+5EeMHqSRTLq6ktZIrclWvG5fJ+4D2/CvnsTWqV5c0la5xJPmcnuzSstKdWVPOF3akjEcygrGB2FeYfFDWNYj1G90K0hew0uMK8f2YbWmzyxJ9OtejaReNYzH7VIq7jjBOAzk8fTPrXjPxG1aVPHFyuoeZdIswjVBx5QPYjuoruyqPNV11sd2XxUqsnNXSRzWj395Z3z6paGSMlAoilbK7fU+pqzJ4s1/R9Ykv31O2uIlIaKCddofJ7Htir3grRbXWrrUoLS/WzvmYultKm1JQOuM8jFZOr2kcN1d22sTNBfRMytEEAC91yPQ+tfR/u5zcWtTvnyzbjI+gdC8U6X4x8PQXcUCkjiYY5ideq+v/ANavMfiZ481GHxH/AGbpM0No0A8uS+mjztOPuqvqPWrfwMd7B7toYJTY3N0A0Z5w20gkf3vWuY+OMkk/xBuJllZIU8q2aAKepGfMJ6CvMpUKdPEunbS2hy4SjGNdw5bpK5gW3iPWI7GKbVNdvXna5wI0wiumcbvof5V6H8GPFLavrOraDr89tMzB/stymF8w91/2iBz+FeVW16sVz9hudOWaQHbG+NzRd+B3yKh8KRre+I9FtdIE6XcuoqXUAkxbWyWBHTgV21qEZ05K1vM9CvShODjt+Z3vjnwxef8ACQywS3awXgQJIzAlZIs/KSfWtew8KeGbTTDPfLONSeEjZuOMjsR7+td5rulLLd6gfE+pJ9nnZVtxCvzwY5P6Dk1lvp2iTzvDBf3GyNTvn8rkHtuPpXDDG88Em2vQ8Plq29139NjziC20aNZEttOiSFThFuE3EH1/E16z8G9Hu7a3udTuk8mK4/dQw4HCg/eP41b8KeEtMeKV2mgv4mTYDjmPPUBeg+td5bwR29vHDCoWKNQqqOwFc2NxqnF049Tjq1N01qPXOBuxn2oLBcZIH1ryP4mfGzRfCWp/2XAst5dK/lzvDjbC3933b1HatHwx44i8SWttqFjdvJbyEpgx4MbjqrL6+9ciwVXkU5KyYo0JSVzrvGepW2neGNSvLq3kubeCAylI+snYAH64/CvmGfxtq3iFxaWepwxtuJa1tI9hQDnBY8nHc17b8S47/wAQ+C7600+K4a9wkiwRfK1wqsCyg9zgdK+XpZbvUbmV9V060QhGDXOPLZSvq479s16uWYePI3Ja3PXy+KpxutXc7X+1NY8SNcSa+Ub+z4GeB0TeqkcKMf3icc15rqt7cLcz6dcyzIzS/ad8fWOXB/T1r2/wEb29+Gmqnw/aSyXa3SGzYgbpdvO4MfvAEVyem/DrxMNXutR8U2dtBDIcy3eoyiKJQ3UgnvXZGrCmpxdlbZHbUcZWheyXpta/kexW3h/SZvCWna/4qaV4bOwWdwnJYhck/p0rwTUfi/4om8UC9sZUtrEP+4tIoh5RjB4BUdTjqa+qTHofifwjLpOk6pZ3Ky2jQKbaZW+XaV6A9Oa+UfDWgeItA8VvZXOi3Ehs45ov3kOQoYEeaDjHHBzXFlsYOnKNRaro+x41L36ztpcz9as9Y8b+O9Qv9G06W/vdTHmhIxxbjHPPZhjivZPhjrl1qvhQWmqzG71TTpzbSSP99U7Bs9e4ryTw54ruPC8fiOxtL4T3t1bCC0ubYcCTdzluxxkVs/Ae11ZvFWpNPH+58ny7iROUMmQQN3TdXTj6KnRldaR2NY8ilZbO/otz22O/ltb9o4yFDfKSnJA7Gu5ufE8drpMUsuVnxh8j0HLD1HeuFvbcPd71GMHb/wDX9qTxilymj29xaeXcSbfLWN8hQ34dq+Uwzi6ijLqTGlCrKKmfLvjPxzquueOL3WReXUREu6BEc4j28L9az9N8ba/oniuLWob2We8TBxMxYOD2xXQ+PYLDRNTSztrBbe9ifz5ruQHbLIeQi/7HWqPj/S9JF7pVzawz2F1d26y3NpjKIx4BQ+/XFfaWhKKilv8AkROFWCfLPZr8f62PTfG+jR+KtOtvHOi28tzBqQxcoPnNtKB84x6V5np/ha/uDKY4rubDHIjUjb9a94/Z91yHR/Ca6c0Za2DNvDH7rHqa9g0S20/U3nnSF4pAxBA4BXsa87+1Pq7dKSvbYqt+6dpL0seVal8B/P1U3uk6t9ndSHWKaMOB7H2rrfA3wisdEvotR1u6/tW+hwYFKbYofovfn1rs7K5GmaQ880cnzPu2EYbJx8v4eteE/FH4069a3uow+GmtrWys28iSVlDylu554XHaualUxeKvSjLTuZe1r4hPXTq9j6Ur5K/bEuYR4w0aKBU+0raFpWxlsbjgUvgr9oLX4ItuuIt7aow3zKgEiqfQd8VsfE3wunxPtrDWdKu44tbSILHI/wAqXMfXBP8ACw963wmDng66nUencyhh5Si2nfQ+ZlDKinYFz79T61asoZHvITEgklMgXZj5Tnsfauqb4d+LrVfLn8M6g8ZkIDRRFwx9iK9p+CfwhvfD11F4j8YwRpcID9k00/O27s79gR2FeriMXSoQ55Mx5Fsz07QbO80nTNJ0aHGLO2XcACAuRyBW1r3jCLRbSSGBPtt7Cg3EuEjDehY8UQXFwsV3qCKJXU9+i8fzrwX4h6ykl81vDGkZhzKx3n983XkCvncDhnipuVT1+Z1UcPGpaPRHe6j8Qb3UbkxWWobCGHMAwij6966KxvvEVnYONUkjuYpVCZZgx56HH05r55sJorhoUkJWaUCR5N20hB/B6c1v23ja/tWSGC4eW0gypWYZVsDgg9q9mpgY2UYJHTUwKt7j/r+uhp+Mvgrc+I9cvLnw9eWymc/aHinXayN7MP4T6Vz2i/BC8tJTL4ouLNYLQ7xBbybpJec7fYe9egeDfG1xNqDSxKftEYDtCuWDqxx/kV7LcadbaqYNQtGQO68PjIZT/Wuati6+HahPbucFScoy97f+v6ucH4H0izNneQNb7xMoljZATtXt9B7Vr6PZNo5Frdym7hdmxuwgiH0711ui6daack5tDkytukbOeR/SuS1uC7N44RmcFjhuema8TE13KblHYdG12keNeO/g1Lf+JJ73w1NAElBaW1kO1Ez1CdiP5UaX8F1uvDyWeqalaW89zc4VbcGXy0B+8G9e1ezRW1z9nKPs2OMbe7D0FTxWf2l2WCIll5J6FR6Cu2nmtbkUG9jsdW921vuUtD8P6Z4S0ODStGtTL5SYZ5X/AHk7Y6se38q6D7bbXWl2MUo8hyBvjDbinGCM965XV4dWTzc28gjUY3qDgge9J4avmt7qSK8h+XONxPT3FcU685S5pGLV0n2OZ+PNgNMls/EFtZubiWE2kjIcozdUEgHUGvJ9J8QQL4ce8j077Fe2jkhoWAU9y2D19OK+p9bsY73SXhntRLaTcOj87sj17V43c/B6CcG3s9acPnEUcsG4xoOoJHUehr28Di6fsuSp0O/DYlKmlJ7X/r5GR4C8P6X45sIbq5vnX7HKr3MCWoXcCful/wCJSOte2XkNokMljMoS0QfuliAxGoHCgD0pPhz4Mh8M6MLbAaR5BJLIUAaVhwCR0A9q0LywWTWTBDH5KyHzWdl4bjnb7152OxEa02k/dWxxVsR7SbV9ERaR9lsrVItMCBio+aQBc+pHvVaWy3SvIZM3P3m3YIP0NXr/AE+1t9rxRnI5JLdMd8VnzSOzG23Ajja+Mcf4V50LN3Rz6t3JdKlc6kixxk4wfr9a8Z+OHhrV9F1W+vreRm0+9Pmx3ZPzQSE5ZG9jjive9ENomoTwIwE6qGCHqFPcGtTUbK21Gzktb2JJoJBhlcZFdeExP1apz2uuprTxLoTemjPlT4WC5vfE9iNSDTXCs8jXo+4i7TnPr6V6P4j8E6PrOrpql3Ncm5kiEBSFwoZB0GPWtmXwK+j3DyaLaQLaF90iQ8M3/wBb2q3pnhLU79w2ozzWkCHMSKwyPyr1Z42E5e0hKx1VcQuZSi9LFazj0PwsbWK5urez03TB53nlvkT/AGCe7n061538UfGvh7WtSkXRNR86C6CG7DKVyycJsz1BHBri/i/4gfxNrup6XEs0Wl6VM0FtAgwzyDguwPUn19K8ru45Lf7OJ5N0cWDs7p3wT6120MFdqtNvmLp81BqrU1b+49Nks1k14r5ym6eAGOK3TLq+PkjVR74rv/BGn/8ACvPAeq+Jda0X7DqUMgSxFwSJZnYY+b0XJ6+xqh+zd4gVrLXLdLeCS4heOaO6EeZAG42Fjzx2r0vxvYt4q0GO0uZGWJjvL98qcgc+p4/GuHEY29f6tJe7dXf4m9TE+1ahFWT6/wBfceBeHPiJr0/ilbnXdXSeIsxuTJzEI/RB2r0LxYbbWvhdJ4g0XUjbAyRyywNOA5Un7rfzArxG/wBFvND1O6trzSrmKW5VlMIGdnOVAP8AEOKwr6aaZktoPtL26oWRUBUu47sPUV60sLCUozhpa23Y5niJ0oJP+v6R7v8As4+KtTTxJc6Tc7poGRp0dTuwgPIY+ncGvqGQuyKYNhyQcsTjb3xjvivmP9mLwylpo2p+JdV2otyRbq2SSiD7xPuT2r3HUPHej6dZLOWbyPuxs3yBj6DNeDmNL2mIfso+vqceIvPlbWp86ftA+AJtO8QXGrWV3AtreX3mCGb5WjkYElge68Gub0vxbB4a+HTabbahIms3l0WF1Gc7Yjwcf3a9+8Y6p4e+IGirpt8ws5JTvgn3BihHfH9K8U134O6rFbBdNgt9aSRh5tzbLiRDnosfWvWw1XmpqFfRrv5GtNu1tpab/L+v61q/DT4h6n4b8ZW0F3dzT6VLMI2WRyUfcceYCehGc19MXXw78I+ItSOp32j273AOH2EqsvfLqODXxVPYXun6kLe+inj+xyFJbeTiTb3+U9K+yPgLcaxffDmzvtalaeeXcsDMoUtEDhc+/WsM0g6cVWpuz206k1ZTUea9mX9fms9L0yey0iGK2WygdoVRcImBwAB2zXxnruqan4jFzfazfebFcOSksxO0Nz9z0WvrfV7u5TVrhXiBiB2yDHb/AANeOfEGx8AHRvtFjcafFdJcb7i0ikyxQddg6A5xRl8lT0au313NVTvFXZ518G7+e3+ImgSxzskqzbZZyxACkY24HXPSvti/0lNTiW6iOHeMhl6B/r9elfIHwWj0tviVprzwCZWjkmVSNpikHK/yr7K02/i8mOP7oI4zx7nFc+bTcakXHexjWUoQjbfU+a9a+AlhZ3BvbzW3tNJmlaZYigVx/s5PTFei+G7XRNG0uOw0SSF7Sz4iRf4mPJcnufU16Nq2i2utROrsCrkhw3zD2A9K4ofD57BZJIizAuX2p1Hf8RXJXxbxFFxnLXsVSlTtZ6Myp5lMxz8wY89hWtbyR3Nk9rPykgzux0Ppiq8ejXAkAkK9wS3GBUhlgsXxNMGYHkJ2+teDySTuuhpddDmPEHw2tdUvLW/urJLy8t/lV1PDgfdLDvina54AtdaTbqFllwgVbgYV4x3AP5V1Mmu7laPTwxfbkP2XPAqBry9iTN9cOzbeQOMD1Nd0MZiEl72xSrytbQ5zS9Ft9As7fT7XOF+RsDG7Hc+prtrfVI/CmgwTeWftN3Jkh84KgHn+VZEMFrqDxqQNsnKgHj6/niq/xSNvf3WnRDbFHbQ7Njj5c+30xVYOHt696jIknVkovW56R4klVEt1k2MHOFGRkk+lfGvizSt3iTUo7O482MXLnY6/6whsYJ9c19X2i32saQUJUyJITEBlWC+5r518d6Le+GdYvnmhnuTLKZ4X4AY5+ZMDuK9rKJxV431HhKacJR3f/DmZZfCnxJfKBBZWlnGGDYmcZc/3eK9j8MaNb6dZxaHFcBtRgiMsiAcDd12+2a86vPHOuW2g29ql60bzRZ894yJUU9s+vvWR4MOvXfitF0m/v7u52rm8WYsCncSA9vavQqQq1YvnaSNPZqnHmjofVfhVpoybfyWECoPnJON3cVr3kFmSr3flgZ43tgE/1rnb7WIvD2nob52inlTLdxHgcnFeXfFDXZW0lreOU/2pdAhNzneif3h9e1eFDCyxFS60OCnQnWqWTPaHvdHmtpLWK5sX3ZXyVlXlvTAPXNfNPxBs5rHxLJKoVUlYNAFTCjjDFj6ivMGVpIBeyTSrLG2CVJMhB/rnvXufwuSHxl4Cv9P1C4jur7TpCZPNP72VCMqSTzkdM161LCrAXqXunudNNfV3zJ3RwDS2scTRLHIzp821RkA+re3pWVBHLbSG5I8uN92+KQcE/Suqu/Al1FZXstveRxz+duaPJLYJ4XNU/wDhE9WvraS3vY3+0ZRUXeO3cH0rvjVg1udf1mnNEXhCQz+IY7mB/mtYW87yBtGOg+tfT+jRahp/hO2W5XMsS7nQn59vXGfX+leTfC7wvDZa1ZxmXzUt3FxdSv8A89AMquf7oOK9yvL+zgt5GmniKgHK7gSfbHevAzfEKTUEeTXnz1L2OSsfEM8l15ZRTFnAA9DWhqkiWsCwyOygJn5Or59T6YrmNHst2oCdy0ZdjhAflUZ7CqvxE8ZQeETJbpavfaxcZdFkPyRxj+Jj2+gry8LTdWfJFXOqlR9pU5YFmTWZT50mX2qf3RGQB649KzLvxXPoHlalc2wudMlJVUtx+/LZ5/3h71j+GPFMWpN9nkjji1AAO0HPlTr1yueeK4zxvrM48ZpLbzbLSE/ZwsTbV2t98YHrzXtU8GufkaPUpYVOTjOO39aHunhn4iaXqJNrqUMmlTbxFGl0RiX2BHGa29U0KxuZEeEeVKx3AR4AY+tfIepTKviSGxtrhpdIhmYpIctweSQPWvsPwau3wrpI3vJ/oyfM/U8d65Mfg40EpRe55+Pw9Oh79J7u1i7plu0FikExDleDzkGuL+Jfj3R/Aum3ZRrVtajtzcQ2rcbhuxk4/Hjqa9Ar4C+IWrXuueLNYvZo7iTUJbl/mLFlSIZAQD2H8qWXYVYib5tkcuGpqpzTlsun9eh7FoX7R+tzQm5v/DFtc2qvsYWkxWQn2Bz0r1Pwl8UdA8c+HtRu9JM0N7ZRF5rSUATIMclcE5HuP0r4wk1G7tNKSCEmBpMl/KbO7tuPoa6X4batP4f+IPhe6WZIwssay+V0KSHawYjqSCc162IyujKLcFZo1dGDtyrWx9VeH/EUWp6jp1lp199timhZpYpR+9tyB/EevtiuzTRrdTlizS7cBjyF9qtRafZJcm5jtIUnbq4QBqmMCm6E+W3hNnXjGc9K+bm4uV4qxxyqXehn3FqIijpHCzo28cYwe54qlNeyCKVVY5z371tSrHI5iJOQMkexrLn04liMbucgntXLPmZpCSfxGBJqc0dxGzSiPcMHnBPNT618SPCnhmU2fiLXrO0vo0DvASWkUEcZCgnNT+Jpo/CnhTVtdFsLuextnuEjzjeVGQCfrXwLf3Fx4jv7/VL+YzahM73EzN/Fk5OPYeleplmXfWbynokKpJSVkeg+OjY3HiTUJfDeow6ra3wZxPkpIM8/MrYOffHNc34a0O+1S/XTtI0251TVJ1O9WTCxD1Of5mubiaFIs308wmTAjReePT2r3r9mLX9Y1ebV9BYSzReStxHcE/NEFIG0k8lTnGK+nxFR0KLlHVpHS8R7aV57/wBf1+R2nw/8GxeBvDX9nvIJL+5cSX08R/i7RqfQd/WvRNGtF1GwltpJGRgB5bDsc8cd65fVtV0zSxNLrN7FayQyFJIzyc/So/AfxS8MTTkXIv7CIAmK5uUxDIBxnI5Ge1fILDYitJ1eVvzLlGdrwWq7Haf8IpdxGNklhlMeNpcZbHcZNebp8Gra01gXmpTT3byyGa5lZvLgJzkLsHt+ddxrnjK4N1D/AGc4W3kUOjbfvKehqr4i1a+1TQIYN8kd3KwyisFBA5Ofrit6GMqqfIna4o1q0dZWOR8deILfQYY7exhNhDcv5isFxGuON5UfeY+griLOz1nVg/lzfb+TP+8xsQZwDj+HrVrxGXfxObWR40MTGNDMPMUccgE8Lxmteyv49LjmbfEIkUNPF99VT3PTPb8a+hglSguXdno4aH7tSerZztzp0QffFdSG5FuNnmyZSSQnGRjoB712fhDxDdabsgnulXUl3SQG4OUaMDBBPpWNDe2bMj3FmR9oBiiUEblYnh2J+7j0Has3w9J9r8QvJaGM+RE5neJRjZgjn8+lOoueLUiMVCMqTct0ex2ujeFfHjyX+q6VZXGtw7Y5jtPbpg/xDHrXZX88Vro5ht2Fm23y7dcBeR0AHYV5p8O5JrXVLk6dmRJLZ5GGN3zfwkV5x8efHmo6PZwW1u8gvLt2ZRIMiID7xAPc9hXjPDyqVfZp6L8DyWrw5pPRdD6Be2k1bTrgwzJ9r8loQQeEkxgMfXnmvju/+G/i3TNSmhn8N3Ug8w4ZVLxSEnqG7gnFYPgb4qeJ/C2vx38eoT3MLMBPbyuWVwTzweh9K+8rLU7bW9Csru3zi9hE0KEgMeN2K2VapgNUlJMzpVNbpaHy78PfBF74c1S71K/leyfAKByHMfHzbiOM9gK9p8M3N/rskc0KSNAhIViuD9c9ga35NAtlgnvNe2i0jXzBH0C/X1Ned6v411661iGw8ORLptiPkEKoPM9m9OlcbVXMKnO7JL7jrlWU7Qgtj2WGCeCfhmYFen8IPvVy1lM0COwwxHI9+9fPer3Wvl5l1DUrzcqq/lpKwKnuykdM1b0Lx/r+l2lk946C2WTdOlxlnaMnGQeoNVUwE+Xmi0zH6u56X1PdnRYyZGQSSZOz5Rn6Zrh/FOjtcakji1dRcY37VBVGxwSfXOK7LRNUttZ0yC+smLQSjIz29RS395b2uDONxX5sBc4rz3Fr3WYU5uEjhl8FalBcR+RLahApZn5Hzdhim6lYTPponuYvNCgxuEOAPbBrt72WG4sUdmbypMHb0LD0rAv7yGa2NsqAW+CCuck+lZSmlojaM5SeqOU0SMG3RYY3ABACgdAPX0ra8X6FNqVlaXNgLh5AdkkcJAzx97P6fjVrQNNit7cQxSKxU7whHY11FkDEu0knj61nTruhU5kayqOL5kcN8MPF9h4hu5bU2kml6pCpY20jZEsfZkPsfxqx8QX07U9SGiXOnm5mNublpN4UIB0H1r5o8P6rJpGqW97a3V6XilWW2mkB5APzJj0NaHxjhu4dd1DVLG4uPJv4BMqRuflDDLAe1fSPAwhiFFO11p6l4qg8PP2lJ2X5f1/WwnizxT4Ah1GZIdGvbhYk2ApcsI2I9Tmui+GXxf8ADXhuKSx0zw2bY3b7lm84MWc9mbknntXzldTRJaNbQGQhsM+7H3h6EdqZpcjpI3lxmSNcMR3GO4/GvVnQhNezldr1Zw1K8p2jJn2x8StZay0S41l0SW4MaLFEDlYye/PXHWvCbC5Z5jPql3Ldzt+8DgBy2OBgn7or1nU/DupeOfhlA9motbpESQ+Z913UDIPt2rxmeOfTZTBqlnJLd23JjUEL16YPas8Coxg4J6rQ9LCSi6acfmdpN4K0LVfh5J4l0yWaTVbZv9JhjfPy+jL7deayfh5dXGn/ABD0G4aM3AMp2oicsp4JJHXHXPatj4SPf6hql8dPgX7NJD/pqkAZ/u57V7j4T0TTIZLcQWUUJhXjC8k/X0qMRiPYKUKmv6X6EVa0aSlF6t/r3NfWvCmj6lcLdzp5Moz+8jYLkkdfrRp/g/TLNlb9/MQCP3kmc+5xiviz4wePNc1zxpqMcl/d2lpaytBDbLIVEag46D6VP8Mvi74m8J6rb+bqdzfaM0q/aLadvN+TPJQtypx6VxvLq/s0o1Ne3/BPLbadj628SXMeiSRWdhBDaxOASVGC/wBf/r1iwxtcNvYAn+EHgfQV0niSxj1i0s9Qt2DQyKsijGCUIBz9cGsW3Tfx03Hgg8kf0r5uq5Ju+5202nG5a0d1ju0+XDq2cg8KPSub+PmlwJZafr8FzJa3JlW2Yom5Zd3KhvTkda27wMAYkLRKy43L97NbFsll4n0aTSNTgFxYzpyCccAg4+vHUVvg63sZqZrSquhUVXp19D5euNR1KJleKE/2pBjzjGcmM/3ye3Hak1OzhaEXUhjSa6RZVijYMj85w5/hIr2zXPghFiRfDOsTWdvIwdrW6Xzk3DoQ33h+OagtPgtfS30h1PXYxZSAB47WDaz47E9q+nWY4e3MpW++566zDDtX5jznwZ4K1nxVPtsX06z0+GRopLmL52lY/eC+2OPavoXUtXj0ext7C0kBMEax5Uegxx9MVJBoVj4W0KKy0O2MUUalF5yRnqSfU+tcjclnu1V0d2kJU4G4L35PYV87j8dLETstEjza9f607/ZWx2nhjW5L92jn5YklTXyj8V9J1bwz4u1TTxZxQx3E5ura+VCP3R4zkdPQj1r6Vgu7fR/LllCGZvmCE7Qo/vMewrjfGXjLw/rstrBq8ml3dku7OVLbT7Htmu3KJVYS5lG6ZOGk6UpJL3XvY+Tb6G5mvCkYZ+MZK7Rn6VvfD7SJdW8QaZBaQs5ju0kuXYZVURskn0HFe3WngrwLrl5FJYsyRxNnENzyCDnAB5rtNOsdBstJaDwxYJp6ByZlf5pZW9WY8mvRx2YulD3Iu/5Glqabkrv9P6/qxt2usa1qkN3cWQtUvEXdH5rERAep/Cr3iHxS1j4em1V7mOO3gh+YKPvyexPQGqOktDbeGbyS6kWDK4aR+AB3/CuR1fxrYXmkXFnotpbausPabiOXHHyjqRXh4SlKr9m6v/Wo8Ph1UnpG6TOY0n40LLqcMGrWDra3GAs0E3mFST0P+17V3knxY0DRbuOKbULi5SMKs+2IkRA9NxPUivJfD19pJ8Tm4ttLSPUIIXaKZcrFBIBw+3puHbNYF3o+p67rd6Z4pvtl1MhTzgAz7jy3pjvmvoZ4HDzfvKyXmdc8LGV9Ln2BrsCa/wCE9QtrRklTULKSOJj91t8ZAyfTmvz01rTrvSNYu7G9je11C3kMTx4x07fSvvX4fwtB4Xj0y6iniTTwId8rcOFGdwbuK4P4tWvh3xEfIk020uLqIbBeyErIxx0BH3h7nv0rhy6t7CpKkldPqeK1Cm3Tl3PjuxDyXe2WBrvcCu0dR9K9x+FetT+BNCu/7J0yO91u8GJ7x5QqW6AcKg/i5wT9KsXFlZaPbWtudFjs9KmBdmQZaZgPlVnPIz6VkSWEtu0N7c7hGsPmxRxLgr3AHv8AWvYm41VyyWh6eEwVOVLnetwfOoah/wATO7N9eO2ZJS24qxPVR6g02RJbm3uLWK/ma4RGQxLFgIF6YxRoV1HuZFhMcM4P2mSVsPv6jZnkHIGfWqNul3Bcyo5LmWMyfK2Bt+vc+1bJdDea5VeOiPRvhS9zeaFPBdeY0Fux8lpJDuRQfuHPTnoK7e+TFjDOI8vbsScjO1Twfw96xPA9jdaZ4SSG63pdTSl5Ublh6fj71a1rx3ofgNETXGee4uYy0dpCm5mXplv7oNfJYm88bJ0VfX/hzzpXe5zPjjw9DJMNQsVla8lTm3BGxv7rr6GsCz0u804ObkeQjsGX7SD+8I5IA78Z/GrvhLxfF421q/s9MgubS4G6S0thJvyg5OD6gc4rqTqVxPcmC8tRG1u6qjM2R78Hoa96E5wXIzKnialH3OhjQ+GrzV47jU9NguCXXO+dNinPpnv61c8P6Vb+HkluJblJhcsTcEcLJjogHp/Ouy1bxJJexCHS3Xynjw7YGN2cdOwqlpfhS41y/t4sTxWsXMsjfcPstZSrycX7TRCrYmdWKi/69Tc+D+mFG1bVplCieTyoQvCKg6hR6ZxXj/7X3h25n1bTdRtIsxiNgyoOvufyr6L1G7tvD+jfZtNjRXT93HHjGDj7x/nnvXD3lvca5dWr3lzFN5Q43gcD615tHEWrutLZnN7Nz16HxHoehajq2pw2ljbu87sBjH3fc+lffPhTwvPY2egSRTxGSygEUsjglpDjnpxWJF4MFjdxXNx5d05BCBQEXHbOOtegeG54m02KFCgkiG1lVs4pY3FQqRUIFQbpRvDqcb8btdi0rw2IJpPLjlO6RvYdAPXn+VeF6V4rvYbtb2GBLA4LRKE3cDuSepNeg/tO2jSwWTSOWt3AUxqTu3ZPIrw1Ehhwiv8AMo2hJCTjjk/h7V62XUY/V0+52YCnF+/JXO71Px7q+rW4lkjVLmRjuZFAYKPT29awtS1i6luoZbuRp4IU8qUuoAAzng1UaKYww20EQmLtkyjhc9lWq8cMwmvXvp1YsmGUqCM554ruVOEVojvVGEvsn0L8Gb/U5NKuIseXpqOJIGYA5UjkZrqtQjW6QLNM23zA6sjEE4P8XtXHfCG2vj4SimvI5NkMRhjc/wAfIwfwrqJzLCpDK7DqQR0/GvlsUr1pcvc86vDkqu25b8RTEQqLRiigYYdie2KwbG7+3ztBO/79T8pX5ScV0VgIL+xjcj7vyeX6H1rDudJNtr1vPa7Ed3xISTwvsK82ST917mcHY1me00S1fW9VnFtb28TGQu20eyj1JryfxR+0NLE8f9g6Pvt25EkrZZh9B0qt+1RqMyajo2mwzM0cds1w0R6Fs7QT2zXhsUCtAkWYzJ99mk4UZ7Cvosuyuk6aq1FdsIw9ouZna+A9HuPEPiDTNP8AKmnigxNdyyE7LcDllI756V7b4m0Cy8RyRBkEJX5IyFyApHp2q/cS2FpaNYaDZwWNooy3lLyx9Se/40WyS+YfLR22/dAHc+prxsVmM61ZVY6W2OivV9p6JHz/AKn8AvEtzqskWmQxT2mTslUiPAPQtmq+h/Dw+G/GFvpN29vea318vzAIYmxn5j/ER6Divr/wms32WV5QdrEbfQ46kV81y6VdXXia8EsP2zU7i5miklkbZFESSXDOf4vQCvbwWPnXb57KyDA4WniJzlPpb+vQuaN4p1K3NxHb69eGeIf6rIWAEfwgHrXrvgm6t/GHhy01PUrCCW4JaOYED5CO6juK+f7S0tbm+ni0CwMSW7nzXmk3mNRwTkcAe9aukfboYrp9P1GWExASLOs5VD/sqO7VvXoRnG6dn/XY9vEYKFWCULRaf9I+mLTQtItbTFlbw21swyRCAoY+pq/a2cdky+UwVMEMCOSe3NcR4F1bULjSWa/ns5tRZFmjjVxmRP7+3sfWuu0m9jmt/wB9MHeRmycfKD3XPt0rwqynFuMnc+Yr0JU5NN6nwh8c9Eu9D+JesJcZaK4lNxBL2kjbkH+lcQrMxXAyx4AUdT9PWv0O8U+CPDPi+zSDXdLtbmEZEMo+WSMnqFYcgVxVl8H/AAP4Gk/tO0sJLu/AIt/tkvmKjddwGMAj1r2aOZwaSadzBx5p6bs7Sw1PTbPwdo0FzJGhaziUW7MFP+rGQ3pjnPTpXKN8SPh9/aP2FNXlaZW2NJHG2xCOmWxjHuK5G/s7zVtN1eKzgE13ckmOKRsPubqfbNfOV1ba1aak8cySIrMwXLDC468+1Z0sro1m3Nu53rDxpQTd3r0PuvQG0XxHYm80q6W5gLFGYEMMjitqw0m2sSDB5g+rV8y/sxXuqSX+o2kUsbQwzrLgnkbuGAHTBr6hurlYLd5H6Kua8zGYNYapyJ3OKc9bLYZq929lpd1dwxGd4Y2cRg43YHSvAda+OOt2ERluLXTLSN2+QHc7kf7ua9BvriV7ebyZ5TDJG0bSNwVz2z2FfDniuaeTxBdm6umlZZCok56A4AFdWX0KdTm51exU6XJHmZ9m/C34raX4+jbSr+YQ6kCChUeX5n4Hof0NeipoFuku7c3XI56/Wvzz8CyXjeLdMFtOySyzxxZBxnLAYr9FtBWZNHtUuXaSVUAZ2OSfrWOYYWnTalHr0M4zklpsfNH7Q+rX8XjEabDD9oslhRCqEqAx5HHcj06VwtpEjxxpKfsouU2rHExbzMdiBzmvV/2jfhveX1+PEelJd3ET4F1DANzR4H3wO49a8IttSntbpXtXJuoyuwhCGhIPXH1r6DASpyw8VT6I9mM7wjKO1l9/UuR3+oafebggtlDbllclWUjtn1r6P+DzHxF4ae7ul3tESvnZ5ds9xXmvh/wR/wALEitL66nmtbi4Zt8ITiRc/wCsA7A17/cX3h74Z+DoY9QuoLGzgTaDnDSH2HVj0rjzSrGpBUUrzZzYjEJe7F3DW/B413wnqGl3kzxtcx4jKH/VkcqT6818y+ItHvfDviC5bWIbz7XGotvOJJDZ4MsQHGMdq9E8N/HJdT8TQ2enTCaxX935Nwm2Rx/eDdeBXrN1rWj6nHGJJoopgRsZ03d+x7CuGlWq5f7sldMrC4t07xkrxv8AcfM7aTdkGyWx1TTYXClllAQXoHJw5+5wK674Xaf4gu9Tg1+ZEh0e0hkgjEp3O6EEKqjuc9TXuM9iZ41kM8csbDIaUbh7ECqwhkkliTeG2EBFC4A/Cirm/NBwUdWdDxvMnZf1939dSW40651HwjDHpl4guFPmAg7kkPPyn/PUV5dcafFIbuO+86K+jcGKJ0Py4PTivUL/AMQ+H/BdiIbyeK2OCy28SksWPOAB61xsfxk8EXl9519aXsJiJVbie1BUfkT/ACpYOVdRbjBteR5kqc5NyUXbvYwobG3v9Cu7fVpVs44nDyXMgwkIJ4O48A145reqaXJcJbReIUlCOW8yeFgp56j+lel/tT69a63oHhq00nUo5bC6aW7LQyZSTaFCg475ZuD0r5xvmhY2/wBkQJcJHiZtwKsfb8K9rBKU6ftJaX6fgdNGpUo0tHue46b8PPEuraQupW0VnqsTvvW4s7xG3L7ZPDdsVu+HvhfcaRcWupa3dm4vROHXT4CDGijkGVu5yBwK8t/Z+8X33h3x7ZWkcrnTdSzbTW4OEJI+V8diDjn0zX0bfXDm4cEDOTxXl5ljcRhp+yTVn1LdedZDbl/tWtsy72lvJAWdjtVB0xXO/Hb4VN4msI9c0V8atDAIpbcnidR3H+1/Oui0YRy3oE0ImjaQEoxwPr/9avOPjr8WtZ8OeJP+Ec8MusFzbKDcXbKGYseQqg9ABXBl7qutzU9zNvka7Hjek/234F8WWV1LE+n6lZP5yi4UqHx1X3BHH419wR6RpfiXSbDUdR09I554UuGwSjKzKCQSMZ696+Q2+IWu6nqej6j4yh0rWbOxmVpUlhRZCp/h6de9fUXizxClx4VnvdOaSeC4tklhQJjaDzkn39K9PHupKUFa0troMTBuC5VY4fxv4n8N+Grxo9MsVuZQxRXmJZN3fYPT3rBt/jdrK28MdjY25JJRQFCoCO2a888Safc6hqsMsavLEkaTKq52ohPPPrmsJ7yG2nSBI1bcrKrM2QFPXP8AtV6UMHScUprmfmOlSXs1KaPpvRfGZ8RrCNQS0khl/ckx5DI3c/QVsx28Wj3ht7q3Ds2SrA9R1GK8H8A6rJa3F/bOvltlbi2iC7QAOx9PWvo/RYIdX0qz1e7OJ/KIbB444rxcww6oP3dETVtT+HY5XWNW1PUSYtPg+zhuAx4B9xW/4D099NWV5TLJLMwDvIeB9KqalexWaTX8khg0+1UNK4xzzjAHfrXBHxjaeJdY1Zr+61bTtGtYwLCa2PltGx6llHUema4qWEnU1a0NIYadaLUVp956X8TvCK+LNDaKOGGS7jU+V5vYnuD2I7V8va94a1HTXOniTzJrdykioQzY77vf2r074x/EvUtJ+EGjyaa0kN9r++Dzy/zwxJw5Uj+I8c9snvivk6C/nhmMyXEscgOVdWO4n1r3cthUpwam9Lu36nLRruhJwmj1PTHuYTM80ckPzBY154I65XsK6fwn4NuNcm/tG8lXT9EVszvKfKCp3xnueg+tdn+znd6P4+0O7h1zTIpdW05gJZ9uBcRuDtLe4wf0rl/2nL+S18Q2GhWgWDQrONGeDpE0j8jd6nA71v8AWnUrOhFWff8AyO2eMiklBa9+h7lpXirRfl0zRbm32WaAvbxsCyqOhyOCT3rB8d/ESPwfp8dzJbG6e6crawl9m4gZYsx4wB0HevLPgNp16dFvtRkkt3tPtQjt8YL9DuOf7o4rW/aBnS+0CwsDc6fujl3iOVv33oGT0HqfSvPhhKf1j2e66mU6HuqUevc6r4S/ESx8Xy3Vu8BtLtmzJEz7k3dmHp6V1c100d6p3Ax5wNpyCK8V+B2gR2Nt4g1MXSeXHIsPmIN24jkn19uPWvWtbeGOG3nt2/csispxgH8K8zNaEadV+zKlT5bN9d/69Djv2i9Gnvxo+uW0TSW6obaQKMmLnIOO4r5+mSWFlkjIm4K7ozz1719e+Gdas9RzZ3UYmtm+Vg4yM+o9KxL/AOEOg6lqd15iDT7ffvjZW+eYnqSfQV6OWZpCFNUqvQz5nBcvb/Mt6XbyBtu9ZNxDcgAD3Fd9oukQpbQzTKd5GdmflB+nrXP/ANnvZ28ksH72ZFD4C8YHp710HhnXINZty1ssqpEfKYyLjLDrXiQoy5OZo56s7WSZsNEBAYov3QIIBQY2/SvFfihoGoaHfarqmmWsl3YamqmVI13fZphw0uO+Rnmva/NUxGRMuoGfl5J+lYnirVoNK0K81F7aS4aCEzeSBgnAyFPpW9CpKnO6VzXAV50aq5Ve/Q+bWm1e20a7trWOe8e9bY0sFiwVoh/e461VbUtHn/s+FLq5n1WYCFrOeDyxCegO4itTU/if4wvGhvYZxp9jM2Ut7aIFYuejMec1c0rxpoes3ttbePdLstUZmJh1OxjKOo9ZFGDgeor6LlqRXNKP3PX8rfcfQyxFSGrj92r/ABS/B/gXPBlm2o+LdNk0WN1TR1eK8uS+fMz0Qe3avaNOUQoWyfLkH3G+baemabo+g6XotkYNGtoILWYiYsjbjIPXPU1W1jxBa2MhijZp5ygUMp4z6fWvIq1XXlaK/r/hzycVifrVT3Fp/X9eR0wRVtwQd4jAKqh2qSOgFct4huP7Y0pnKGCW13OVJ3ZOMAAjvmuZuPjD4dtLqDTbm5tUllyjqJeEPu3RT7V2fhPU9O1e2ZLd5JWC8xSgZVT0+o96zVGdFe0nE4LOlK7Wx816Z8cHtbbUo7jTB/a7blt51Hyhh0DjvXnWuSXfiGKXULyBllmImklAx16n/d9q95+IP7P76prlzqPh69hgWZ/NaGVSAjHqVx60ngH4L6hpN9eXGszRTKY2SNZCRFGD/Fjuw9a9yni8JCLqQau+nX0OtVIXd2nFnG/s16Xqula5Pq7wyxWDxbEikTmfPRh3AHrX0zqt0i6TCs8qebKV3FOAPU1m+GfDenaVcJLLf/aJ4kygD4jRR/nNL4q0i91ieO602WKWIAbdr8gjr7GvFx2IVepdHG1BzS6EOtmCz0xmMhczbUSDHfu2evNeJ+OPgpFr95Pf6WyWUzks0DH92x9c9jXu0uiX97FDLOIhLEgWNHJ+X3OKsW+hGNmlvZB5YGSB/D9PauSGIq0ZXpvc2VSNmnrc8T+FPwSXw5qMGp63dxX11A2+G2gX5I37OzdyO1fQWki4RJEuFAAOVOeSPeuE8XeKLTw1bT3Gp3HlWDMEtogoDscc4Neea38d7+N2t9O02OzVMbp7mXefbCj1rqWGxWNaqPX8jT6pOcfdVkfR341ymsfDvwjrOpf2hqOg2Ut5nJlClCx9TtIz+NcR8KfjVa+MdTi0nUbP7FqEuRFIp/dSsBkrzyD1x616hrus2WiWZuL+UIv8K92PtWUqVfDVOTVPyOJxnTfKVr8WfhrRbq8sLCNfJjyRGgBIA/iPXAr4Y+N+vatr/i1rnV3bGweSmflVTz8o9K+kfEXx606FpbXTtLe5dj5Y85wqnPXjv+FeVeJI/D/xAuYY9RgOial5i20dzbgvEuTwHU8ge46V6uCw9WledWOr69TaODnKDbR4XpUtxDqNu9oxW4WVWRgf4s8CvsCRJbeOJZ2xKsa7kIzg45rE8I/s3f2RqVteajqcGpRK6yCKNCqZHIJPeu5exeO4lnkUOzMV3E5x7VxZniIVFFQd7DwseVbk2jatqNsxjVDLEBlVIJPT/PFaup+JHtfD/wBptVjW8mbyo0XlkJ6k5rOsr4RSbUQ7s5PYfWneOJomtNLNsAzszLIYxjacdOO9cGFjCdRRki5q72PHvGttPFrJ1SSZ45JoipZjnBzyeev0rEv7C6ZbGZ7c3tuw3RFV27yP4mI/lXXfETWLa6jj0S2QmGNQ8pcZZ37D2Arh7q6v4dJET6pJaJbcLas2D+FfXUHJwV1/XQ7VWdrGRCsF3a3mnarbm1MzERSDIEM394+x6GsHVfDus+HbgQXGkzAMvyuYyVl91Pce4rp9Ot59Zmto9MVgzgKFbIC/7Wf1zX1B4F1t9P0FdPuS90bOMKtyF+Vj6fTPeoxOKlh1eKv5GNepBJNq7/r1Pnv4MfDfUbPU7XxXr8BsbSDL2drMMSzNggOV7KOuT1xXr8l2ZJ2CFSScsav6hPJqVwjnc5Y7jg9qga3SMNgAH+939q+RxmIniKjqT+RlG0VYm02eOKVJI0UyKQQG6E+/pXkX7QHg/UL/AFc+MNCgaQyqFvoU5eBwMbsdwa9OkuRbvsxkZxuHJqtJd3EdyrQSsjP/AKw4zke/pSwmJnQnzItNM+c/h94N1PxT4itIHtZbe0Vw1zcTghSAeRz3PSvrjxVoq2vw2urbRlZclTs3MAOQDj2rDsoRHOs6qXJ5AZuhrudJuYdfsJrC8Xb8uMoSM/Su2eYOtVjOWyIryahaOx8sal4muYGutHt4xGIVaKRkIbI9M9ucVxsMENzOl5t2RxEEEcZYeteyePPgzrkOqz3enBNQt33TDyV2Op7A+teeWHw48XbZHj029LsMytKm2JV+navqqNejKPNCSIjUSildF34eLLf67JJOhSJA7I8nGcnGPfNfR9tf29j4TtLGJ9paPOIuz5ziuC8B/DlvC0K3+sAyzjEiRSNnew5AA9Ks3usWkl8wjvYhLC3m+ShysffH4V52JlHET9zVIqC9s7LoT+Pb8/8ACNTvfBmt2liygX7wyM59MV4xrvi0aVBdx26z3STsV8sfciiBz19cV6Z8SNattY8Otp8Gbi+vDuzGdqxhRktu6Z4wPrXhuv2cl3q9lb2C3Ua3YSHyGA8wHOCxA6j610YWCjSvNHbGrOhQ5Fo7neeJfBOv+K/hVot7bqBeafPI1tpStk/Z5iCNpP3myBx6V45c+HNSsdYaw1iyls7pGAkWcbNn1r0L4ieL9SGsR+HdBvZIdL01UjZ1OGnkA++T14PSk0zw9emwlv8AUbS9eHqb1lYjHfLHvSwSqSp89d77L1OFUlXqOXTv3PUvgp4p8D/Dbw7cWc2pz3eqXTC4u5obZmQY4VVPcDJ59Sag+MGmWXj6VPE/hJI9UaGPZc2rk7tq9JBH3xwK89s7YXM0R3uYnJXnAzntTjeXfhzUY7uxEljMpwyKDtx7/X3qlhIwqurBvmffY6p4CUF7WLv5FDwh481fw/Y3OnwFFFxLtigMfEcnOGXPQZ4xXOapaeIvEesK9xDf3d7O5R5fKJMjf3Mj07V9d+C5vDPjPw5Hr0KQ296w2TAhRtkUYIwf0xWZ4p+IOi+AYrA6nbyOWJMflKGasfrnvyjCn73Uxc4VI2d9PkQ/CzwbfeEPh7DFqcYt729l8yYLjEC4OBx1OKZelrn/AEa2Abe+IxnIz2Gav6R8WPD/AI9svsumXD2t4jLKYJ1AkcDsoPX8Khne3vbgjTrqFbm3cGW2jI3q2ehHY14WLhWlLnqr1FFyl77HrpcmkxNKhaKUsp27cn3BH8qteM/ENzdeGbY6fbXEtxHdBCVO1mTY3P0zitmaObxL5EYWSIw485sYc+wP0roj4bs5IApDxnIPyMRgAdPpWeHlClOM3qJVYJp1Dj3+JPhuSNbWRL+wtmx5M89uyROOwHrmut0aOMWiOBG9vcAMhi44P+ea+eNZlliW10eyY3AgKSvMs7So27kYB+6QeOK734WXV9p+rX2kzXE8mnGBrhkfrbSd9vcA+lehXwsYQcqb/wCD/wAE7K+AjGjzwfmexvshs22sVjVOGUZIGOoFcf4lnujaJAp82Z22btnLjPUjt610ejzxBBaeYC4Xcobqy+teYfHvWNT02TTLO0c2unXccpmmjGHkcDiIHtmuHDw56qh3OLB0nKuqZ5/r6+HdN1q4t5rE6hcIjOwWcrDuJ6NjvXkOr6hLc6m8sFqCbdikSwjJROoBHfjjNaGjRLHYqxvLyF5rjyvKkT925HJ3N3xXc+GPCmsa9Yr4g0y0tZZbh5NPvrKQ7PtC9mB7GvqklQV5Py/roetUm5Qte2q/rsevfCvxLFq3w7eK7jl+2aKiqfMOMhlzGc/Q4/CvlbXfE/iC78cu+oXU0c0NzhYkzhVzzhR7fnX1v8MPh9/wjXgy/srlkF9fj99HGdyRYGFQevufeuButNtZNTnFxZxfbGiMRfyxkA8Hn0rzsNVpRrVHDVf1+p58Ywqc0YStqtvx+V9jwS30ZdU1+4jS7hW2Vm8kXH7ssx6ZXqTXo3wg+ILeHfE2naXqT/aIlxDLdZwyljgKQev1rzfXdPbwv4nltbqd/tKvujniO7A6q3qMV7PofhTRLPV7PVNNgku724RZBKWEkTu33nVT0Pp6V6OJnTdP3tU0ZulzOUevU+mJryGK0a6dwIFXeWJAG31ycV8w/Fb4pXevyvb6XLNbaakrW+I2wJmOQGLdhWp8ftZ1NrDT9LjunSxaTZLCpP7wKOAxHqe1edeHrDTriGTTZJM3W7YWkU4jJ4AAPceteZlmDgo+3lr2NcNh407Slu/wNTwr4m1PQjG8F9dXdrKC9xBcKcKg67Sa9v8Ahx4ustQeOW1nZ/tOBLFMdsiejbT2968y1vwDqHhyKM2lxbajBuH+nsMGD/eHp71x4mvLXWV1CK+H2u0RZtynCAZ/UfSuutRpYqLcToqYeNeneD3Ps93CIWY8DrWRr8j2+kSRpMWeTPzPjoT/AEzVKLWftWj6fOsx82WNWdox/FgZ/M1ZnC6ho7LuaVlO7acZIH9K+WhJRqcr6M8iEHBpvueI/FrR7ufTdP1eO4dkhZ7cxkA7VIPIB6k15Na3hums4ImtkvYlO5pgAqgfwkHrXp3xt1fVrW+0m1tSi6VvaWUsM/vF7Mfp2rwzWNNnupLieLzJ4RJvSaNcKB/F+Ar63BJyopv5Ht88oU04rXX7j2X4OeGLmbxFpOsyXFjJHazMGSJPnVuy+w962f2i57q71yGCIq9msJjbD7cN1x+dXP2eLB7i4uZHkE8duIzuX7itjnAqp8e0Ol6vNK0HnRTMswDDAA24bB9c1yKXNjrPWyOao4vEJS6I8dbRUnu47mWd5JoSvnFPuRnugPfjriuh07R9VvdRVrLS4o7XdvEm7KBPVvU+9ctZT299DCkwmW0EokeGPJY+3vXpnwv8RQx/2tp1qPtMUihlkOVMKg4CivRxEpQg3FXNE+XVI9t+HviH+0dBlh1WUxT2bYO0bQY+AMfyrKvb6OeedBD9nhEziMnpsHRj6ZrJ8HxXUt1qF8wVbYKFG0/e9z6irmI5WXzYgYycgE+npXx2NsqritjiVJU5NnP22ryyeIL63ntvLtoADBP/AH+P0+teg6TZp4h8NR2sxUTK3mK4J49D71W1jTo7y+ggtAZIRDlAo5lbvk9vSuW+NNpqHhj4aXE9ldT+XIywXMcIxiN8ggEds8fjU4aLlUik7MqTVVqK0bOI8c6B9k1tprvULD7THh3ijnGHXpz3BFc5/wAItqF1Erz7XiJOZEO/eexx29K84kuIrS0F2bXZM3yNE8nJ/A1p2L6hHEl5DrNyWQ+b5MMjBFPZfTNfYQhNRST/AAN3S5bRjI9y+GvgNbS+SbU821ucSbScyP6fQCvYvFEEdto0UNnCiQM6htgwNvpn34r5O8H6tqqeJ4pLjVJJjdLgxmQ7UJ6Dn+Yr6DvPH0fhrSFsddtjdTJiMFWGHGOM+9eFmNKpzrW9znxVF07TKDXjw3G9lACkA4GOnam3F+5DyHIwCST3PtVjSEl1/T/tdhZ7xkghWA98c1j+I4Lq0HkSqUyoJO77pPYn1rx3BrR9BKz0K15O0el6nq88Ttb6egllRDySThVHuTisy11TUW1qbTtVsxYSDY0eGzgMMhHPYn1pY9QQWM+mXxkbTLqWKW4COFcsjBlAPblRxWrd2GkX2trqtq2q+W/Nz9ql837QQPlGckjBxXbRjhlTftN/6t+pKbjdNehJcXcphWRHwv3Ov3vUf/Xq5o2q3FtPLMPkjxn1qrNqVnIzDaiBTsxnnI7Cs+4v2eMpGm1RyM9686+ugm+bRns/h/W4b6yhZ2IY4U7vWtogb8A47kY615F4MtJNSs5rQuyQzEKXJxtXvj3rsfE+qyWOmC2s51E5TaJTyUUdTn1/rXVFJpMwdG7sjzv49asfts9j9oe2jitAPMViDuY9vXsK8u03VrK1eNpTcPprBYTDGn/HywHLE+tb3je/0y4t521QyyhR5bM5LPL9fWuX8P8AhKTUVil0nV5V0XJ/cXDcRn8ehr18HjaMaXLK6SPWwk1RhyMveMtYsLnT7qBYpbOCKLzLaCJuvHVz7VB8HtFCX8finXW/cxDMDTjBLd/wFdbY/DrwvbqzXME93csBuIlOwHrwPSuk1ApHCIWt49nCpEANo9BissbmcJ0/Y0b67sirKMndHzeLS8ufHuprawgzvcs+JflUAHOK7678d6/qGip4cudTgOl7gWHk7Zchs7Cf7ucfWux8Z+CoPE0llJaKNP11lKpFHEdt4v8AtEdMetcl4l8Ha/odzHNc2Mihv3b7+VXjGQe4r1sNiKNeEL2uu/Q5KVaFH3ZrRO5kpKBH5pbzI3+86rtMLDpj1x6VD4i1O3mafzm+0StEPMkIILEDAIHb6VX1GW4g377VRBEMOUGQCOhx71z841/xFfumk6VcTyIy7jHGWAPYk9q7nZe89jvnj4crUHdnoHw08RXlh4A8WNaDEMVykkAKkgMEbOM++Cao/DXVrrxjqF3ofimAX+n3aszTSxljbzdVcEcge1eh+HvDMWheDLPRp3Q3TlmvT1BeQYP1IHSvLtW1PxP8NLqbTtG1BLaIyA7RGGefOcMcjJGK87C14Yn2jp73/pnHfk956rqP1bwBrHgZJtXMFrMLFjILhZcKcnClV6gjI4rpfgHrcE3jWSynt2f7ba/aJJC2ZGkB+Yueuan0Lx5a/Evw5L4T8ULHpupy7TBdJykrLzyv8LcV1/gPwhZeALy+1i5uxfvIFiDBAGQeigfhTxFRuk6dVe89jWlqvc0jt/X4HvlhZQ2ceIF6/wAR5b8TTbu+S3AwCzZxisf/AISmxTQ47+aeKBCPmMzhQp9MnvXlHxw8b+INK1DSrHwzFbCWe3+1yPNgnaTgDB/nXhUMLOtU5X+PkcMKE5ys02ypL4Y8SW8drG66daw3cwJmMo+ZR/ex/DVWeV/D2pXsGk6rHbNeHdPeW5Djjsp/u5rk9X8QT21no0cF8J9MWB5IoXbLQBj0PvW54M0z/hLdNubLR7mDbG3m3NvKuHG7oyt1x7V7MoShHnqNW9Pzvf8AyPplKMVerJWflp5P8jvvAGt3knim3j1S5i1GG2sXZ9RxtEAznBPSl8ffFvwRJHcaLOsuswSKUme0UMkeR/C/TcPavOfinEPDXh600Cz1Oe8e6AS7n6FUHSMe3868g+zQyK6QlYkRQNzn55D9KdHLqVZ+1lt06fM8TEuMqqqQ0ttb+u57f4f8LeCdf1WCOy8VzCZEwlrfRqrqCOqngV0vxG1rRvhP4X0+w09nkdmZY0LZaRz952P9a+f/AApAum6pFJ9muDcRNvjkc46c8+vHauj+PSahqfhbRtQuIW8uF3iUt1iBOQD7n9K0r4d88U5Nx7EVMRWqXU3/AF8kc9bfGbxG2rCYTGKMSgiCNyQT/I17X4q1TQ9Y8D6f4iGpwaY8sqDdJGW8zB+ZcLyB618h2lrJdXEcUKvJMzBVRBlmJPRR3Ne5rdHwxbQ6TNbJPcaVagSeY2UjuJTklx3IzimqV7NKzX4oyy6Mp1e3c5Dxh4auv+EtuhZajba3Jdp9oEmnkuSG5+4OQB717/8ABrUdKh8FQhURdRsVNvPbvjzF2/xkdlNeT6g9wdamvNPu5bfVLuBf3cZAbkYIP90Y6Vd+Gtje+DvF9jNrVzH9lnL2j+VJ5hYOvT86WPpOrh3G+u/qejVwfJzSXm/69T2rxz4HuPGvw+trq3iiOuQMZ7VTwsiZ+431HOfXFeFPpt/4evp9LZbpL9WABMTMd38SD1B6ZFeuWXjFPC+oKLnURb6EGKk3EgHHoq1vaT428P8Aii7SPS7iyvpYFO0I48xB3I74rzKONqYOPLKN47+hyQquN4z17Gvcao39lQ2iWwYSRhJ3K44A55rlbX4eaFqfiCOa0s5YXiYSSKGJgbHPIPRfpXUx6fpt1MpkgYqCMx7ztJ9a3BepDbCG0j2qePw7ZrheYxpp+yumxQnKlHlgZ+qxpb3rGL5UICsi9Bjuo7VXh1JrK48yLJx19Me9R3TIN7FQCedw/rWVdsDInyYyc565968hTk5XBRTVmaHjXw7pninw9fQqQtxcjzIWYZEco6H6GvA5fh34lu9Tg0p9Nmjt4YykMxcLbgnqWI6ivdwZYYyY5C6NjCkDC+wxyc+9Ry291NENoYlenuf616eGzWtQXLHVeZ1UqrhHlep0nwu8LWXhHwla6bYzJcOBvnmTjfIevHb6Vc8beEdM8Y6S1hqqNt/hkQ4Zf/rVmeGxfWt3YxykIZ2fzEK5yoUkZPY12tHtqjn7W/vbnmVeanPmvqfM138BvE0VypstS0yVYDiBypQ7fRhj+Vdr4F+EM2jiSfVb6MTSIFZIB8o/vY9jXslRXC74HABOR0HWuqeZ4iceVsuWMqSXLojhr2S0jhk03TFDJC2JXA4LegPTNZEdjP8AvTJIjOW6JnGP8fWtXUoDExaEr5hfG1ccMepqvJEUjjaRQCMtweT9TXkzlrdm6Zoabdvp/lZ3MoGAM8DNa2sG0v8ARtQttZjWawmgbzUIyGj7/Q+9c0rySAu46nkqe3rVfVNUuhbXFpbxxygxGMlpMYJHDY7inRneWpLhzNNbnzb4p8J6XfWd3feDrm+nks5Cz2067gEB6qf7oHWufh1FYQjJJZmEH+AE5cjkgeor3bwpoUmg6mby5WK4SRGjlgLbVIb7xwOaNW03QPDyWlz4Z8N2cZcN5hlJmO7+982cY7V9LTzOEXyR1O6dSMJu2vp/w6PMPC9ne6jd2LwwMLG2k82WRvl3H+7z1zXtWn+B7vWrxNT1dTb6cAJCrH5mAHAArF0GK91S4udSnZ2W0iaUxhcKxUdMDoK8p8V/FnxZrmoCFdYewgGUeCOMJFGv5c/jSqwrYuT5LKxhiKkqyTWiR9O6OdJXUoDaN9gSRTgs2xpPRWWofHlqbfVYruLeYZVHA+6D0/WvDNE1mTxfo2Lx1/tO05DA7fNGOH9hnGcVqW3xNht7k6HJf/aRMqRM6tmISDturill9S9k9VuckaLg+Zs7+48E3ups8uhw24tFXhZjjL98H0/SucnttR0hfs+q2NxZMMgFxlOPRhwRXvPhq2W00KziRgy+WHyPfn+tWNStre7tJY7yBZ4Sp3RsMg1505K1miHXd9T5o1tBc7ULFCpDK44x3z9TWjocc9/OikqybwjL1Y57rXMXkAt7iQBndTI7Lu5KoTwufaul+Hs40/XF1BwWEIOUBzuUjkj371Cir2Om143PZPDGhy6fDH9ojAJ5WIN09z71N4z8P2er6PJB5n2SdfnjljIUhvcdwe9UJfiT4eSAtPd+U5G5Eb7xHrWBB4w8NZiEknmRySmeNnfPzDufU+1bypVUvhehyRk3LzPH/EWg3k+tQRaskVpZW6lpmceXgj+LJ6Kexqz4d8QeGLG9W3sdRkkt3YK8soPk57fN/WnftJeMHvDp2k2txH9jMf2i7IUAv3SPHpXj1oiCeZ3ULbPGo+zq2HUsQBx/er0MHlvt6alUe/Q9CM9Pe0Pqexjs9ZilFhcW6TYxu84FW/3f6VSksJNM1Hzb0uzlNgB6Aeo/xr5o8M6tNoeru2m3YjukBjUgnYTngt619ZeFS3jXwZb36h3mZcEuPvH2P1rnx+W/VY88XdMwc+vQ2tDupNkaqUGBwwGMVpeOvEVp4f0MXepyJHaYLSlhnKgdB75xiodG0K5tZo9w/dogUg9z61zP7SVg918MLny4fNEMiO3sMj+uK87AUfaYiMXsyVyzqRR4rrvxCj1SV18PaRp1pbwjL3F9Cu9snoO3NYkvxX17T7ltQsINOhhUC2MAX7+OrYHasHV47qfTJYIbcTzoii4kcbWjXsvvT7HTZ9MspYlmsluywkO7BDqRwVz19MV9w8NScOSSuj0HTl8EVbz/AK3PXvBfiaPxhoBv5IpIT5hjnjiBbY3bb3960PGfgb/hKbe1neZrO+tVMcV8Yx90/wALA/zrhZtcHg34f2PhrTFMfiO6dr3UJ3G1o1JyFH+1jtXnuu6pqms/ZrXUNV1GQMNywyE7VJ6kV5GEyyvTm6lOXKr6ddDzp10pOCV2tPmew2/w2sfBdgviPWtQeaKP93CxAykh43gDkk9hWFrHxETULeSy024ARVANxcDbg57L6+9eUfbNS0tVs57iSS1kcM0e4t5eO4HY1HPNKwhtnaPbK3mR3DnG5c8GvWhhX8VV8z9LG1HFNaNWa6HS+LZbnWLxJLuW4u1JG7qIo/cY4ziuh+Gvh27+Ik9xoV3q0iJpEe+0nb5iImIBjz6A4IHauO8MXGlXKzW2t6q9nZRRs2y1iLyXD/wgdhk9zXpHw38X6J4K3yaPGPtV1F+9kufmfAPC4HAFOu5KDVJar7jobjUbqQ3LPgLwZaeKLS8121vTHJHE9rJaEBGiLLgN7jvXq/wp0OHwjosls11Hc3rHzJZZFO93HQEj+EdhXlXwQa5h8VXVnYuZ7Ga3ZZZMckqMiu60Z2tvEcrmQPbNkoc4OfYV4OZVqsarpSl7rs/+AZVpTd4y9f6+453X0hvX1me8tTOwJclmxsftj6V5vc6faGyNzJBvuwctIi7goHUnsK+ivFOgJrVjcyWZhRJItjx7clvf/CvBz4G8THWprK0097izVCElMnyM3r+Nelg8fRlDWVreZkk7XWq/r+mafgiCynspdQg8x2gl25lPzJjso9/X0r2a48FJ4h8DxW13MsN7gzRIy5BHo/1rjfh38Or/AEkTajr0xjMqhUsI2yEwc5OOMGvVNMtbmcu7hiuM5TsB2FedjsenVtRlfz/Qxcbvc5TQvh5o2ix75VhS+iORPHHtII7A9s1494jiuND8WaxfS2Nxci8uDEscsefOyPlIJ619LXUm+AkKxZBvUkcKvv61y/je2TW9KWCO/FjcW7B4ZnGQj+uPTtToY5wneo73PQwlSNJ2e35eZ4r4R0XTJHuG1ecSXZOWgHy4z2Pp6VqfDDwbZ3fi3Ur+6MpttNVvssZf5BKeAfw60xPB+qDVnU3ell2kB+0Byc45JAHrXtdzpOl6N4Cng024UGIJLNct9+RmI5JHr6V1YjGq3uSvzaeh2YvEUvZ+yi+Zs+M/jLqM9747v45WIitm8uFegA9fx61zvhLVL3R/EVhe6ZJIl1HMuwL/AB8/dPqD0xX0VrXw00TxUDd6tfyWV2xws8Sbgw7bvWut+FXwa8NeHdSW9upW1W7UbonuEASEf3gv97Pc051IQjeXRbW/pHgV6Eudy2OouXeCePKFcIGKj1I6VItxIsg2szbhyzDGfYVveLLe1hhhdRlc7Qyn7v1PpWBOPMw6SDbgYIOR+HvXyUocrudUfeiiaM+ZcsFxgYyuea3/APhHFurFZFbDOAyj0FYul2Lz3aAL8y/MVA5YH3rvYALSz/fOqpGpJJPCgf4CqpU+bVmFabjpE5PxDbLpGkJcG1guZcqNsrYAx/hXFal4g1aXcttKsboeViUD5fTPrWb428b2N3qv2uS4la38tls7duA3Ytj3Pc1keGdUtdYmliu7a5t53P7yVZgAo7kCvocNl0aUeecTanzSinb5nZaR4l13TUjS0iS9VhvdJjy3PJDdjXbeFvGdprVw1ncQvZagv/LGQ5Dj1U9685vVXTZLZLW9hmgjIwvmgc/jVK+unm1Rr+zdVFuAomUjezj37irnhYVVoreZnOlGXqe+ZOenHrSAjeQAfXPasjwlq/8Abeg296wAlIKyYGBuHXHtWjqF7badYz3l9MkFrAhkllkOFRQMkmvGlBxlyvc47NOxxGuWt7aybJpROATJ5pQKTk+g/Ks03LEN5i/Nz/8AWq7b/FvwDql9FZrrduzuu9GlRlQ9vvEYrpJtAtbtVmhkDI65Ur90g9CP8ayr4epD4otHXGsrLnOZhlSGFpJiAqjJYjGSa4yQHWNRmmmLRITsiKnCqT610/jmxurCGGKOMrbSN80gbOT6VUe2it7RLDTszS3EY8zccADFVQopK76m0XpdGGthqVtcMGwyY5BBycVe0lob3UPJwfLZSgTs3/6qpyWGqO8X2K9li2sCHkO6J2/u+mMVFrdnqFxK1vosSyTKuXMI+8x9PSun6qk1ZkuTZ38egDwn4WvLmCYtcDEkuBkMgP3P/r18m+ONAuLXV7u7Cxy2dzKzwuQdqFv4G9CPevs3whaXsvguytPEce66eAxzo5ycHIwffGK8x8Z6DHo73FulrugblCVyrjsGr0MDifZylF6syoVbXUup80Q2lxbWgvLu4BmijLARA5KkYGSO1ccS6qFDYZiWx0/Svf8AxVoE1x4YuNO0qOG0e4Ad4lH3tp3YB65OOleLXNu9rKtsyksx2ldmZQfQY7160KqqbaGtSN9j7V+CPi2DU/AelQ6hcIl3DCEDSPgSqOhBPU9q7vVNVgtLKWWNlmlVSUjQgknHH4V8h2mpQ+B/C2m2Gpxtc6om65aCOT93Bk5CN6t6jtVe4+L3iW9kZLH7Jpcew73jjzn2BPSvIqZZKtNyhs2YTovm23O2m0G5hs0uGViWZt0ankHPPFGjyta3ccZEu58qWI4U/wB1q5fRfivq5kSDVYoLyHKh3xiQZ6sDXe+I0il8N2ut+H5ZWhkmXdJbkEr6g+9Yyy6dOoufr9xv7SNj5y+JetX8viC709pttrbMYlSPgMPU+tc7omr3mnXcLW80mxW/1ecqc9eK9o1LwDD4xa5uN62V1GCy3DDhwOzj+tcnpnw9NlrQWW5F8Y8Mht1ITdnjcT2r0qkXGXM3ojz4U5SloWfHMM6awbuTE1xLDH9nDjnbjqo70zwxpeo39zcm1to7ryUMlxK/Ygdge/pXtlj4Z0+68MW9rcQxXV3buXKtw2D1CsOgpdHsYrSeLT9D0qeDzX+aNl+Yv7nuKujmFJwtDdHqSmoq/U8AfTEZ3htYJTeyLvVQv38nse2K+ufBt/a/D/4a6Paam+69aHzDADuYZGfyqz4O8Cvp2oy6priWKkKWRI0AK9yWb2ryfxZrSX2uT381x5cLyMyqH5CL6L6YqKlWOOfs18K1fmcNWpz2hE7W+8da1LfSNa3CpA4G2ONRhB6561HB4zu/EWhGy1CBzbTo8csc6BWkA757eoPtWH4D1LRb++GBJOFG7bKPmA9h3FJ4v1Kzk1Kb+yrdbie3z5kavsUegPoaI0IKXIoaohLlZwlx4Du7vUH/AOEe1dFeWXNtDcNjdjsxr2H4W/Bq28Nyx6p4puI9S1OJD5MIXMFqp5IUH7xz3rzXR/FkFzcgX1ukLMd6SSnC7+yD/Gvdvhrrn2/wy95qOVnt3MTuSTle35ZpZjKvGFk9DpniarVra9z5N+M1rdf8J7rdyt55qPdhhID2J4wPbpis2C9a5sYlCxiOEsYwV+Zj3G7qR/KvVv2lPCsr6oniTw7D9qspcNe+QMmKQcByPQ56+teLxiIQia3dvPyfMiA5Vh/Fj3r1cNUVSlGS7GGEiot3Leova2toR5LeaxGLgPnA7gD+tL8MLfRtQ8W2uh+KLWWXTr6QwJ5cmx7eQ/ddT+HIrMkv1mbzDsi2nLKSORnriuq+D+lyax4wj1KWMfY9My3nAf6x+ir7+tTjqip0JSbtodFlOqv69Tj9a0ltD8Y6lpMUhkktrl4R5v8Ay0APGT9K3dK0iW0iR7kDzGU5jC+aVyeMkdPpV/486PNp/jH+14gEttVUSblH3JBwwPv3rnvD97NBbmS2bbcP12Pg7fof51jgq/tqKkaYTljU5ZI+qdI+Hdr8PfDMl6txLNrEqeXLIG+QD0Hf8a46Rr27uzIQuBnaAORg9T6173410qTVdFeK3UNMpyqnvXn2j+FZ7aeGKW3lBBBLHoD9a+Rq1Z16jnN3ZEK3Mry1ZnaRc3VtGsNy8gGcgAdc9j6V1mn24u0QWrjbk5A6/XFKLeE3t1oE6vbXs0W+G6WIMFP49R9a67QbCC302FFKTEIoeQAZkYDliOx9qmeHVrtk1ZOFrrc5ubQ7m7ultd4jj2B5C3Ue2a8L8R/EzVfDmtXkOnXbW1lHM0XkIu9lVT13H1Ne9+Pb+50e2i+wbIluJMTSk5IB4wB6V86avpf9oEafIEkmiYo0xXCvz9/PpXu5Xh4cvNNJo68FBVoyUvkdh4U+Jer6heiO/nklgnQYi8sbhk9W+vrW/eEaha+dHgy5O8KflOP8K84s7ea01axWOW3msSBEfKOH2r0GfrXcX6yrKTFG0DAlnjjPJJ6jHrW2MwdOb9xWCvTVKaUUReGIftCTXF3JGREQNkQ3dOxP6VH4j1+e+klt5LqW2i24EA+7Gfp3471P4e0+5tWvFkRY1OAAcYf1J+tZPiGyd72J7CaNEyZJJQcgD+5+JqcNQpwnodkIxfQxrPxHf28UscMipCoCrFjl/VvfNeq/DnUorydraZH/AHIw/mtnOeMfWvJbrS4JYWkml/fk5cAlVHoK7n4YWVnbyTSz3ktrcYDRjdlSSOMk9q6cXCDptrcKtJ2d9jX+JuoNFetZWd1ILFVBeFcBY8dWA714SvxPu7S8k/sjTYbmzjONsjkSH3OK9i+MukyDR9RubGR2ZLYI8nVueGx+FeDTP4Q0Zb6y0+e/unLKyTN8hJHVWHTGa4MBhqdeLdRX6GNKknBXdl3/AK6nvPwQ+LWka/qT6Zf+Zp+pS4SKCd94c+iMfX0r1/xgWHhrUFjlETvEVDfXqPyzXwjfwLpl1Z39vcLDdFhdJJE24gg5UnH3SPSvuLRrtvFXgGwvWVfOv7FJsEcCRkBP05zUY7Bww0oVI7XPOr0XRqJyd0fM+sQTvqN7HbxquEDeZj/Vp3wT+oqSCS4sppvtS+VABtY/xkf7Q9PpUniiG5HiW4nm2yYYiOEEqFZeufeo7K9tRMDPCk164JVQNyOpPTJ6Y617iu4o9ynyypqyJ31DT7nObc3ZTPnyITsTjoh/iNXLK5GlYNzayPazIGjQnPlnqCV9cdapXKfZ1ndUDCWMgsgCquOqY7/Wszw0r6xcvaJ+7ErhUllJO3HXJ9alxTTvsVVUXC8v6/yPoD4UXZj0vVXllV4hMrgKchSw7H0PFfPnxp8d67rPjbVtFEsw0u1fyVtiSsb4/idf4snpmvpLR9JXw94PnY20SyTlXkSMbQq8BR+H9a8A+M+mf2H48g8TRgzWt6i75FXcsUwxjdnjnFeXg5U3iZS77Hk4aKm3N9zhfiL8ObzwXaaRfPfSXdncxf6yNCBE39019I/sy3OsyeACNeecjz3a084YPk+3+znpXzV4k+KviPVbiZbvUJFtnDRPbW4CxKB90hehPTmvcf2c/HWueKvt9nqlvHcmygQi9wUVxnAVh0zjnPtW2OhVeHtOztqZ1XCaaj/wP6/rqe6axpkGrWfkzAeqN12n1rgfE+j3ej3EeoQRo0Sph2TIC/h6V3U9zcWivc3Lp5OOUAwU9/es211eHUppLCeWJsnLnHyleuB714UFJLmWqMKfNFX6HPWNu+vXMahxJFKAZGQYVVHpjv2p3jLxZYeCtDv5obB/s9sAimPgzSH+HPp6muxtNLs9MtLn7BFs8wFzhicnHb0H0rwb4rrPd+DG8q3ln8q4Ekse/wC6h4JIHUc5xXbhKca9RJ7BG1Wduhw0/wAdvFzXH2mKeOK0Jz5HlcAegbqT717joPihfEmlQx38fnpeRI9vKMZU/wC1XyB4k025gnht5AocjCPnhh2Ir0r4OyX0epSWukTMLdhxzuETDqfoa9rF4Ol7PmgkrFKkpNq2x6F4thhttWO1gsi8LuHAPpXOauLSwtJdfj02B9ZbEMc0acrngv8AgO9ereKfDC6iLdblQt20IMgPG4+ufrXHeOvCc8PhaF44pD5LsJp42x5eeB9eorxaE3KcVJ6XN6NqklTT/r8D5/1SV5tTmuWhLPN0XPO7uahht45o3M8bRyRr91s/MB149BWnBdW8F+kM7MzIxwzKMlugBHcGrV3bIBvYq8bk4ROCWPH4c19M9NDpcFJuxsfDzQP7Q0bUB5aKbdg6DA8x1YcH6V3vwWvV0nxZeaNcE3OnXkJcxFd0fmqck7fXANcD4L1qDRr+4jE8iyTgW4D9B6c11fwyuZLn4mWE8KKxVySCCGc9D+hJrirpuM+baxwVaVpe6e5eJPCulSW6TQ2UcMKghhGpVzkEflzXnN89msJNrBFBbRAq+FAAI75r2nxBKbbT5rjzJInjHyuoyMngCvD/ABJL59yybVVGyjjbkMD2PtXzFaq5wSbFQk5LlKkc4sX82HKRSHJA6Z7MK2NK1K7XV4SkxCvjHsf6GsrTIjc3KJGVYoMbCuAK9N8I+ERFMtxdjsG2+nt+NcNpdDadorU6DxHNPL4Ku5Yi3mtb/NxgkdG/TNfHXiC7guNUEKzGC5TKxlyduM/dFfcM6wPE1vNs2SDYUJxkHtXxl8TNBk0PxHqllI7GMyEW7iMfKD0QH09a+nyWa96D3ObDtc7ZgphtYUWl+bQ4LyNETt3DqoIrZvLm4MBuHmSWZBt3K4+bHGW/A1zthHa2UNuJHWdGO6UjjP8AsmtOC5jsWncpHcSuUjRET5Rk5YgfQda95o7XTSlqV5JYZbRJrh3uVWULbxeWGWMV7f4F1S20fwXJquv3MpWNOCeDK5PCAf3q8m8LWH/CR69FaNpkwdm35QnaQOgArv8A4jTW2nXn9hJMgi0aESyPuG8TSKdoVe5Hr6Vx4q02qXz+Q4U41aihLTqXdR8e60pvrvTraKxtkjLzJIA7gH+J0/u/WuS8O2Xhjx34jSz1qOJFuB5aX1lELaQTnpuXHIrmdK8NNdeHrm8kmvp7udy1wsWfLMKjLOX6E4HSjwvfQ6Xr1nfaQiRpEHktnnj807lBxuA6n0qFSUYyVLR+R6H1anKLi4rb5/edr4x+A+laJcQRjV7q4jlDSBXUBhtx1PfOcVr6Np0OnaZFHpkMVnZKMeUnBdv7xPeuo8FeIdS8a6RcXGp21vcXlu/luyoVCqQT07dKivbCd5QqwBEPHC9vQV4GYYqs/wBzVd7HlRpSoN057kGm2EOr4s9UsYL22Zx+7mXcjH3z0+tQWdr4M8PXc403QNLllY7ZHkj3oDnlVFbms21zpHhOe4ixHczuI0O7DYPXHp71xtvZxvCsjwSRTHiTOCM+wq8soXg5Sej6EynJfA7H0feXUFlay3N3KkMES7nkc4Cj1Jrwnxr8eo7a9ltfC1jHcLEmftN0rKpPsODj+ddx8YbS41fw3faZpszJesiyMh5Dxg5IA9a+ddF+HXiLUZgiWF2u8nzjIu1Wjzwu4966MuwlGcXUrF4bD0/Z+0nqzt9E/aDv5L3y9e0CH7HOvyyQMVYKfTPWvbfB2q6Ne6VaXOkTubSWMyI0hOWOeQfcV8l61pcun3s+j6hHFAlvkly/mgD0BFez/Bi8ksvDGlWTxgbbhxGV6MM5BHv3rbMMLSjR9pSVh18Mqeif9WOt+IlxcSWtq1urEu5VlJ+8M+vpXiPibVRptzfPLKrMMGONlPTONte9amE1PfDchZkyAAem7sw9PpXlPi/4ca8dVnnsrZr+1uV3EsA+z/ZHoKwyrF07clR2OjCtQ66nBajrl74iOnQWsaWa2y58+OPbuGev4evrWt4O1KWXW4JY7q4n+0uY543JIjRer7j3Na+j/D/xbO0tvaac9kCEQvPIQvB7L6Vua38P9Q8J+FNSlLRXerahC0InQECAkHCovp/WvYqYiil7NNXZnWkpPlk7s4fXfi3pela3JFaxS6lHG207ThGUeh7kV2ngjxn4b8XRzRJCLK7iT7kxwEzwB6V8n3yTRuBIm0oSCMYKnPeur+FAuZ/FkKrI5glz5y5zuAHGR9aynQg/dV0+558cVUpyt07H1TN4AvbtWaJlurSUBmYsDv8AbH9aW20e78ORzXU9k0kCZxmQY2j+Ig8Aism3+JsPgmwXT57dpbtELssa5GB2NcJqfxw1G81QWd/pkUFq4Mn7klnYHkN7j1rmVDFVPdduX8zvhmEtprT0f9fcekap460q70/VIiCqXkJtZGbnAxjP15614Prug6X4W1uNtRWSeweLfZ3BGY5ieufp0rvNE8Mnxrt/sba8Mp3ErMCI+evtXt/g74e2+neFho3iQWuswCTzY47i3VliJ64J6/WrnWo4Fe7v1XU5qGMlTb5tUfH/AJEPiDU10rw7bhpr2YBZFyBg9QfQCvq28+J/g3wVpFppkN99s+xxpbqloBJwgAJJH0rg/jlqOi+EdNg0TwjZ2elXV5uF5LbQhJUixymeoya+bobjyHaG0t1C7cSBXOW9Tmuh0I4+EZ1E0u3f1NsRJVnGT0X3fhqfTN7qHh34n3jXHhu7ktdVOdtndqIhM+Pvoe59qwX8CeKNIthFJZLJM4JYjDArnkD3NeU+G7yW1u7a9t7dXFkdyKCQFb1J7mvpP4TeMdS8RR3FrLPFLcMGYxbstCR256iprxqYSnenrFdGONWVCPMtV5nIeHvCOsalcyWbWYs3JV9x+bC9Pl9q7HR/B+meC76TUdXljvbpXBhhVtqoAOMj/GpbfxjdXGt3el2kjf2lAcyxeWUfbnHIqzfeFtV1CVLmZGIkYb8clfTjrXi18wqzvHZP+uppVqTkuSpojsNG8Q2/iFJrVI/KmION671I9ef5Vl+LvCMWsWc2nXVn9ssJznG7BQnvnrXn/wAa/EE/wu8DW0Ggo0esauzx/bM8wAAFio/vc4H4n0rwnwT8bvGXhzXor3UNUvNZsWO2a0vJiysv+yTnY3oR+OaWHwVSpH2sHbt8jhVR0HzQ2PYIP2edOu9SkEtxew2rKCI2UbkOefm71zF74gk0m8ufDPgzUJdH0KyLRm4L7Xu5V4Znc8gHoB05r6b8G+JdP8XeGrHW9JctaXSbgGGGRujKfcHI/Cvjj4weEn0LxxfWZKJ5krzxsxPzxucg56Ajpiu/A1Z1qkqdd6roz0MHWVZycoptW00X9dD0P4ffEzWdFvCPEMlxqfh8BY7iVh5htWPGQ38Smurk1/w/rWp31roerQSzOu9EQbSMe56nHavE7aSK30qWM3EkKeRzFCN6XOBhizdBWda6hFqGnI0GmfZ5IMBWtuNoHVm713ywUJSc1o/I65UIc946N/cfWfgjXppB/Zl0rSOBhSeAB9ff0rw/4peONb8H+MbuwsEihtAg/wBdbiUsD1JzXZfDxtR1jTtOupFw9xECrl8HcODn0+taHjrRvDfiadf+EgSR3s/lluRJ5TED/a7j615NOpGhiXGUbrqefOlFSa7/AJnzWuutdo0k8XmxtJuWfZjyVxg8DtzXvvwL0KLTsXV4UEl/hY0AwscQ6HHq3rXF/wDFqtA1e2up7jVLk8pEjt5sUQ98V6fpF3DKq6pprxy6aBuWWE7tw/D8sV15jjX7PlUGr9yX8Lindmz8UPEMdvOYINpMMZeWVjhY/r6im+D/ABl4b8YaNL4fk1SE3rx+WyZwT6EZ615f8Vpb3WvCDTJ5yk3YNwIcE+WDxkdwDjivErDTXzPBBcSTyyOAvYZz1pUMvjOkk3Zr8zn9hLQ6/wAXeFn0TxVe210jIof5ZSOCpPUGslp0LmCKVokUAB92T16j6V2Pw416w1LUU8LeMo573TJD5UV/K586FwPuD+8nHGeRXsy/A7w298lxb3N4ISvAVlK4z246+9dNfGxoe7Wvf8zrjiYwVmrHzdoukXt9cu5hZER98UzHAkI68DkZr03wXK3hSC98Tao8Fmybo7VpSP3rHg49TjNb3xVl8L/De0htbHTJ7vUnHmRmSXAT39z+lfNviTXbzXo1l1S4uGZH3wWw+aJAT0Hpmik3i4czVov8TnqYmLTUN9T6Bg+L0usRCB7qC5tWJiKBwCCejE9SBXS22iXt9YxXdparcxSrnepC8/4V8f2kzQzzMIWWdFzFGoPBzyT+Ga+1/wBmu+fVfhlBNO7MBM6KpOdgGOB7V5maYSEIKcEc9Op7MXwp4Tvf7eD3TRC2QB3UKfm9s123irUv7JtoIrd44fNJXgDIHqB+dbkKJCSgfLMc4JGa8z+P+oXeg+FF12yhima2kWNvNBKoGYDcQOvWvNwdJSqxi+oSqc8tdj5g8d/ELxraeMr2W41O9sHjlPkRR8oVB+UjPBB9a9U8G67YfFTR7T/hI9Okgv4nxJeRDbE8o6E+nqR0rw7xT4iTxzr9mLqO20uRmWDzUyY+Tjc4PT8K6PSPiDaeDwdB0bTLa90+KUia5d2WS4PQvxwPYelfUTpuy5Vqu3QdLlhJu+nT1O48T/CnXvDMM08Fst1E8q/voCGQJnJHlnoT/OsLTvAeuateTPa2klvaeaNzNHtO3v8AL7mvqrUJDF4Wsi5aQmNDuJBP3c/jXFm+upwAGy55464rx551WguWyb7nXSquS95F/wCHOhWPhG1K3E8El44zuIG7NeRfFHRrrT/iDfXursLnTr2WKeCfZsWZcYaLcPukdq7+6LrPhpNrAZC9/rXS+H7uHVtPn07VLS2vrQEFoZgG59QDXDhsxnGs51Nb/wBaGlKs6NT2slfufKupRul9btobyiRJSF0yF95QerEcH6Gtw+H7mO2tJ/EtpdQWdsXkESocyyMDsQEf7WK+j4vhxoUHiO61Wzt1jW5RMQKihFK/3e496n8catpPhvR0v9bhj8qJlWEFN+6T+EIo/iyO1e28xU2o01/mbPMqV+WEW77/ANdX+Hkcz4QktPAvwvsz4ruEh1C4Y3EzPyys3QcdSF7fWsS0+Mui/wBppa3doy6Y2Amovgkg9GKdf8K5jx1qqeNdJhu7VpbGe2nLXNveL8wVgRlh+OAe2a88CQLqemHVAi2m9pI0K7RGAOFcnqjd6dPAU6kXKqrt3/pBChzt1K27f3f1/XU+svFem2N/4SiubPZcxrtlSRTkOD3968sW5SGLc6zTxbyu+Nec+4/rVD4A6rqUl5q+hTXom0i4gM8ZBIW3O7GEB6Kc/pW7rmmyWGotFeTyWzsMh1J2OO2PQ1jRiqM5UJPbb0OGpQdKXK3uepa8xuNMgvVAyo2tkYwf8K8D8ZfEbUp9duIlleLTEzCYVO1XA6Nn174r0e6+JGieG0ls9aY/Z5V+YKwLJx3XrzXnEPgOy8VavHc+EfENheWbklxPhZIATjBX29aWAiqa5q0dOj/rY0wvsVzKputv6/Q8+NyNXvpLKDzrm9uZAIgg4I7KT/WvePBmkDRv7FsTEPNgj82Rg+5VJ6n8KueDvhGugTB9yyzqSonfGFU9Qor0NNDhs7J0jVpJXU75jyR+FRmWPhOm4U9UE68XK17nOXE0UfnTRJ0b7v8AeNbFpr0Wn6ckl7IxBwqr1LHuRWNb6ZIZFbl1U449Pp/KqfjW0fSZIJ5GUxLEwjRRzwOQfavDwVH2k1FjnFTfJ1GeLviXbWloLf7KfNuFJSHeC7Ad+OgrynWPiN4q1623QzwW1k3ylGIMi+rfhXG6/qk2v6p9q8sW0ipjYp5wfT0+govLiOKRJLJ2j2RjzFaPARsc4z619lh8DSpJe7qdVLCwgrbs0/7V0TWNSjbxBoNncdVe4wElIHRsjqa9Bg8KaFpXhq48U+EEjM6ALMmwFowfX3zivMmgjfT3njgj81yDHg5frzn2rqfh14il0nULOwupgmm3KtFPnnzAexB6Yp16LceaD26dGRXwylFuG6PIfE1+dUmkvL6eaLUJXPk28WDHjP8AEaoSPs1+H7Nc3PlbFjE4bG849fQGu9+MHgR/C/id5EQyaK7faIRGMFg3UL6iuIv4J7+8MME0u1sRwwKmCcn07CuunOM4qUdjzZWtv2PUf2dbxfDvxCaO8uYmtJYHG+P7o9/pmvreyvbW/iMtlcRTxg4LRsGAP4V+emq6s/h2Q2WkTM14gC3V6DuBI/gT/ZHT3r1H4AfEqWPxVFZ6hIFEpI3IMLIuOcj1HWvHzHCe3lzxeqRzzaUvd6ml+0vBft8QBNcQtDpiWu2ORBjzHPJ59e1eL3OmpG8EkLu0kuWdM4ZR6e9ez/Fz4lt43ln0uxjhh0WOdoUkb/WzMvc+i56CuE0rRI9Rukj3Mlr5i27ksEdT3Cg816WD5oUIqorNI9d4eUoJ21sV/C+h6nf+Y2kTFbGUEyM+dpx1X2PvX0F8D/Dg0CHUvEer3YjTaTJKflj2genTj86f4b8D3EWnLoOnSwxWCOHliaYGUL6vjnmrfxs1JdC8EWehaC9uFu3eBwCGyEGSv1z/ACrgxOJ+sNYeD+L8jk5XUkqdtDh/HvxA03WNfvb3w2EtFVVtri9VMS3Khh37DsO9YEniTXdCvQ9vqF/I8jbwROfkQ9AR3+hrkdGNzDeMxESxxAdtzNng4q/d+aYFt5beOGUZIVR80w68nsBXbTwtKklCK0PbpxSp8lttNdzofiX4yb4g+FLTS9UtY4dWgY3FvOrYEiYwVx6nj8q+f72GSBmhuE2MhOQRgg16MWktryWJlFy0bKwid9wAJ/hPbivVfhh8NvCXjnw1e6x4mjuTqNtO6TCObYNgGVJHqRn8qmsqeEpXS0/zPNxcKfs1bS115b3PH/BfxY1/wj4HuvDukSi3S4uTOLrnfCCACq/XA/X1rLbxt4j1y5jOqXba0A33LxQw+meo/OuXvki/tK6WMOtqkjYB6hc8f0qC1YqzKq7gQc4NKMYqeiWv3nkRfK00e3/D/SNP8RaDLMl3e2UcT+XJbIPM2Z6++2us034cm4uow19bNpjOpnit4ykkqL1HsPavE/h/4l1PSbueSxlAJQeaGBIdQe/v6V9a/s8y6rqXh261PXY4hFcThrLoTtAOT9c1ji606NN1YvQ9GjmU4rlepsaZoBsbeOcoYcL5cESjaFUdMCvnH40+Lo7jxZJoau0enWRMcnlPy83Rmb1A5AFfYGv2TXtiUQBipDbCM7h6V84/F74WHWdQn13QI47m+uWMlzYSt5YLYwWRv6GuHLa0ZT55vUlVZ1b6nmWj+DdQ8Q6Rq1/phh8+zUy3VtnMrwYyHjH04xXY/s5aktnc6vomq2Mk2nXdvLMFbnY0Yzjb2bjr9Ko6RrepfCWzkvJbC1j1vUoALWAuXMManlpPy4Fan7NQ1PxR8TtU1i8kxA0Ezz4UDeZDjAHYZOfwr0sVLmpTcvhtp/XqaNqLaa1XYpQ/EO8lmMg02BLLeyxw9ZML7+p9K2tWn8L654JeaOOC3ulJeJYlCyeaOdrfWuW+LfhzVfDWqXdrEg+ytM08d3GMFsngEjpXO6BPqSwTWkiwvdthwJMFiD12+pqoQhNKcNDodNXtC/8AmWNL05YvGFldecZoJGBwOTHJ7ivsfwhq4k8OQS3ku7aMCQKTle2fftXz38OvComaTVNekg0u33EBrgiPYcdWzxn0r1nVfGHhSx05NC0nxLpElxKmwYukdmbgAcHAJ/pXm5rJVLRir2OTEqKfJ1PO/wBqu2g1KDStSsQtyFR4XZB9zJ4JP9Pavmm8glW4WFpI/PGN2OME+vuK+oro3MjzW17G8trJxLHICA5HT/8AXT9G+HGgazNDNd6YpjifdIZDxt9iffHFRg8zp06apyvoZexUdb6Hy3pFhd6vqxt9LtJ7i7mXy4liJJLcAsfbrX1BB4rj+HHw/sdOt4GW4tY/JlaJsLPKRn8MfnXoXjQ6F8LfAOoalo2mWVncrH5UGyMAtI3A9+OT+FfHOqz3Gq3MzGe5uZy3mq5zt3Z5J/DNd1G2PXM17qf3hTimtDtrb4peIZ9UhvLny5YBJgxo2GCeoPfFfRPgjxPbeMLK70DxBEtys8WNkqcSxkd/X618o6ZdaZerHDqafvopMs/QOgHavcvDbpaeJbO5jnWO0VVZG3Y+TGcZ9aeMw9NwslZrY1q0I8inA89+IfwM8QaV4yuW8OWMc2jzybrVlYEIp/gbPOR61qaN+zxqZ8TacJhBceHZysk85fEsQA+ZQO+egNepnxLrHijxnc2+kPb22kWZV7yXdmSROgVf8a0da8SzwkRRMSm7gyfMvtn0rzsRmFago05W5rf18zOjrG6Wp6NeabHNpgs4/kRECIPTAwK46XQ7jSmeYq0kQGSVGSg9RXNT+Mb3QYo5LRUmkuHO9XOduB1A9KdbeMNZ8R6hDaQkQtJwY4/T1ry/q7nHnvoTFVIO1iw9g+oTl40LMxC5Axgn0HrVeTV9E8D6jFDrmpQ2l6xG2JyMlSeGP1rofG3iZfAvgWS/vI4m1I5jgSTGHfHU47Af55r4z1/WNQ8Ra5Pql68k91Ngb5OqnsT7egrrwGU/WbzqaR8upLryk+SCPuyHxVopsVktb23uARkCKQEEjk85rwj9pa5uNS03Q543McCs5SYPtVJCR+oHQ187GbULS5Evny7Uxkxucp74r3jwF4307xA0XhXxFN9vhvUBgk2YQyAZ2+zcV3ywTwUlWp+8lv3Hh5RjP96tf6/E4XQLpxfR3ct3JM2BYSrOThk9d3c59apa5BPL4jSP7d/aSwgkRt83lIOgz0P4V6Xd/CG7/e2vh7VPJtmkMohnwQWxgn8jW3oHwnsYgt7q4jupQm1nLhI1HcjFbvNKHLzp38j2va07Jtqy/r+roT4YaPB4bs1vJbv7df3ignYcJGnZcdK9h0f7Dr9iPtkKSxRn5dxyQa89TSjbWkcVjEhhU7YzGcqFPpW3c/aNC023hsy3nznzXcttwMYxn19q+fqTliMReL1ZwYmftJOSPifxLeXd1qs8t5MZp2O7zs8yDsTW18PNbn0vWYJ0knjui4VWVCyuvdCB616H42+Dl1ZamwsGW5s2l3K5bbIq9lGeCK0fhZ8LL+PxKt3fRvBpUbBnjdgzsc5Ar6R42g4c3Orf10MJ4ecZOW6/r+u59O+CtZOs6FBLN8t0gCzJ6Gt+qlhb2kEKpZqqIvGE/r6/jVuvl6jUpNxVkca8xoRQxYKAx6nHWuH+JCLJc6crFRu3ff8AukccGu6rA8Y6bJfacs1she6tjvRB/H6j+v4Vph5qFRNm1F++rnzJqujT2Ot3dosHlwbyY5CvDoeT/gKy7+zhNyscc6u6p88YHG7+pr1vUNK0/X7cQ3n2hLpPkRw2wqf/AK/pUOh+FtHt1xfqbyaOT/VzKFK++O4r6iOKSjd7ntQxkElz7nk0OfILQq5ikXy8FcZYelNijJlSCOUxTSgJ5jDLM/px0r6K1i10a1trBNOtbaW2YnICg7cdsVyWlaBpUfiSFrK3YXz5CLuJQcfdA/qelTDHRmm7NEvFRjBu2vQ7+x0fR/FfhOy0nW7WK7a3gUZIyUO3GVb1rh7j4IaTpA/tKC6u76a2y3kkAbl9PfFes6FZ/wBm6colhVLiQbpEj5APoPXFaAyWbJxjqO1fOTx9SjNqlLRvY8ZaPuj86PFvhXV7HVbomyuJYMmT7QiExspPXPb6V3XwM8Cajd6pJrV4v9n6dbwt5cs4xvkIwMD0BOc9K+z20HS2dmW1iRnO47QOTXF/brDQBeWbypqFx5xkESqFKp6Htn1r0oY91U+SPvM2gqXN7Ts72PlXVdMuNPLjznN6ZWExkXAU+3ofekOnarMsc95bSxajKQY2lGPNPZlavdfFNlpetalFPHbRWeqKd8q4/dXGOmf7p9fWuan8JeI7zWnms4Ybhd4K7Jcxgd1A/pXrRxa5Vzqx79Kph60ueMreTdv68jg9M1/WtNv5sy3EN9bsJ31A5V2Yfw47rXsvxa0C8v8AwnZa7e2yxRRlbieJWO4SSAAnHbkgkVU0r4cLoWkQ6v44WS4eC+E8NrbncAvVY2PfLYzmvTZ/EmkeKdAdgXbTHVluo3Qg49PwNefiMUnOFSmrpPV/oc1fEqM4+z1Wzfl2vt6Hy+mi3DwNLp0jyQoMySBSBIT6Htj0rUfwL4hlit5JtMubjch2SW8ocRof89K1ta8M3Gh+bc6TeXN1ZhgyPChZWGcjco6t2rptH8RXn9nyWlgJUucllQIXP0+v0rueJckpU2mTVqzhqlpt/X+R4sbaG3nYSyhLtn2QpIerjrvx0/GvZ/g5qOn+F/B3io6ldtIZNvWMksxQjaMdQM1wHjZtW0C2n1fxBBbQPNKXjQIC0xP8DZ5Axz7V41ceKNWlbAvZ44FJ2Qo5CIPQCnipQq0+WT3/AEPNx1Wz9mi54ntkOt3xsTuguJTKCMgLnJwfxPFZMNlMJeFfzFIIUpjd69a6vUdVt7rwnp1wZQNYmnIbsFCfx+nPTFYMNzcyjz5meRCx80lu31raKU7M89anrPwB8H2niLxEy3wjLj5nRcDavt6mvrLXNV0PwJ4Y+13xjsdKswFUIucE9AB1JNfJHwR8Vpo/juyeOMst4ywlnO3bk4/I16j+1jcvMNB0yOcoG8ydkz8voGYegPevLxtCVfFQpyfuv+ma0U6kuUWX9pTT5NbNvBo90umbvlvCRu2f3in9OtdhF4h0Txj57aLq0ck4Te0e0q6DHUqe2e9fOXhDwnLqOnX+pr5fl6egS83TfMQ3QgHqMdxRqWvz+DdRsdb0QHa8heN5cPuUDBQnuPauh4Cir+y0a/rU7/q0acHNPVf1/XY9j8SfDxPExtYtd86Ce2yIrm3ccg8YJ716R8KvAek+B9DlttLMsstywe4nlbLOQMAewHpXm/wv+IbeNfDmrreQxx39k6yKq5AkRxjcD1B9q6W18T6lYrCtmIUspEJkDD5kb+8PU/WvHxdaprQnK1vu7im5VYWX9fPc0PiXYPLcuqRxXKTIC8MmCGGe/oBWBpXgSGy0+S+msrbTrO3ja5kuIQN+1RuOO/QU0a/JJM7bg4bIYs2C341Z1F7rXPC+qaPY6g1l9qgaNR/CWIwRk8gH2rnpYtxtC9l3KjzqKgnY+bfF/idvFt9dX14TCsDhbW1Q7Yo0GTg+rHHJrEv7ayti090HZLiJnhgBBK5HG4jpzVe+tdQ0TULnw/qkf2GRZQlzG67mHOQQfTvxVW2mj1C7+xGLcoYKkh4IA5xjvnFfV03BxXLt0NvaxsoJWf6/13Pqjwg8DfBXStffU2TyrcxTy3C72OG2gL6/1ritR8eeJZrlZLMWVpplmiyiS5AJmVuA+PqRxXPeKdauPDWk6D4VmeR/7NiWdoEXKPLJ8x3/AN7HQDtmsLU9NubJrTVZLEJBeTeWls8/DsRncB6VyUMDTTc2k7t29DSNOKTc7PU9dm8VP8VvDN94bvI7ex1C2iEnnGQGPIPHHUc44riZvg54xsbFZLewiv4cqWFrcKvmjOSSDzn2qn8MEksvixaQuYZolAhke3YMuXHIz6/4V9h6TFHHZJBjJTIww96wxWJeBajSSs9bGFfloJOC0Z8I3XhTxLpt0sOo6NdxbnO0GPAVR1Ab6dq9Q+FVtDrtrc6HeSTxxwcNMM52N/Cp/vV9G3vheyurtbhlUspLYZc81RuvC9pYO0uk2sVsME/ulCgnvkVhXzdTpNJe8YU8RFwcZLU4/TdM0zw1ZT2mkCTEjZZ3O5sDtnvVG8he5kCAbt5GTmtg6LeyXxExKRZzljinXCQMksEMdyUjYK0qAqS3fae4r5tudSblLVmi20OXl097/VE8td0UaGNs9HY8YFdN4a0mDSNdhnWFvPztAJyCfTPrVvxfcWGk+G9LSPav2h9hYcMDtJHHrnArnPAviSW11G3glZpLcDLg8l2Pf2Ir2qNGU6HMuxhKbmrIyv2tjqB0XRGhjc6Ysr/aGHckDCn06V8vtMhvXGdqfdMq/NjPYfSvvXx3pmneLvCt/pDz20k00RaFWYcSAHacfWvgzUbW70O/vNJ1BVhntnO5VGS7A8YPpXr5TVTo8lrOJzUrKTTG2Y4/flyjNhmYY/M1teA45n8Xadb2eVkmuE8rBwA24DOe3FYDG4aJ5W3MFUYI55z3r2D9mj4e3XiDxIniO7CQ6dptwDsc5d5ByAB2Gcda769WNKm5y6I0lo0egfEzX9W03xVZ6b4QvLU3Vjb4uxMOJ5T/AAZPt2rz/V/Fd5r1jNLq+oXAgZ9k1nYkosQ/i3etV/iBNNH4/wDEB85bmCe/kBt3GfmGcH+lc1p0Vvd2MltK11HK7bJFi6S46KO9cuGwtOnCLt8z26dCPKrK7t177/r228y94X8bP4W1qyu9Ovrq9iRtr2khKpJADkqQeA2Ohr6V8ZX2k6/4Y0fWoHVrS6AZM54ypODjuOR+FfNuleB7q7ULYWVzkHMU8xCJEv8AFn1Ne4eGFSx8PxeHyRJbWxEqZ5GcEHH5muPMPZUpxrLdb27HLi6LlG70l5djr7uELP5N2qSkKQquvQev/wBahZPLhZY87V9Rn8jXNfFz4uaB4N1WPT/sD6pqBCvKkbhVQHpluzVzel/HLwdq6pFJb6lp19JIsaW7qGVmY4yGHQZPU18w8BiuTm5W0ZOolbm0PW/D+oyCdTKHTcACGwQO5AI649q7BWDqGXkEZFcObd7aWXfz3wRgLnt705NVa0jSG1kMMaHcUABHPPHtWdKovhbM6lHn1R29FZOh35uVaN1QMPnBTvnk59/X1qTxFqsOh6Ld6jdMFht0LsSwH866UruyOX2cubk6mP4l8Kwandm/tjtuVGGQH5ZCOn0Nc3P4W1m43s9tCz7cb3kG7OeMemK+cfHHxe8XeIdYjuLHUWsLC35QW52qxB4Y+re1eqfCv47za5dRadr1q0V3IoMUq/ckIHIPoTXvfVMVRpqzTt07Gtpp27HTnRdXiuZ0nsWgkYgRTMPMSRs98dAPWuw8O6Rb6DCbq8kWbUTwz7cKM9lrZkv/ALZpUV5bZALEbevtzXNgu4GTvX+LnjOf88V4uKxlWS5djoT542asdPDqBupJEEWY1H3+x9vrVu1QoihgcgAZY5J+p7mvKvFHxN03wpeR6dZqmoX7RFiRIBHHxwGPc+wrhR+0Lr006CHRNOhXBzHK7ln9Md6dDK8TiF7RRsvMTwtRr3Voz3vxZerpOnS34DCQIY9+75VHJyfy/OvmjUfGN7qOqudCijjgAZ5JJ1Bk2g/eGf5V6d4f+Idj8SfDFzpF5s03X5InP2YkmOUDONrH27da8SktLywuWstT08+TvZFjx9xs9fp6V9BlmG9kpRqL3l+RdChdNTWqOr0nxlqV0rrqFnFPI6lUlHyPMgPRV6Z711kGr2SxWt5aXka2rnYoQlWQ9930rxOJTFfB5JZjPkssiniP8PUdxWje+I5/sUlraAywGMCd1XaD7Ff1r0amGT20L+rU2rPQ+ovBGrya3pd1pmoEXF1AuGk/hdT90muQ8RQXWjxpaRRCP5y3lJwi89R7Va/Z7huP+Ec+1zplHXb5xH38HjHtis7xH4xtLvX73Tb7StSlEtykUTQj5cYwct0684r5fF4acqs6dLZNXOWhdScVqiDSdfubS0uIbqTybSRdrso6jocelbcfxS8NaSkX2prS2kKfKeNzY7kjn86qeItJt7GCA2cQghmdWCv1A9CK8H8m2j1vWmkixeSXTCMXAKpb9drhv8aMuwSr3dRuyPQpYaNeOuiOq+M2s+H/AIianDaRalHFcMFS2ZAXj3Z4yR3OcV4vqfw48S6feeTNp7spbaJlIMZ5657V0GhyEK9tIgOxmZpY+v1B9a+h/h9qWjeKtK0yw1O5jbVZg0MyMNhl2jqV9cD8a92tRWHgrK6X4HPXwUI0+ZHx7qMTQXP2ZZBItt8m6PoG7n86jlSSWRIngIZFwAox+J967X4q+D7/AMFeLpbO8hZbfzWNvchDtmjJyMnucda4iDOxypPmb84xniu2LjJXTumeW42dju/hXatf+LdH8yNkEdzCzFycEbh09BXsn7SPhfXb/wAZpqccFxcaSLVUVoULiH+8CBzk5yK8z+A2havq/jbT7dop47PzQ80kgIAVecDP06V9yPGrspIGQc5715ePxjw1aElq7P8AEujP2cua1z5W8JeDNWj8GeJbsW9xD9vt0isrNmw7lCG3Edhx0NeW6lpur3GnrA1jfXWXO+NY2IjfPCqO2a+9zbRNklACTn6H1FU9QvdN0W0eW/uI4I2zlnPzN7Dua5oZvJt2hds7PrcWnzR/H/gHgvw78FXPhHQ5YNSGNV1JRPcxqNqWqgfLGPetoW8zWUk0cUkiRLhn27snpnHWrHjPx2lw7f2ZcW6WoGc4zJKewPp9a5ez+LeqWFyfN0u3vI0QRN5LEEnOdwA4z71zSy/E4hurPd9Ni6cKk1zKN0alzYzyDKLIy4+Xg5zjnNXdFtrkqv2iJvNbClVOQqjgcf1rpNL1XS9c8Pya7p6Wsc0ybJoJHBlgb+6R61d8V6hFY+Cxf+H7+CK4neOCKWZQ6byeQR2PWuH6nUcuVq2thLmbUUt3Y81+KGleBbqaKDxtO1rqyxjy5bYFpymPlyB1HpmsfwD4Q8EWM7apo9wNYKspiNywHlt2JT1Hoa828ZapqeqavrmpXk32u485bV5Hjx5cYHBj9BVuITt4bt79litrh51jWW3/ANZsH8TIOD9ete4sqnGkoRqNfkdtPDyatez9F+e56D8Wor+61mHxBb2ovI7mJLe5RI8lGX7rj0PvXA39rfR3OpHTV/10SqUvIMlOQdyjH3u3HrXpngLxI16W07WpIvtBXkg43L2INeq+FriG1uHivFhksdoeKaSPLQyZwVY44HQg1jDG1cGvYVI3a280Ht1Qj7OrFu21nY+ZvB+iavd3CXlpZtpWnW9wtzPdTr5ZmZRyFHp1Neuw/HDSdOt/KtY5L6cj/XFThyO3HWs39o3xXa+ZBp8C/aFdd0uG+ZQDwQOwPrXz0ltHcRmRbo+apOfK+6q9c7vWvUhRWNpqpWXojmqzVeOqsfWXh741adeHGo2zRKTgvGc7fqOor0zQtb0/XbMXOmXCzR9GHRlPoR2r4d8J6Zfv4itLaWR50VS5RTkBMH5vevavh1eXOh+JgYpH2XkJWQFMBcdPxrixmV0km6ejOWdC7stGe1+JbqysLeSWeMblAdmC5J9B+NcNfeIEcJI0LSRNn/Vnbs+vrXH/ABW8Y6mNYXS4JI4rMRZupIRulmY/dUDtXk3hXxDfaT4kllvnu7jTlBe4tXfzDH2GOwauJZVKdPmvqehRwMuVOXU+hfHmk2+ueGNL1KOa4Q20gUBOFIPdvpXLaVve6eLSxlywBZjksB7+9bp8Q6XeeCr5dK1a0nSEpLLCTyq9wR1x06154fF9rbPHcaPbXATAZfn29PvEZ7D0rry+nVdHka27nLyuMnGx1OpwXWkSTReYnlsd8lw/RPXJ7muH1ltA8QTSWmoiK6ZJFSO7zh8HsG7mpPEHi658SbLaGCaCyb5irj53x6k9OecVy806HUZbKUvGMLiVU+VyOpf0r1KNKSjeW5pGhdWl+R6z4O+BfhnTry01STU7rWyg86OxYAIx7Zx6HHWvctH0mx0iGV7W0trR5sSTmFdoLAda8L+BniqSx1Y6TO3mxTgsHJyRj0NeleMdfa2spbe2G1CCTgnJB/z0r53Mp1I1PZ1ZXX9dDlrUKlN8vf7jwv4oWU1l4tlmit7P7G873lncZIkkyMFCfYnOKPhZpNzpgl1rUIUa5Z2EO5c47lgK7KwvkuW826jWUjIJddwOe9ak0imNTHDtCDjZxgdhSebv2fs3E9KGJtBRs72te5l3N9PNdedNFiTG5FA2iQn26D6VU+xyx3AmkkMjsm1YkOAgzzz9cVqTXeEwIkyR8wIwT7CrGk6VNqjb3yibSQzDOeR6Vx4jHSqrlitDmk10P//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone marrow aspirate from a patient with chronic myelogenous leukemia shows hyperplasia of elements of the granulocytic series (eg, promyelocytes, myelocytes, metamyelocytes, band forms, and mature granulocytes).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David S Rosenthal, MD and Anna J Mitus, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8375=[""].join("\n");
var outline_f8_11_8375=null;
var title_f8_11_8376="Rhabdomyoma fetal";
var content_f8_11_8376=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F53795&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F53795&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Small cardiac rhabdomyomas in a 36 week autolyzed and hydropic stillbirth",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 314px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Death presumably due to conduction anomalies from the multiple cardiac rhabdomyomata. These are very often associated with tuberous sclerosis and may be the only feature of this disease in the fetus. It necessitates familial genetic counselling when found.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8376=[""].join("\n");
var outline_f8_11_8376=null;
var title_f8_11_8377="Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)";
var content_f8_11_8377=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/11/8377/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8377/contributors\">",
"     Shai Padeh, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/11/8377/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8377/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8377/contributors\">",
"     Robert Sundel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8377/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/11/8377/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8377/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/11/8377/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recurrent fever syndromes are autoinflammatory diseases that are characterized by attacks of seemingly unprovoked inflammation without significant levels of either autoantibodies or autoreactive T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The known genetic causes of these syndromes derive from defects in proteins of the innate immune system. More than ten hereditary autoinflammatory syndromes, caused by over 770 different mutations, have been identified. In addition, 30 to 70 percent of cases referred to the United States National Institute of Health Translational Autoinflammatory Disease Section do not have mutations diagnostic of known genetic autoinflammatory disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/3\">",
"     3",
"    </a>",
"    ]. The most common such condition is",
"    <strong>",
"     p",
"    </strong>",
"    eriodic",
"    <strong>",
"     f",
"    </strong>",
"    ever,",
"    <strong>",
"     a",
"    </strong>",
"    phthous stomatitis,",
"    <strong>",
"     p",
"    </strong>",
"    haryngitis, and",
"    <strong>",
"     a",
"    </strong>",
"    denopathy (PFAPA syndrome).",
"   </p>",
"   <p>",
"    PFAPA was first described by Drs. Gary Marshall, Alexander Lawton, and colleagues in 1987 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/4\">",
"     4",
"    </a>",
"    ]. It is one of two truly predictably periodic fever syndromes. The other is cyclic hematopoiesis, which has indistinguishable clinical features. PFAPA is a sporadic syndrome, unlike most hereditary autoimmune fevers, and second cases in siblings are rare. Two large registries, one in the United States and one in Israel, form the basis for the following description [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. An overview of the periodic fevers and other autoinflammatory diseases is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15494?source=see_link\">",
"     \"Periodic fever syndromes and other autoinflammatory diseases: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pediatrician is generally the first clinician to evaluate the child with recurrent fever, since these disorders often become clinically apparent in childhood. The approach to a child with unexplained fever is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9706?source=see_link\">",
"     \"Approach to the child with fever of unknown origin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38905?source=see_link\">",
"     \"Etiologies of fever of unknown origin in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periodic fever in children diagnosed with PFAPA generally begins between the ages of two and five years (3.7 &plusmn; 3.8 years of age in the Israeli cohort of &gt;500 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/7,9,10\">",
"     7,9,10",
"    </a>",
"    ], although a younger median age of onset (11 months) was seen in a smaller Norwegian cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/11\">",
"     11",
"    </a>",
"    ]. There is a slight male predominance (55 to 71 percent). There is no predilection for a particular ethnic or racial group. Familial cases are rare [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/12-15\">",
"     12-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Attacks cease before 10 years of age in most patients. However, this syndrome has been described in adults. The first cases in adults were reported in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/8\">",
"     8",
"    </a>",
"    ], with over 30 cases diagnosed within two years of that report [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of PFAPA is unknown. Known monogenic causes of periodic fevers have been excluded as the cause of PFAPA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/17\">",
"     17",
"    </a>",
"    ]. The striking response to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    suggests that dysregulated production of cytokines may contribute to the fevers. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Elevations of several inflammatory cytokines, most notably interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and IL-6 and IL-18, occur during episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5,18,19\">",
"     5,18,19",
"    </a>",
"    ]. IFN-gamma-induced cytokine",
"    <span class=\"nowrap\">",
"     IP10/CXCL10,",
"    </span>",
"    <span class=\"nowrap\">",
"     MIG/CXCL9,",
"    </span>",
"    and granulocyte-colony stimulating factor (G-CSF) are increased after the onset of fever, while IL-7 and IL-17 are suppressed during afebrile and febrile periods [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Proinflammatory mediators (eg, IL-1 beta, IL-6, TNF-alpha, and IL-12p70) may even be elevated between febrile attacks [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cellular responses are also generally distinct from those seen in infections. Monocytes are increased and eosinophils and lymphocytes are often decreased during febrile episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Thrombocytes are increased in the afebrile interval. Complement, interleukin-1 (IL-1)-related, and IFN-induced genes are overexpressed during PFAPA attacks [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/19\">",
"     19",
"    </a>",
"    ]. These changes imply activation of innate immunity, resulting in increased IL-1 beta secretion and precipitation of attacks. Increased IL-1 beta secretion is commonly found in autoinflammatory syndromes, suggesting similar pathogenic mechanisms between this group of diseases and PFAPA syndrome. A model was proposed in which microbial triggers activate a cascade beginning in the innate immune system and culminating in recruitment of activated T cells to the periphery [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The remarkable similarity of uncomplicated episodes of cyclic neutropenia and febrile attacks in PFAPA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/21\">",
"     21",
"    </a>",
"    ] suggest a \"biologic clock&rdquo;. Cyclic neutropenia is caused by an unidentified defect in hematopoietic precursor cells [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/22\">",
"     22",
"    </a>",
"    ] or by alterations in the regulation of cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/23\">",
"     23",
"    </a>",
"    ]. Mutations of the gene ELA2 encoding neutrophil elastase cause a perturbed interaction between neutrophil elastase and serpins or other substrates that regulate the clocklike timing of hematopoiesis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/24\">",
"     24",
"    </a>",
"    ]. PFAPA and cyclic neutropenia may share common pathways of immune dysregulation.",
"   </p>",
"   <p>",
"    Alternative theories to explain the periodicity of the PFAPA syndrome include intermittent expression or suppression of antigens or epitopes of infectious agents, or an alteration in the nature or kinetics of the immunologic response [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/25\">",
"     25",
"    </a>",
"    ]. However, lack of second cases in siblings or other close contacts, lack of seasonal or geographic clustering, and the progression-free duration of PFAPA for years weigh against an infectious etiology. In addition, histology and electron microscopy of specimens collected from tonsils removed from PFAPA patients are unrevealing, and deep cultures are negative [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Increased numbers of class-switched IgD+IgM- plasmablasts and more mucosal IgD-armed basophils were found in patients with PFAPA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/26\">",
"     26",
"    </a>",
"    ]. Furthermore, an increased proportion of these cells and IgD class-switched plasmablasts were demonstrated in tonsil tissue specimen from PFAPA patients",
"    <strong>",
"     ,",
"    </strong>",
"    suggesting that microbial antigens with IgD-binding activity may trigger release of IL-1&beta; and LL-37 from mucosal basophils, resulting in inflammation. This effect could account for the elevated serum IgD, IgG, and IgA titers often observed in individuals with these syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6,26,27\">",
"     6,26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The course of PFAPA syndrome is attenuated by carrier state of MEFV, the familial Mediterranean fever (FMF) gene [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/28\">",
"     28",
"    </a>",
"    ]. PFAPA attacks in carriers of MEFV mutations were shorter and less likely to occur at regular intervals, and fewer patients had oral aphthae, compared with patients without mutations. A lower glucocorticoid dose was needed to abort the attacks in these patients as well. No differences were observed in other clinical and laboratory parameters.",
"    <strong>",
"    </strong>",
"    These data suggest that in PFAPA, MEFV is a modifier gene associated with an attenuated disease severity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Symptoms and physical findings",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever begins abruptly, often accompanied by chills. Prodromal symptoms of malaise, irritability, sore throat and aphthous ulcers may occur during the preceding day. Temperatures range from 38.9 to 41.1&ordm;C for three to six days (4.5 &plusmn; 1.7 days in an Israeli cohort of &gt;500 patients) and then abruptly fall to normal. Episodes rarely last for more than seven days.",
"   </p>",
"   <p>",
"    In a United States series, episodes of fever occurred at intervals of 28.2 days (26.0 to 30.4), resulting in 11.5 episodes per year [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5\">",
"     5",
"    </a>",
"    ]. Israeli children had attacks at a similar interval of 4.0 &plusmn; 1.4 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6\">",
"     6",
"    </a>",
"    ]. Between febrile episodes children with PFAPA are healthy and have normal growth. Symptoms or abnormal laboratory studies between fevers, or abnormal growth or development, exclude a diagnosis of PFAPA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Aphthous ulcers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aphthous ulcers (",
"    <a class=\"graphic graphic_picture graphicRef63475 \" href=\"UTD.htm?13/25/13713\">",
"     picture 1",
"    </a>",
"    ), usually on the lips or buccal mucosa, occur in about 40 to 70 percent of patients. There may be only a few small aphthae that are easily missed, as they are not as large or painful as the ulcers of Beh&ccedil;et&rsquo;s disease, nor do they scar.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Pharyngitis and adenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharyngitis (",
"    <a class=\"graphic graphic_picture graphicRef68744 \" href=\"UTD.htm?3/15/3313\">",
"     picture 2",
"    </a>",
"    ) and cervical adenopathy accompany the fever. Tender cervical adenopathy occurs with the majority of episodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Other, probably unrelated, symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other symptoms reported with lower frequency by parents of children in the United States registry and in other reports are headache (73 percent) and muscle pain (63 percent). Diarrhea, arthralgia, cough, coryza, and rash were reported to a much lesser degree in the United States cohort and not at all in the Israeli cohort. Abdominal pain was reported by 45 to 60 percent, but was never sufficiently severe to warrant surgical consultation. Parental reports of subjective symptoms, such as headache, myalgias, and abdominal pain in young children have limited reliability. Based upon observations of episodes in the clinic and in hospitalized patients, the authors' opinion is that none of these symptoms are integral to the PFAPA syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no diagnostic laboratory test for PFAPA syndrome at present. Prior to recognition of the periodicity, episodes are usually ascribed to tonsillitis or a viral syndrome. However, in the United States cohort, only 28 of 284 throat cultures yielded Group A streptococcus. These &ldquo;positive&rdquo; throat cultures probably represent benign carriage, since patients with PFAPA do not respond to penicillin therapy.",
"   </p>",
"   <p>",
"    Moderate leukocytosis (13.6 &plusmn; 4.5 x 10(9)",
"    <span class=\"nowrap\">",
"     cells/L)",
"    </span>",
"    and elevation of the erythrocyte sedimentation rate (49 &plusmn; 30",
"    <span class=\"nowrap\">",
"     mm/hr)",
"    </span>",
"    and C-reactive protein (2.5 &plusmn; 4.7",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    are usually present during episodes, but normalize between attacks. Distributions of T cell subsets were normal in all 12 patients studied in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IgE levels are not routinely measured, but in one case series were found to be elevated in 8 of 16 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5\">",
"     5",
"    </a>",
"    ]. Twelve of 18 Israeli patients had significantly elevated serum concentrations of IgD, but not at the levels reported in the hyper-IgD syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6\">",
"     6",
"    </a>",
"    ]. IgD levels were normal in early reports from Europe and the United States, but subsequent reports showed elevated IgD in some of the patients presenting with a similar phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5,27\">",
"     5,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Procalcitonin concentrations do not increase in correlation with the increase in other acute-phase reactants during an attack, a finding that may be unique to PFAPA patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/29\">",
"     29",
"    </a>",
"    ]. Anti-nuclear antibody was present in 1 of 30, consistent with the known frequency of ANA in healthy children [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Imaging studies, including chest films, sinus films, gastrointestinal series, CT scans of the head and abdomen, gallium scans, and bone scans, were all negative in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5,10\">",
"     5,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PFAPA is made on clinical grounds. The primary reasons for making this diagnosis are to relieve parental anxiety, avoid unnecessary and expensive laboratory evaluation, and prevent potentially harmful treatment. Strict adherence to the following clinical criteria will assure that the more serious diseases associated with recurrent fever are excluded. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;To diagnose PFAPA syndrome, all of the following should be present (at any age):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      More than three documented episodes of fever, lasting no more than five days and occurring at regular intervals (For individual patients, intervals between attacks are nearly identical within a range of three to six weeks, and the symptoms with each episode are identical).",
"     </li>",
"     <li>",
"      Pharyngitis plus tender cervical lymphadenopathy or aphthous ulcers.",
"     </li>",
"     <li>",
"      Normal growth parameters and good health between episodes.",
"     </li>",
"     <li>",
"      Prompt resolution of symptoms with a single dose of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"       prednisone",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5-7,10\">",
"       5-7,10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Exclusion criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of any of the following features, precludes the diagnosis of PFAPA syndrome:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neutropenia &mdash; Neutropenia immediately preceding or during an attack suggests cyclic hematopoiesis, the disease that resembles PFAPA most closely.",
"     </li>",
"     <li>",
"      Atypical symptoms &mdash; PFAPA attacks have stereotypical symptoms that are easily recognizable by caretakers. The following symptoms as a part of most attacks should trigger consideration of other diagnoses: cough, coryza, severe abdominal pain, significant diarrhea, rash, arthritis, or neuromuscular symptoms. Genetic testing for autoinflammatory diseases should be considered for patients with the above symptoms, except cough and coryza [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Elevated acute phase reactants between attacks &mdash; Laboratory evidence of a persistently elevated acute phase protein response (eg, elevated ESR or CRP) suggests a chronic illness with intermittent flares rather than a true periodic disorder.",
"     </li>",
"     <li>",
"      Family history of recurrent fever &mdash; A family history of periodic fevers should lead to consideration of one of the hereditary autoinflammatory syndromes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15494?source=see_link\">",
"       \"Periodic fever syndromes and other autoinflammatory diseases: An overview\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The importance of strict adherence to diagnostic criteria is illustrated in the following case: a child was diagnosed at the age of eight years as having PFAPA on the basis of recurrent attacks of fever with aphthous ulcers, pharyngitis, and cervical lymphadenopathy at variable intervals [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/32\">",
"     32",
"    </a>",
"    ]. He had an apparent remission after tonsillectomy. However, as an adult he had attacks that included conjunctivitis, myalgia, flank and abdominal pain in addition to pharyngitis and oral ulcers. These attacks lasted one to two weeks. At age 22 he was diagnosed with TNF receptor 1 associated periodic syndrome (TRAPS) by genetic analysis. As pointed out in an editorial that accompanied the instructive case report, the childhood episodes had neither the periodicity nor the short duration that define PFAPA attacks [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28551?source=see_link\">",
"     \"Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only other childhood disorder with truly periodic fever is cyclic hematopoiesis (also called cyclic neutropenia). Most patients with cyclic neutropenia exhibit a 21 day cycle (range 14 to 35 days), and the period is consistent within each patient. Patients may develop extensive gingival disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"     \"Cyclic neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recurrent fevers that are not periodic suggest hyper-IgD syndrome, familial Mediterranean fever (FMF), TNF receptor 1 associated periodic syndrome (TRAPS), or Muckle-Wells syndrome. A screening panel for mutations in seven genes that cause periodic fever syndromes is available at at least one reference laboratory. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15494?source=see_link\">",
"     \"Periodic fever syndromes and other autoinflammatory diseases: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24487?source=see_link\">",
"     \"Cryopyrin-associated periodic syndromes and related disorders\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H13\">",
"     'Exclusion criteria'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Periodic fever without other systemic manifestations or sites of disease has a short list of differential diagnoses. An infectious disease or malignancy is rarely diagnosed in an individual who has predictably periodic fever [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A formula to help decide when to test a patient for mutations in genes associated with periodic fevers was proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/31\">",
"     31",
"    </a>",
"    ]. This formula was based upon the results genetic testing in 393 patients with periodic fevers. The so-called Gaslini diagnostic score is based upon the higher frequencies of abdominal pain, diarrhea, vomiting, cutaneous rash, and arthralgia in children with identifiable genetic explanations for their fevers. Genetically negative patients, on the other hand, had a higher frequency of exudative pharyngitis. This study supports our criteria, and also validates the recommendation that genetic analysis need be considered only in children who do not fulfill the criteria for PFAPA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;PFAPA is a benign and self-limited disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5-7,10,11,36\">",
"     5-7,10,11,36",
"    </a>",
"    ]. Affected children grow and develop normally and experience no long-term sequelae. The mean duration of attacks ranges from 4.5 to 8 years. Those with persistent symptoms tend to have episodes that are shorter in duration and that occur less frequently.",
"   </p>",
"   <p>",
"    There are reports of sporadic cases of adults with PFAPA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/37\">",
"     37",
"    </a>",
"    ]. The author follows 15 patients 20 to 38 years of age who have PFAPA. Most of these patients were self-referred after learning about the syndrome on the internet [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal treatment for patients with PFAPA is uncertain. Given the favorable natural history, treatment of any kind is clearly optional and the risks of symptomatic treatment must be weighed against adverse effects. Clinical experience suggests that antipyretics, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , and nonsteroidal antiinflammatory drugs (NSAIDs) are ineffective in controlling the symptoms of PFAPA other than fever. The authors' preliminary experience with prophylactic",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?1/26/1446?source=see_link\">",
"     montelukast",
"    </a>",
"    or a single dose of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/35/37424?source=see_link\">",
"     ofloxacin",
"    </a>",
"    at fever onset was also discouraging [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/16\">",
"     16",
"    </a>",
"    ]. Reports of benefit from glucocorticoids,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"     cimetidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/50/14118?source=see_link\">",
"     colchicine",
"    </a>",
"    , tonsillectomy, and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/52/33605?source=see_link\">",
"     anakinra",
"    </a>",
"    with or without adenoidectomy have appeared in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6-8,10,19,38-50\">",
"     6-8,10,19,38-50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The decision to treat or not should be made by the family in conjunction with their pediatrician. Questions to be considered in this decision include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Whether the child can afford to miss four to five days a month of school?",
"     </li>",
"     <li>",
"      Whether a parent or caregiver can miss work to care for a febrile child?",
"     </li>",
"     <li>",
"      Does familial stress related to fevers justify the potential risk of treatment?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many parents worry about the potential side effects of glucocorticoid therapy. However, toxicity related to the low doses of glucocorticoids used in PFAPA, aside from possible restlessness and changes in mood on the day of administration of the drug, have not been reported in either the United States or Israeli cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    , in doses of 1 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    orally relieve the fever and pharyngitis (but usually not the aphthous ulcers and adenitis) in a dramatic fashion, usually in a matter of hours [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6-8,10\">",
"     6-8,10",
"    </a>",
"    ]. This response may be useful in distinguishing attacks of PFAPA from FMF or other hereditary autoinflammatory periodic fever syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6-8\">",
"     6-8",
"    </a>",
"    ], and had even been proposed as a diagnostic criterion for PFAPA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6\">",
"     6",
"    </a>",
"    ]. Its usefulness as therapy, however, is limited by the fact that prednisone treatment results in shortening the interval between attacks in about 25 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6,8,38\">",
"     6,8,38",
"    </a>",
"    ]. In the Israeli cohort, the frequency of attacks increased following the initiation of glucocorticoid therapy in up to 30 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/6\">",
"     6",
"    </a>",
"    ]. Many children suffered even weekly attacks for a few months before the frequency changed back to monthly.",
"   </p>",
"   <p>",
"    We recommend giving a single oral dose of 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    (maximum dose 60 mg)",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    at the onset of fever. This is sometimes followed by recurrence of symptoms in 48 to 72 hours. In such cases, subsequent episodes may be treated with a dose of 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    on days one and two and 0.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    on days three and four. Alternatively, a single dose of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/7/28791?source=see_link\">",
"     betamethasone",
"    </a>",
"    (0.3",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    at fever onset has been suggested by the Israeli group in view of its longer half-life.",
"   </p>",
"   <p>",
"    A smaller single dose of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    (mean 0.6",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, range 0.15 to 1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) was found to abolish fever within an average of 10 hours in 51 of 54 patients in one uncontrolled series [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/38\">",
"     38",
"    </a>",
"    ]. The lower doses were chosen by the parents, due to concern about side effects of glucocorticoids. Thus the doses were adjusted individually. Most of the associated symptoms also resolved with the lower glucocorticoid dose, with aphthous stomatitis being the slowest manifestation to respond [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/16\">",
"     16",
"    </a>",
"    ]. The efficacy of lower doses of glucocorticoids was noted in another series as well [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the efficacy of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    , nearly half of the children were not treated for febrile episodes on a regular basis. The most common reported side-effect of treatment was restlessness and sleep disruption. This may be minimized by giving the glucocorticoids at least four to six hours before bedtime.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Cimetidine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beneficial effects of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"     cimetidine",
"    </a>",
"    have been noted in some small case series and in case reports. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a United States series, there were 28 patients in whom",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"       cimetidine",
"      </a>",
"      had been used. There was no benefit in 57 percent and a good response in 28 percent by parental report [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another United States cohort, 7 of 26 patients (27 percent) in a larger series had resolution of symptoms after treatment with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"       cimetidine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"       Cimetidine",
"      </a>",
"      in doses of 20 to 40",
"      <span class=\"nowrap\">",
"       mg/kg/day",
"      </span>",
"      was reportedly effective in inducing remission of PFAPA in three cases; remission was sustained when the drug was discontinued after six months [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Three patients with a diagnosis of PFAPA responded to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"       cimetidine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/40\">",
"       40",
"      </a>",
"      ]. However, two of the patients had chronic sinusitis and one had weight loss, making the diagnosis questionable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When the caretaker(s), despite reassurance about the benign prognosis of PFAPA, desire an intervention to try to prevent episodes, we suggest a trial of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"     cimetidine",
"    </a>",
"    (20 to 40",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    in divided doses every 12 hours). If cimetidine reduces or eliminates recurrent episodes, an attempt to discontinue the drug is appropriate after six month of continuous use. At times cimetidine must be given up to four times daily for optimal efficacy, an inconvenience that some families may prefer to avoid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Colchicine",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a small case series, prophylaxis with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/50/14118?source=see_link\">",
"     colchicine",
"    </a>",
"    (0.5 to 1 mg per day) was offered to nine patients with PFAPA episodes occurring at intervals of &le;14 days [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/41\">",
"     41",
"    </a>",
"    ]. All of these patients were being treated with glucocorticoids. The patients were followed for an average of two years (range 6 to 48 months). In eight of nine patients, treatment with colchicine was associated with an increased interval between episodes (the average interval increased from 1.7 to 8.4 weeks). In two patients discontinuation of colchicine was associated with increased frequency of episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/41\">",
"     41",
"    </a>",
"    ]. However, in the author's experience, the effect of colchicine is short-lived and the drug has failed in a large number of cases. Thus, colchicine is not routinely recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Diagnostic criteria'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/3/8247?source=see_link&amp;anchor=H2#H2\">",
"     \"Management of familial Mediterranean fever\", section on 'Prevention of attacks with colchicine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Tonsillectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tonsillectomy is the most controversial of the treatments used for PFAPA, since PFAPA is a benign and self-limited disease and tonsillectomy has attendant significant risks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/22/35178?source=see_link&amp;anchor=H20#H20\">",
"     \"Tonsillectomy and adenoidectomy in children\", section on 'Complications and adverse effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most case reports and case series support the effectiveness of tonsillectomy with or without adenoidectomy in inducing remission or decreasing symptoms in most, but not all, patients with PFAPA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/5,6,8,10,11,38,42-48,51,52\">",
"     5,6,8,10,11,38,42-48,51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two randomized trials have confirmed these observational findings [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/53\">",
"     53",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first trial, 26 children with &ge;5 fever episodes diagnosed as PFAPA were assigned to treatment with tonsillectomy or follow-up alone [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/49\">",
"       49",
"      </a>",
"      ]. Six months after randomization, all of the children in the tonsillectomy group, but only 6 of 12 of the children in the follow-up group, were symptom free. However, this study had several limitations. Eleven of these patients had no symptoms other than fever and would not have met the criteria for a diagnosis of PFAPA as outlined here or the alternative slightly less stringent criteria of the Israeli group [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/7\">",
"       7",
"      </a>",
"      ]. One child in the study and two who were not included had a sibling with PFAPA. One-half of the patients not subjected to tonsillectomy had a remission within six months. This rapid rate of remission is very atypical.",
"     </li>",
"     <li>",
"      The second randomized trial used standard diagnostic criteria for PFAPA [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/50\">",
"       50",
"      </a>",
"      ]. In this trial, 39 patients were assigned to treatment with either adenotonsillectomy or expectant management. Sixty-three percent in the surgery group had immediate and complete resolution of symptoms and the remainder had a decrease in the frequency and severity of episodes. Only 1 of 20 children in the control group went into remission during the 18 month follow-up period.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is clear from the literature and personal experience that tonsillectomy results in resolution of PFAPA attacks in some, but not all, patients with PFAPA. Attacks recurred between 0.5 to 10 years after the removal of the tonsils in one-third of the cases in the Israeli cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/16\">",
"     16",
"    </a>",
"    ]. Treatment of PFAPA episodes with moderate doses of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    is effective in most patients and is a safe alternative.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/50/14118?source=see_link\">",
"     Colchicine",
"    </a>",
"    treatment may be helpful in those patients who have an increased frequency of episodes when treated with prednisone. Thus, we suggest that tonsillectomy be reserved for patients with PFAPA who fail to respond to conservative management. The diagnosis of PFAPA alone, without first attempting conventional medical therapy, should not be considered an indication for tonsillectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7323284\">",
"    <span class=\"h2\">",
"     Experimental therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;IL-1&beta; is elevated during PFAPA flares, suggesting a potential line of treatment. In a pilot study, five patients were treated with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/52/33605?source=see_link\">",
"     anakinra",
"    </a>",
"    , a recombinant IL-1 receptor antagonist, during flares [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8377/abstract/19\">",
"     19",
"    </a>",
"    ]. All patients demonstrated clinical improvement and decreased levels of",
"    <span class=\"nowrap\">",
"     IP-10/CXCL10.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      PFAPA syndrome is a disease of unknown etiology and uncertain pathogenesis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It usually presents in childhood and is characterized by periodic fevers at regular intervals of four to six weeks and by stereotypical clinical features of pharyngitis, aphthous ulcers, and cervical adenitis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of PFAPA is based on clinical criteria and the exclusion of other causes of recurrent fevers (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above). Clinical features that",
"      <strong>",
"       exclude",
"      </strong>",
"      PFAPA include: the presence of neutropenia before or during an episode, the presence of atypical symptoms (ie, cough, coryza, severe abdominal pain, diarrhea, rash, arthritis, or neurologic deficits) in association with most episodes, an elevated ESR or CRP between attacks, impaired growth, or a family history of recurrent fever. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Exclusion criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Optimal treatment of PFAPA syndrome is uncertain. Because the disease has a benign and self-limited course, effective education of caretakers may allow expectant management of febrile episodes without use of potentially toxic medications. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A single dose of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"       prednisone",
"      </a>",
"      (2",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      can be used as a diagnostic trial. We suggest giving a single dose of 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      prednisone at the onset of fever (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). This is sometimes followed by recurrence of symptoms in 48 to 72 hours. In such cases, subsequent episodes may be treated with a dose of 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      on days one and two and 0.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      on days three and four. An alternative, longer-acting glucocorticoid is",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/7/28791?source=see_link\">",
"       betamethasone",
"      </a>",
"      , given 0.3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      in a single dose at the onset of fever. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"       Cimetidine",
"      </a>",
"      is safe, but we have doubts about its efficacy as a remittive agent. If prevention of episodes is desired, we suggest a trial of cimetidine (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). A commonly used dose is 20 to 40",
"      <span class=\"nowrap\">",
"       mg/kg/day",
"      </span>",
"      in divided doses every 12 hours. This may be combined with early treatment of episodes with a single dose or short taper of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"       prednisone",
"      </a>",
"      as described above. If regular use of cimetidine prevents recurrent febrile episodes, an attempt may be made to discontinue the medication after six months of use. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Cimetidine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tonsillectomy is effective in some, but not all, patients with PFAPA. In addition, PFAPA is a benign and self-limited disease and tonsillectomy has attendant significant risks. Thus, we suggest that tonsillectomy be reserved for patients with PFAPA who fail to respond to conservative management (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Tonsillectomy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/1\">",
"      Reiman HA. Periodic disease: a probable syndrome including periodic fever, benign paroxysmal peritonitis, cyclic neutropenia and intermittent arthralgia. JAMA 1948; 136:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/2\">",
"      Reimann HA, McCloskey RV. Periodic fever. Diagnostic and therapeutic problems. JAMA 1974; 228:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/3\">",
"      Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell 2010; 140:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/4\">",
"      Marshall GS, Edwards KM, Butler J, Lawton AR. Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 1987; 110:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/5\">",
"      Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr 1999; 135:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/6\">",
"      Padeh S, Brezniak N, Zemer D, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 1999; 135:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/7\">",
"      Padeh S. Periodic fever syndromes. Pediatr Clin North Am 2005; 52:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/8\">",
"      Padeh S, Stoffman N, Berkun Y. Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J 2008; 10:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/9\">",
"      Sampaio IC, Rodrigo MJ, Monteiro Marques JG. Two siblings with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome. Pediatr Infect Dis J 2009; 28:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/10\">",
"      Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatr 2010; 99:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/11\">",
"      F&oslash;rsvoll J, Kristoffersen EK, &Oslash;ymar K. Incidence, clinical characteristics and outcome in Norwegian children with periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome; a population-based study. Acta Paediatr 2013; 102:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/12\">",
"      Adachi M, Watanabe A, Nishiyama A, et al. Familial cases of periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. J Pediatr 2011; 158:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/13\">",
"      Sampaio IC, Rodrigo MJ, Monteiro Marques JG. Two siblings with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome. Pediatr Infect Dis J 2009; 28:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/14\">",
"      Valenzuela PM, Majerson D, Tapia JL, Talesnik E. Syndrome of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) in siblings. Clin Rheumatol 2009; 28:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/15\">",
"      Ant&oacute;n-Mart&iacute;n P, Ortiz Movilla R, Guill&eacute;n Mart&iacute;n S, et al. PFAPA syndrome in siblings. Is there a genetic background? Eur J Pediatr 2011; 170:1563.",
"     </a>",
"    </li>",
"    <li>",
"     Padeh S, Sheba Medical Center, personal communication, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/17\">",
"      Dagan E, Gershoni-Baruch R, Khatib I, et al. MEFV, TNF1rA, CARD15 and NLRP3 mutation analysis in PFAPA. Rheumatol Int 2010; 30:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/18\">",
"      Stojanov S, Hoffmann F, K&eacute;ry A, et al. Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw 2006; 17:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/19\">",
"      Stojanov S, Lapidus S, Chitkara P, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A 2011; 108:7148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/20\">",
"      Brown KL, Wekell P, Osla V, et al. Profile of blood cells and inflammatory mediators in periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome. BMC Pediatr 2010; 10:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/21\">",
"      Wright DG, Dale DC, Fauci AS, Wolff SM. Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore) 1981; 60:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/22\">",
"      Dale DC, Hammond WP 4th. Cyclic neutropenia: a clinical review. Blood Rev 1988; 2:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/23\">",
"      Engervall P, Andersson B, Bj&ouml;rkholm M. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol 1995; 91:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/24\">",
"      Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999; 23:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/25\">",
"      Long SS. Syndrome of Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis (PFAPA)--what it isn't. What is it? J Pediatr 1999; 135:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/26\">",
"      Chen K, Xu W, Wilson M, et al. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol 2009; 10:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/27\">",
"      Kovacs L, Hlavat&aacute; A, Baldovi�� M, et al. Elevated immunoglobulin D levels in children with PFAPA syndrome. Neuro Endocrinol Lett 2010; 31:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/28\">",
"      Berkun Y, Levy R, Hurwitz A, et al. The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome. Semin Arthritis Rheum 2011; 40:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/29\">",
"      Yoshihara T, Imamura T, Yokoi K, et al. Potential use of procalcitonin concentrations as a diagnostic marker of the PFAPA syndrome. Eur J Pediatr 2007; 166:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/30\">",
"      Gattorno M, Sormani MP, D'Osualdo A, et al. A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum 2008; 58:1823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/31\">",
"      Gattorno M, Caorsi R, Meini A, et al. Differentiating PFAPA syndrome from monogenic periodic fevers. Pediatrics 2009; 124:e721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/32\">",
"      Saulsbury FT, Wispelwey B. Tumor necrosis factor receptor-associated periodic syndrome in a young adult who had features of periodic fever, aphthous stomatitis, pharyngitis, and adenitis as a child. J Pediatr 2005; 146:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/33\">",
"      Long SS. TRAPS and PFAPA. J Pediatri 2005; 146:2A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/34\">",
"      Knockaert DC, Vanneste LJ, Bobbaers HJ. Recurrent or episodic fever of unknown origin. Review of 45 cases and survey of the literature. Medicine (Baltimore) 1993; 72:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/35\">",
"      Cabral DA, Tucker LB. Malignancies in children who initially present with rheumatic complaints. J Pediatr 1999; 134:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/36\">",
"      Wurster VM, Carlucci JG, Feder HM Jr, Edwards KM. Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. J Pediatr 2011; 159:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/37\">",
"      Ridder GJ, Fradis M, Berner R, L&ouml;hle E. [PFAPA Syndrome: Current Standard of Knowledge and Relevance for the ENT Specialist]. Laryngorhinootologie 2002; 81:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/38\">",
"      Tasher D, Somekh E, Dalal I. PFAPA syndrome: new clinical aspects disclosed. Arch Dis Child 2006; 91:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/39\">",
"      Feder HM Jr. Cimetidine treatment for periodic fever associated with aphthous stomatitis, pharyngitis and cervical adenitis. Pediatr Infect Dis J 1992; 11:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/40\">",
"      Pillet P, Ansoborlo S, Carr&egrave;re A, et al. [(P)FAPA syndrome: value of cimetidine]. Arch Pediatr 2000; 7:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/41\">",
"      Tasher D, Stein M, Dalal I, Somekh E. Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes. Acta Paediatr 2008; 97:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/42\">",
"      Galanakis E, Papadakis CE, Giannoussi E, et al. PFAPA syndrome in children evaluated for tonsillectomy. Arch Dis Child 2002; 86:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/43\">",
"      Dahn KA, Glode MP, Chan KH. Periodic fever and pharyngitis in young children: a new disease for the otolaryngologist? Arch Otolaryngol Head Neck Surg 2000; 126:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/44\">",
"      Berlucchi M, Meini A, Plebani A, et al. Update on treatment of Marshall's syndrome (PFAPA syndrome): report of five cases with review of the literature. Ann Otol Rhinol Laryngol 2003; 112:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/45\">",
"      Wong KK, Finlay JC, Moxham JP. Role of Tonsillectomy in PFAPA Syndrome. Arch Otolaryngol Head Neck Surg 2008; 134:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/46\">",
"      Licameli G, Jeffrey J, Luz J, et al. Effect of adenotonsillectomy in PFAPA syndrome. Arch Otolaryngol Head Neck Surg 2008; 134:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/47\">",
"      Parikh SR, Reiter ER, Kenna MA, Roberson D. Utility of tonsillectomy in 2 patients with the syndrome of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis. Arch Otolaryngol Head Neck Surg 2003; 129:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/48\">",
"      Pignataro L, Torretta S, Pietrogrande MC, et al. Outcome of tonsillectomy in selected patients with PFAPA syndrome. Arch Otolaryngol Head Neck Surg 2009; 135:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/49\">",
"      Renko M, Salo E, Putto-Laurila A, et al. A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr 2007; 151:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/50\">",
"      Garavello W, Romagnoli M, Gaini RM. Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomized study. J Pediatr 2009; 155:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/51\">",
"      Garavello W, Pignataro L, Gaini L, et al. Tonsillectomy in children with periodic fever with aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr 2011; 159:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/52\">",
"      Licameli G, Lawton M, Kenna M, Dedeoglu F. Long-term surgical outcomes of adenotonsillectomy for PFAPA syndrome. Arch Otolaryngol Head Neck Surg 2012; 138:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8377/abstract/53\">",
"      Burton MJ, Pollard AJ, Ramsden JD. Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA). Cochrane Database Syst Rev 2010; :CD008669.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5953 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9662981F41-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8377=[""].join("\n");
var outline_f8_11_8377=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Symptoms and physical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Fever",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Aphthous ulcers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Pharyngitis and adenopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Other, probably unrelated, symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Exclusion criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Cimetidine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Colchicine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Tonsillectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7323284\">",
"      Experimental therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/5953\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5953|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/25/13713\" title=\"picture 1\">",
"      Aphthous ulcers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/15/3313\" title=\"picture 2\">",
"      Pharyngitis in a patient with PFAPA syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9706?source=related_link\">",
"      Approach to the child with fever of unknown origin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24487?source=related_link\">",
"      Cryopyrin-associated periodic syndromes and related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=related_link\">",
"      Cyclic neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38905?source=related_link\">",
"      Etiologies of fever of unknown origin in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/3/8247?source=related_link\">",
"      Management of familial Mediterranean fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15494?source=related_link\">",
"      Periodic fever syndromes and other autoinflammatory diseases: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/22/35178?source=related_link\">",
"      Tonsillectomy and adenoidectomy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28551?source=related_link\">",
"      Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_11_8378="Clinical evaluation of the obese child and adolescent";
var content_f8_11_8378=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical evaluation of the obese child and adolescent",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/11/8378/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8378/contributors\">",
"     William J Klish, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/11/8378/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8378/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8378/contributors\">",
"     Mitchell Geffner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/11/8378/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/11/8378/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/11/8378/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity has become one of the most important public health problems in the United States (",
"    <a class=\"graphic graphic_figure graphicRef65047 \" href=\"UTD.htm?19/56/20366\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. As the prevalence of obesity increases, so does the prevalence of the comorbidities associated with obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"     4",
"    </a>",
"    ]. For this reason, it is imperative that health care providers identify overweight and obese children so that counseling and treatment can be provided.",
"   </p>",
"   <p>",
"    Recommendations, guidelines, and consensus statements for the evaluation and treatment of obese children and adolescents have been published by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/5\">",
"     5",
"    </a>",
"    ], an Expert Committee convened by the Maternal and Child Health Bureau (MCHB) of the Health Resources and Services Administration (HRSA) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/6,7\">",
"     6,7",
"    </a>",
"    ], the American Heart Association [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/8\">",
"     8",
"    </a>",
"    ], the United States Preventive Services Task Force (USPSTF) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/9\">",
"     9",
"    </a>",
"    ] an international Obesity Consensus Working Group [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/10\">",
"     10",
"    </a>",
"    ], and the National Association of Children&rsquo;s Hospitals and Related Institutions (NACHRI) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical evaluation of the overweight child and adolescent will be presented here. Other aspects of clinical management of obesity in children are discussed in separate topic reviews:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18378?source=see_link\">",
"       \"Management of childhood obesity in the primary care setting\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link\">",
"       \"Definition; epidemiology; and etiology of obesity in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link\">",
"       \"Comorbidities and complications of obesity in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calculation of body mass index (BMI) is a clinically practical tool for the assessment of overweight and obesity in children. BMI is equal to the body weight (in kilograms) divided by the height (in meters) squared (",
"    <a class=\"graphic graphic_table graphicRef71431 \" href=\"UTD.htm?0/28/459\">",
"     table 1",
"    </a>",
"    ). It correlates with adiposity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/12-14\">",
"     12-14",
"    </a>",
"    ] and complications of childhood overweight [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. Because BMI does not directly measure body fat, it may overestimate adiposity in a child with increased muscle mass (eg, an athlete), and underestimate adiposity in a child with reduced muscle mass (eg, a sedentary child). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6760?source=see_link&amp;anchor=H2#H2\">",
"     \"Measurement of body composition in children\", section on 'Estimates of adiposity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All children older than two years should have their BMI calculated at least annually from measured height and weight [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/6,7,19,20\">",
"     6,7,19,20",
"    </a>",
"    ]. The results should be plotted on an appropriate growth curve (",
"    <a class=\"graphic graphic_figure graphicRef60784 graphicRef68478 \" href=\"UTD.htm?10/0/10247\">",
"     figure 2A-B",
"    </a>",
"    ). Health care providers typically underestimate weight status on casual examination, so it is important to use measured heights and weights to determine and track obesity status [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19943?source=see_link&amp;anchor=H7#H7\">",
"     \"The pediatric physical examination: General principles and standard measurements\", section on 'Standard measurements'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The BMI percentile and trend of percentile for age and sex determines whether the child is underweight (&lt;5th percentile), of normal weight (between 5th and 85th percentile), overweight (BMI &ge;85",
"    <sup>",
"     th",
"    </sup>",
"    percentile and &lt;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile), or obese (&ge;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile). BMI percentiles also can be determined using a calculator for boys (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?35/14/36070?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) and for girls (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?34/60/35782?source=see_link\">",
"     calculator 2",
"    </a>",
"    ). Management strategies vary accordingly (",
"    <a class=\"graphic graphic_algorithm graphicRef63062 \" href=\"UTD.htm?16/34/16928\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increasing BMI trend &ndash; If the BMI is below the 85",
"      <sup>",
"       th",
"      </sup>",
"      percentile but has increased more than three to four units",
"      <span class=\"nowrap\">",
"       (kg/m",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      per year and begins to cross percentile lines, particularly if the child is older than four years, the family should be warned that the child is at risk of becoming overweight and be provided with simple tips for maintaining a healthy weight [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/6,20,22\">",
"       6,20,22",
"      </a>",
"      ]. The tables give examples of tips to help families improve nutrition and reduce caloric intake (",
"      <a class=\"graphic graphic_table graphicRef50935 graphicRef62686 \" href=\"UTD.htm?38/22/39277\">",
"       table 2A-B",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef67313 graphicRef81884 graphicRef62244 \" href=\"UTD.htm?1/37/1631\">",
"       table 3A-C",
"      </a>",
"      ), increase physical activity (",
"      <a class=\"graphic graphic_table graphicRef71972 \" href=\"UTD.htm?16/10/16556\">",
"       table 4",
"      </a>",
"      ), and adopt parenting strategies to support these goals (",
"      <a class=\"graphic graphic_table graphicRef78525 \" href=\"UTD.htm?19/14/19692\">",
"       table 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Overweight &ndash; If the BMI is &ge;85",
"      <sup>",
"       th",
"      </sup>",
"      percentile but less than the 95",
"      <sup>",
"       th",
"      </sup>",
"      percentile, the child is overweight by definition. He or she should be screened for comorbidities of obesity (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Evaluation'",
"      </a>",
"      below), and given counseling to optimize lifestyle habits with a goal of slowing the rate of weight gain [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/6\">",
"       6",
"      </a>",
"      ]. These families should be provided with information about healthy lifestyle such as the tips outlined in the tables above. They also may benefit from direct counseling from the clinician or from a dietitian to address their specific challenges (",
"      <a class=\"graphic graphic_table graphicRef80182 \" href=\"UTD.htm?0/47/766\">",
"       table 6",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Obese &ndash; If the BMI is &ge;95",
"      <sup>",
"       th",
"      </sup>",
"      percentile, the child is obese by definition. He or she has a significant likelihood of obesity in adulthood [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/23-26\">",
"       23-26",
"      </a>",
"      ]. He or she should be carefully evaluated for comorbidities of obesity, be provided with direct counseling from the clinician or allied health care provider, and have regular follow-up to monitor progress [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Evaluation'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link\">",
"       \"Comorbidities and complications of obesity in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The age of the child and growth patterns of the family must be taken into consideration when evaluating trends in BMI percentile [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"     4",
"    </a>",
"    ]. The influence of maternal nutrition and intrauterine environment are reflected primarily in the growth parameters at the time of birth, whereas genetic factors have a later influence. Thus, the weight percentile of some children whose birthweight percentile is less than what would be expected based upon family growth patterns may increase over time. However, less than 5 percent of children cross two major percentiles lines upward on the growth charts of the CDC after four years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/27\">",
"     27",
"    </a>",
"    ], and children who do so are at risk of overweight [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=see_link&amp;anchor=H2#H2\">",
"     \"Normal growth patterns in infants and prepubertal children\", section on 'Determinants of normal growth'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of the overweight or obese child should identify treatable causes and comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. The evaluation should include a complete history and physical examination. Laboratory and radiologic studies also may be obtained as indicated by the history and examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history should include the age of onset of overweight and information about the child's eating and exercise habits. The age of onset is helpful in distinguishing overfeeding from genetic causes of overweight since syndromic obesity often has onset before two years of age (",
"    <a class=\"graphic graphic_table graphicRef70658 graphicRef82307 \" href=\"UTD.htm?8/43/8894\">",
"     table 7A-B",
"    </a>",
"    ). Information from the dietary and activity history may identify potential areas for intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The dietary history should include the following factors, as summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef63820 \" href=\"UTD.htm?27/18/27950\">",
"     table 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4,28\">",
"     4,28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identification of the caretakers who feed the child",
"     </li>",
"     <li>",
"      Identification of foods high in calories and low in nutritional value that can be reduced, eliminated, or replaced (eg, juice, soda)",
"     </li>",
"     <li>",
"      Assessment of eating patterns (eg, timing, content, and location of meals and snacks); a child or adolescent who feels unable to control consumption of large amounts of food may have an eating disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/29\">",
"       29",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The activity history should include the following factors, as summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef75838 \" href=\"UTD.htm?28/21/29019\">",
"     table 9",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identification of barriers to walking or riding a bike to school",
"     </li>",
"     <li>",
"      Evaluation of time spent in play",
"     </li>",
"     <li>",
"      Evaluation of school recess and physical education (frequency, duration, and intensity)",
"     </li>",
"     <li>",
"      Assessment of after-school and weekend activities",
"     </li>",
"     <li>",
"      Assessment of screen-time (television, videotapes and DVDs, and video games)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The medical history should include review of all medications, particularly those that are known to be weight-promoting (eg, certain psychoactive drugs such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/5/32857?source=see_link\">",
"     risperidone",
"    </a>",
"    , antiepileptic drugs, and glucocorticoids) (",
"    <a class=\"graphic graphic_table graphicRef57541 \" href=\"UTD.htm?26/50/27436\">",
"     table 10",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H11#H11\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Medications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Review of systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;The review of systems should probe for evidence of comorbidities or underlying etiologies (",
"    <a class=\"graphic graphic_table graphicRef67972 \" href=\"UTD.htm?2/53/2909\">",
"     table 11",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. An abrupt onset of obesity with rapid weight gain should prompt investigation of medication-induced weight gain, a major psychosocial trigger, endocrine causes of obesity (eg, Cushing disease, hypothalamic tumor), or some obesity syndromes (Prader-Willi syndrome, or rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor [ROHHADNET syndrome]) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H13#H13\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Endocrine disease'",
"    </a>",
"    .) &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of comorbidities of obesity is strongly influenced by the family history of such morbidities, whether or not the affected family member is overweight [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/31\">",
"     31",
"    </a>",
"    ]. Obesity in one or both parents is an important predictor for whether a child's obesity will persist into adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/32-35\">",
"     32-35",
"    </a>",
"    ]. Thus, the family history should include information about obesity in first-degree relatives (parents and siblings) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"     4",
"    </a>",
"    ]. It also should include information about common comorbidities of obesity, such as cardiovascular disease, hypertension, diabetes, liver or gall bladder disease, and respiratory insufficiency in first- and second-degree relatives (grandparents, uncles, aunts, half-siblings, nephews and nieces).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Psychosocial history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The psychosocial history should include information related to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Depression (eg, sleep disturbance, hopelessness, sadness, appetite changes) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=see_link\">",
"       \"Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Information about school and social issues (eg, does the child have friends? Is he or she a target for teasing?)",
"     </li>",
"     <li>",
"      Tobacco use, since cigarette smoking increases the long-term cardiovascular risk [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7,36-39\">",
"       7,36-39",
"      </a>",
"      ]&nbsp;(see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link\">",
"       \"Comorbidities and complications of obesity in children and adolescents\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with the history, the examination of the overweight child or adolescent should evaluate the presence of comorbidities and underlying etiologies. Key findings to note are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef73272 \" href=\"UTD.htm?6/51/6973\">",
"     table 12",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     General appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important aspects of assessment of general appearance include assessment for dysmorphic features, which may suggest a genetic syndrome (",
"    <a class=\"graphic graphic_table graphicRef70658 graphicRef82307 \" href=\"UTD.htm?8/43/8894\">",
"     table 7A-B",
"    </a>",
"    ), assessment of affect, and assessment of fat distribution [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The distribution of the excess fat may help to distinguish the etiology of obesity. The excess fat in obesity from overeating or overfeeding usually is distributed in the trunk and periphery. In contrast, the \"buffalo type\" distribution of body fat (concentrated in the interscapular area, face, neck, and trunk) is suggestive of Cushing syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H13#H13\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Endocrine disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Cushing's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Abdominal obesity (also called central, visceral, android, or male-type obesity) is associated with certain comorbidities, including the metabolic syndrome, polycystic ovary syndrome, and insulin resistance. Measurement of the waist circumference, in conjunction with calculation of the body mass index (BMI), may help to identify patients at risk for these comorbidities. Abdominal obesity and measurement of the waist circumference are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6760?source=see_link&amp;anchor=H5#H5\">",
"     \"Measurement of body composition in children\", section on 'Fat distribution'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link&amp;anchor=H6#H6\">",
"     \"Comorbidities and complications of obesity in children and adolescents\", section on 'Metabolic syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=see_link\">",
"     \"Clinical features and diagnosis of polycystic ovary syndrome in adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Blood pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful blood pressure should be obtained with a proper sized cuff. The bladder of the cuff should cover at least 80 percent of the arm circumference (the width of the bladder will be about 40 percent of the arm circumference) (",
"    <a class=\"graphic graphic_figure graphicRef73414 \" href=\"UTD.htm?1/0/1025\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/40\">",
"     40",
"    </a>",
"    ]. In many children and adolescents with obesity, this will require use of \"adult\" or \"large adult\" sized cuffs. Hypertension increases the long-term cardiovascular risk in overweight or obese children [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, hypertension may be a sign of Cushing syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Cushing's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypertension is defined as a blood pressure greater than the 95",
"    <sup>",
"     th",
"    </sup>",
"    percentile for gender, age and height on three separate occasions (",
"    <a class=\"graphic graphic_table graphicRef63856 \" href=\"UTD.htm?7/45/7894\">",
"     table 13",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef52646 \" href=\"UTD.htm?7/46/7910\">",
"     table 14",
"    </a>",
"    ). Age- and height-specific blood pressure percentiles also may be determined using calculators for boys (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?9/15/9463?source=see_link\">",
"     calculator 3",
"    </a>",
"    ) or for girls (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?9/33/9751?source=see_link\">",
"     calculator 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17113?source=see_link\">",
"     \"Definition and diagnosis of hypertension in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Stature",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of stature and height velocity is useful in distinguishing exogenous obesity from obesity that is secondary to genetic or endocrine abnormalities, including hypothalamic-pituitary lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Exogenous obesity drives linear height, so most obese children are tall for their age. By contrast, most endocrine and genetic causes of obesity are associated with short stature (",
"    <a class=\"graphic graphic_figure graphicRef87007 \" href=\"UTD.htm?42/17/43288\">",
"     figure 4",
"    </a>",
"    ). Growth velocity may be slowed in children with endocrine causes of obesity, and children with Prader-Willi syndrome are often short for their genetic potential",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fail to have a pubertal growth spurt. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Head, eyes, throat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the head, eyes, and throat may provide clues to the etiology of obesity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Microcephaly is a feature of Cohen syndrome.",
"     </li>",
"     <li>",
"      Blurred disc margins (",
"      <a class=\"graphic graphic_picture graphicRef50378 \" href=\"UTD.htm?30/30/31215\">",
"       picture 1",
"      </a>",
"      ) may indicate pseudotumor cerebri, an unexplained but not uncommon association with obesity [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/43\">",
"       43",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17417?source=see_link\">",
"       \"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nystagmus or visual complaints raise the possibility of a hypothalamic-pituitary lesion [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/42\">",
"       42",
"      </a>",
"      ]. Other findings that support this possibility are rapid onset of obesity or hyperphagia, decrease in growth velocity, precocious puberty, or neurologic symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/42\">",
"       42",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/56/13192?source=see_link\">",
"       \"Clinical manifestations and diagnosis of central nervous system tumors in children\"",
"      </a>",
"      .) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Clumps of pigment in the peripheral retina may indicate retinitis pigmentosa, which occurs in Bardet-Biedl syndrome.",
"     </li>",
"     <li>",
"      Enlarged tonsils may indicate obstructive sleep apnea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link\">",
"       \"Evaluation of suspected obstructive sleep apnea in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Erosion of the tooth enamel may indicate self-induced vomiting in patients with an eating disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Skin and hair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the skin and hair is particularly useful in evaluating signs of endocrine etiologies or complications [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dry, coarse, or brittle hair may be present in hypothyroidism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link\">",
"       \"Clinical manifestations of hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Striae and ecchymoses are manifestations of Cushing syndrome; however, striae are much more likely to be the result of rapid accumulation of subcutaneous fat.",
"     </li>",
"     <li>",
"      Acanthosis nigricans (",
"      <a class=\"graphic graphic_picture graphicRef53776 graphicRef72964 \" href=\"UTD.htm?10/17/10516\">",
"       picture 2A-B",
"      </a>",
"      ) may signify type 2 diabetes or insulin resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/44-46\">",
"       44-46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hirsutism may be present in polycystic ovarian syndrome (PCOS) and Cushing syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Abdomen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal tenderness may be a sign of gallbladder disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7\">",
"     7",
"    </a>",
"    ]. Hepatomegaly may be a clue to nonalcoholic fatty liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Musculoskeletal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The musculoskeletal examination may provide evidence of underlying etiology or comorbidity of childhood overweight:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonpitting edema may indicate hypothyroidism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link\">",
"       \"Clinical manifestations of hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Postaxial polydactyly (an extra digit next to the fifth digit) may be present in Bardet-Biedl syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/47\">",
"       47",
"      </a>",
"      ], and small hands and feet may be present in Prader-Willi syndrome (",
"      <a class=\"graphic graphic_table graphicRef70658 graphicRef82307 \" href=\"UTD.htm?8/43/8894\">",
"       table 7A-B",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The musculoskeletal examination may provide evidence of slipped capital femoral epiphysis (limited range of motion at the hip, gait abnormality) or Blount disease (bowing of the lower legs). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23209?source=see_link\">",
"       \"Slipped capital femoral epiphysis (SCFE)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link&amp;anchor=H24#H24\">",
"       \"Comorbidities and complications of obesity in children and adolescents\", section on 'Tibia vara (Blount disease)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dorsal finger callousness may be a clue to self-induced vomiting in patients with an eating disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Genitourinary",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genitourinary examination and evaluation of pubertal stage may provide evidence of genetic or endocrine causes of obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"     4",
"    </a>",
"    ]. Evaluation of pubertal stage is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=see_link&amp;anchor=H4#H4\">",
"     \"Normal puberty\", section on 'Sexual maturity rating (Tanner stages)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\", section on 'Hypogonadism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Undescended testicles, small penis, and scrotal hypoplasia may indicate Prader-Willi syndrome.",
"     </li>",
"     <li>",
"      Small testes may suggest Prader-Willi or Bardet-Biedl syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Delayed or absent puberty may occur in the presence of hypothalamic-pituitary tumors, Prader-Willi syndrome, Bardet-Biedl syndrome, leptin deficiency, or leptin receptor deficiency.",
"     </li>",
"     <li>",
"      Precocious puberty occasionally is a presenting symptom of a hypothalamic-pituitary lesion [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/42\">",
"       42",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/56/13192?source=see_link\">",
"       \"Clinical manifestations and diagnosis of central nervous system tumors in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=see_link\">",
"       \"Definition, etiology, and evaluation of precocious puberty\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of the syndromic causes of overweight in children are associated with cognitive or developmental delay (",
"    <a class=\"graphic graphic_table graphicRef70658 graphicRef82307 \" href=\"UTD.htm?8/43/8894\">",
"     table 7A-B",
"    </a>",
"    ). Prader-Willi syndrome is also associated with marked hypotonia during infancy and delayed development of gross motor skills. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\", section on 'Behavior characteristics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1947276\">",
"    <span class=\"h3\">",
"     Suggested tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory evaluation for overweight and obesity in children is not fully standardized. Most experts suggest routine screening for type 2 diabetes mellitus, dyslipidemia, hypertension, and fatty liver disease in children with BMI &ge;85",
"    <sup>",
"     th",
"    </sup>",
"    or &ge;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile, using a basic panel of tests (ie, fasting glucose, serum alanine aminotransferase [ALT], and lipid panel [total cholesterol, triglycerides, LDL-cholesterol and HDL-cholesterol], and serum ALT) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7,8,10,41\">",
"     7,8,10,41",
"    </a>",
"    ]. Some providers also measure a fasting insulin level (for purposes of counseling rather than screening), as discussed below. The recommended threshold for performing this screening varies slightly; an expert panel from the United States National Heart, Lung, and Blood Institute (NHLBI) recommends initial lipid screening for children between two and eight years of age with a BMI &ge;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile (or other risk factors for cardiovascular disease), and for older children with a BMI &ge;85",
"    <sup>",
"     th",
"    </sup>",
"    percentile [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/48\">",
"     48",
"    </a>",
"    ]. Abnormal laboratory tests can be an added stimulus for weight loss. The rationale for these laboratory tests is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/17/281?source=see_link\">",
"     \"Definition and screening for dyslipidemia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link\">",
"     \"Comorbidities and complications of obesity in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Assessment for other comorbidities including type 2 diabetes, sleep apnea, and polycystic ovary syndrome, depends on the presence of risk factors or symptoms, as outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef65547 \" href=\"UTD.htm?17/39/18045\">",
"     table 15",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Screening for diabetes should be performed in children over 10 years of age who are overweight or obese AND have two or more additional risk factors, which include a family history of type 2 diabetes in a first- or second-degree relative, high-risk ethnicity, acanthosis nigricans, or PCOS (",
"      <a class=\"graphic graphic_table graphicRef56279 \" href=\"UTD.htm?39/46/40683\">",
"       table 16",
"      </a>",
"      ). For these patients, screening should consist of fasting plasma glucose (FPG) or an oral glucose tolerance test (OGTT). Hemoglobin A1C (A1C) can be used as an alternative to fasting glucose for patients who are not fasting. Patients with intermediate or conflicting results for any of these tests should undergo repeat testing and be monitored for future development of diabetes. Definitive diagnosis of diabetes mellitus requires meeting diagnostic criteria on at least two separate occasions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/25/4506?source=see_link&amp;anchor=H21#H21\">",
"       \"Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents\", section on 'Screening'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vitamin D deficiency appears to be common among children and adolescents with obesity either because of generalized vitamin and mineral deficiencies secondary to poor eating habits,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      due to sequestration in excess adipose tissue. In studies from Spain, Texas and New York, Vitamin D deficiency was present in about half of children and adults with severe obesity, and was associated with higher BMI and features of the metabolic syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/49-52\">",
"       49-52",
"      </a>",
"      ]. However, there is currently inadequate evidence to determine whether the risk of vitamin D deficiency is sufficiently high in all populations of children with obesity to justify routine screening. Vitamin D levels depend on several factors, including sunlight exposure, skin color, the use of sun screen, and diet quality. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=see_link&amp;anchor=H23365759#H23365759\">",
"       \"Vitamin D insufficiency and deficiency in children and adolescents\", section on 'Causes of vitamin D deficiency'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30873013\">",
"    <span class=\"h3\">",
"     Interpretation of results",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A fasting glucose of 100 to 125",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (5.55 to 6.94",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      is considered to be prediabetic, and a level of &ge;126 mg per dL (7.0",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      (on two occasions) is consistent with the diagnosis of diabetes. Children with an elevated fasting glucose should have a confirmatory oral glucose tolerance test (OGTT) or be referred to an endocrinologist for further evaluation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/25/4506?source=see_link&amp;anchor=H21#H21\">",
"       \"Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents\", section on 'Screening'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Measurement of hemoglobin A1C (A1C) is a useful marker of the average blood glucose concentration over the preceding 8 to 12 weeks. Because of improved assay standardization and validation against other diagnostic methods, it can now be used for screening or to make a diagnosis of diabetes mellitus, provided that an assay that is certified by the National Glycohemoglobin Standardization Program (NGSP) is used. Patients with A1C 5.7-6.4 percent are considered prediabetic (impaired glucose tolerance), and those with A1C &ge;6.5 percent probably have diabetes. Both groups of patients should have a confirmatory OGTT or be referred to an endocrinologist for further evaluation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/25/4506?source=see_link&amp;anchor=H24#H24\">",
"       \"Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents\", section on 'Hemoglobin A1C'",
"      </a>",
"      .) &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Some providers measure fasting insulin because abnormal results can be helpful in explaining clinical risks to patients and families. Other providers use the finding of acanthosis nigricans as a basis for the same discussion. In either case, the provider can explain that there is a significant likelihood that type 2 diabetes mellitus will eventually develop if weight loss is not achieved (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=see_link&amp;anchor=H3#H3\">",
"       \"Pathogenesis of type 2 diabetes mellitus\", section on 'Impaired insulin secretion and insulin resistance'",
"      </a>",
"      ). Of note, the fasting insulin level should not be used as a clinical screening tool for type 2 diabetes. It is an unreliable measure of insulin sensitivity, because it is poorly correlated with whole body insulin sensitivity as measured by the euglycemic hyperinsulinemic clamp. Moreover, currently there is no FDA-approved pharmacologic treatment for isolated insulin resistance.",
"     </li>",
"     <li>",
"      Fasting total cholesterol of &gt;200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (5.18",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      or a LDL cholesterol of &gt;130",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (3.38",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      is consistent with hyperlipidemia (",
"      <a class=\"graphic graphic_table graphicRef68183 \" href=\"UTD.htm?42/51/43836\">",
"       table 17",
"      </a>",
"      ). Obese children with hyperlipidemia should be monitored and perhaps treated, since hyperlipidemia increases the risk of atherosclerosis as the obese child grows older. Fasting serum triglycerides of &gt;150",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.70",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      in adolescents with obesity are considered to be elevated and an early sign of the \"metabolic syndrome\". Non-fasting measurement of total cholesterol and non-HDL-cholesterol is an acceptable alternative in children with low risk for cardiovascular disease, but fasting lipid profiles are preferred for children with obesity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/17/281?source=see_link\">",
"       \"Definition and screening for dyslipidemia in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/63/12282?source=see_link\">",
"       \"Management of pediatric dyslipidemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Liver function tests should be obtained because nonalcoholic fatty liver disease (NAFLD) is typically asymptomatic [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/5\">",
"       5",
"      </a>",
"      ]. Obese children with an elevation of ALT greater than two times the norm that persists for greater than three months should be evaluated for the presence of NAFLD and other chronic liver diseases (eg, viral hepatitis, autoimmune hepatitis, Wilson disease, alpha-1 antitrypsin deficiency) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link&amp;anchor=H15#H15\">",
"       \"Comorbidities and complications of obesity in children and adolescents\", section on 'Nonalcoholic fatty liver disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If screening for vitamin D deficiency is undertaken, levels are measured as serum 25(OH) vitamin D. The reference range varies by region, but levels &lt;20",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      are generally considered deficient. In populations of children with obesity, vitamin D deficiency was not generally associated with overt clinical symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]. However, if deficiency is found, vitamin D supplementation should be initiated to avoid long-term consequences. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=see_link\">",
"       \"Treatment of vitamin D deficiency in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional testing may be necessary if there are findings consistent with hypothyroidism, PCOS, Cushing syndrome, and sleep apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/5,8,10,53\">",
"     5,8,10,53",
"    </a>",
"    ]. Syndromic obesity should be evaluated in children with developmental delay or dysmorphic features (",
"    <a class=\"graphic graphic_table graphicRef70658 \" href=\"UTD.htm?23/24/23949\">",
"     table 7A",
"    </a>",
"    ). Endocrine causes of obesity are unlikely if the growth velocity is normal during childhood or early adolescence [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/41\">",
"     41",
"    </a>",
"    ] (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Stature'",
"    </a>",
"    above). Thus, laboratory screening for hypothyroidism is rarely indicated in a child with normal growth velocity. Of note, mildly elevated levels of thyroid stimulating hormone (TSH) are more often found in obese children as compared to normal-weight children, but this is a consequence rather than a cause of the obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/54\">",
"     54",
"    </a>",
"    ]. Moreover, most of the weight gain in hypothyroid individuals is due to accumulation of salt and water, so hypothyroidism rarely causes substantial weight gain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Radiographic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The radiographic evaluation of overweight or obese children is directed by findings on the history and physical examination.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain radiographs of the lower extremities should be obtained if there are clinical findings consistent with slipped capital femoral epiphysis (hip or knee pain, limited range of motion, abnormal gait) or Blount disease (bowed tibia). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23209?source=see_link\">",
"       \"Slipped capital femoral epiphysis (SCFE)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Abdominal ultrasonography may be indicated in children with findings consistent with gallstones (eg, abdominal pain, abnormal transaminases) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Abdominal ultrasonography also may be used to confirm the presence of fatty liver. However, the severity of liver involvement does not correlate with radiographic findings. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link&amp;anchor=H15#H15\">",
"       \"Comorbidities and complications of obesity in children and adolescents\", section on 'Nonalcoholic fatty liver disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who have comorbidities of obesity that require rapid weight loss warrant referral to pediatric obesity centers for appropriate dietary, pharmacologic,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/7,11\">",
"     7,11",
"    </a>",
"    ]. These comorbidities include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type 2 diabetes, strong evidence of increased diabetes risk, or polycystic ovary syndrome (PCOS) (should also be referred to a pediatric endocrinologist) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/25/4506?source=see_link\">",
"       \"Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=see_link\">",
"       \"Clinical features and diagnosis of polycystic ovary syndrome in adolescents\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pseudotumor cerebri (should also be referred to a pediatric neurologist) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17417?source=see_link\">",
"       \"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Sleep apnea (should also be referred to a pediatric sleep medicine specialist or pulmonologist) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link\">",
"       \"Evaluation of suspected obstructive sleep apnea in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Obesity hypoventilation syndrome (should also be referred to a pediatric sleep medicine specialist or pulmonologist) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38661?source=see_link\">",
"       \"Clinical manifestations and diagnosis of obesity hypoventilation syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Slipped capital femoral epiphysis or tibia vara (Blount disease) (should also be referred to a pediatric orthopedist) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23209?source=see_link\">",
"       \"Slipped capital femoral epiphysis (SCFE)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other children who may merit referral to a pediatric obesity center include severely obese children younger than two years, and children with severe obesity (eg, BMI &ge;40",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     ,",
"    </span>",
"    or &ge;120 percent of the 95",
"    <sup>",
"     th",
"    </sup>",
"    percentile), even if they have no comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/6\">",
"     6",
"    </a>",
"    ]. Severely overweight children may benefit from referral to a pediatric obesity specialist for more intensive therapy than can usually be provided by the primary care provider.",
"   </p>",
"   <p>",
"    Finally, certain overweight or obese children require referral to mental health specialists. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overweight children who are depressed should be referred for psychologic evaluation and treatment, since weight loss therapy may be ineffective without concurrent psychologic care [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Overweight children with findings suggestive of an eating disorder (eg, inability to control consumption of large amounts of food, self-induced vomiting or laxative use to avoid weight gain, dorsal finger lesions) should be evaluated by a therapist with experience in eating disorders; such children require psychologic treatment and should not participate in weight control programs without the concurrence of a therapist [",
"      <a class=\"abstract\" href=\"UTD.htm?8/11/8378/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resources related to overweight in children and adolescents for health care providers and families include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Maternal and Child Health Library Knowledge Path (",
"      <a class=\"external\" href=\"file://mchlibrary.info/KnowledgePaths/kp_overweight.html\">",
"       mchlibrary.info/KnowledgePaths/kp_overweight.html",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The American Academy of Pediatrics (",
"      <a class=\"external\" href=\"file://aap.org/obesity\">",
"       aap.org/obesity",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The Centers for Disease Control and Prevention (",
"      <a class=\"external\" href=\"file://cdc.gov/nccdphp/dnpa/obesity\">",
"       cdc.gov/nccdphp/dnpa/obesity",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Produce for Better Health Foundation (",
"      <a class=\"external\" href=\"file://5aday.com/\">",
"       5aday.com",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The Child Care Nutrition Resource System (",
"      <a class=\"external\" href=\"file://nal.usda.gov/childcare/\">",
"       nal.usda.gov/childcare/",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Weight Control Information Network (",
"      <a class=\"external\" href=\"file://win.niddk.nih.gov/index.htm\">",
"       win.niddk.nih.gov/index.htm",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/30/23010?source=see_link\">",
"       \"Patient information: My child is overweight (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obesity has become one of the most important public health problems in the United States (",
"      <a class=\"graphic graphic_figure graphicRef65047 \" href=\"UTD.htm?19/56/20366\">",
"       figure 1",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H3#H3\">",
"       \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Epidemiology'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The body mass index (BMI) is the accepted standard measure of obesity and overweight in children. It is equal to the body weight (in kilograms) divided by the height (in meters) squared (",
"      <a class=\"graphic graphic_table graphicRef71431 \" href=\"UTD.htm?0/28/459\">",
"       table 1",
"      </a>",
"      ). \"Obesity\" is defined by a body mass index (BMI) &ge;95",
"      <sup>",
"       th",
"      </sup>",
"      percentile for age and sex (",
"      <a class=\"graphic graphic_figure graphicRef60784 graphicRef68478 \" href=\"UTD.htm?10/0/10247\">",
"       figure 2A-B",
"      </a>",
"      ), and \"overweight\" is defined by a BMI between the 85",
"      <sup>",
"       th",
"      </sup>",
"      and 94",
"      <sup>",
"       th",
"      </sup>",
"      percentile for age and sex (",
"      <a class=\"graphic graphic_figure graphicRef60784 graphicRef68478 \" href=\"UTD.htm?10/0/10247\">",
"       figure 2A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Height and weight should be measured and BMI calculated at least yearly in children older than two years. Those who are overweight or obese should undergo evaluation to identify treatable causes and comorbidities. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H6#H6\">",
"       \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Etiology'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link\">",
"       \"Comorbidities and complications of obesity in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The evaluation should include a complete history and physical examination, with particular attention to the signs and symptoms of comorbidities and genetic and endocrinologic causes of overweight. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Overweight or obese children and adolescents should undergo basic screening for dyslipidemia and nonalcoholic fatty liver disease, with a fasting lipid panel and measurement of alanine aminotransferase. The clinical utility of routine screening for insulin resistance or vitamin D deficiency in this population has not been established. Overweight or obese children greater than 10 years of age who have two or more risk factors including a family history of type 2 diabetes, high-risk ethnicity, acanthosis nigricans, or polycystic ovarian syndrome (PCOS) should be screened for type 2 diabetes, using a fasting blood glucose",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hemoglobin A1C (",
"      <a class=\"graphic graphic_table graphicRef56279 \" href=\"UTD.htm?39/46/40683\">",
"       table 16",
"      </a>",
"      ). Evaluation for other comorbidities should be performed as indicated by the history and physical examination. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Laboratory studies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Radiographic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Overweight and obese children and adolescents with diabetes mellitus, PCOS, pseudotumor cerebri, sleep apnea, obesity hypoventilation syndrome, fatty liver disease, slipped capital femoral epiphysis, and tibia vara (Blount disease) should be referred to a pediatric obesity specialist for weight control. We also recommend referral for obese children younger than two years. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Indications for referral'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Overweight and obese children and adolescents with symptoms and signs of depression should be referred for psychologic evaluation and treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=see_link\">",
"       \"Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Overweight and obese children and adolescents with symptoms and signs of an eating disorder should be evaluated by a therapist with experience in eating disorders. We recommend that such patients should not participate in weight control programs without the concurrence of their therapist. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link\">",
"       \"Eating disorders: Treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/1\">",
"      Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/2\">",
"      Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001; 286:2845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/3\">",
"      Jolliffe D. Extent of overweight among US children and adolescents from 1971 to 2000. Int J Obes Relat Metab Disord 2004; 28:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/4\">",
"      Dietz WH, Robinson TN. Clinical practice. Overweight children and adolescents. N Engl J Med 2005; 352:2100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/5\">",
"      Baker S, Barlow S, Cochran W, et al. Overweight children and adolescents: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/6\">",
"      Barlow SE, Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007; 120 Suppl 4:S164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/7\">",
"      Krebs NF, Himes JH, Jacobson D, et al. Assessment of child and adolescent overweight and obesity. Pediatrics 2007; 120 Suppl 4:S193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/8\">",
"      Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005; 111:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/9\">",
"      US Preventive Services Task Force, Barton M. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. Pediatrics 2010; 125:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/10\">",
"      Speiser PW, Rudolf MC, Anhalt H, et al. Childhood obesity. J Clin Endocrinol Metab 2005; 90:1871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/11\">",
"      Young KL, Demeule M, Stuhlsatz K, et al. Identification and treatment of obesity as a standard of care for all patients in children's hospitals. Pediatrics 2011; 128 Suppl 2:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/12\">",
"      Dietz WH, Robinson TN. Use of the body mass index (BMI) as a measure of overweight in children and adolescents. J Pediatr 1998; 132:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/13\">",
"      Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 1991; 65:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/14\">",
"      Freedman DS, Wang J, Maynard LM, et al. Relation of BMI to fat and fat-free mass among children and adolescents. Int J Obes (Lond) 2005; 29:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/15\">",
"      Clarke WR, Woolson RF, Lauer RM. Changes in ponderosity and blood pressure in childhood: the Muscatine Study. Am J Epidemiol 1986; 124:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/16\">",
"      Gidding SS, Bao W, Srinivasan SR, Berenson GS. Effects of secular trends in obesity on coronary risk factors in children: the Bogalusa Heart Study. J Pediatr 1995; 127:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/17\">",
"      Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999; 103:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/18\">",
"      Raitakari OT, Porkka KV, R&auml;s&auml;nen L, et al. Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults. The Cardiovascular Risk in Young Finns Study. J Clin Epidemiol 1994; 47:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/19\">",
"      Krebs NF, Jacobson MS, American Academy of Pediatrics Committee on Nutrition. Prevention of pediatric overweight and obesity. Pediatrics 2003; 112:424.",
"     </a>",
"    </li>",
"    <li>",
"     Institute of Medicine. Preventing childhood obesity: health in the balance. Institute of Medicine, Washington, D.C., 2004. www.iom.edu/report.asp?id=22596 (Accessed on September 26, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/21\">",
"      Smith SM, Gately P, Rudolf M. Can we recognise obesity clinically? Arch Dis Child 2008; 93:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/22\">",
"      Miller LA, Grunwald GK, Johnson SL, Krebs NF. Disease severity at time of referral for pediatric failure to thrive and obesity: time for a paradigm shift? J Pediatr 2002; 141:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/23\">",
"      Guo SS, Roche AF, Chumlea WC, et al. The predictive value of childhood body mass index values for overweight at age 35 y. Am J Clin Nutr 1994; 59:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/24\">",
"      Mossberg HO. 40-year follow-up of overweight children. Lancet 1989; 2:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/25\">",
"      Stark O, Atkins E, Wolff OH, Douglas JW. Longitudinal study of obesity in the National Survey of Health and Development. Br Med J (Clin Res Ed) 1981; 283:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/26\">",
"      Braddon FE, Rodgers B, Wadsworth ME, Davies JM. Onset of obesity in a 36 year birth cohort study. Br Med J (Clin Res Ed) 1986; 293:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/27\">",
"      Mei Z, Grummer-Strawn LM, Thompson D, Dietz WH. Shifts in percentiles of growth during early childhood: analysis of longitudinal data from the California Child Health and Development Study. Pediatrics 2004; 113:e617.",
"     </a>",
"    </li>",
"    <li>",
"     Hoppin, AG. Obesity. In: Pediatric Gastrointestinal Disease: Pathopsychology, Diagnosis, Management, 4th ed, Walker, WA, Goulet, O, Kleinman, RE, et al (Eds), BC Decker, Ontario, 2004. p. 311.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/29\">",
"      Morgan CM, Yanovski SZ, Nguyen TT, et al. Loss of control over eating, adiposity, and psychopathology in overweight children. Int J Eat Disord 2002; 31:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/30\">",
"      Bougn&egrave;res P, Pantalone L, Linglart A, et al. Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood. J Clin Endocrinol Metab 2008; 93:3971.",
"     </a>",
"    </li>",
"    <li>",
"     Pediatric Obesity. In: Pediatric Nutrition Handbook, 6th ed, Kleinman R (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.733.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/32\">",
"      Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997; 337:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/33\">",
"      Blair NJ, Thompson JM, Black PN, et al. Risk factors for obesity in 7-year-old European children: the Auckland Birthweight Collaborative Study. Arch Dis Child 2007; 92:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/34\">",
"      Reilly JJ, Armstrong J, Dorosty AR, et al. Early life risk factors for obesity in childhood: cohort study. BMJ 2005; 330:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/35\">",
"      Rudolf M. Predicting babies' risk of obesity. Arch Dis Child 2011; 96:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/36\">",
"      Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/37\">",
"      Nilsson PM, Lind L, Pollare T, et al. Increased level of hemoglobin A1c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism 1995; 44:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/38\">",
"      Axelsen M, Eliasson B, Joheim E, et al. Lipid intolerance in smokers. J Intern Med 1995; 237:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/39\">",
"      Weitzman M, Cook S, Auinger P, et al. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation 2005; 112:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/40\">",
"      National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/41\">",
"      August GP, Caprio S, Fennoy I, et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 2008; 93:4576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/42\">",
"      Taylor M, Couto-Silva AC, Adan L, et al. Hypothalamic-pituitary lesions in pediatric patients: endocrine symptoms often precede neuro-ophthalmic presenting symptoms. J Pediatr 2012; 161:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/43\">",
"      Brara SM, Koebnick C, Porter AH, Langer-Gould A. Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J Pediatr 2012; 161:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/44\">",
"      Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997; 100:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/45\">",
"      Hud JA Jr, Cohen JB, Wagner JM, Cruz PD Jr. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 1992; 128:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/46\">",
"      Brickman WJ, Huang J, Silverman BL, Metzger BE. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr 2010; 156:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/47\">",
"      Green JS, Parfrey PS, Harnett JD, et al. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 1989; 321:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/48\">",
"      Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 Suppl 5:S213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/49\">",
"      Smotkin-Tangorra M, Purushothaman R, Gupta A, et al. Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 2007; 20:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/50\">",
"      Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/51\">",
"      Kelly A, Brooks LJ, Dougherty S, et al. A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child 2011; 96:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/52\">",
"      Turer CB, Lin H, Flores G. Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics 2013; 131:e152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/53\">",
"      Yanovski JA, Cutler GB Jr. Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 1994; 23:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/11/8378/abstract/54\">",
"      Reinehr T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 2006; 91:3088.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5861 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-190.81.197.98-74C7246191-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8378=[""].join("\n");
var outline_f8_11_8378=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Review of systems",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Family history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Psychosocial history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - General appearance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Blood pressure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Stature",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Head, eyes, throat",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Skin and hair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Abdomen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Musculoskeletal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Genitourinary",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Development",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1947276\">",
"      - Suggested tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30873013\">",
"      - Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Radiographic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      INDICATIONS FOR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5861\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5861|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?16/34/16928\" title=\"algorithm 1\">",
"      Management plan by BMI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5861|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/56/20366\" title=\"figure 1\">",
"      Prevalence obesity children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/23/38257\" title=\"figure 2A\">",
"      CDC BMI for age boys 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/2/40993\" title=\"figure 2B\">",
"      CDC BMI for age girls 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/0/1025\" title=\"figure 3\">",
"      Determining BP cuff size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/17/43288\" title=\"figure 4\">",
"      Abnormal growth in a child with Cushings disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5861|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/30/31215\" title=\"picture 1\">",
"      Papilledema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/7/3198\" title=\"picture 2A\">",
"      Acanthosis nigricans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/40/17026\" title=\"picture 2B\">",
"      Acanthosis nigricans on neck",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5861|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/28/459\" title=\"table 1\">",
"      Calculation of BMI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/23/9596\" title=\"table 2A\">",
"      Healthy weight nutrition tips A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/40/2701\" title=\"table 2B\">",
"      Healthy weight nutrition tips B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/55/22396\" title=\"table 3A\">",
"      Low-fat low-sugar guide A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/0/2060\" title=\"table 3B\">",
"      Low-fat low-sugar guide B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/21/2398\" title=\"table 3C\">",
"      Low-fat low-sugar menus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/10/16556\" title=\"table 4\">",
"      Healthy weight exercise tips",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/14/19692\" title=\"table 5\">",
"      Healthy weight parent tips",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/47/766\" title=\"table 6\">",
"      Dietary counseling tips",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/24/23949\" title=\"table 7A\">",
"      Genetic syndromes associated with obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/4/8268\" title=\"table 7B\">",
"      Single gene defects associated with obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/18/27950\" title=\"table 8\">",
"      Nutrition assessment in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/21/29019\" title=\"table 9\">",
"      Physical activity assessment in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/50/27436\" title=\"table 10\">",
"      Drugs that cause weight gain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/53/2909\" title=\"table 11\">",
"      ROS overweight child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/51/6973\" title=\"table 12\">",
"      Physical findings in obese children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/45/7894\" title=\"table 13\">",
"      Normal BP boys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/46/7910\" title=\"table 14\">",
"      Normal BP girls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/39/18045\" title=\"table 15\">",
"      Assessment for weight-related comorbidities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/46/40683\" title=\"table 16\">",
"      Screening for type 2 diabetes mellitus in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/51/43836\" title=\"table 17\">",
"      NHLBI pediatric definition of lipid levels",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?35/14/36070?source=related_link\" title=\"calculator 1\">",
"      Calculator: Body Mass Index (BMI) percentiles for boys (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?34/60/35782?source=related_link\" title=\"calculator 2\">",
"      Calculator: Body Mass Index (BMI) percentiles for girls (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?9/15/9463?source=related_link\" title=\"calculator 3\">",
"      Calculator: Blood pressure percentiles for boys (2 to 17 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?9/33/9751?source=related_link\" title=\"calculator 4\">",
"      Calculator: Blood pressure percentiles for girls (2 to 17 years)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=related_link\">",
"      Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/56/13192?source=related_link\">",
"      Clinical manifestations and diagnosis of central nervous system tumors in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38661?source=related_link\">",
"      Clinical manifestations and diagnosis of obesity hypoventilation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=related_link\">",
"      Comorbidities and complications of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17113?source=related_link\">",
"      Definition and diagnosis of hypertension in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/17/281?source=related_link\">",
"      Definition and screening for dyslipidemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=related_link\">",
"      Definition, etiology, and evaluation of precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=related_link\">",
"      Definition; epidemiology; and etiology of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=related_link\">",
"      Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=related_link\">",
"      Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=related_link\">",
"      Eating disorders: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=related_link\">",
"      Epidemiology and clinical manifestations of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/25/4506?source=related_link\">",
"      Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=related_link\">",
"      Evaluation of suspected obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17417?source=related_link\">",
"      Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18378?source=related_link\">",
"      Management of childhood obesity in the primary care setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/63/12282?source=related_link\">",
"      Management of pediatric dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6760?source=related_link\">",
"      Measurement of body composition in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=related_link\">",
"      Normal growth patterns in infants and prepubertal children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=related_link\">",
"      Normal puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=related_link\">",
"      Pathogenesis of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/30/23010?source=related_link\">",
"      Patient information: My child is overweight (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23209?source=related_link\">",
"      Slipped capital femoral epiphysis (SCFE)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19943?source=related_link\">",
"      The pediatric physical examination: General principles and standard measurements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=related_link\">",
"      Treatment of vitamin D deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=related_link\">",
"      Vitamin D insufficiency and deficiency in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_11_8379="Glucose transporters";
var content_f8_11_8379=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F67470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F67470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Glucose transporters",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <strong>",
"         Intestine, kidney",
"        </strong>",
"        : energy-dependent sodium/glucose co-transporters",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Other cells:",
"        </strong>",
"        diffusion via GLUTs 1 to 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GLUT-1: All human tissues; high affinity; basal glucose uptake; central nervous system, vessels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        GLUT-2: Beta cells, liver; low-affinity; post-prandial action",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GLUT-3: All tissues; major transporter in neurons of central nervous system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GLUT-4: Skeletal muscle, fat cells; insulin stimulates translocation from cytosol to cell membranes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GLUT-5: Brush border of intestinal cells, liver, spermatozoa; primarily transports fructose",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8379=[""].join("\n");
var outline_f8_11_8379=null;
var title_f8_11_8380="Assessment of activity RA";
var content_f8_11_8380=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F76890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F76890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Assessment of disease activity in rheumatoid arthritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Duration of morning stiffness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain score (visual analogue scale)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fatigue - severity (visual analogue scale)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient's global score of disease activity (visual analogue scale)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Physical examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Number of swollen joints",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Number of tender joints",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Degree of swelling and/or tenderness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Extra-articular disease:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Minor nodules, episclertis, pure sensory neuropathy, pleruropericardial disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Major vasculitis, Felty's syndrome, motor neuropathy, interstitial lung disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Laboratory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated erythrocyte sedimentation rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased C-reactive protein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia (in the absence of chronic blood loss or hematuria)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leukocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal liver function tests (low albumin, raised alkaline phosphate) in the absence of drug toxicity or liver disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammatory joint fluid (high polymorph count, low complement, fibrin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Imaging",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low bone mineral density (juxta-articular, vertebrae, pelvis) in absence of glucocorticoid therapy or known cause",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8380=[""].join("\n");
var outline_f8_11_8380=null;
var title_f8_11_8381="Allergic rhinitis treatments during breastfeeding";
var content_f8_11_8381=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F58772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F58772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Therapies for allergic rhinitis in lactating women",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug category",
"       </td>",
"       <td class=\"subtitle1\">",
"        Amount passed to infant in breastmilk",
"       </td>",
"       <td class=\"subtitle1\">",
"        Conclusions about maternal use during breastfeeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intranasal glucocorticoid sprays",
"        <br/>",
"        (budesonide preferred)",
"       </td>",
"       <td>",
"        Minimal",
"       </td>",
"       <td>",
"        Compatible",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Second generation oral antihistamines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cetirizine",
"       </td>",
"       <td>",
"        Minimal to small amounts",
"       </td>",
"       <td>",
"        Large doses or prolonged use may cause sedation in nursing infant; may decrease milk supply if combined with a sympathomimetic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Loratadine",
"       </td>",
"       <td>",
"        Minimal to small amounts",
"       </td>",
"       <td>",
"        Compatible but might reduce milk supply if combined with a sympathomimetic such as pseudoephedrine",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Antihistamine nasal sprays",
"       </td>",
"       <td>",
"        Minimal",
"       </td>",
"       <td>",
"        Probably compatible; use intranasal steroid preferentially",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Oral decongestants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pseudoephedrine",
"       </td>",
"       <td>",
"        Passes into milk",
"       </td>",
"       <td>",
"        Use short-acting preparations only and take just after breastfeeding to minimize amount entering milk. Use intranasal steroid preferentially for persistent congestion; topical vasoconstrictor nasal spray for therapy of less than four days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Phenylephrine",
"       </td>",
"       <td>",
"        Little information available",
"       </td>",
"       <td>",
"        Not recommended",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Cromolyn nasal spray",
"       </td>",
"       <td>",
"        Insignificant",
"       </td>",
"       <td>",
"        Compatible",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Leukotriene receptor antagonists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Montelukast",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"       <td>",
"        Use only if other compatible agents not sufficient and symptoms are significant; avoid in newborn or preterm infant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Zafirlukast",
"       </td>",
"       <td>",
"        About 20 percent",
"       </td>",
"       <td>",
"        Use only if other compatible agents not sufficient and symptoms are significant; avoid in newborn or preterm infant",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Ipratropium nasal spray",
"       </td>",
"       <td>",
"        Unknown; maternal serum levels are negligible and milk levels will be very low, if at all; any drug in milk would not be absorbed by the infant",
"       </td>",
"       <td>",
"        Probably compatible",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The US Food and Drug Administration has developed a drug classification system consisting of five pregnancy precaution categories, A, B, C, D, and X; no similar classification exists for lactation. No rhinitis medication meets the requirements for pregnancy category A: well controlled human studies show no risk for the developing child. There are several rhinitis drugs within category B, for which either animal studies show no fetal risk and human studies are unavailable, or animal studies show a risk but human studies have not.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Incaudo AF, Takach P. The diagnosis and treatment of allergic rhinitis during pregnancy and lactation. Immunol Allergy Clin N Am 2006; 26:137.",
"       </li>",
"       <li>",
"        Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 9th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2011.",
"       </li>",
"       <li>",
"        LactMed: United States National Library of Medicine.",
"        <a href=\"file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT\" target=\"_blank\">",
"         file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT",
"        </a>",
"        .",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8381=[""].join("\n");
var outline_f8_11_8381=null;
var title_f8_11_8382="Prevalence arrhythmias pregnancy congenital heart disease";
var content_f8_11_8382=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 511px\">",
"   <div class=\"ttl\">",
"    Prevalence of arrhythmias during pregnancy in women with congenital heart disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 491px; height: 317px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AOS: aortic stenosis; ASD: atrial septal defect; AVSD: atrioventricular septal defect; CC-TGA: congenital corrected transposition of the great arteries; CHD: congenital heart disease; PAVSD: pulmonary atresia with ventricular septal defect; TGA: transposition of the great arteries; TOF: tetralogy of Fallot.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49:2303.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8382=[""].join("\n");
var outline_f8_11_8382=null;
var title_f8_11_8383="Bx solid lesions";
var content_f8_11_8383=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 491px\">",
"   <div class=\"ttl\">",
"    Tissue biopsy algorithm for solid lesions, indeterminate or suspicious",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 471px; height: 516px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LCIS: lobular carcinoma in situ.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Esserman, L, et al. Current Oncology Reports 2000; 2:572.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_11_8383=[""].join("\n");
var outline_f8_11_8383=null;
